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Abstract  
 
 
Reducing medication wastage is a paramount objective in promoting appropriate 
utilisation of finite resources and preventing negative consequences. The aim of this 
research was to investigate aspects of medication wastage in Malta by applying 
mixed methods research and, by doing so, contribute original knowledge to this 
area.  
 
A systematic review was conducted to appraise critically, synthesize and present the 
available evidence on the possible causative factors associated with medication 
wastage and the effectiveness of any interventions focusing on wastage reduction 
as an outcome measure. Findings indicated that only one published paper reported 
a definition of medication wastage. The main factors contributing to wastage were 
‘change in medication’, ‘patient's death’, ‘resolution of patient's condition’ and 
‘passed expiry date’. Very few studies reported medication wastage as an outcome 
measure.  
 
The Delphi technique was applied to define ‘medication wastage’ and its 
contributory factors in the context of the Maltese population. A definition for 
medication wastage was generated with 86% of panellists agreeing/totally agreeing 
and sixty-one possible factors leading to wastage were identified by the panellists. 
 
The perspectives of the Maltese population, healthcare professionals and students 
on medication wastage were investigated through cross-sectional surveys. Results 
of questionnaires indicate lack of patient education and knowledge with the free 
healthcare system and the overstocking of medication by patients due to previous 
or potential out of stock situations as contributors to medication wastage.  
 
The beliefs and behaviours regarding medication wastage of the Maltese public and 
healthcare professionals were explored during focus groups. The theoretical 
domains framework was adopted to design the focus group guide and to interpret 
  iv 
 
systematically the findings. Five key themes emerged which were proposed as 
solutions to minimise medication wastage: system effects, practitioner effects, 
patients effects, political effects and awareness and educational effects 
 
Research results and findings from all four phases will facilitate the systematic 
development of strategies and policies, with emphasis on prioritisation, with the aim 
of minimising medication wastage at all levels.  
 
Keywords: Awareness, Delphi technique, focus groups, medication wastage, 
systematic review, theoretical domains framework. 
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“If we knew what it was we were 
doing, it would not be called 
research, would it?” 
Albert Einstein 
[Theoretical physicist and philosopher of 
science 
1879-1955] 
 
Chapter 1: Introduction  2 
 
Introduction 
 
 
This chapter commences with an overview of healthcare provision in Malta and 
legislation and practice relating to prescribing and supply of medication, prior to 
detailing the issue of medication wastage in the Maltese and international 
context. An overview of the development and evaluation of complex 
interventions is provided and the research aims stated. The term 'medication' is 
used throughout this PhD in preference to ‘medicine’ to prevent any 
misunderstanding between ‘medicine’ as it relates to pharmaceutical products 
and the clinical practice of medicine. 
 
1.1 The Republic of Malta 
The Republic of Malta is a southern European island country consisting of three 
main islands, Malta, Gozo and Comino, forming an archipelago in the middle of 
the Mediterranean Sea (Figure 1.1). Malta is one of the smallest and most 
densely populated countries of 316 square kilometres with a population of 
421,364 based on the 2012 census (National Statistics Office, 2013). Malta is 
divided into six districts: 1) Southern harbour, 2) Northern harbour, 3) South 
eastern, 4) Western, 5) Northern and, 6) Gozo and Comino, comprising a total of 
68 localities. 
 
 
Figure 1.1: The Maltese Islands [Source: Azzopardi Muscat et al., 2014] 
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Malta obtained independence from Great Britain in 1964 and became a republic 
in 1974. A liberal parliamentary democracy, Malta holds elections every five 
years to elect a unicameral parliament made up of 65 representatives. The 
President is the head of state, while the head of Government is the Prime 
Minister, who is the leader of the party with the electoral majority. Accession to 
the European Union (EU) in May 2004 has largely dominated the political agenda 
in recent years. Malta is also a member of international organizations including 
the North Atlantic Treaty Organization Partnership for Peace, the United Nations 
and the World Trade Organization (Azzopardi Muscat et al., 2014). 
 
1.2 The Healthcare system in Malta 
The healthcare system in Malta is based upon the Beveridge 'public' model, 
whereby funding for the system is provided mainly through taxation and is 
distinguished from other models of healthcare by a centrally organized National 
Health Service (NHS) (PwC, 2012). The Ministry for Health is responsible for the 
provision of healthcare services to all persons residing in Malta who are covered 
by Maltese social security legislation and is also responsible for the provision of 
health services regulation and standards. The public funded healthcare system 
also provides services to groups such as irregular immigrants and foreign 
workers who are in possession of valid work permits. To a lesser extent, private 
financing through ‘out-of-pocket’ expenditure and health insurance complement 
the current system (Azzopardi Muscat et al., 2014). 
 
Primary care is readily accessible, with free of charge health services at the point 
of delivery, as well as private general practitioners (GPs) who provide 
independent services. Public and private hospitals provide secondary and tertiary 
care, with Mater Dei Hospital being the main general hospital on the island. 
Figure 1.2 depicts the financial flow sustaining the healthcare system in Malta, 
which is proving to be a challenge in ensuring sustainability in view of an ageing 
population, rising citizens’ expectations and the rising costs of medication 
(Azzopardi Muscat et al., 2014). 
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Figure 1.2: Financial flow chart sustaining the healthcare system in Malta [Adapted from Azzopardi Muscat et al., 2014] 
Governmental financing 
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Annual Government 
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Practitioners 
Ambulatory 
specialities 
Acute hospitals 
Non-EU Nationals 
paying for health 
services 
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Private financing system 
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1.2.1 Medication supply in Malta 
Medication in Malta is either supplied to the patient against payment, as 
illustrated in Figure 1.3 or else provided free of charge by the government as 
shown in Figure 1.4. Prescription and over-the-counter (OTC) medication can be 
obtained at direct cost to the individual from a private community pharmacy or 
obtained free of charge from government pharmacies or from private pharmacies 
through the ‘Pharmacy of Your Choice’ (POYC) scheme. This is a government 
subsidised service introduced in 2009 to facilitate patients’ access to free 
medication.  
 
The system for obtaining free of charge medication in Malta is complex. A list of 
prescribed and OTC medication which can be obtained free of charge from 
government pharmacies or POYC is found within a Government Formulary List 
(GFL) which is available online (Ministry for Health, 2014a). The GFL also lists 
medical conditions for which patients may obtain specific medication. Patients 
requiring free of charge medication on an out-patient basis must be in 
possession of a valid entitlement card, as shown in Figure 1.4. The annual 
expenditure on medication supplied free of charge is approximately 69 million 
Euro (The Times of Malta, 2012a). There are currently around 1,300 medication 
which can be supplied free of charge via the GFL (Ministry for Health, 2014a). 
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* Legal Notice 22, 1985 
 
Figure 1.3: Medication supplied to patient against payment from a private community pharmacy 
 
 
Medication supply against 
payment 
[from private community 
pharmacy] 
Prescription only medication Non-prescription medication 
Prescription for narcotic & 
psychotropic medication 
[seventh schedule ‘green’ 
prescription valid for one 
month + valid control 
card]* 
Prescription for antibiotics 
[valid for 10 days] 
Prescription for other 
medication: 
1. One-time prescription 
OR 
2. Repeat prescription 
valid for 6 months 
OTC 
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Figure 1.4: Medication provided free of charge to patient from government pharmacies or POYC
Medication supply free of 
charge 
[from government 
pharmacies or POYC] 
Prescription needed for both 
‘prescription only medication’ and 
‘non-prescription medication’ 
Prescription for narcotic & 
psychotropic medication 
[seventh schedule ‘green’ 
prescription valid for one 
month + valid control 
card] 
Prescription for other 
medication 
[one-time prescription:  
maximum supply of 2 
months] 
Apart from a valid entitlement 
card, the patient must also 
have a valid medication 
approval for some GFL 
medication 
Patient must have one of the 
following entitlement cards: 
1. Schedule V ‘yellow’ card 
for government approved 
chronic condition 
2. Schedule II ‘pink’ card 
approved in view of limited 
financial means 
3. Schedule II ‘pink’ card 
approved for patients with 
diabetes 
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1.3 Medication wastage: The international scenario 
According to the World Health Organization (WHO) global estimates published in 
2004, more than half of all medication is inappropriately prescribed, dispensed or 
sold with a resultant “wastage of scarce resources and widespread health hazards” 
(World Health Organization, 2004a). A study commissioned by the Department of 
Health (DoH) in England in 2009, which explored the scale and cost of medication 
wastage, concluded that direct costs of unused prescription medication to the NHS 
amounted to £300 million annually (York Health Economics Consortium and School 
of Pharmacy University of London, 2010). 
 
In 2011, the DoH in England recruited a group of patients, healthcare professionals 
(HCPs), representatives of NHS organizations and the pharmaceutical industry to 
consider these findings and to identify measures to minimise wastage, optimise 
medication taking and improve health outcomes. The DoH Medicines Pharmacy and 
Industry Group subsequently issued a report ‘Making Best Use of Medicines’, stating 
that “wastage of medicines involves a wide range of different stakeholders who all 
have a contribution to make to reducing its occurrence and improving quality of 
care” (Department of Health Medicines Pharmacy and Industry Group, 2011, p.6). 
 
White (2010) reviewed aspects of the published literature on medication wastage, 
focusing on estimated costs of medication returned to community pharmacies 
following patient death. Net ingredient costs of medication and pharmacy costs (i.e. 
dispensing fees and associated allowances) were assigned at individual patient and 
national levels. Extrapolated data indicated that, at 2007 prices, around one quarter 
of the total cost of the medication left behind following death was likely to be 
equivalent to the total pharmacy costs attributed to dispensing. Acknowledging the 
limitations and assumptions of the economic modelling, White concluded that the 
unnecessary spending on pharmacy charges has the potential to outstrip the 
estimated cost of wastage in the United Kingdom (UK) and that there is an urgent 
need to examine the cost-effectiveness of interventions aiming to reduce wastage. 
 
 
 Chapter 1: Introduction  9 
 
1.4 Medication wastage: The Maltese scenario 
The scale of medication wastage has been voiced at the highest of political levels in 
Malta. In an article published in the popular press in Malta in April 2012, the Health 
Minister expressed concern about medication wastage, urging “people to act 
responsibly and to keep in mind that although medicines were given to them free of 
charge, they were an investment by the government” (Times of Malta, 2012a). It 
was noted that “80 different types of medicine worth around €10,000” had been 
returned to government pharmacies by members of the public during a three month 
period. The Health Minister stated that “this was likely to be only the tip of the 
iceberg, since many people kept unused medicine at home”.  Shortage of 
medication on the NHS formulary was highlighted by the shadow Health Minister as 
a contributory factor, "on the other hand, about 632 different medicines were out of 
stock in 2011. In simple words: shortages lead to hoarding, and hoarding leads to 
unused medicine” (Maltatoday, 2012).  
 
Later that year,  it was reported that “just over €29,500 worth of medicines was 
retrieved from pharmacies in Gozo last month after serious doubts arose as to the 
ambience in the contractor’s carriage of the medicines” (Times of Malta 2012b). It 
was further noted that “in June there had been €893.32 worth of expired or 
damaged medicines retrieved, as well as €439.72 worth of medicines for 
redistribution to other pharmacies”. The following year, the popular press detailed a 
report revealing 455,000 Euro of expired medication at the Oncology and 
Dermatology Hospital in Malta (Calleja, 2013). It should, however, be noted that 
these data have not been scientifically validated and the results have not been 
published in peer reviewed journals or conference presentations. 
 
In April 2014 the Times of Malta issued findings of a survey study carried out by 
WasteServ (the company responsible for waste management on the Maltese 
islands) which concluded that only one tenth of the Maltese population disposed of 
expired medication and syringes appropriately. WasteServ also added that funds will 
be sought from the EU to launch a nationwide awareness campaign regarding the 
civic amenity sites and hazardous waste (Times of Malta, 2014). In September 
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2014, the Times of Malta reported that three tonnes of medication had been 
disposed of in civic amenity sites (Micallef, 2014). 
 
1.5 Laws, directives and policies relating to medication 
wastage 
The EU directive 2008/98/EC of the European Parliament and of the Council of 19 
November 2008 on waste states that ‘waste' refers to “any substance or object 
which the holder discards or intends or is required to discard” (Directive 
2008/98/EC, 2008, p.9). The focus of this directive is on management strategies on 
issues such as disposal and recycling, with lack of guidance focusing specifically on 
medication. The Medicines Act of Malta (Malta Government Gazette, 2003, p.A205) 
enacted by the Parliament of Malta legislates in terms of the “manufacture, 
preparation and assembly, wholesale distribution, storage, destruction, disposal, 
advertising and authorisation of medicinal products and any activity connected 
therewith and the regulation of the sale of medicinal products, pharmacies and 
related pharmaceutical activities and for any other matters ancillary thereto or 
connected therewith”. While this Act prohibits the sale of expired or damaged 
medication, it provides little guidance on the handling of medication wastage and no 
guidance at all on minimising wastage.  
 
The Environment and Development Planning Act, under the force of the Malta 
Environment and Planning Authority, issued waste regulations in 2011 (Environment 
and Development Planning Act, 2011). ‘Healthcare waste’ includes medication, 
categorised as: generated by a pharmacy or a medical, nursing, dental, or 
veterinary practice within their own premises; or returned from households or by 
individuals pending disposal at a pharmacy, or any other authorised facility. This Act 
provides detail only of the maximum amount and duration of storage of wastage.  
 
Following the accession of Malta into the EU, the Ministry for Resources and Rural 
Affairs (2009) prepared a National Waste Management Plan strategy stipulating a 
number of implementation aspects to be addressed but with no consideration of 
medication.  
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1.6 Development and evaluation of complex interventions 
From the above, it is clear that there is a need to reduce medication wastage in 
Malta and elsewhere. It is likely that such interventions will be complex. Complex 
interventions are defined by the Medical Research Council (MRC) as “interventions 
with several interacting components” (Medical Research Council, 2008, p.7). The 
dimensions of complexity can be multiple, such as the:  
• “number of and interactions between components within the experimental and 
control interventions 
• number and difficulty of behaviours required by those delivering or receiving the 
intervention 
• number of groups or organizational levels targeted by the intervention 
• number and variability of outcomes 
• degree of flexibility or tailoring of the intervention permitted”. 
 
The MRC highlights a number of implications for development and evaluation of 
complex interventions and emphasises the need for a good theoretical 
understanding of how an intervention could bring about change. The key elements 
of the development and evaluation process are illustrated in Figure 1.5.  
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Figure 1.5: Elements of the development and evaluation process [Source: Medical 
Research Council, 2008] 
 
The development of a complex intervention should be based on relevant, existent 
evidence such as that identified through a systematic review. This is then followed 
by the development of a theoretical understanding of the potential process of 
change, through the use of evidence and theory, supplemented by new primary 
research. Feasibility and piloting methods are essential to determine acceptability of 
an intervention, likely rates of recruitment and retention of subjects and to calculate 
sample sizes. A systematic process of evaluation is then needed to identify 
implementation problems and ensure successful implementation of interventions. 
Evaluation of complex interventions should include the effectiveness of the 
intervention in everyday practice and should establish how the particular 
intervention exerts its effect. An economic evaluation should be included if possible 
to assess cost-effectiveness (Medical Research Council, 2008).  
Feasibility/piloting 
1. Testing procedures 
2. Estimating recruitment/retention 
3. Determining sample size 
Evaluation 
1. Assessing effectiveness 
2. Understanding change process 
3. Assessing cost-effectiveness 
Development 
1. Identifying the evidence base 
2. Identifying/developing theory 
3. Modelling process and outcomes 
Implementation 
1. Dissemination 
2. Surveillance and monitoring 
3. Long term follow-up 
 Chapter 1: Introduction  13 
 
This doctoral research focuses on the initial stages of the development of a complex 
intervention. 
 
1.7 Research aims 
The overall aim of this research was to investigate aspects of medication wastage in 
Malta by applying mixed methods research.  
 
The research was conducted in four phases, each with aims leading from one phase 
to the other as described below: 
 
Phase 1: to appraise critically, synthesize and present the available evidence on the 
possible causative factors associated with medication wastage in all populations and 
settings and the effectiveness of any interventions focusing on wastage reduction as 
an outcome measure.  
 
Phase 2: to apply the Delphi technique to define ‘medication wastage’ and its 
contributory factors in the context of the Maltese population.  
 
Phase 3: to investigate issues of awareness, perceptions, attitudes and behaviours 
regarding medication wastage amongst the Maltese population, HCPs and respective 
students.  
 
Phase 4: to describe and understand the beliefs and behaviours regarding 
medication wastage of the Maltese public and HCPs and to explore potential 
solutions to reduce medication wastage.  
 
Specific research questions for each phase will be described in each corresponding 
chapter. 
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Chapter 2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Philosophy is common sense with 
big words”  
James Madison 
[Statesman, political theorist and the 
fourth President of the US  
1751-1836] 
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Methodology  
 
 
This chapter reviews the research philosophy, methodology and methods that 
were applied throughout this research. The processes of data collection and 
generation, sampling and analysis are described along with justification for the 
choice of specific approaches. 
 
2.1 The research process 
Four philosophical dimensions distinguish research paradigms (Creswell and 
Plano Clark, 2011; Wahyuni, 2012). These fundamental beliefs, which influence 
how researchers conduct and report their inquiries, are namely:  
1. Ontology, which is the view of how one perceives reality (Wahyuni 2012);  
2. Epistemology, which is the theory of knowledge that is embedded in the 
theoretical perspective, also referred to as philosophical paradigm (Crotty 
2005); 
3. Axiology, which is concerned with ethics and the role of values in research 
and the researcher’s stance (Wahyuni 2012);  
4. Methodology, which is the strategy, plan of action, process or design lying 
behind the choice and use of particular methods and linking the choice and 
use of methods to the desired outcomes (Crotty 2005). 
 
Crotty (2005) describes the research process in terms of four basic elements, 
one leading to the other: epistemology, theoretical perspective, methodology 
and methods (Figure 2.1). The theoretical perspective is the philosophical stance 
informing the methodology and thus providing a context for the process and 
grounding its logic and criteria. Methods are the techniques or procedures used 
to gather and analyse data related to the research question or hypothesis 
(Crotty, 2005; Feast and Melles, 2010).  
 
There are three distinct epistemological positions: objectivism that asserts that 
social entities exist in a reality which is independent or external to consciousness 
and experience, constructivism which follows a belief that different individuals 
construct meaning in different ways, even in relation to the same phenomena 
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and subjectivism which is the understanding of meanings that individuals attach 
to social phenomena (Crotty, 2005).  
 
 
 
  Objectivism        Positivism       Experimental research     Sampling 
  Constructivism       Interpretivism       Survey research     Statistics 
  Subjectivism       Transformatism       Ethnography     Questionnaire 
         Pragmatism       Phenomenology              Observation  
            Grounded theory     Interview 
            Heuristic inquiry     Focus group 
            Action research    etc. 
            Discourse analysis         
            etc. 
Figure 2.1: The research process [Adapted from Crotty, 2005]  
 
2.1.1 Theoretical perspectives: Philosophical paradigms 
Guba and Lincoln (1994, p.105) define paradigm as a “basic belief system or 
world view that guides the investigation”. The term was originally described by 
Kuhn in 1962 (Kuhn, 1962), who later gave a more precise explanation of this 
general concept (Kuhn, 1970). Morgan (2007) described four different meanings 
of paradigms, namely: worldviews, epistemological stances, shared beliefs 
amongst members of a specialty area and model examples of research. Four 
distinct philosophical paradigms are identified; each of them relating to different 
epistemological and ontological positions, and are described below. 
 
2.1.1.1 Positivist paradigm 
A positivist paradigm maintains that reality is concrete and objectivity is 
achievable through rigorous methodology, assuming that reality is constant 
(Broom and Willis, 2007). A positivist stance presumes that knowledge is 
politically and socially neutral and can be obtained with quantitative precision 
through an accumulation of facts that build a close approximation to a reality 
that exists independently of human perception (Rubin and Rubin, 2012). Post-
positivism is an offshoot of positivism and a reaction to it. However, to some 
extent, post-positivists seem less sure than classical positivists that one can 
Epistemology Theoretical 
perspectives Methodology 
Methods 
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separate the knower from the known and that there is a single shared reality 
which excludes all others (Rubin and Rubin, 2012). In fact, O'Leary (2004) 
describes post-positivists as seeing the world as ambiguous, variable and 
multiple in its realities, which aligns to some extent with the constructivist 
paradigm (O'Leary, 2004).  
 
2.1.1.2 Interpretevist/Constructivist paradigm 
O’Leary (2004) distinguishes between ‘interpretivism’ as the acknowledgement 
and exploration of the cultural and historical interpretations of the social world 
and ‘constructivism’ which claims that meaning does not exist in its own right but 
is constructed by human beings as they interact and engage in interpretation. 
Therefore, interpretivists/constructivists claim that truth is relative and that it is 
subject to one’s perspective (Baxter and Jack, 2008). Within the interpretive 
constructionism paradigm, the core knowledge is the understanding of what 
people make of the world around them, how people interpret what they come 
across, and how they assign meanings and values to events or objects (Rubin 
and Rubin, 2012). The interpretevist/constructivist ontological view of the world 
is advocated by qualitative researchers (Broom and Willis, 2007). Therefore, they 
are focused less on generalizability or external validity and more on the degree 
to which the data accurately represent attitudes, perceptions and views of the 
population being studied (Broom and Willis, 2007). 
 
2.1.1.3 Advocacy/participatory/transformative paradigm 
The advocacy and participatory (later referred to as transformative) stance is 
reported to have emerged during the 1980s and 1990s through critiques which 
considered that the positivist paradigm imposed structural laws and theories that 
did not fit marginalized individuals in society or issues of social justice that 
needed to be addressed (Creswell, 2014). Inquirers moreover considered that 
the constructivist stance did not go far enough in advocating for an action 
agenda. The latter is contained in the advocacy/participatory research to help 
marginalized individuals. The advocacy/participatory stance find reality as always 
being negotiated and cast within a political context (Creswell, 2014). This 
perspective may utilise qualitative and quantitative approaches (Mackenzie and 
Knipe, 2006) although it is more often associated with qualitative approaches 
(Creswell, 2014).  
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2.1.1.4 Pragmatic paradigm 
Pragmatism is not committed explicitly to any one philosophy or reality 
(Mackenzie and Knipe, 2006). The pragmatic paradigm views reality as both 
singular (positivist) as well as multiple (constructivist) (Creswell and Plano Clark, 
2011). Pragmatism is typically associated with mixed methods research, thus 
integrating the strengths of both methodologies (Onwuegbuzie and Leech, 2005; 
Creswell, 2014). Pragmatists do not view the world as an absolute unity but 
assume different worldviews and assumptions and utilise multiple methods and 
different forms of data collection and analysis (Creswell, 2014). For the 
pragmatist, contributory facts are a matter of degree, with some more true than 
the others. The pragmatic researcher rejects traditional dualisms such as 
subjectivism versus objectivism and favours rational versions of philosophical 
dualisms based on how well they work in unravelling problems (Johnson and 
Onwuegbuzie, 2004).  
 
2.1.2 Overall philosophical paradigm in current research 
This doctoral research was conducted in four phases: systematic review of the 
literature (chapter 3), consensus-based technique (chapter 4), quantitative, 
cross-sectional survey study (chapter 5) and qualitative focus groups (chapter 
6). A pragmatic stance was therefore adopted, employing mixed methodologies 
and methods as described below. 
 
2.2 Quantitative versus qualitative methodologies 
Quantitative methodological approaches are most commonly aligned with the 
positivist stance (Mackenzie and Knipe, 2006). These generate numerical data 
that are measured in a strictly objective way and described by a set of rules or 
formulae. Common methodologies that utilise a positivist paradigm include: 
• Descriptive research which explores and describes phenomena in real-life 
situations to determine meanings and frequencies of the phenomenon under 
investigation, and describe and categorise information related to the 
phenomenon (Burns and Grove, 2011) 
• Correlational research which explores relationships between variables to 
determine the degree of relationship between the two variables without 
introducing an intervention (Walker, 2005; Burns and Grove, 2011) 
 Chapter 2: Methodology   19 
 
• Causal research which refers to experimental research designs whereby the 
researcher manipulates an independent variable and observes the outcome on 
a dependent variable whilst keeping other unrelated variables constant 
(Walker, 2005). 
 
Qualitative methodological approaches accentuate the importance of multiple 
subjective realities whilst exploring the psychological approach of human 
behaviour (Sahu, 2013) and are a means of capturing lived experiences of 
groups and individuals (Nagy Hesse-Biber, 2010). Common methodologies that 
utilise an interpretivist paradigm include:  
• Phenomenology which provides an in-depth understanding of the distinctive 
lived experience of individuals by exploring the meaning of a phenomenon 
(Petty et al., 2012) 
• Ethnography which describes and interprets human cultures using methods 
such as participant-observation or interviews with the aim of getting an in-
depth understanding of a particular culture (Teddlie and Tashakkori, 2009) 
• Grounded theory which attempts to develop a theory constructed from the 
data of participants with an experience of the phenomena under investigation, 
to explain these phenomena (Petty et al., 2012b) 
• Case study which explores a case (or multiple cases) through in-depth data 
collection involving multiple sources of information rich in context (Baxter and 
Jack, 2008) 
• Narrative research which relates to spoken or written text of a single event or 
a series of events which are chronologically connected (Czarniawska, 2004). 
 
2.3 Mixed methods methodology 
The pragmatic philosophy of mixed methods research is a methodological 
approach to knowledge that strives to consider multiple viewpoints, perspectives, 
positions, and standpoints (Johnson et al., 2007). In an attempt to define mixed 
methods research through discussion with several leaders in the field, Johnson et 
al. (2007, p.129) described mixed methods research as: 
 
“an intellectual and practical synthesis based on qualitative and quantitative 
research; it is the third methodological or research paradigm (along with 
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qualitative and quantitative research). It recognizes the importance of traditional 
quantitative and qualitative research but also offers a powerful third paradigm 
choice that often will provide the most informative, complete, balanced, and 
useful research results.” 
 
2.4 Quantitative versus qualitative methods 
As highlighted earlier, quantitative methods produce numerical data which are 
analysed and are typically deductive in nature. Data may be collected to test a 
hypothesis, resulting in accepting or rejecting the null hypothesis of no difference 
(Johnson and Onwuegbuzie, 2004). Qualitative methods generate data which are 
in a narrative form and the data are used to build theory, themes, or 
conclusions; thus inductive in nature (Teddlie and Tashakkori, 2009). Methods 
that utilise a positivist paradigm include epidemiological/analytical approach 
design strategies (such as randomized controlled trials and cross-sectional 
studies), survey research, secondary document analysis (such as content 
analysis), and systematic reviews that employ a meta-analysis design (Broom 
and Willis, 2007). Methods utilizing an interpretivist/constructivist paradigm 
include in-depth, semi-structured or unstructured interviews, participatory or 
non-participatory observational studies, focus groups and secondary discourse 
analysis (Broom and Willis, 2007). Table 2.1 summarises the two distinct 
research paradigms whilst Table 2.2 describes the methods as applied within this 
research. 
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Table 2.1: Summary of the distinct research paradigms [Petty et al., 2012] 
Characteristic Positivist view Interpretivist/ 
Constructivist view 
Ontology One objective truth exists There are many 
subjective truths and 
realities 
Epistemology Accepts what can be 
directly observed 
Understands multiple 
social constructs 
Knowledge Background knowledge 
and beliefs of the 
researcher influence what 
is observed 
Observation involves 
interpretation 
Research methods Quantitative (deductive) Qualitative (inductive) 
Research question Explicitly defined at the 
start 
Broad question refined 
throughout the study 
Research instrument Valid and reliable tools The researcher 
Study sample Detailed inclusion and 
exclusion criteria 
Purposive sample 
Data collection Measurable outcomes  Explore, describe and 
understand 
Variables Controlled Not controlled 
Data analysis Statistical tests following 
strict rules and 
procedures 
Iterative process; 
interpretation of words to 
gain understanding of 
phenomena 
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Table 2.2: Summary of the distinct research paradigms employed in this 
research 
Characteristic Positivist view Interpretivist/ 
Constructivist view 
Beliefs One objective truth exists There are many 
subjective truths and 
realities 
Research methods Quantitative (deductive) Qualitative (inductive) 
Research question Explicitly defined for 
Delphi and questionnaire 
phases in a research 
protocol 
Broad question refined 
throughout the study for 
focus groups 
Research instrument Questionnaires used 
during Delphi and cross-
sectional survey phases 
The researcher acting as 
a moderator using semi-
structured topic guide 
during focus groups 
Study sample Detailed inclusion and 
exclusion criteria 
Purposive sample (Delphi 
and focus groups) 
Data collection Measurable outcomes 
from Delphi (chapter 4) 
and questionnaire data 
(chapter 5) 
Descriptive and 
contextual from data 
generated through focus 
group discussions 
(chapter 6) 
Data analysis Statistical content 
analysis (chapter 4)and 
descriptive and 
inferential statistics 
(chapter 5)  
Framework approach 
(chapter 6) 
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2.5 Quantitative methods 
Two common types of quantitative data collection methods are through 
experimental research and cross-sectional research. An experimental research 
design assumes that the cases being studied can be manipulated by the 
researcher in order to measure a change or a difference (Matthews and Ross, 
2010). Therefore, the presence of a ‘control group’ is imperative in experimental 
research and thus could not be applied to this research. Cross-sectional research 
designs are associated with survey methods, which utilise sampling of 
participants (Matthews and Ross, 2010). A cross-sectional survey design was 
employed in the current research, as it is most appropriate for describing 
occurrences at a fixed point in time (Polit and Beck, 2008). 
 
2.5.1 Sampling and data analysis in quantitative research 
A representative sample is required to ensure that findings are generalizable, 
that is they can be widely applied outwith the specific study population (possess 
external validity). Random sampling ensures that each individual has an equal 
and fair chance of participating in the study (Newell and Burnard, 2011). 
Different types of random sampling exist. Table 2.3 describes different random 
sampling techniques and their advantages and disadvantages (Howitt and 
Cramer, 2011; Newell and Burnard, 2011).  
 
The survey study used simple random sampling to ensure that each member of 
the public and each practitioner from the HCP group had an equal chance of 
being selected. 
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Table 2.3: Random sampling techniques 
Random sampling Advantages Disadvantages 
Simple random sampling using 
random numbers which are typically 
computer generated 
Every individual or element studied has an 
equal chance of being selected 
Does not ensure that the sample is 
representative of the population from which 
the sample was taken (e.g. if biological sex 
in the population is 1:1 it might not be the 
case during simple random sampling) 
Stratified sampling which identifies 
sample numbers in proportions e.g. 
by biological sex would include both 
males and females proportionately 
Ensures that the sample is representative 
of the population from which the sample 
was taken for specific characteristics under 
investigation (e.g. gender) 
Relevant information about the 
characteristic under investigation is needed 
Cluster sampling which randomly 
selects participants from particular 
geographical areas 
Restricts the amount of time required to 
draw up sampling lists 
Less likely to be representative of the 
population because individuals within a 
cluster are likely to be more similar to one 
another and their behaviours may be 
influenced by the cluster 
Systematic sampling which uses 
fixed intervals in assigning 
participants to a study 
It is simpler to use with a printed list such 
as electoral registers; quicker than random 
sampling; people close together in the list 
will not be selected, thus avoiding couples 
or relatives 
Not completely random; if list is not 
sampled this will introduce biases; does not 
ensure that the sample is representative of 
the population from which the sample was 
taken 
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Quantitative data generate numerical information which can be analysed using 
different methods, which include (Moule and Goodman, 2014):  
• Descriptive statistics which organize numerical data to describe outcomes of 
study 
• Correlation coefficient which measures the strength of association between 
two variables 
• Tablets and charts to present exact and visual representation of figures 
respectively 
• Inferential statistics which use data to make generalisations 
 
Although content analysis is used to interpret data generated through open 
questions and thus seems qualitative in nature, it is considered to be a 
quantitative and systematic technique as it counts all the number of tangible and 
observable occurrences (codes) being studied. It is objective in terms of 
categorization using defined criteria. During content analysis, the researcher 
systematically codes, counts and analyses the content following an explicit, 
precise and replicable procedure (Treadwell, 2014). This technique was used in 
the data analysis of the open questions in the Delphi research in chapter 4 and 
the questionnaire phase (chapter 5). 
 
2.5.2 Cross-sectional study: mailed questionnaire survey 
A quantitative design, rather than a qualitative one, was chosen for the 
questionnaire phase of this research (chapter 5). A cross-sectional design 
utilising self-administered structured, postal questionnaires assessed awareness, 
perceptions, attitudes and behaviours. This specific approach was selected based 
on a number of factors: ability to collect large amounts of data in a short 
timescale (Mann, 2003); recruiting parts of the population that would be 
otherwise difficult to include (Owens, 2002), such as busy HCPs; and reduced 
cost. The survey approach employed a deductive approach within the positivist 
paradigm. 
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2.6 Qualitative methods 
In qualitative research designs data are predominantly linguistic. Conversation is 
the most frequent means of generating data, most commonly focus group 
studies, case studies and one-to-one in-depth interviews, followed by researcher 
observations (Jonker and Pennink, 2010). One-to-one interviews are suitable for 
obtaining individual biographies and provide the opportunity to research in-depth 
an individual's perspective. However, they are considered to be time-consuming 
(Matthews and Kostelis, 2011) and can be an intensive and intrusive experience 
(Frith and Gleeson, 2012). Direct observation is considered more suitable for 
studies of social roles and formal organizations (Kitzinger, 2006). Case studies 
are useful to explore variables and to bring about new ideas (Siggelkow, 2007), 
and the phenomena are explored within their real-life context (Yin, 2009). Case 
studies involve a full variety of evidence, including direct observation of the issue 
in question, one-to-one and group interviews, documents and artefacts (Yin, 
2009). Focus groups are a form of group interview that exploits discussion 
between research participants to generate data (Kitzinger, 2006). Through focus 
groups participants may acquire particular perspectives as a consequence of 
group interaction with others who share similar experiences. Focus groups are 
considered more appropriate when the researcher wishes to encourage 
participants to explore issues of importance to them, in their own language, and 
pursuing their own priorities. They are also suitable for exploring how opinions 
are developed (Kitzinger, 2006). 
 
2.6.1 Qualitative data collection: use of focus groups  
The last phase of this research used an interpretivist phenomenological 
methodology to explore the meaning of lived experiences of participating 
individuals in relation to medication wastage. Focus group discussion, as opposed 
to other qualitative methods, was chosen as the method for this phase of the 
research as it is considered most suitable to the study of attitudes and 
experiences. Furthermore, participants' perspectives are elicited through the 
group debate and therefore focus groups facilitate the expression of ideas and 
experiences that might be left underdeveloped in a one-to-one interview 
(Kitzinger, 2006).  
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Focus groups make use of group dynamics to encourage discussion, gain insights 
and generate ideas in order to pursue an issue in greater depth (Bowling, 2009). 
Additionally, they encourage diverse communication between participants and 
provide insight into the functioning of a group's process in the expression of 
knowledge. The dynamic interaction between participants of focus groups can be 
used to highlight participants' attitudes, priorities as well as language and 
context, which is useful considering that people's knowledge and attitudes go 
beyond responses to direct questions (Kitzinger, 2006). The earliest published 
work on focus groups was in 1926 with Bogardus' work describing group 
interviews (Morgan, 1997). Focus groups were later used in the 1950s to study 
people's reactions to wartime propaganda and continued to be used as a method 
throughout the 1970s and 80s (Kitzinger, 1994) and in more recent studies 
(Jochemsen-van der Leeuw et al., 2011; Badertscher et al., 2012; Bassett-Clarke 
et al., 2012).  
 
Focus groups are associated with a number of strengths and weaknesses. The 
dynamic interaction between group participants decreases the influence of the 
researcher on that group. Different opinions in a group can stimulate discussion 
and allow elaboration and appraisal of opinions. Generally silent individuals can 
also be encouraged to express their opinions in focus groups (Frith and Gleeson, 
2012). Through focus groups participants can engage in discussion on 
embarrassing topics with free expression of criticism.  
 
There are also a number of limitations when focus groups are employed. 
Individuals with a very busy lifestyle or who feel uneasy sharing their opinions 
with others may be unwilling to participate (Frith and Gleeson, 2012). During the 
focus group discussions participants might deviate from the specific topic being 
discussed (Frith and Gleeson, 2012). Some participants who might consider 
themselves a minority in the group might find it difficult to share their point of 
view (Frith and Gleeson, 2012). 
 
The focus group study was conceptualised within the interpretative paradigm and 
phenomenological methodology which maintains that the world is socially 
constructed and the researcher is party to what is being observed. The 
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researcher induced themes from the understanding of the perceptions and 
meanings described by participants. This study sought subjective views and 
contextual accounts of participants. 
 
2.6.2 Sampling and data analysis in qualitative research 
Sampling in qualitative research is multidimensional. Adequate reflection is 
required during sample size and sampling method selection to ensure that the 
topic under investigation follows the concept of saturation i.e. data generation 
continues and new findings are fully uncovered until new data are not generated 
(Leech, 2005). Non-random sampling techniques are mainly used to recruit 
participants, with many recommending purposive or theoretical sampling (Coyne, 
1997). Table 2.4 describes different non-random sampling techniques and their 
advantages and disadvantages (Strauss and Corbin, 1998; Bowling, 2009; 
Draper and Swift, 2011; Howitt and Cramer, 2011; Moule and Goodman, 2014). 
 
Purposive sampling was used to select participants for the focus group and the 
Delphi technique studies as participants with specific characteristics were 
required. The Delphi technique also used snowball sampling to recruit further 
‘expert’ individuals who otherwise may not have been identified. 
 
Data generated through qualitative methods are analysed through an iterative 
process as the researcher keeps going back to interpret and reinterpret the data 
(Teddlie and Tashakkori, 2009). The data analysis approach varies in terms of 
basic epistemological assumptions about the nature of qualitative enquiry and 
aims of the analytical process. Different data analysis approaches include:  
• those which focus primarily on language, such as discourse analysis, 
conversation analysis, symbolic interactionism, ethnomethodology and 
narrative analysis; and  
• those whose primary aim is concerned with capturing and reporting views and 
culture and interpreting meanings, such as grounded theory and framework 
approach (Ritchie et al., 2014).  
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Table 2.4: Non-random sampling techniques 
Non-random sampling Advantages Disadvantages 
Convenience sampling which samples 
participants in the most convenient way 
to the researcher because they are 
easily recruited 
Easier to recruit and possibly less 
expensive 
Conclusions limited to type of population 
studied and subjectivity of researcher 
Volunteer sampling which samples 
individuals volunteering participation in 
a study  
Easier to recruit and possibly less 
expensive 
Conclusions limited to type of population 
studied and subjectivity of researcher 
Quota sampling which recruits 
participants based on whether they fit 
one of various researcher specified 
categories 
Reduces chance of over- or under-
representation 
Researcher needs to find individuals who 
fulfil specified categories (e.g. males in 
specific jobs); systematically biased 
sample 
Purposive sampling which selects a 
group of participants with a specific 
characteristic which is of theoretical 
interest to the research 
Accesses participants with specific 
characteristics of interest to the 
research 
Over-representation of specific group 
being studied and subjectivity of 
researcher 
Snowball sampling which is dependent 
on an initial group of participants to 
recruit others 
Identifies hidden samples and possibly 
less expensive 
Conclusions limited to type of population 
studied and subjectivity of researcher 
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Social network sampling which uses 
social or other networks to recruit 
participants 
Easier to recruit and possibly less 
expensive 
Conclusions limited to type of population 
studied; selection is not independent as 
participants are known to one another 
Theoretical sampling which initially 
includes a small number of similar cases 
of interest and consequently exceptional 
cases are selected to test the emerging 
hypotheses 
Explores new areas by enabling the 
researcher to choose those avenues of 
sampling which produce the greatest 
theoretical returns 
Conclusions limited to type of population 
studied 
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2.6.2.1 Grounded theory to develop code structure 
The code structure in grounded theory is purely inductive. Codes are assigned to 
each emergent concept from the data (Bradley et al., 2007). Grounded theory 
uses a systematic ‘constant comparison method’ first described by Glaser and 
Strauss (1967) to search for similarities and differences between different groups 
and thus generate theory. In developing theory, conceptual categories are 
generated which can then be tested with other comparison groups (Glaser and 
Strauss, 1967). Since grounded theory is more concerned with the development 
of theory derived from data through a set of procedures and interconnected 
stages, it was not appropriate in this research.  
 
2.6.2.2 Framework approach to develop code structure 
A less inductive approach is the framework approach (Bradley et al., 2007), 
which uses the thematic framework as its central component. It is a matrix 
based analytic approach which extrapolates data into cases (rows) and codes 
(columns) (Ritchie et al., 2014). Interpretation of the matrix and generation of 
descriptions, categories, explanations and typologies are important features of 
the framework approach (Gale et al., 2013). Since the framework approach is 
most commonly applied for thematic analysis of semi-structured interview 
transcripts, and is not aligned with a particular epistemological, philosophical, or 
theoretical approach but can be easily adapted to different approaches (Gale et 
al., 2013), it was used to analyse focus group data in chapter 6. This approach 
was considered most appropriate to analyse the focus group data generated in 
this research and to reflect the phenomenological methodology.  
 
2.7 Evidence synthesis through systematic review of the 
literature 
2.7.1 Evidence-based practice and the hierarchy of evidence 
Farrelly (2013) argues that in an age where quality assurance and clinical 
governance dominate healthcare systems and new evidence constantly 
emerging, HCPs must strive to provide the best possible care and must thus 
follow evidence-based practice (EBP).  
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Evidence-based medicine (EBM) is the most widely applied form of EBP and 
refers to “the use of evidence, specifically in the form of quantitative research 
data, concerning the effectiveness of a variety of medical interventions, to guide 
decisions about whether to use those interventions in medical practice" (Gupta, 
2003, p.111).  
 
EBM makes an epistemological claim of being the most effective means of 
pursuing health by the assumption that the most effective means of achieving 
health is by following the truth, which is achieved through EBM (Gupta, 2003). 
EBM follows a hierarchy of evidence, with the strongest evidence lying within the 
top most layer of systematic reviews and meta-analysis, with the strength of 
evidence decreasing down the pyramid (Figure 2.2) (Jonas, 2001). 
  
 
Figure 2.2: Hierarchy of evidence [Adapted from Jonas, 2001] 
 
2.7.2 Systematic reviews 
Systematic reviews differ from more traditional, scoping or narrative reviews, 
collating and synthesising evidence according to pre-specified eligibility criteria in 
order to address specific research questions, while minimizing bias by adhering 
to explicit, systematic methods (Lang, 2004; Mickenautsch, 2010; Higgins and 
Green, 2011; Rosner, 2012).  
 
Systematic 
reviews and meta-
analysis
Randomized controlled 
trials
Non-randomized trials and 
observational studies
Case series, case studies, anecdotes, qualitative 
research, surveys
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On the other hand, narrative reviews are mainly descriptive and selection of 
evidence is based on availability or author selection, introducing selection bias. 
Moreover, in systematic reviews, as opposed to narrative reviews, contradictory 
reports are reconciled by combining specific outcome measures (Lindsay, 2011). 
 
Systematic reviews can be carried out to address different types of research 
questions, such as (Gough et al., 2012):  
• to determine the effect of an intervention through, for example, a statistical 
meta-analysis of experimental data 
• to assess the cost of an intervention through a cost-benefit analysis 
• to identify the meaning of a phenomenon through meta-ethnography and 
• to determine the attributes of an intervention through, for example, 
framework synthesis. 
 
Systematic reviews can take a deductive approach to help the researcher 
develop a theoretical or conceptual framework which is subsequently tested 
using data. An inductive approach in a systematic review explores data to 
develop theories and subsequently relate these to the literature (Saunders et al., 
2009). Criticism of systematic reviews is mainly directed towards the assumption 
that systematic reviewing is only applicable to quantitative research (Gough et 
al., 2012), although systematic reviews of qualitative data are now emerging. 
 
2.7.2.1 Systematic review within this research 
The systematic review in this research helped to identify all evidence regarding 
medication wastage which in turn informed the next phases of the research and 
thus could be used to inform policy and practice.  
 
2.7.3 Critical appraisal of the literature 
In a systematic review, identified literature is appraised critically with the aid of a 
pre-selected quality assessment tool, whilst quality is not an initial priority in 
scoping or narrative reviews. Four critical approach aspects have been discussed 
in the literature, namely (Mingers, 2000): 
• critique of rhetoric, which is the need to use the skills both of making 
reasoned judgements and of discussing effectively in writing; 
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• critique of tradition, which refers to the questioning of conventional wisdom; 
• critique of authority, which refers to the dominant view portrayed in the 
literature being reviewed; and 
• critique of objectivity, which acknowledges that the knowledge and 
information in the review are not value free. 
 
Detailed data pertinent to the results of study findings are extracted in a 
systematic review, clearly highlighting any similarities or differences between 
studies and exploring the reasons for any variations.  
 
2.7.4 Data synthesis 
Data synthesis in systematic reviews refers to the gathering, combination and 
summary of the findings of studies that are included in the systematic review. 
Data synthesis usually takes two forms: an aggregative or configurative 
approach. Aggregative reviews, typically employing a realist philosophy, assume 
that there is one reality. This approach uses predefined concepts and tests these 
to generate empirical statements within predefined conceptual positions and 
methods. These reviews aggregate similar forms of data and are more 
considered about homogeneity. Configurative reviews, which fall under the 
idealist philosophy, develop concepts by trying to interpret and understand the 
world and by exploring patterns provided by heterogeneity. Therefore, 
aggregative reviews generate empirical statements to inform decision making 
instrumentally whilst configurative reviews develop concepts. Aggregative 
reviews follow epistemological and methodological assumptions similar to 
quantitative research, and configurative reviews have similar assumptions to 
qualitative research (Gough et al., 2012). 
 
There are diverse distinguishable approaches to reviews such as the quantitative 
use of formal statistical techniques to aggregate findings in meta-analysis or the 
use a more textual approach such as that embraced by narrative synthesis. 
Meta-analysis utilise a positivist paradigm (Broom and Willis, 2007) and generate 
quantitative outcomes. Mixed-method approaches in systematic reviews combine 
qualitative and quantitative studies, or use qualitative information to inform 
decisions made in statistical synthesis. 
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2.7.4.1 Narrative synthesis 
The systematic review carried out in this research (chapter 3) used a narrative 
synthesis to provide an analysis of relationships within and between studies, and 
an overall assessment of the robustness of the evidence. Narrative synthesis 
begins with the development of a theory of how the intervention works, why and 
for whom and links resources, activities, intermediate outcomes and ultimate 
goals. The systematic review in this research employed a predominantly 
configurative approach but included elements of both aggregation and 
configuration.  
 
2.8 Mixed methods 
There are two major types of mixed methods research: a mixed method and a 
mixed-model research (Johnson and Onwuegbuzie, 2004). A mixed method 
research employs both quantitative and qualitative data collection and analysis 
techniques either in parallel or sequentially. In a sequential mixed methods 
design the process begins with either a quantitative study followed by a 
qualitative study (explanatory sequential design) or a qualitative study followed 
by a quantitative study (exploratory sequential design) (Baxter and Jack, 2008). 
A mixed-model research makes use of both quantitative and qualitative data 
collection and analysis techniques within the stages of the research process or 
across other phases of the research (Saunders et al., 2009).  
 
2.8.1 Rationale for the use of mixed methods designs 
Greene et al.’s (1989) five-purpose conceptual framework for using mixed 
methods research is: 
• for triangulation purposes which refers to the convergence of quantitative and 
qualitative research  in order that the findings of these may be mutually 
corroborated;  
• for complementarity purposes which seek clarification, enhancement, 
illustration, explanation of the results from one research strategy with the 
results from another; 
• for development whereby the result from one method inform the next method 
which includes sampling and data collection and data analysis decisions; 
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• for initiation purposes which seek to discover inconsistencies, new 
perspectives and to modify research questions or findings from one method 
with questions or findings from the other method; and 
• for expansion purposes which seek to extend the level of enquiry by using 
different methods for different inquiry components. 
 
Bryman (2006) later described a more detailed rationale scheme for the use of 
mixed methods research, namely: a) triangulation, b) to offset weakness of 
mutual research designs used, c) completeness of study, d) to provide a sense of 
process as well as an account of structures, e) to answer different research 
questions, f) to use one method to explain the findings of the other, g) to identify 
unexpected results, h) one method is used to develop the instrument for the 
other method, i) for sampling purposes, j) to enhance credibility of findings, k) to 
provide contextual understanding through a qualitative research coupled with 
either generalizable, externally valid findings or broad relationships among 
variables uncovered through a survey, l) to use qualitative data to illustrate 
quantitative findings, m) to improve the usefulness of findings, n) to generate 
and test a hypotheses within a single research study, o) to obtain diversity of 
views and p) to enhance findings. 
 
2.8.2 Rationale for the use of mixed methods designs in this research 
The rational for employing a mixed methods design in this research study was to 
ensure a more iterative process rather than a static one. In this study, the 
researcher engaged the use of within-stage mixed-model design by combining a 
summated rating scale and close-ended questions (quantitative data collection) 
together with open-ended questions (qualitative data collection) in the same 
research phase (questionnaire [chapter 5]). The current research explored, 
through the systematic review (chapter 3) and Delphi study (chapter 4), the 
variables that need to be studied and sequentially studied some of these 
variables with a random sample of the population. This study also employed a 
mixed methods sequential explanatory design, whereby the quantitative study 
enabled the researchers to select cases for their qualitative study, whereby the 
qualitative component was primary and the quantitative survey provided a 
sample of selective cases for the focus groups.  
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A mixed methods design also ensured triangulation. Due to the multifaceted 
nature of the research study, it was felt that there was no single paradigm that 
could satisfactorily deal with all of the required methodological aspects. 
Therefore, the use of mixed methods research enabled the researcher to 
statistically analyse the quantitative data generated through the questionnaire 
whilst encompassing the different factors that give rise to wastage from the 
participants own point of view. 
 
2.8.2.1 A within-stage mixed-model design in this research 
A further application of the mixed methods in this research was the use of a 
consensus based technique, which is categorised as a within-stage mixed-model 
design. In a review by Campbell and Cantrill (2001, p.5), consensus techniques 
are described as group facilitation techniques which seek to determine the level 
of consensus among a group of experts by “aggregating opinions into refined 
agreed opinion”. Moule and Goodman (2014) discuss three main consensus 
techniques, mainly the Delphi technique, the Nominal Group technique (NGT) 
and the Consensus development technique (CDT) (Moule and Goodman, 2014). 
Consensus methods, such as the Delphi technique and NGT, follow pragmatic 
paradigm, harnessing an interpretivist paradigm generating subjective ideas 
whilst utilising positivist assumptions through statistical measures to grade 
consensus (Gallagher et al., 1993; Keeney et al., 2011).  
 
2.8.2.1.1 Consensus techniques 
The Delphi technique  
The Delphi technique originated in 1948 and has been employed by many 
researchers. The Delphi technique was originally developed by the Rand 
Corporation for technological forecasting. It takes the name after the famous 
oracle at Delphi (Hasson et al., 2000). It has been defined by Campbell and 
Cantrill (2001, p.7) as “a structured, isolated, indirect, multistage interaction 
method for deriving consensus using repetitive administration of anonymous 
questionnaires, usually across two or three postal rounds”. 
 
The classical Delphi technique typically employs a first round qualitative 
questionnaire to identify a wide array of opinions (Keeney et al., 2006) with 
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administration of quantitative questionnaires during subsequent rounds. Rowe 
and Wright (1999) characterize the classical Delphi technique by anonymity of 
Delphi participants, with the advantage that it prevents the possibility of a group 
of participants dominating over others (Hsu and Sandford, 2007). Delphi 
provides a means of communication between a group of individuals without the 
need for the group to meet (Clayton, 1997). Therefore, through the Delphi 
technique different participants, some of whom have no prior history of 
communication with one another, can effectively discuss a topic as a group, yet 
with sufficient time to generate their opinions at their convenience (Akins et al., 
2005). Therefore, the Delphi study can generate a group opinion rather than 
individuals' opinions. Other characteristics of the Delphi technique are iteration, 
through a number of questionnaire rounds; controlled feedback where 
participants can reconsider their responses which could be different from 
responses of previous questionnaires; and the statistical aggregation of group 
response which is fed back to all participants (Woudenberg, 1991). Originating 
from the classical Delphi, nowadays different types of Delphi methods can be 
employed, such as the modified Delphi, decision Delphi, policy Delphi, real time 
Delphi, e-Delphi, technological Delphi and online Delphi amongst others (Keeney 
et al., 2011). 
 
The Delphi technique recruits a panel composed of experts in the field of study. 
The composition of panellists is crucial as it can affect the final findings (Keeney 
et al., 2001) and therefore definition of the necessary expertise for a particular 
Delphi study must be defined a priori. Murphy et al. (1998) conclude that 
heterogeneity amongst expert panel members leads to better performance than 
homogeneous groups. Heterogeneity also helps in preventing as much as 
possible the ‘bandwagon effect’ where from one questionnaire round to the next 
(Linstone and Turoff, 2002), respondents potentially change their views to 
conform with other respondents rather than because the latter is their true 
opinion (Geist, 2010). 
 
Different descriptive statistics can be used to measure consensus, ranging from 
measure of central tendency (median and mean) and dispersion (interquartile 
range, standard deviation, coefficient of variation). Other measures of consensus 
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include the a priori stipulated number of rounds, subjective analysis (where 
researchers decide to stop the Delphi technique based on subjective criteria), the 
“average percent of majority opinions” and certain level of agreement (von der 
Gracht, 2012, p.1529). von der Gracht (2012) argues that measure of consensus 
by a certain level of agreement is particularly meaningful if Likert scales are 
used. There is no published evidence on the level of consensus that needs to be 
achieved. Different studies have employed different minimum consensus levels. 
Keeney et al. (2006) state that as a minimum, a consensus level of 75% should 
be adopted. Post-group consensus measures the extent to which panellists agree 
with the final group aggregate after the Delphi has been completed (von der 
Gracht, 2012). 
 
A limitation of the Delphi technique, especially compared to qualitative 
approaches to data generation such as face-to-face unstructured interviews, is 
that participants cannot be probed by the researcher to explore their opinions or 
ideas in depth (Sandrey and Bulger, 2008). The participants’ personal and 
professional responsibilities may have an influence on their responses. While this 
has been acknowledged as a limitation by others (Sandrey and Bulger, 2008), it 
is also one of the strengths and attributes of the Delphi technique and 
emphasises the need for defining the inclusion criteria of panellists. Another 
limitation of the Delphi technique is that it captures opinion of a specific type of 
‘expert’ panel at a specific point in time only (Campbell and Cantrill, 2001). Most 
of these limitations are not exclusive to the Delphi technique but are also 
attributed to structured questionnaires. 
 
The NGT 
The NGT, developed in the late 1960s in the United States (US) by Van de Ven 
and Delbecq following research funded by the Institute for Research on Poverty 
and National Aeronautics and Space Administration, is a structured procedure 
which brings together views from groups of people who speak a common 
language and have an understanding of the issue in question (Gallagher et al., 
1993). NGT is similar to the Delphi in structure, but involves face-to-face 
meetings that allow discussion between rounds (Rowe and Wright, 1999) and is 
highly controlled (Gallagher et al., 1993). However, the generation of ideas and 
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opinions is rigorously individual and independent of other participants (Clayton, 
1997). NGT assembles all participants for a specified period of time and asks 
them to individually list their own ideas on a specific issue. The ideas are then 
drawn into a discussion and the participants’ views are ranked. During the 
meeting which follows, experts review the rankings and discuss the differences, 
with a final ranking of ideas through voting (Moule and Goodman, 2014). 
 
CDT 
The US National Institutes of Health developed the CDT whereby a selected 
group of approximately ten people are assembled in a face-to-face chaired open 
meeting (Murphy et al. 1998), which might potentially carry on over the course 
of a few days, to reach consensus about a specific issue (Moule and Goodman, 
2014). An initial systematic review or scoping of the literature may be 
undertaken to provide evidence to participants before the initial meeting. The 
expert panel will then identify gaps in knowledge and research priorities (Moule 
and Goodman, 2014). The face-to-face setting can influence the group's 
judgement (Murphy et al., 1998).  
 
Differences between the three consensus techniques are highlighted in Table 2.5. 
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Table 2.5: Comparison between different consensus techniques 
 Delphi technique NGT CDT 
Aim To gain consensus 
among a panel of 
experts 
Combines aspects 
of Delphi technique 
with that of focus 
groups 
To gain further 
understanding or 
consensus in a 
particular field 
Technique 
used 
A series of rounds 
using 
questionnaires 
where information 
is fed back to panel 
members  
 
Face-to-face highly 
controlled meetings 
for a specified 
period of time to 
generate and rank 
ideas 
Face-to-face chaired 
open meeting by 
experts followed by 
a privately chaired 
meeting by the 
decision-making 
group 
Panel of 
experts 
Experts in the field Experts in the field Multi-disciplinary 
Sample size Varies Between five to 
nine people 
Approximately ten 
people 
Anonymity Yes No No 
Number of 
rounds 
Varies (until 
consensus is 
achieved) 
Two One 
 
Of the three techniques described, the Delphi technique is the most commonly 
used in healthcare research, whilst the NGT is applied mainly for organizational 
planning and assessment of management systems, with the CDT used mainly for 
the development of practice guidelines (Moule and Goodman, 2014). Therefore, 
the Delphi technique was applied in this research. This research adopted different 
pragmatic assumptions, but mainly committing to an ontological assumption of a 
single reality in which the panel of experts aimed to agree to a definition of 
‘medication wastage’. The first round is coherent with an interpretivist paradigm 
which relies on participants’ views, with subsequent rounds adopting an 
epistemological basis favouring a positivist paradigm utilising a quantitative 
approach to data collection and the application of statistical measures to 
determine consensus (Hanafin, 2004). 
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2.9 Quality assurance in research 
Each paradigm described in this chapter requires paradigm-specific criteria to 
ensure robustness and rigour (Morse et al., 2002). In quantitative research, 
robustness is measured by applying elements of validity and reliability. In 
qualitative research, rigour is measured by adopting elements of trustworthiness 
(Hasson and Keeney, 2011). 
 
2.9.1 Robustness in quantitative research 
The criteria to reach the goal of robustness in quantitative research are internal 
validity, external validity, reliability, and objectivity. 
 
2.9.1.1 Validity 
Validity refers to “the accuracy and truth of the data being produced in terms of 
the concepts being investigated, the people and objects being studied and the 
methods of data collection and analysis being used” (Farrelly, 2013, p.81). 
Research designs are concerned with two types of validity: internal validity, 
which is concerned with the confidence placed in the cause and effect 
relationship, and external validity which measures the generalizability of the 
findings (Hasson and Keeney, 2011). Different validity measures exist and are 
described in Table 2.6 (Long and Johnson, 2000; Hasson and Keeney, 2011; 
Howitt and Cramer, 2011). 
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Table 2.6: Different type of validity measures  
Validity Description 
Content validity Assesses if a test covers the aspects 
under investigation – depends largely 
on sampling and careful construction of 
the instrument 
Face validity Assesses whether from the appearance 
of items, the test measures what it 
claims to measure 
Construct validity 
  
The development of theoretical and 
conceptual understanding of the item 
being measured and assesses how well 
a construct is understood 
Criterion-related validity  Assesses the effectiveness in predicting 
criterion or indicators of a construct – 
assesses the correlation between the 
instrument and findings and an 
established standard 
Concurrent validity  
 
Assesses whether a test is correlated 
with another test which measures the 
same concept when administered at 
the same time 
Predictive validity  Assesses whether the measure predicts 
accurately some later measure 
Triangulation Assesses area under investigation by 
using multiple types of measure; can 
be considered as an additional form of 
addressing construct validity 
 
2.9.1.2 Reliability 
Reliability refers to “the extent to which methods and settings are consistent 
over time, across groups and between researchers” (Farrelly, 2013, p.81). There 
are distinct types of reliability defined in Table 2.7 (Howitt and Cramer, 2011). 
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Table 2.7: Different reliability measures 
Reliability Description Measurement 
Internal reliability The consistency by which all 
items in a scale measure the 
concept in question 
• Split half reliability – summation of the first half items of the test 
and summation of the second half items; the Pearson correlation 
between the two halves is then calculated 
• Odd-even reliability – items are divided into odd and even numbers 
and a correlation between these two sets of scores is made 
• Cronbach’s coefficient alpha - measures the correlation between 
each different item and then gives an average of all those 
individual correlations 
Stability over time  The consistency of an item 
when measured over a time 
interval  
• Test-retest reliability – the same measure administered to the 
same sample at two different points in time; the two sets of data 
will then be compared statistically using weighted Kappa for ordinal 
data and kappa coefficient for nominal data (Bowling, 2009) and 
the Spearman’s Rank Correlation Coefficient for continuous data 
(Williams, 2003), assuming reliability if there have been no 
changes  
Stability over 
different measures 
The similarity of measurements 
across similar versions of a test 
• Alternate forms reliability – Tests available in two versions 
containing different items; a correlation between these two tests is 
then measured 
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2.9.1.3 Objectivity 
One should ensure that the tested measure produces similar outcomes 
irrespective of who carries out the measure, thus the term objectivity (Howitt 
and Cramer, 2011).  
 
Attention was paid to aspects of data validity and reliability throughout this 
research by implementing face and content validity, piloting and triangulation. 
 
2.9.2 Rigour in qualitative research 
Aspects of trustworthiness in qualitative research include credibility, 
transferability, dependability and confirmability and are defined in Table 2.8.  
 
Table 2.8: Components of trustworthiness [Adapted from Hasson and Keeney, 
2011; Farrelly, 2013] 
Trustworthiness Description 
Credibility (comparable to internal 
validity) 
The degree to which meaning or truth 
of data can be recognised 
Transferability (comparable to external 
validity)  
The degree of transferability of the 
findings to other settings 
Dependability (comparable to 
reliability)  
Study findings need to be consistent 
and correct 
Confirmability (comparable to 
objectivity) 
Conveys neutrality which requires an 
audit or decision trail 
 
 
Credibility and transferability can be ensured through the following (Long and 
Johnson, 2000): 
• self-description and reflective journal-keeping – researcher reflects on own 
beliefs regarding area under investigation and makes these beliefs explicit 
• respondent validation – checking findings of data collection with members of 
studied group 
• prolonged involvement – spending a significant length of time in contact with 
members of studied group and with the topic under investigation 
• persistent observation – focuses on the observation in more detail 
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• peer debriefing - discusses emerging findings at intervals with knowledgeable 
colleagues, or present and defend research at national research conferences, 
or present the findings and implications to interested groups 
• triangulation - employment of multiple data sources, data collection methods, 
or investigators. 
 
This research used peer debriefing and triangulation to ensure credibility and 
transferability. 
 
The means by which dependability and confirmability can be ensured is through 
audit of the decision trail and triangulation (Long and Johnson, 2000). A detailed 
decision trail was kept, as suggested by Sandelowski (1986), which includes 
description, explanation and justification of: 
• origin of research interest  
• researcher views of the study 
• the specific purposes of the study 
• participants selection and recruitment  
• the impact the subjects and the researcher(s) had on each other 
• details of data collection  
• duration of data collection  
• data synthesis, analysis, interpretation, and presentation, including coding 
instructions and definitions, category development, notes and memos 
formulated during the study and the way different data were linked to each 
other 
• weighting of various elements of the data  
• the techniques used to determine the applicability of the data. The latter was 
achieved through a detailed description of the research findings to provide 
adequate information for evaluating the analysis of data. 
 
2.9.3 Bias as a limitation in research 
Bias is a form of systematic error which alters the measurement process, thus 
compromising validity, reliability and trustworthiness in relation to the degree of 
the bias. Thus, the goal of any research is to minimise bias while recognising that 
it can never be completely excluded (Sica, 2006). Biases are categorised into 
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random biases, concerned with sampling variability or measurement precision 
and systematic biases, defined as “reproducible errors that produce a 
consistently false pattern of differences between the observed and the true 
values” (Krishna et al., 2010, p.2320). The most common categories of bias are 
described in Table 2.9 (Marlowe, 2000; Litosseliti, 2007; Bowling, 2009; Krishna 
et al., 2010) together with measures taken to minimise bias in this research. 
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Table 2.9: Most common categories of bias and measures taken to minimise bias in this research 
Biases in research Measures taken to minimise bias in this research 
Selection biases 
1. Volunteer or referral bias - individuals who volunteer or 
are referred to participate in a study are different than 
non-volunteers/non-referrals 
 
 
 
 
 
 
 
 
2. Non-respondent bias – those who do not respond to a 
survey differ from those who respond 
 
 
 
 
 
1. In Delphi technique (chapter 4) volunteer or referral 
bias could not be completely excluded, especially when 
selecting patients who were nominated by patient 
associations; however, it was minimised by sampling 
participants occupying the highest position in their field 
rather than volunteers within the field; participants for 
questionnaires (chapter 5) were randomly selected and 
those for focus groups (chapter 6) purposively selected; 
participants for focus groups were chosen through the 
questionnaires to minimise selection bias as much as 
possible 
2. A number of measures were taken to enhance response 
rates in questionnaires and are discussed in respective 
chapters; this bias could not be eliminated completely, 
particularly in the focus group as those expressing an 
interest in participation may have been more interested in 
the topic 
  
Chapter 2: Methodology         49 
 
 
3. Respondent order effect (some participants go first and 
others go last), dominance/shyness bias (dominant or 
quiet personalities) and acquaintance/stranger bias 
(participants who know each other thus effecting each 
other’s response) 
3. Potentially dominant or reluctant focus participants were 
managed through effective moderation; rules of behaviour 
were established at the outset 
Measurement biases or other biases during data collection 
and generation 
1. Instrument bias – calibration errors leading to 
inaccurate recordings  
2. Insensitive measure bias - when the measurement tool 
is not sensitive enough to detect important differences in 
the variable of interest 
3. Expectation bias – when there is no masking or blinding   
4. Recall or memory bias – outcomes being measured 
require individuals recalling past events 
5. Attention bias – individuals are aware of their 
involvement in study and tend to give more favourable 
responses or perform better due to the attention received 
6. Verification or work-up bias - when the sample used to 
assess a measurement tool is restricted only to those who 
 
 
1. Not applicable to this research 
 
2. Measurement tools were validated and piloted 
 
 
3. Not applicable to this research 
4. Questionnaires did not require participants to recall 
events beyond six months 
5. Minimised through the use of self-administered 
questionnaires. During focus groups bias was minimised by 
following a topic guide 
6. Not applicable to this research 
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have the condition of factor being measured 
7. Acquiescence response set bias where the respondent 
tends to go with the 'yes-saying' 
 
8. Assumption bias which can arise due to a faulty logic of 
the researcher 
9. Evaluation apprehension where respondents might be 
anxious in answering specific questions and therefore 
might not answer truthfully 
10. Reporting bias whereby respondents fail to disclose the 
information that is being asked from them 
11. Social desirability bias 
12. Interviewer bias 
 
13. Expectancy bias whereby participants have different 
expectations of the purpose of the study 
 
7. Questionnaire items were mainly in the form of Likert 
scales, semantic differential scales and close-ended 
questions with standardised options 
8. Questionnaire validation, piloting and peer debriefing 
were employed 
9. Minimised through the use of self-administered 
questionnaires  
 
10. Minimised through the use of self-administered 
questionnaires 
11. Minimised by providing clear purpose of the study 
12. Focus group moderator facilitated rather than led the 
discussions  
13. Clear statements of the purpose of the research 
phases  
Intervention biases (mainly associated with research that 
compares groups) 
1. Contamination bias – when participants from control 
group receive intervention inadvertently 
 
 
1. Not applicable to this research 
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2. Co-intervention bias – when some participants receive 
other interventions at the same time 
3. Timing bias – timing of intervention can affect outcomes 
4. Compliance bias – difference in participants’ adherence 
to intervention 
5. Withdrawal bias – individuals who leave the study differ 
from those that remain 
6. Proficiency bias – when interventions are not applied 
equally to subjects 
2. Not applicable to this research 
 
3. Less relevant to the study of medication wastage 
4. Not applicable to this research 
 
5. Not applicable to this research 
 
6. Not applicable to this research 
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2.10 Philosophy of ethical research 
Ethics is a branch of moral philosophy. Three central branches of ethics have 
been described by Comstock (2013, p.10):  
 
“1. descriptive ethics, the empirical study of what people actually do, believe, 
and value; 
2. normative ethics, the evaluative study of how we should behave in particular 
cases; 
3. metaethics, the philosophical study of the foundations of moral language.” 
 
Moral philosophy is guided by normative ethics. Theories of normative ethics 
guide researchers on how to behave when faced with conflicting interests. Four 
common theories are: egoism, contractualism, moral rights and utilitarianism. 
Description of each theory is provided in Figure 2.3. Based on some of these and 
other philosophical theories, Shamoo and Resnik (2009) suggest 12 principles for 
ethical conduct in research (Table 2.10). These principles are in line with the 
quality of evidence described earlier in this chapter and adopted throughout this 
research.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter 2: Methodology   53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: The expanding moral circle described by Comstock (2013) 
 
Table 2.10: The twelve principles for ethical conduct in research [Adapted from 
Shamoo and Resnik, 2009] 
Twelve principles for ethical conduct in research 
Honesty Objectivity 
Openness Confidentiality 
Carefulness Respect for colleagues 
Respect for intellectual property Respect for the law 
Respect for research subjects Stewardship 
Social responsibility Freedom 
 
Egoism 
Protect my 
interests 
Report misconduct 
Avoid plagiarism 
Beware intuition 
Justify decisions 
Contractualism 
Promote our 
group’s interests 
Articulate reasons 
Write cooperatively 
Protect manuscripts 
Clarify statistics 
Moral rights 
Respect strangers’ rights 
Inform subjects 
Mentor inclusively 
Recognise property 
Reveal conflicts 
Utilitarianism 
Honour all interests 
Treat humanely 
Preserve environments 
Cultivate responsibility 
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2.11 Schematic summary of the research approaches  
Figure 2.4 illustrates a schematic summary of the research paradigms, 
methodologies and methods employed for each phase of the research. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Methodological phases of current research
 
Questionnaires: 
Survey research  
[Positivist] 
Systematic review: 
[Configurative + aggregative] 
Delphi study:  
Within-stage mixed-model 
design   
[Positivist + Interpretivist] 
Sequential explanatory design: 
Pragmatic assumption 
Focus groups:  
Phenomenology  
[Interpretivist] 
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Chapter 3  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“The first precept was never to 
accept a thing as true until I knew 
it as such without a single doubt” 
Rene Descartes 
[Philosopher, mathematician and writer 
1596-1650] 
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Systematic review of the literature on medication 
wastage: an exploration of causative factors and effect 
of interventions  
 
 
This chapter provides a detailed account of a systematic review of the literature 
on medication wastage, with emphasis on introduction, rationale for undertaking 
a systematic review, method, results, discussion and reflection. 
 
3.1 Introduction 
3.1.1 Systematic reviews 
As depicted in Figure 2.2 (chapter 2), systematic reviews occupy the highest 
echelon in terms of the quality of evidence. Ng and Peh (2010, p.362) describe 
systematic reviews as the “best, least biased and most rational way to organise, 
gather, evaluate and integrate scientific evidence from the rapidly-changing 
medical and healthcare literature”. The need for systematic reviews to aid 
decision-making has been articulated by many. Mulrow (1994) highlights that at 
a time when policy makers and HCPs are inundated with different sources and 
amounts of information, systematic reviews assimilate this information and 
generate data for rational decision making. Mulrow (1994) further describes that 
systematic reviews determine whether scientific findings are consistent and can 
be generalised across populations, settings, and treatment variations, or whether 
there are significant variations between particular subsets.  
 
The systematic review question is framed in terms of the population, 
intervention(s), comparator(s) and outcomes of the studies that will be included 
in the review (PICO) (Centre for Reviews and Dissemination, 2009). More 
recently, focus has been placed on systematic reviews of studies employing 
qualitative approaches. For qualitative reviews the question frame is around the 
population, phenomenon of interest and context. A systematic review is 
conducted by a review team with at least a minimum of two researchers working 
independently to minimize bias and error at all stages of the review.  
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3.1.2 Rationale for systematic review 
To date, there have been no systematic reviews focusing on potential and actual 
causative factors of medication wastage, their relative importance and 
intervention studies with wastage as a key outcome measure. Thus, the rationale 
for this systematic review was to collate all evidence regarding these outcome 
measures and to identify gaps in the literature. 
 
3.1.3 Study aim and research questions 
The overall aim of the systematic review was to appraise critically, synthesize 
and present the available evidence on the possible causative factors associated 
with medication wastage in all populations and settings and the effectiveness of 
any interventions focusing on wastage reduction as an outcome measure.  
 
More specifically, this review sought to answer the following questions: 
1. What is the methodological quality of the literature related to medication 
wastage? 
2. What are the definitions and scope of medication wastage? 
3. What are the documented factors which give rise to medication wastage? 
4. Which interventions are effective in reducing medication wastage? 
 
3.2 Review methods 
3.2.1 Systematic review protocol  
An initial scoping literature review, described in chapter 1, was carried out to 
obtain a preliminary perspective of this area of interest. A protocol was then 
developed by the principal researcher in collaboration with the other members of 
the research team to provide full coverage of the systematic review process. The 
Centre for Reviews and Dissemination (CRD) guidance on systematic reviews 
(Centre for Reviews and Dissemination, 2009) and the Cochrane Handbook for 
Systematic Reviews of Interventions (Higgins and Green, 2011) were used as 
reference tools to aid construction of the review protocol. Following several 
revisions amongst the supervisory team, the protocol was externally reviewed by 
Professor Peter Reid, Professor of Librarianship and Head of Department of 
Information Management at Robert Gordon University.  
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3.2.2 Inclusion criteria 
3.2.2.1 Study Population and Setting 
All studies carried out in any setting were included. Both male and female 
populations of different ethnicity and of all ages, including patients, HCPs 
(doctors, pharmacists and nurses) and healthcare students, were included. 
 
3.2.2.2 Phenomena of interest 
While there was no intervention (as for reviews of effectiveness or cost-
effectiveness), the review considered studies that investigated the phenomenon 
of medication wastage from a number of different perspectives (e.g. doctors, 
nurses, pharmacists).  
 
3.2.2.3 Comparators 
There were no comparators in this systematic review. 
 
3.2.2.4 Outcomes 
• Methodological quality of the literature related to medication wastage 
• Definition and scope of medication wastage 
• Documented factors associated with or contributing to medication wastage 
• Any outcome related to reduction of medication wastage 
 
3.2.2.5 Study design 
All study designs using any methodological approach, including qualitative, 
quantitative and mixed, were considered. Primary research studies, reviews, 
systematic reviews and meta-analysis were included. 
 
3.2.2.6 Language 
Limiters were used in databases to include only English language records. Due to 
time constraints it was thought to be impractical to engage a translator to 
translate non-English literature.  
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3.2.2.7 Date limit 
The search was limited to literature dated from 1970 to the present. During the 
scoping review, no key studies were identified preceding 1970 and hence this 
date limit was chosen. 
 
3.2.3 Exclusion criteria 
Studies describing medical wastage (not pharmacologically related e.g. clinical 
tissue waste and medical devices) and studies focusing solely on medication 
storage and disposal were excluded. Studies focusing solely on the potential 
impact of medication wastage on the environment were also excluded. Studies 
reported in non-English language (the number of such studies was recorded), 
grey literature and conference abstracts were also excluded as information was 
considered to be incomplete.  
 
3.2.4 Search Strategy 
The search was applied to five relevant databases: Cumulative Index to Nursing 
& Allied Health Literature (CINAHL) (EBSCO Publishing, 2011), Embase (Elsevier, 
2011), Medline (U.S. National Library of Medicine, 2011), PubMed (National 
Center for Biotechnology Information, 2011), Science Citation Index (SCI) (Web 
of Science®, 2011), and The Cochrane Library (The Cochrane Collaboration, 
2010). The search commenced at the start of June 2011 and was completed by 
the end of September 2011. 
 
CINAHL includes some nursing and allied health journals not included in Medline. 
Embase covers over 24 million indexed records with more than 7,500 journals; 
2,000 biomedical titles are not offered by Medline. Medline offers over 18 million 
references to journal articles, with approximately 5,516 worldwide journals. 
Medline covers core biomedical subjects; 2,000 journals are not offered by 
Embase. PubMed comprises over 20 million citations; it is a free resource and 
provides access to older references. Moreover, PubMed records entries in 
advance of Medline indexing. SCI includes cited reference searching, with records 
listing references from original record. The Cochrane Library is a collection of six 
databases, including a database of systematic reviews containing a high level of 
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evidence. The search strategy was adapted to meet the specifications of the 
different databases as described in Appendix 3.1. 
 
Study selection was carried out by an initial screening of all titles, followed by 
screening of abstracts and by full paper screening against systematic review aim 
and inclusion/exclusion criteria. Reference lists were scrutinised and any 
additional relevant titles included. During the title and abstract screening phases, 
inter-rater reliability was confirmed by two independent researchers (first author 
and one of the other authors) comparing a random sample of 10% of titles and 
abstracts. 
 
3.2.5 Quality assessment and data extraction 
Quality assessment was performed using two quality assessment forms which 
were adapted from standard sources, each specific for primary quantitative 
studies or literature reviews (Kmet et al., 2004; Koufogiannakis et al., 2006; 
Public Health Resource Unit, 2006; Young and Solomon, 2009) (Appendix 3.2). 
These modified forms were pilot tested on 10% of the sample of reports to 
identify any further modifications required. Data extraction tools were developed 
and included information pertinent to the review aim (Appendix 3.3). Papers 
were reviewed for quality and data extracted by the principal researcher (first 
author) and independently by a second researcher (one of the other authors). 
Any inconsistencies amongst the two reviewers were resolved by consensus.  
 
3.2.6 Data synthesis 
Due to differences in study design and the heterogeneous nature of reported 
data, a meta-analysis was considered inappropriate. A narrative synthesis 
approach was used to highlight methodological quality and study findings. 
Attention was paid to the robustness of the synthesis in terms of methodological 
quality of the included studies and/or the credibility of the product of the 
synthesis process by reflecting critically on the synthesis process (Centre for 
Reviews and Dissemination, 2009). A conclusion was then generated relating to 
the review aim (Brien et al., 2010) and recommendations for further research 
provided. 
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3.3 Results 
3.3.1 Search results 
Forty-three papers (42 primary quantitative studies and one literature review) 
were identified. The Prisma flowchart (Liberati et al., 2009) is given in Figure 3.1. 
A total of 20,356 titles were retrieved from all databases, of which 6,199 were 
duplicates within the same databases, leaving 14,157 titles to be screened. Of 
these, 13,450 were excluded as they were not related to medication wastage. A 
further 274 were duplicates between different databases and were also excluded. 
Four hundred and thirty-three abstracts were screened, of which 376 were 
excluded giving a resultant 57 relevant papers. Following full paper screening, 31 
fulfilled the inclusion criteria, with another 12 papers derived from the references 
of these, resulting in a total of 43 for critical appraisal. The list of included papers 
is presented in Appendix 3.4, whilst excluded studies and the reasons for 
exclusions are presented in Appendix 3.5. 
 
The review by White (2010) focused on economic modelling rather than on 
contributing factors hence was excluded from the systematic review. Critical 
appraisal and data extraction was performed for 42 studies (no studies were 
excluded on the basis of quality). Papers were published between 1975 and 
2010. 
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Identification 
 
 
 
 
 
Screening 
 
Eligibility 
 
 
 
 
Included 
Figure 3.1: Prisma diagram of inclusion and exclusion of identified published 
literature for systematic review 
(*Number of titles screened after duplicates from each database removed 
+274 titles were duplicates in between different databases and were removed 
** One other paper could not be retrieved 
 
3.3.2 Study design  
The 42 studies were all of cross-sectional design, with most using a 
questionnaire as the data collection tool. Studies largely focused on medication 
returns, with 31 (74%) (Halloran et al., 1978; David et al., 1979; Henderson, 
1984; Longmore et al., 1990; Kiyingi and Lauwo, 1993; Longmore et al., 1995; 
Cook, 1996; Hawksworth et al., 1996; Isacson and Olofsson, 1999; Bronder and 
Klimpel, 2001; Grant, 2001; Abou-Auda, 2003; Ekedahl, 2003; Ekedahl et al., 
2003; Wasserfallen et al., 2003; Garey et al., 2004; Wongpoowarak et al., 2004; 
Langley et al., 2005; Zargarzadeh et al., 2005; Ekedahl, 2006; Abahussain and 
Ball, 2007; Al Siyabi and Al Riyami, 2007; Mackridge and Marriott, 2007; 
Mackridge et al., 2007; Braund et al., 2008; Coma et al., 2008; Braund et al., 
Database 
Search 
CINAHL 
n=252 
PubMed 
n=9,154 
EMBASE 
n=1,125 
MEDLINE 
n=680 
Cochrane 
n=2,094 
SCI 
n=7,051 
Abstract 
screening n=433 
Total titles* 
n=14,157 
Declined  
n=13,450+274+ 
Declined 
n=376 
Paper screening 
n=56** 
Papers accepted 
n=31 
Papers from 
references n=12 
Total papers 
included n=43 
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2009a; James et al., 2009; Guirguis, 2010; Pervanas et al., 2010; Sweileh et al., 
2010) quantifying medication wastage in terms of packages, containers, items, 
or units returned over the period of collection.  
 
The majority of the studies which quantified medication wastage (18/40) were 
undertaken in a community pharmacy setting (David et al., 1979; Harris et al., 
1979; Longmore et al., 1995; Cook, 1996; Hawksworth et al., 1996; Boivin, 
1997; Isacson and Olofsson, 1999; Bronder and Klimpel, 2001; Grant, 2001; 
Ekedahl, 2003; Ekedahl et al., 2003; Garey et al., 2004; Ekedahl, 2006; Braund 
et al., 2007; Braund et al., 2008; Coma et al., 2008; Braund et al., 2009a; 
James et al., 2009) whilst three were set in both community pharmacies and GP 
surgeries (Langley et al., 2005; Mackridge and Marriott, 2007; Mackridge et al., 
2007). Hospital pharmacy was the setting in another four studies (Henderson, 
1984; Abahussain et al., 2006; Al Siyabi et al., 2007; Guirguis, 2010) and two 
used both community and hospital pharmacies (Bradley and Williams, 1975; 
Longmore et al., 1990). Nine studies were performed in participants’ households 
(Halloran et al., 1978; Kiyingi and Lauwo, 1993; Abou-Auda, 2003; Wasserfallen 
et al., 2003; Wongpoowarak et al., 2004; Subratty and Hassed Nathire, 2005; 
Zargarzadeh et al., 2005; Abahussain and Ball, 2007; Sweileh et al., 2010), 
three in a retirement community/local health plan facility (Brown and Kirk, 1984; 
Morgan, 2001; Pervanas et al., 2010) and one via a Poisons Centre website 
(Braund et al., 2009b). The two studies which investigated instalment dispensing 
as a potential solution to reduce medication wastage were carried out in a 
general medical practice (Millar et al., 2003; Millar et al., 2009). 
 
3.3.3 Quality assessment results 
The methodological strengths and weaknesses of the included papers are 
reported in Table 3.1 (first 21 studies) and Table 3.2 (the other 21 studies). Y 
means 'Yes' and indicates that the study fulfils the respective quality assessment 
question. 'P' refers to 'Partial' and indicates that the study partially fulfils the 
question. 'N' refers to 'No' which means that the study did not fulfil the criterion, 
'U' means the study was 'Unclear' in the respective criterion and 'N/A' means the 
question was 'Not applicable' for the particular study. 
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Table 3.1: Methodological strengths and weakness of studies regarding medication wastage  
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1. Did the study ask a clearly-focused and 
relevant question(s) (aims, objectives)? 
Y Y Y Y Y N P Y P Y N Y Y P P N Y Y Y Y Y 
2. Was a definition of waste described? N N Y N N N N N N N N N N N N N N N N N N 
3. Was the definition of waste for this study 
clearly explained? 
N N Y P P P P N P Y P P P P N Y P P Y P P 
4. Was ethics approval reported? Y N N N N N Y N N N N N N N N N N Y N N N 
5. Was the study design/method justified 
and appropriate for the research 
question(s)? 
P N Y P P P P P P P P Y Y P P P P P Y P Y 
6. Were limitations of study design/method 
considered? 
P P N P N N P P P P N P P N N N Y P N Y N 
7. Was the sampling population and 
strategy clear and justified? 
P P N P N P P Y P Y Y P P Y P P P P N N P 
8. Was the sample size justified? N Y N N N N N N N N N N P P P N P P N N N 
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9. Were participant recruitment strategies 
clearly described? 
P P N N N N P Y Y Y N Y Y Y Y N N Y Y P N 
10. Were the data collection tools 
described, piloted and validated? 
P Y Y P P N P P P P P P P P P N Y P P N P 
11. Were analysis strategies (quantitative 
and any open comments) clear and 
justified? 
N N P N N Y P Y N P N P P P N P P N P P P 
12. Were participant characteristics 
sufficiently described? 
N Y N P N N P P N P N N Y N N N P N N N N 
13. Is the loss of any of the participants 
explained? 
NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Y NA NA NA 
14. Are the results of the study clearly 
explained and do the results address the 
original research question? 
P Y P P P Y Y Y P Y P P Y Y Y P P P P P Y 
15. Were limitations (bias, confounders, 
generalizability etc.) of findings considered? 
P P N N N N Y Y N Y N N P N P P Y P Y Y P 
16. Were all important outcomes considered 
so the results can be applied? 
P P Y N N Y Y Y P Y P P P Y Y P Y Y P P Y 
17. Are the conclusions supported by the 
findings? 
P Y Y N N N Y Y P Y P P Y Y Y N P Y Y P N 
18. Is conflict of interest reported? Y N N N N N Y Y N Y N N N N N N N N N Y N 
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Table 3.2: Methodological strengths and weakness of studies regarding medication wastage  
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1. Did the study ask a clearly-focused and 
relevant question(s) (aims, objectives)? 
P P U Y Y Y N Y P P Y P P Y Y P Y Y Y Y Y 
2. Was a definition of waste described? N N N N N N N N N N N N N N N N N N N N N 
3. Was the definition of waste for this study 
clearly explained? 
Y N P P P P P P P P P Y N N Y Y N Y Y P Y 
4. Was ethics approval reported? N N N N N N N N N N Y Y Y Y Y N N Y Y N Y 
5. Was the study design/method justified 
and appropriate for the research 
question(s)? 
Y P P Y Y Y P Y P Y Y Y N Y P P P Y Y P Y 
6. Were limitations of study design/method 
considered? 
Y N P N P N N P P P Y P N Y Y P N N P Y P 
7. Was the sampling population and 
strategy clear and justified? 
P N P N Y Y P P P P Y Y U P P Y P P Y Y Y 
8. Was the sample size justified? N N N N N N Y N N N P P N Y N N P N N Y Y 
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9. Were participant recruitment strategies 
clearly described? 
P Y Y Y N P Y Y Y Y Y Y Y Y Y Y Y P Y P Y 
10. Were the data collection tools 
described, piloted and validated? 
P N P P N P P P P P P P N Y P N P P P Y P 
11. Were analysis strategies (quantitative 
and any open comments) clear and 
justified? 
P N N N P Y P N P P P P N N N N P P Y Y Y 
12. Were participant characteristics 
sufficiently described? 
N N Y N P N N Y N N P Y Y N Y N Y Y Y Y Y 
13. Is the loss of any of the participants 
explained? 
NA NA Y NA NA NA Y NA NA NA NA NA Y Y NA NA NA NA NA NA NA 
14. Are the results of the study clearly 
explained and do the results address the 
original research question? 
Y P Y Y Y P P Y Y Y Y Y N P P P P Y Y Y Y 
15. Were limitations (bias, confounders, 
generalizability etc.) of findings considered? 
Y N P P N Y N Y N N Y Y P Y Y N N P P Y N 
16. Were all important outcomes considered 
so the results can be applied? 
P N Y Y Y Y P Y Y Y Y Y N Y Y P Y Y Y Y Y 
17. Are the conclusions supported by the 
findings? 
N P N P Y P P P Y Y Y Y N Y P P Y Y Y Y Y 
18. Is conflict of interest reported? N N N N N N N N N N Y N N Y N N N N N N N 
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Results of the quality assessment of these studies are given in Figure 3.2, 
highlighting that while 62% (n=26) stated a clear research aim (Brown and Kirk, 
1984; Henderson, 1984; Boivin, 1997; Isacson and Olofsson, 1999; Grant, 2001; 
Morgan, 2001; Abou-Auda, 2003; Ekedahl et al., 2003; Wasserfallen et al., 
2003; Garey et al., 2004; Wongpoowarak et al., 2004; Langley et al., 2005; 
Subratty and Hassed Nathire, 2005; Zargarzadeh et al., 2005; Abahussain et al., 
2006; Ekedahl, 2006; Abahussain and Ball, 2007; Al Siyabi and Al Riyami, 2007; 
Braund et al., 2007; Mackridge and Marriott, 2007; Coma et al., 2008; Braund et 
al., 2009a; James et al., 2009; Millar et al., 2009; Guirguis, 2010; Sweileh et al., 
2010), 40% (n=17) adopted an appropriate research design (Halloran et al., 
1978; Brown and Kirk, 1984; Henderson, 1984; Longmore et al., 1995; Isacson 
and Olofsson, 1999; Grant, 2001; Abou-Auda, 2003; Wasserfallen et al., 2003; 
Garey et al., 2004; Langley et al., 2005; Zargarzadeh et al., 2005; Mackridge 
and Marriott, 2007; Mackridge et al., 2007; Coma et al., 2008; James et al., 
2009; Millar et al., 2009; Sweileh et al., 2010). Research design was considered 
to be partial or inappropriate for those studies where the method was limited and 
did not target all of the study’s objectives. Two percent (n=1) defined medication 
wastage or related terms (Abou-Auda, 2003) and 12% (n=5) justified sample 
size (Kiyingi and Lauwo, 1993; Wongpoowarak et al., 2004; Zargarzadeh et al., 
2005; Abahussain et al., 2006; Millar et al., 2009).
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Figure 3.2: Stacked bar chart representing quality of quantitative studies 
 
3.3.4 Definition and scope of medication wastage 
A general definition of medication wastage (or related terms) was reported only 
in one (Abou-Auda, 2003, p.1277) primary research paper (2%) and stated that 
medication wastage refers to "any drug product, either dispensed by a 
prescription or purchased over-the-counter (OTC) that is never fully consumed. 
Medication wastage may be due to poor compliance of patients, excessive and 
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irrational prescribing, or the lack of control of the sales of prescription 
medications in the community pharmacy".  
 
The type of wastage that was being studied was described clearly in eleven 
papers (26%) (Halloran et al., 1978; Morgan, 2001; Abou-Auda, 2003; Ekedahl, 
2003; Wasserfallen et al., 2003; Garey et al., 2004; Zargarzadeh et al., 2005; 
Braund et al., 2007; Mackridge et al., 2007; Pervanas et al., 2010; Sweileh et 
al., 2010) with little consistency between studies. While all eleven referred to 
‘medication’, five explicitly described medication as ‘prescribed and OTC 
medications’ (Abou-Auda, 2003; Wasserfallen et al., 2003; Garey et al., 2004; 
Zargarzadeh et al., 2005; Pervanas et al., 2010). Some studies mentioned 
possible causative factors within the scope of the definitions for their study, 
which is the main focus of this study. Four made reference to the ‘expiry date’ in 
the definition for their study (Halloran et al., 1978; Morgan, 2001; Zargarzadeh 
et al., 2005; Sweileh et al., 2010), with Halloran et al. (1978, p.85) referring to 
wastage as “drugs which are no longer in use because ... the expiry date of the 
drug is passed (or it was thought to be too old)”, Morgan (2001, p.779) stating 
that in their study wastage was defined as “any medication prescribed within the 
past year that the study participant did not intend to use before its expiration 
date”, Sweileh et al. (2010, p.60) referring to medication wastage in their study 
as "any drug product that had expired or had no clear expiration date or not 
being used at all” and Zargarzadeh et al. (2005, p.972) describing medication 
wastage as "any medication (prescription or over-the-counter [OTC]) that had 
expired or did not have a clear expiration date on the labelling or package". 
 
Abou-Auda (2003) made reference to patient ‘non-adherence’, to ‘excessive and 
irrational prescribing’ and to the ‘lack of control of the sales of prescription 
medications in the community pharmacy’ in their definition of medication 
wastage for their study. These inconsistencies limited any direct inter-study 
comparisons. 
 
3.3.5 Factors associated with or contributing to medication wastage 
Table 3.3 summarises studies reporting reasons for medication wastage. Thirteen 
studies (31%) (Cook, 1996; Hawksworth et al., 1996; Morgan, 2001; 
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Wongpoowarak et al., 2004; Langley et al., 2005; Abahussain et al., 2006; 
Ekedahl, 2006; Mackridge and Marriott, 2007; Braund et al., 2008; Coma et al., 
2008; Braund et al., 2009a; Braund et al., 2009b; James et al., 2009) 
investigated reasons associated with or contributing to wastage that were given 
by patients or their carers. Eight were surveys amongst patients or someone on 
their behalf (Cook, 1996; Abahussain et al., 2006; Braund et al., 2008; Braund 
et al., 2009b; James et al., 2009), customers returning medicines (Coma et al., 
2008; Braund et al., 2009a) and retirement community residents (Morgan, 2001) 
ranging from 73 retirement community residents (Morgan, 2001) to 653 
individuals returning medicines (Braund et al., 2009a). Three were interviews of 
individuals from households (n=523) (Wongpoowarak et al., 2004), individuals 
returning medications to pharmacies and GP surgeries (n=not specified) (Langley 
et al., 2005), and patients (n=1,022) (Ekedahl, 2006). It was not clear whether 
the study by Hawksworth et al. (1996) (n=366 patients) and Mackridge and 
Marriott (2007) (n=910 patients) was an interview or self-reported survey. None 
of the studies focused on collecting data from prescribers, other HCPs, or 
stakeholders. 
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Table 3.3: Study design of papers included in the systematic review 
Authors  
Year, Country 
Setting and duration 
of data collection 
Method of data collection Findings (the 3 most commonly 
reported reasons for wastage) 
Abahussain, Ball, 
Matowe 2006, 
Kuwait 
Outpatient ambulatory 
pharmacies at 5 large 
public hospitals 
Duration: 4 months 
Cross-sectional questionnaire (n=300 
patients or family members) 
1. Medication changed or discontinued 
by doctor  
2. Excessive stock   
3. Self-discontinuation of the 
medication  
Braund, Chuah, 
Gilbert, Gn, Soh, 
Tan, Tiong, Yuen 
2008, New Zealand 
Pharmacies 
Duration: 5 weeks 
Cross-sectional questionnaire (n=126 
patients), collation of returned 
medications (n=163 patient 
medication returns) 
1. Medication changed  
2. Passed expiry date 
3. Condition improved/resolved 
 
Braund, Gn, 
Matthews 2009a, 
New Zealand 
31 community 
pharmacies 
Duration: 4 weeks 
 
 
Cross-sectional questionnaire (n=653 
individuals returning medications), 
collation of unwanted medications 
(n=1605 patient medication returns) 
1. Passed expiry date 
2. Medication changed  
3. Condition resolved 
 
Braund, Peake, 
Shieffelbien 2009b, 
New Zealand 
New Zealand National 
Poisons Centre website  
Duration: 3 months 
Online survey (n=452 individuals) 
 
1. Condition resolved 
2. Medication changed  
3. Excess supplied 
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Coma, Modamio, 
Lastra, Bouvy, 
Mariño 2008, Spain 
38 randomly selected 
community pharmacies 
Duration: 3 months 
Cross-sectional questionnaire (n=227 
customers), collation of returned 
medications (n=227 patient 
medication returns) 
1. Passed expiry date 
2. Condition improved/resolved  
3. Patient's death  
 
Cook 1996, 
England 
17 pharmacies 
Duration: 1 month 
 
Cross-sectional questionnaire (n=133 
patients or someone on their behalf),  
Response rate: n=123 patients or 
someone on their behalf), collation of 
returned medications 
1. Patient's death 
2. Medication changed 
3. Passed expiry date  
 
Ekedahl, 2006, 
Sweden 
 
 
 
A random sample of 
the 59 pharmacies in 
Sweden 
Duration: Until number 
of interviews 
completed 
Cross-sectional study (n=1,557 
patients), interviews with patients 
returning medications (n=1,022 
patients), collation of returned 
medications (n=1,001 patient 
medication returns) 
1. Passed expiry date 
2. Patient's death 
3. Condition improved/resolved  
 
Hawksworth, 
Wright, Chrystyn 
1996, England 
30 community 
pharmacies  
Duration: 1 month 
Cross-sectional questionnaire (n=366 
patients), collation of medications 
1. Patient's death 
2. Medication changed  
3. Excessive stock  
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James, Helms, 
Braund 2009, New 
Zealand 
24 community 
pharmacies 
Duration: 6 weeks 
 
Cross-sectional study (response rate 
not specified), collation of returned 
medications (n=716 patient 
medication returns) 
1. Unknown  
2. Patient's death  
3. Surplus to requirements 
4. Medication changed  
Langley, Marriott, 
Mackridge, 
Daniszewski 2005, 
England 
8 community 
pharmacies and 5 GP 
surgeries 
Duration: 4 weeks 
Cross-sectional observational study 
(number of patients not specified), 
collation of returned medications 
(n=114 patient medication returns) 
1. Medication changed or discontinued 
by doctor  
2. Excess supplied or clear out  
3. Patient's death 
Mackridge, Marriott 
2007, England 
51/60 pharmacies and 
42/61 GP surgeries 
Duration: 8 weeks 
Cross-sectional study (n=910 
patients), collation of returned 
medications (n=910 patient 
medication returns) 
1. Patient's death,  
2. Clear-out of old or expired 
medications 
3. Medication changed  
Morgan 2001, New 
Hampshire USA 
A convenience sample 
of a retirement 
community of residents 
age 65 years or older 
Duration: 7 months 
Cross-sectional questionnaire (n=73 
retirement community residents), 
collation of unwanted medications 
1. Condition resolved 
2. Patient-perceived ineffectiveness 
3. Medication changed by doctor 
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Wongpoowarak, 
Wanakamanee, 
Panpongtham, 
Trisdikoon, 
Wongpoowarak, 
Ngorsuraches 
2004, Thailand 
 
Households 
Duration: In 2000 
 
 
Cross-sectional interview 
questionnaire (n=931 households), 
households with unused medications 
(n=453 households), response rate: 
n=523 individuals  
1. Patients’ perception that their 
symptoms or disease had resolved 
2. Patients perceived their condition as 
mild and that it was unnecessary to 
take all of their medications 
3. Patients perceived that the person 
dispensing the medication did not 
emphasise that all of the medications 
should be used 
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The most commonly cited reasons are given in Figure 3.3 highlighting the number 
of studies reporting ‘medication changed’ (Cook, 1996; Hawksworth et al., 1996; 
Morgan, 2001; Langley et al., 2005; Abahussain et al., 2006; Mackridge and 
Marriott, 2007; Braund et al., 2008; Braund et al., 2009a; Braund et al., 2009b; 
James et al., 2009), ‘patient’s death’ (Cook, 1996; Hawksworth et al., 1996; 
Langley et al., 2005; Ekedahl, 2006; Mackridge and Marriott, 2007; Coma et al., 
2008; James et al., 2009), ‘resolution of patient's condition’ (Ekedahl, 2006; 
Mackridge and Marriott, 2007; Braund et al., 2008; Coma et al., 2008; Braund et 
al., 2009a; Braund et al., 2009b) and ‘expired medications’ (Cook, 1996; Ekedahl, 
2006; Mackridge and Marriott, 2007; Braund et al., 2008; Coma et al., 2008; 
Braund et al., 2009a). The most commonly cited reason was ‘medication changed’ 
by the prescriber (Cook, 1996; Morgan, 2001; Langley et al., 2005; Abahussain et 
al., 2006; Mackridge and Marriott, 2007). Braund et al. (2008) reported that the 
main reasons for change in patients’ medication were due to side-effects of the 
medication and ineffectiveness of the medication in treating the condition. Other 
studies (Hawksworth et al., 1996; Coma et al., 2008; Braund et al., 2009a; Braund 
et al., 2009b; James et al., 2009) stated that the ‘medication was changed’ to 
another treatment but did not specify who made the change. Coma et al. (2008) 
also reported that physicians primarily discontinued patient medications, followed by 
self-discontinuation by the patients. Self-discontinuation was reported for a number 
of reasons mainly (Wongpoowarak et al., 2004): 
• Patients’ perceptions that their symptoms or diseases had resolved 
• Patients’ perceptions that their conditions were mild hence unnecessary to take 
all of their medications 
• Patients’ perceptions that HCPs did not emphasise that all of the medications 
should be used.  
 
Key limitations of these studies are that these factors were based on self-reports by 
patients or someone on their behalf, with no HCP perspective. None of the studies 
applied statistical analysis of association of demographic variables (univariate or 
multivariate analysis) with the outcome of wastage.  
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Figure 3.3: Number of times a reason was cited in different publications 
 
3.3.6 Interventions to reduce wastage 
Only two studies (5%) (Millar et al., 2003; Millar et al., 2009) were identified 
reporting wastage as a research outcome measure following intervention. Both 
studies described community pharmacy instalment dispensing as a potential 
solution to reduce medication wastage. During a four-month study period by Millar 
et al. (2003), doctors issued an ‘instalment prescription’ for any newly prescribed 
medication to be taken for longer than two weeks, which was subsequently 
dispensed in instalments (period of instalment was not specified) following 
discussion between patient and pharmacists. Medication not dispensed (reasons 
could include adverse events, medication not required etc.) were recorded. 
Medication was stopped by doctors in 20.6% of occasions whilst pharmacists 
advised 10 patients to stop their medication, both on account of adverse drug 
reactions. Forty-six patients left instalments in the pharmacy with a total of £475.90 
worth of drugs remaining undispensed. It was not reported how this cost was 
calculated. Millar et al. (2003) concluded that instalment dispensing for newly 
prescribed medication to be taken for more than two weeks could be a useful 
method of reducing medication wastage, thereby reducing the overall general 
practice drugs bill. 
 
10
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Medication changed
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Resolution of patient's condition
Passed expiry date
Unknown
Excessive stock
Self-discontinuation
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In a later study, Millar et al. (2009) reported a randomised controlled design. 
Intervention and control group patients required a ‘new’ medication of more than 3 
weeks duration. The intervention comprised instalment dispensing of an initial 14 
day supply followed by pharmacist assessment and supply of the remainder of the 
medication (if tolerated), with the control group receiving the full quantity on initial 
presentation of the prescription. Seven patients did not return to collect the 
remainder of their prescription, while 13 patients out of the 54 who completed the 
1-month follow-up (24%) reported that they had discontinued their medication. 
There were no reports on quantity of undispensed medication. There was an 
average difference between prescribed and dispensed drug costs of £0.98 per 
patient (95% confidence interval £0.14–£1.82), calculated by subtracting the 
dispensed costs £12.63 (8.96–16.30) from the prescribed costs £13.61 (9.86–
17.37) of medication. However, there were no direct measures of reduction in 
wastage; therefore, reduction in costs cannot be equated to reduction in medication 
wastage. 
 
3.4 Discussion 
3.4.1 Key findings  
The aim of the systematic review was to appraise critically, synthesize and present 
the available evidence on the possible causative factors associated with medication 
wastage in all populations and settings and the effectiveness of any interventions 
focusing on wastage reduction as an outcome measure.  
 
The sampling population and strategy was clear and justified in 12 studies and 
partially justified in 23. Sample size was only justified in five papers and partially 
justified in another eight studies. 
 
A definition of medication wastage was reported only in one of 42 papers. There was 
a significant lack of any standard definition for medication wastage. 
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The main reasons cited were ‘change in medication’, ‘patient's death’, ‘resolution of 
patient's condition’ and ‘passed expiry date’. Medication was primarily changed by 
the doctor. 
 
Studies which focused on potential solutions to reduce medication wastage 
described the implementation of instalment dispensing (Millar et al., 2003; Millar et 
al., 2009). Millar et al. (2003) concluded that instalment dispensing for newly 
prescribed medication to be taken for more than two weeks could be a useful 
method of reducing medication wastage, thereby reducing the overall general 
practice drugs bill. In the study by Millar et al. (2009) there were no direct 
measures of reduction in wastage; therefore, reduction in costs cannot necessarily 
be equated to reduction in medication wastage. 
 
3.4.2 Strengths and weakness of the systematic review 
This systematic review has a number of strengths and weaknesses. The strengths of 
this systematic review are the inclusion of a clearly focused research aim and the 
exhaustive search for evidence. The review protocol was developed in line with best 
practice and inter-rater reliability checks were undertaken at each stage of 
screening, critical appraisal and data extraction. Key gaps in the literature have 
been highlighted.  
 
Weaknesses include restricting the search to peer reviewed studies published in 
English and excluding grey literature. Using a narrative approach for the data 
synthesis may lack transparency and is more subjective than a meta-analysis 
approach hence bias is more likely to occur. 
 
3.4.3 Interpretation of findings 
This systematic review focused on the methodological quality and key findings of 
the research literature on medication wastage. As described, only thirteen studies 
reported reasons associated with or contributing to wastage. One key finding of this 
review is that studies were limited in terms of providing a standard definition for 
medication wastage with only five clearly justifying the sample size. Seventeen 
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studies had a fully justified method appropriate for the research question. All 
thirteen studies reporting reasons for wastage applied a positivist stance and did not 
utilise qualitative methods to explore in-depth factors which give rise to these 
reasons or situations associated with wastage. Studies also focused on the patient’s 
perspectives rather than any other stakeholder, such as HCPs. Despite these 
limitations, key recurring issues appear to be the accumulation of wastage due to 
change in medication and patient's death, followed by resolution of patient's 
condition and expired medication. There could be various reasons which warrant a 
change in medication, such as lack of effectiveness or an adverse event. These 
factors cannot be predicted and in such situations some wastage is inevitable, 
however, the amount of wastage will depend on the quantity of medication 
prescribed and dispensed. Before recommending a minimum supply to prevent 
excessive wastage, further cost-effective studies need to be undertaken to ensure 
that this does not incur additional costs through the need for subsequent healthcare 
visits to obtain further supply of medication.   
 
Notwithstanding the number of reasons that have been attributed as the cause of 
medication wastage, the factors responsible for these reasons such as the supply or 
presence of excessive stock or short expiry dates were not explored. Determining 
these factors will identify the root cause of wastage and can also aid to provide 
recommendations when implementing policies regarding medication wastage. 
Additionally, studies investigating medication inappropriateness as an indirect factor 
responsible for medication wastage were not identified. 
 
Despite the identified extensive literature on pharmaceutical care, few studies 
reported wastage as an outcome measure. Indeed, only two studies were identified 
which had specifically measured medication wastage following intervention. There is 
therefore a need to consider how interventions impact wastage. In addition, further 
attention should be paid to adopting standard definitions for medication wastage 
which would aid in the development of valid and reliable study outcome measures. 
However, while a more consistent approach would strengthen the research evidence 
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base, cognisance needs to be taken of the differences in healthcare systems, 
practices and cultures throughout the world. 
 
The findings of this systematic review should be interpreted with caution due to the 
small sample sizes and often convenience approaches to sampling of many of the 
included studies. There is a clear absence of qualitative research exploring wastage 
from the perspectives of key stakeholders (members of the public, patients, HCPs 
and policy makers). Such research would provide richness of data and allow 
exploration of the underlying factors associated with wastage.  
 
There are several areas which warrant further research: exploring wastage from the 
perspectives of key stakeholders; the use of qualitative research methods to gain 
detailed understanding of the context of wastage; case study approaches to 
research patient cases where wastage has been identified as a key issue; the 
attention given to wastage within undergraduate healthcare student educational 
programmes and continuing professional development (CPD) for professionals; and 
defining and standardising outcome measures. 
 
3.5 Conclusion 
The systematic review has identified a limited literature on medication wastage with 
a lack of consistency of terms. While studies reported change in medication, 
patient's death, resolution of patient's condition and expired medications as key 
causes of wastage, there is a paucity of robust research focusing on the impact of 
healthcare interventions on outcomes around medication wastage. 
 
3.6 Reflections and future direction  
Completion of the systematic review of the literature informed the next phases of 
the research. There was a clear need to use a robust approach to define and scope 
‘medication wastage’ prior to researching different perspectives on wastage. 
Furthermore, a paucity of research exploring issues relating to medication wastage 
from the perspectives of patients, HCPs or healthcare students, was identified. 
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Researching these perspectives, using a theoretical framework of behavioural 
change, would aid the development of interventions to reduce wastage. 
 
Research was therefore undertaken to define and scope ‘medication wastage’ in the 
Maltese context (chapter 4), and apply quantitative (chapter 5) and qualitative 
(chapter 6) approaches to researching individual perspectives.  
 
Identification of a lack of any standard definition of medication wastage, informed 
the next phase of the research which employed an expert panel consensus based 
approach to achieve agreement (Delphi technique) in relation to defining 
‘medication wastage’ in the context of the Maltese population (chapter 4). 
The systematic review also identified a lack of published literature related to 
awareness, perceptions, attitudes and behaviours of the general public, HCPs and 
students regarding medication wastage which were targeted through questionnaires 
described in chapter 5. 
 
A number of reasons have been attributed as the cause of medication wastage. 
Nonetheless, the factors responsible for these reasons such as the supply or 
presence of excessive stock or short expiry dates were not explored. In-depth 
assessment of potential factors leading to medication wastage was explored during 
focus groups with key stakeholders including the general public (chapter 6). 
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Chapter 4  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“The knowledge of anything, since 
all things have causes, is not 
acquired or complete unless it is 
known by its causes“ 
Avicenna 
[Philosopher, physician  
c. 980-1037] 
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Defining ‘medication wastage’ in the Maltese context: a 
Delphi technique 
 
 
One key finding of the systematic review discussed in chapter 3 was that studies 
were limited in terms of providing a standard, or indeed any, definition of 
‘medication wastage’. This chapter provides a detailed account of applying the 
Delphi technique to define the term ‘medication wastage’ and its scope in the 
Maltese context. Research aims and questions are described followed by 
consensus methods, results and discussion. 
 
4.1 Introduction 
4.1.1 Definition of medication wastage 
The lack of standardised terminology, and in particular inconsistencies around 
the definition and scope of ‘medication wastage’, limited direct inter-study 
comparisons when synthesising data from the systematic review studies. One 
consequence is a weakened evidence base, with potential limitation of 
generalizability of findings to other healthcare systems, practices and cultures. 
Prior to conducting research in Malta on aspects of medication wastage, it was 
essential to adopt a clear definition and detailed scope through consensus.    
 
Consensus, which could also be termed ‘collective agreement’, usually involves 
collaboration (Keeney et al., 2011) and its approaches are justified in the 
following situations: 
• Where unanimity of opinion does not exist and is sought in view of a lack of 
scientific evidence or where there is contradictory evidence on an issue (Jones 
and Hunter, 1995) 
• To enhance decision-making (Hasson et al., 2000), to develop guidelines 
(Hutchings et al., 2006), as well as develop policies and estimate unknown 
parameters (Campbell and Cantrill, 2001)  
• To develop diagnostic or review criteria (O’Brien et al., 2011) 
• To assess or develop quality indicators (Gill et al., 2012; Dancet et al., 2013) 
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4.1.2 Rationale for Delphi technique 
Of the three techniques described in chapter 2, the Delphi technique is the most 
commonly used in healthcare research (Moule and Goodman, 2014). Moreover, 
as opinions were to be sought from a number of individuals with diverse 
backgrounds, it was considered impractical, expensive and time consuming to 
organize face-to-face meetings. Group opinions are highly influenced by 
dominant participants and by the pressure to conform (Clayton, 1997). In light of 
these reasons, the NGT and the CDT were rejected.   
 
The Delphi paradigm meets three key characteristics: anonymity, iteration and 
controlled feedback. Woudenberg (1991) stated that the best-known structured, 
indirect interaction method is the Delphi technique. To formulate a definition of 
‘medication wastage’, subjective judgements and opinions should be gathered 
and agreed.  
 
4.1.3 Study aim and research questions 
The overall aim of this phase of the research was to apply the Delphi technique 
to define ‘medication wastage’ and its contributory factors in the context of the 
Maltese population. 
 
More specifically, this study sought to answer the following questions: 
1. Can consensus be achieved on the definition of medication wastage and views 
of factors contributing to wastage? 
2. If consensus is achieved: 
i. What is the consensus based definition for ‘medication wastage’? 
ii. What is the consensus view on the factors contributing to wastage? 
 
4.2 Delphi technique method 
4.2.1 Panel of experts 
The selection and recruitment of panellists is a crucial step in the Delphi 
technique. Scheele (2002) describes three types of panellists: the stakeholders, 
the experts and the facilitators. Elwyn et al. (2006) defines four types: decision 
aid developers and researchers, policy makers, health practitioners and patients. 
Hsu and Sandford (2007) discuss recommendations by Delbecq, Van de Ven, and 
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Gustafson to include three types: top management decision makers, professional 
staff members and their support team, and respondents who can provide 
judgement. The panel of experts in this study was composed of a heterogeneous 
sample of academics, practitioners, Government officials, officials of professional 
organizations, and patients, as recommended by Okoli and Pawlowski (2004).  
 
While there is little evidence for the appropriate panel size, Sandrey and Bulger 
(2008) argue that minimal change in reliability of findings is likely beyond 30 
members. They suggest a panel composed of 15-20 members from a 
homogeneous population and 5-10 members with a different social or 
professional background and level of expertise. Iljaž et al. (2011) discuss that 
the panel should include a high percentage of decision makers in the considered 
field. Notably, a large panel becomes difficult to coordinate, can become 
complicated and costly (Fink et al. 1984). Williams and Webb (1994) note that 
questionnaire response rate can decrease in inverse proportion to the size of the 
panel.  
 
The target recruitment number in this study was 26 representing mixed 
disciplines (academics, practitioners, Government officials, officials of non-
governmental professional organizations) and six patients representing a 
different level of social involvement.  
 
4.2.2 Recruitment of panellists 
An ‘invitation to participate letter’ (Appendix 4.1) was emailed to each member 
of the panel. Each member was given two weeks to accept participation, with the 
possibility of clarifying any queries with the researcher before enrolling and 
throughout the study period. All members completed a consent form (Appendix 
4.2). 
 
4.2.2.1 Academics 
In view of published research related to medication wastage, the two 
corresponding authors most cited in the systematic review (chapter 3) were 
invited by email to participate. 
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4.2.2.2 Government officials, practitioners, and officials of professional 
organizations 
Six government officials were asked to participate: the Health Minister, Shadow 
Health Minister, two other members of the Maltese parliament, the EU Health 
Commissioner and an EU official (or other nominations if unavailable). 
 
Four practitioners were chosen from the Maltese DoH and the Maltese Medicines 
Authority. The occupant of the highest position in the Malta Medicines Authority 
and DoH were asked to participate. If unable to participate, he/she were 
requested to nominate a potential replacement. These individuals were also 
requested to recommend another individual within their department or 
organization considered to be suitable in terms of either working directly on 
aspects of medication wastage or indirectly through experience with medication. 
Through this snowball sampling technique, further ‘expert’ individuals were 
identified for recruitment. 
 
The presidents of the following professional organizations were invited to 
participate and nominate another key individual within their organizations. In 
total, fourteen officials from the following organizations were invited to 
participate: 
• Pharmacists: Malta Chamber of Pharmacists, Malta College of Pharmacy 
Practice  
• Medical practitioners: Medical Association of Malta, Association of Physicians 
of Malta and the Malta College of Family Doctors 
• Dental surgeons: Dental Association of Malta 
• Nurses and midwives: Malta Union of Midwives and Nurses 
 
These were selected according to the Healthcare Professions Act of Malta (Health 
Care Professions Act Chapter 464, 2011) to represent general healthcare rather 
than specialised fields such as ophthalmology. From the three dental associations 
listed in the Healthcare Professions Act of Malta (Health Care Professions Act 
Chapter 464, 2011), only the Dental Association of Malta was chosen as this is 
the umbrella organization for dentistry in Malta, representing over 98% of 
registered dental surgeons in Malta. 
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4.2.2.3 Patients 
Six patients, who were members of voluntary patient associations or groups, 
were recruited. These had at least one chronic condition (minimum of two years) 
and receiving prescribed medication.   
 
Patients were selected from the six most prevalent chronic medical conditions in 
Malta, according to the DoH Information and Research (2008). Medication was 
grouped according to British National Formulary (British Medical Association and 
the Royal Pharmaceutical Society, 2012) chapters: cardiovascular, central 
nervous system (analgesics), musculoskeletal and joint, central nervous system 
(depression and anxiety), endocrine, and respiratory disease. Four associations 
were approached: the Cardiovascular Patient Group, the Association of Arthritis 
and Rheumatism of Malta (also covering analgesics), the Maltese Diabetes 
Association and the Asthma Society Malta. These were approached by phone or 
during group meetings and were asked to nominate a suitable patient(s) (two for 
cardiovascular and asthma). 
 
Table 4.1 describes the panel of experts invited to participate in this study. 
 
Table 4.1: Panel of experts invited to participate in Delphi technique  
Panel of 
experts 
Recruitment source Number of 
panellists 
Academics From journal 2  
Practitioners DoH and Medicines Authority 4  
Government 
Officials 
Ministries and EU officials 6 
Professional 
Organizations 
Malta Chamber of Pharmacists, Malta College of 
Pharmacy Practice, Medical Association of Malta, 
Association of Physicians of Malta, Malta College 
of Family Doctors, Dental Association of Malta, 
Malta Union of Midwives and Nurses 
14 
Patients Patient associations and patient groups 6 
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4.2.3 Delphi technique 
4.2.3.1 Consensus level 
As Sandrey and Bulger (2008) state, there is little guidance regarding the level 
of agreement required for consensus to be achieved. McKenna (1994) discusses 
that 51% agreement amongst panellists is considered consensus. Since there is 
no scientific evidence for setting consensus levels, a minimum level of 75% 
consensus was applied, as suggested by Keeney et al. (2006). 
 
4.2.3.2 Response rates 
Response rates in Delphi studies range from from 8% to 100% (Keeney et al., 
2011). While there is no universally agreed  minimum response rate for 
questionnaire based research, several recommend that rates of 75% and above 
are considered to be good (Bowling, 2009; Williams, 2003), with  below 60% low 
(Bowling, 2009). Low response rates in Delphi studies greatly compromise 
internal and external validity.  
 
A systematic review by Edwards et al. (2009) identified the following measures, 
amongst others, to enhance response rates of studies employing postal 
questionnaires: monetary and non-monetary incentives; unconditional 
incentives; pre-study notification as well as follow-up contact; shorter 
questionnaires; providing a second copy of the questionnaire at follow-up; 
mentioning an obligation to respond and university sponsorship; personalised 
invitations; hand-written addresses; use of stamped return enveloped; use of 
coloured as opposed to blue or black ink; and an assurance of confidentiality.  
 
In this study, an e-Delphi approach was employed, which is similar to the 
classical Delphi but is administered by email. Measures to enhance response 
rates of studies employing electronic questionnaires include: non-monetary 
incentives; lottery with immediate notification results; shorter e-questionnaires; 
including a statement that others had responded; a more interesting topic; use 
of a white background; an offer of survey results; personalised invitations; a 
simple header; including a picture; textual representation of response 
categories; and giving a deadline for response (Edwards et al., 2009).  
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Relevant elements from both postal and electronic questionnaire measures were 
adopted: consise questionnaires with a white background; personalised covering 
letters; an ‘invitation to participate’ letter to pre-inform participants; support of a 
scholarship through MGSS; reassurance of confidentiality throughout; 
personalised reminder emails with the link to the questionnaire; and an 
extension of deadlines when requested or required.  In addition, a key element 
of the Delphi technique is to provide all panellists with detailed responses from 
each round. 
 
4.2.3.3 Controlled feedback 
The rationale for providing controlled feedback is to inform the panel members of 
all panellists’ views, providing opportunity to reflect and either confirm or alter 
their responses in subsequent rounds (Campbell and Cantrill, 2001; Skulmoski et 
al., 2007). Response and any comments generated are anonymised when 
providing feedback.  
 
4.2.4 Delphi round 1 questionnaire  
The questionnaire contained four open-ended questions, derived from the 
findings of the systematic review in chapter 3. Panellists were requested to 
propose a definition for ‘medication wastage’ and to list possible contributing 
factors. They were given an initial two week deadline and a subsequent one week 
extension.  
 
4.2.4.1 Pilot study of round 1 questionnaire 
Prior to round 1, a pilot was conducted for several reasons: to identify and 
resolve any issues with the process of administering the Delphi questionnaire; to 
obtain feedback to allow refining of the open-ended questions; to familiarise the 
researcher with process of content analysis (Ryan and Bernard, 2003); and to 
overall increase study robustness thereby increasing the likelihood of a well-
constructed and content-valid questionnaire (Davis, 1992; Clibbens et al., 2012).  
 
Pilot testing was undertaken with a convenience sample of six (one medical 
practitioner, one pharmacist, one nurse, two academics and one patient). 
Findings indicated that questions were clear, not too complex, taking around 20 
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minutes to answer and the process of administration was appropriate. No 
amendments to the questionnaire were necessary. 
 
4.2.4.2 Conduct of round 1  
A covering letter (Appendix 4.3) was emailed, along with the URL link to the 
questionnaire (Appendix 4.4), describing the study and its importance, stating 
the anticipated number of rounds and potential time commitment.  
 
4.2.4.3 Analysis of round 1 
Textual responses generated were analysed using a content analysis approach. 
Responses were read several times and similar responses grouped into themes 
and sub-themes. Similarities and differences were highlighted by the use of: 
word repetitions, key-words, indigenous typologies, metaphors and analogies. 
 
4.2.5 Delphi round 2 questionnaire 
The round 2 questionnaire was structured comprising different definitions of 
medication wastage and statements around contributory factors derived from 
round 1 (Appendix 4.5). These had been reviewed and agreed by the research 
team. Panellists were given eight definitions and instructed to rank, in order of 
preference, the four definitions they considered most appropriate. They were 
then required to rate their levels of agreement or disagreement with each 
statement on a 5-point Likert scale (totally disagree, disagree, neither disagree 
nor agree, agree, totally agree) related to factors contributing to medication 
wastage. A two week deadline for completion of round 2 was given. 
 
4.2.5.1 Analysis of round 2 
Responses were analysed using descriptive statistics (frequencies and 
percentages) to determine the number of statements that have reached 
consensus at this stage. The statistical analysis generated, highlighting levels of 
consensus, was provided to each panellist with the subsequent questionnaire 
round along with the panellists’ additional verbatim comments. 
 
4.2.6 Delphi round 3 questionnaire 
The round 3 questionnaire included only those statements that did not meet 
consensus in round 2. Panellists were asked to reconsider their responses in light 
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of the feedback and again rate their levels of agreement. In addition, the 
definition of ‘medication wastage’ most highly ranked was presented  and 
panellists asked to rate their level of agreement on the 5-point Likert scale 
(Appendix 4.6). A two week deadline for completion was given. 
 
4.2.7 Promoting quality in research: validity and reliability 
Kanoute et al. (2014) suggests the use of an iterative multistage process, such 
as the Delphi technique, to clarify and strengthen quality of consensus. However, 
the Delphi technique has been criticised for lack of evidence of validity and 
reliability. Goodman (1987) states that if panellists are representative of the area 
of knowledge under investigation then content validity can be assumed. Others 
have suggested that, following the first Delphi round, researchers should send 
the consolidated lists and categories to panellists for their feedback to ensure 
validation. 
 
In the current study a number of measures were taken to promote validity and 
reliability: 
• A heterogenous panel 
• A pilot study was conducted 
• A peer debriefing was undertaken (Long and Johnson, 2000) 
• A clear decision trail was maintained throughout.  
 
4.2.8 Research Governance 
The study was approved by the School of Pharmacy and Life Sciences Research 
Ethics Committee, Robert Gordon University (Appendix 4.7) and the University of 
Malta Research Ethics Committee (Appendix 4.8). The UK Data Protection Act 
(DPA) (The National Archives, 1998), the Maltese DPA (Information and Data 
Protection Commissioner, 2001) as well as the EU Data Protection Directive (The 
European Parliament and the Council of the European Union, 1995) were adhered 
to at all times by the use of password protected databases accessible only by the 
principal researcher.  
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4.3 Results 
4.3.1 Panel of experts 
Out of the original 32 individuals invited to participate, 27 consented: one 
academic, four practitioners, three Government officials, thirteen officials of non-
governmental professional organizations and six patients. The panel composition 
is summarised in Table 4.2.  
 
One Government Member of Parliament and two from the opposition consented. 
No recommended EU officials were able to participate due to a busy schedule and 
perceived lack of expertise. One doctor and three pharmacists, all in leading 
positions, participated on behalf of the DoH and the Malta Medicines Authority. 
Only the president of one non-governmental professional organization declined 
participation, nominating another person. All others from non-governmental 
professional organizations consented: two pharmacists (also senior lecturers), 
one senior clinical pharmacist, one community pharmacist, three consultant 
physicians, two GPs, two dentists and two nurses. With regards to patients, two 
male members from the cardiovascular patient group, one female member of the 
rheumatology association, two female members from the asthma society and one 
male member of the diabetes association were recruited.   
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Table 4.2: Composition of the panel of experts (n=27) 
Panel of experts Male Female Total 
Academic 1 0 1 
Practitioners 
• Pharmacist 
• Doctor 
 
0 
0 
 
3 
1 
 
3 
1 
Government Officials 
(Members of 
Parliament) 
• Doctor 
• Nurse 
• Lawyer 
 
 
 
1 
1 
0 
 
 
 
0 
0 
1 
 
 
 
1 
1 
1 
Non-Governmental  
Professional 
Organizations 
• Pharmacist 
• Doctor 
• Dentist 
• Nurse 
 
 
 
0 
5 
2 
2 
 
 
 
4 
0 
0 
0 
 
 
 
4 
5 
2 
2 
Patients 3 3 6 
Total 15 12 27 
 
4.3.2 Round 1 Delphi technique 
Twenty-three panellists (85%) completed round 1; non-respondents were one 
practitioner, one representative of non-governmental organizations and two 
Government officials.  
 
4.3.2.1 Definition of medication wastage 
Four themes and ten sub-themes emerged which aided synthesis of definitions of 
‘medication wastage’. The themes, sub-themes and terms used by panellists are 
presented in Table 4.3 with the resultant eight definitions presented in Table 4.4.  
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Table 4.3: Themes and sub-themes for ‘medication wastage’ definition  
Key Theme Definition Terms used by panellists 
Theme 1 Unused/expired 
Sub-theme 
 
Sub-theme 
Sub-theme 
Unused medication  
 
Expired medication 
Fate of wastage 
“Not used”, “unused”, “partly used”, “no longer needed”, “not required”, 
“end up not being used” 
“Expired”, “expiry date”, “shelf life” 
“Thrown away”, “disposed of” 
Theme 2 Inappropriate medication and other reasons  
Sub-theme  
 
 
 
 
 
Sub-theme  
 
 
Sub-theme 
Inappropriate 
medication 
 
 
 
 
Educational need 
 
 
Other reasons which 
give rise to medication 
wastage 
“Inappropriate use”, “non-prescribing of better alternatives, more 
efficacious, better tolerated”, “the prescribing of ineffective medicines, 
inadequate dosage regimens, and inadequate dosage forms. In a 
pharmacogenomic/genetic scenario, the prescribing of medication to non-
responding patients”, “incorrect indications”, “over-consumption”, 
“unnecessary”, “misuse, abuse, under-use”, “when not really needed” 
“Education of all people concerned is important”, “extraordinarily stupid”, 
“lack of appreciation on the side of those who are in acute need of such 
resources” 
“In excess of his requirements”, “adherence”, “just for the sake of 
heaving a stock ready”, “patient behaviour”, “side effects”, “change in 
treatment”, “self-medication”, “non-adherence to guidelines (unjustified)”, 
“inappropriate prescribing”, “over-ordering”, “acquired free of charge” 
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Definition Key Themes Terms used by panellists 
Theme 3 Healthcare setting factors associated with wastage and other type of wastage 
Sub-theme 
 
 
 
Sub-theme  
 
 
Sub-theme 
Healthcare setting 
factors associated with 
wastage 
 
Type of medication 
wastage 
 
Indication for wasted 
medication 
“medication storage scenario, whether at wholesale distribution level, at 
hospital ward, inpatient and/or outpatient level, at community pharmacy 
level”, “health department and of course government”, “in situations”, 
“homes” 
“Dispensed”, “free by the state”, “bought”, “prescribed”, “selected”, 
“dispensing.... Issued.... purchased OTC”, “procurement”, “certain types 
of medicine” 
“It’s intended and scientifically justified scope”, “for a particular 
condition”, “intended for use in the diagnosis, cure, treatment, or 
prevention of disease”, “intended licensed or off-licensed purpose” 
Theme 4 Implications for the individual and society 
Sub-theme Financial implications for 
the individual and 
society 
“Resources and financial wastage”, “unnecessary waste of money”, “pays 
a heavy toll on the patients themselves, on the economy due to bad use 
of medication resources”, “tax payer is paying for it”, “I feel it eats a large 
piece of our financial system” 
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Table 4.4: Eight definitions of ‘medication wastage’ 
1. Medication wastage refers to any medication which expires or remains unused 
throughout the whole medicines supply chain. [Contains themes 1 and 3] 
2. Medication wastage refers to any medication which expires or remains unused 
throughout the whole medicines supply chain. Medication wastage also refers to 
the unnecessary or inappropriate consumption of medication by patients, or the 
unjustified non-adherence to treatment guidelines by HCPs. [Contains themes 1, 
2 and 3] 
3. Medication wastage refers to any medication which expires or remains unused 
throughout the whole medicines supply chain. Medication wastage also refers to 
the unnecessary or inappropriate consumption of medication by patients, or the 
unjustified non-adherence to treatment guidelines by HCPs. Medication wastage 
poses a financial burden on patients themselves and the state's economy and 
requires adequate education of all people concerned. [Contains themes 1, 2, 3 
and 4] 
4. Medication wastage refers to any medication which remains unused or partly 
used by patients and that needs to be disposed of, either because it is no longer 
needed or because it has passed its expiry date. Medication wastage also refers 
to the unnecessary or inappropriate consumption of medication by patients or 
incorrect prescribing and dispensing. [Contains themes 1, 2 and 3] 
5. Medication wastage refers to the financial burden on patients themselves and 
the state's economy due to bad use of medication resources. [Contains theme 4] 
6. Medication wastage refers to any medication that does not end up fulfilling its 
intended and scientifically justified scope before its expiry date or which is 
inappropriately prescribed or dispensed due to unjustified non-adherence to 
guidelines. [Contains themes 1, 2 and 3] 
7. Medication wastage refers to the excessive collection of any medication which 
is provided free of charge by the state on a periodical basis. [Contains themes 1 
and 2] 
8. Medication wastage refers to prescribed or OTC medication which is purchased 
or obtained free of charge which expires or remains unused. [Contains themes 1 
and 3] 
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Some panellists suggested alternative terms to ‘any medication’: 
Option 1: ‘prescribed or OTC medication’ 
Option 2: ‘medication intended for licensed or off-licensed purposes’ 
Option 3: ‘medication intended for use in the diagnosis, cure, treatment, or 
prevention of disease’. 
 
4.3.2.2 Views of factors contributing to wastage  
Twenty-one panellists did NOT consider medication commonly found in 
households and intended to be used only if required or in case of an emergency 
as wastage. The two panellists who agreed that these should be considered as 
wastage gave the following comments:  
• “… abusing of such medication would be considered as waste”.  
• “If medications are kept in large amounts that is still a waste”.  
 
Panellists' responses in relation to the maximum number of weeks of medication 
supply (based on regular consumption) that they considered acceptable to have 
in a household ranged from one week to more than 26 weeks as detailed in 
Figure 4.1. 
 
 
Figure 4.1: Number of weeks of medication supply suggested by panellists 
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Possible factors that give rise to medication wastage 
Content analysis of responses identified nine main themes and thirty-six sub-
themes (Tables 4.5, 4.6, 4.7 and 4.8). These are categorised as: ‘physical and 
environmental factors’; ‘social and psychological patient factors’; ‘cultural 
factors’; and ‘practitioner factors’. Sub-themes are listed in order of ranking, with 
the ones mostly cited listed first within each category. 
 
Table 4.5: Physical and environmental factors contributing to medication wastage 
Category 1 Physical and environmental factors 
Theme Storage and expiry dates 
Sub-theme 
Sub-theme 
Sub-theme 
Sub-theme 
Storage  
Expiry dates  
Lack of rotation  
Overstocking 
Theme Pharmacy logistics 
Sub-theme 
Sub-theme 
Sub-theme 
Sub-theme 
Returns not accepted  
Inadequate audit of consumption trends  
Inadequate information technology (IT) facilities  
Large pack sizes 
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Table 4.6: Social and psychological patient factors contributing to medication 
wastage 
Category 2 Social and psychological patient factors 
Theme Lack of patient education 
Sub-theme 
Sub-theme 
Sub-theme 
Sub-theme  
 
Sub-theme 
Sub-theme  
Sub-theme 
Sub-theme  
Hoarding 
Non-adherence 
Lack of patient knowledge and education 
Collecting more supply even though these medication are 
available at home 
Cost awareness 
Irresponsibility 
Patient's expectation 
Unnecessary self-medication 
Theme Fear of dependency by patient 
Sub-theme 
Sub-theme 
Sub-theme 
Fear of medication unavailability 
Dependency on others 
Refusal of treatment next time 
Theme Lack of communication regarding patient 
Sub-theme  
 
Sub-theme  
Sub-theme  
Lack of communication between primary and secondary 
healthcare 
Lack of communication between patients and healthcare system 
Other family members collecting supply 
Theme Patient's Death 
Sub-theme Patient's death 
 
Table 4.7: Cultural factors contributing to medication wastage 
Category 3 Cultural factors 
Theme Entitlement system 
Sub-theme 
Sub-theme 
Sub-theme 
Free system 
Out of stock 
Patient's right 
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Table 4.8: Practitioner factors contributing to medication wastage 
Category 4 Practitioner factors 
Theme Medication inappropriateness or cure 
Sub-theme 
Sub-theme 
Sub-theme 
Sub-theme 
Sub-theme 
Sub-theme 
Sub-theme 
Sub-theme 
Unnecessary medication by HCPs 
Adverse events 
Over prescribing or dispensing 
Symptoms or condition resolved 
Stopped by doctor 
Ineffectiveness 
Medication easily purchased 
Inadequate training of HCP students and inadequate CPD 
Theme Lack of medication reviews and inappropriate counselling 
Sub-theme 
Sub-theme 
Medication reviews 
Advice from more than one HCP and family and friends 
 
These themes were then used to derive round 2 Delphi questionnaire 
statements.  
 
4.3.3 Round 2 Delphi technique 
Twenty-three panellists (85%) returned Round 2 questionnaire; non-respondents 
were one patient, one representative of non-governmental organizations and two 
Government officials.  
 
4.3.3.1 Definition of medication wastage 
Definition 3 was ranked highest ten times (43% of all times) and was the most 
preferred definition by panellists overall, being chosen by 16 out of 23 panellists 
(70%) in any of the top four rankings. Table 4.9 gives the ranking of each 
definition. 
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Definition 3: Medication wastage refers to any medication which expires or 
remains unused throughout the whole medicines supply chain. Medication 
wastage also refers to the unnecessary or inappropriate consumption of 
medication by patients, or the unjustified non-adherence to treatment guidelines 
by healthcare professionals. Medication wastage poses a financial burden on 
patients themselves and the state's economy and requires adequate education of 
all people concerned. 
 
Table 4.9: Ranking results for the eight definitions of medication wastage (n=23) 
 Rank 1 Rank 2 Rank 3 Rank 4 Total times chosen 
(percentage agreement)  
Definition 1 2 2 2 3 9 (39%) 
Definition 2 2 4 2 3 11 (48%) 
Definition 3 10 2 2 2 16 (70%) 
Definition 4 2 6 4 3 15 (65%) 
Definition 5 0 4 2 4 10 (44%) 
Definition 6 3 3 6 2 14 (61%) 
Definition 7 2 0 3 5 10 (44%) 
Definition 8 2 2 2 1 7 (30%) 
 
In round 2, panellists were asked to indicate whether they preferred to retain the 
term ‘any medication’ within the definition or to replace it with one of the three 
options suggested in round 1: 
Option 1: ‘prescribed or OTC medication’ 
Option 2: ‘medication intended for licensed or off-licensed purposes 
Option 3: ‘medication intended for use in the diagnosis, cure, treatment, or 
prevention of disease’ 
 
Figure 4.2 highlights that the majority of panellists opted for 'any medication'. 
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Figure 4.2: Optional statements as opposed to the term ‘any medication’ in the 
definition of medication wastage 
 
4.3.3.2 Consensus on factors contributing to wastage  
Figure 4.3 illustrates the maximum number of weeks of medication supply that 
panellists considered acceptable to have in a household. Thirty-nine percent 
(n=9) of panellists were in favour of a maximum of 5-8 weeks, while 39% (n=9) 
opted for 9-12 weeks.  
 
 
Figure 4.3: Preferred maximum number of weeks of medication supply 
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Potential factors for medication wastage 
The consensus level of 75% was met or exceeded for 22 out of 61 statements 
(36%) during Round 2. 
 
A. Physical and environmental factors 
Table 4.10 lists the statements that met consensus, whilst Table 4.11 lists the 
statements that did not meet consensus. 
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Table 4.10: Panellists responses (n=23) to physical and environmental factors contributing to medication wastage that met 
consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
Medication which should be 
refrigerated and is left out of 
refrigeration is considered as wastage 
1 0 3 6 13 83% agree 
Large pack sizes when patients require 
only a short course of these 
medication 
0 4 1 5 13 78% agree 
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Table 4.11: Panellists responses (n=23) to physical and environmental factors contributing to medication wastage that did 
not meet consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
Lack of medication rotation on 
pharmacy shelves 
0 1 6 10 6 70% agree 
Inadequate computerised audits and 
medication consumption trends 
0 1 7 6 9 65% agree 
Government medical stores overstock 
with medication which subsequently 
expires 
2 1 6 10 4 61% agree 
Medication no longer in use and not 
accepted back by pharmacies 
1 1 8 11 2 57% agree 
There is an inadequate IT 
implementation and interoperability 
across interfaces 
0 1 11 4 7 48% neither 
disagree nor 
agree 
Medication dispensed with short expiry 
dates 
0 6 8 7 2 39% agree 
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B. Social and psychological patient factors 
Table 4.12 lists the statements related to social and psychological patient factors 
that met consensus while Table 4.13 lists those not meeting consensus.  
 
Possible reasons cited by participants for excessive stocking of medication by 
patients were:  
• Persons of a more mature age may depend on others to supply them with 
their necessities. So, they stock medication to a certain excess, to ease their 
minds that they can always be comfortably self-sufficient. 
• Fear of future unavailability of medication. 
• Different family members collecting patient’s medication supply. 
• The lack of patients’ knowledge and education about medication and its cost.  
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Table 4.12: Panellists responses (n=23) to social and psychological patient factors contributing to medication wastage that 
met consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
Patients are afraid that their 
medication will be unavailable when 
they need it 
1 0 0 11 11 96% agree 
Patients continue to receive the same 
amount of medication notwithstanding 
that their dose has been decreased, 
due to fear that it will be out of stock 
in the near future 
1 1 1 11 9 87% agree 
Patients should ask their family doctor 
to prescribe the medication that they 
consume only and not the whole list 
that is listed on their yellow 
entitlement card 
0 1 2 10 10 87% agree 
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Persons of a certain mature age may 
depend on others to supply them with 
their necessities. So they stock 
medication to a certain excess to have 
their minds at rest that they can 
always be comfortably self sufficient 
0 0 3 15 5 87% agree 
Patients purchase different 
medication, especially non-
prescription medication, upon the 
advice of different persons, both 
healthcare professionals and 
family/friends (n=22) 
0 0 3 12 7 86% agree 
Patients regularly receive medication 
for pain, or other minor ailments, 
notwithstanding they still have a good 
supply at home 
1 0 3 15 4 83% agree 
Non-adherence (when patients do not 
take their medication as intended) to 
treatment (n=22) 
0 1 3 7 11 82% agree 
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Different family members collect the 
medication without taking any notice if 
the medication is being consumed or 
not 
0 2 3 14 4 78% agree 
Patients are not educated about the 
cost of medication 
1 1 3 9 9 78% agree 
Patients lack the knowledge about 
their medication 
0 1 4 13 5 78% agree 
Patients fail to take the whole course 
of antibiotics (n=22) 
0 1 4 11 6 77% agree 
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Table 4.13: Panellists responses (n=23) to social and psychological patient factors contributing to medication wastage that 
did not meet consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
Many people believe that once they do 
not collect all of their periodical 
medication they will automatically be 
refused the same medication in the 
future 
0 2 4 10 7 74% agree 
The healthcare system fails to support 
medication taking by vulnerable 
individuals who cannot independently 
adhere to their treatment regimens 
1 1 5 10 6 70% agree 
Patients read about illnesses on the 
internet and they subsequently take 
medication which they do not require 
(n=22) 
0 2 5 10 5 68% agree 
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Due to patients' expectation that 
medication will solve every problem, 
patients take medication when they 
could have modified their lifestyle 
behaviour instead 
0 2 6 8 7 65% agree 
Due to lack of communication 
between hospital and community 
care, patients continue to receive 
medication even if this has been 
stopped 
0 1 8 9 5 61% agree 
Patients get an oversupply of 
medication through the POYC scheme 
even though they do not need it 
0 5 5 8 5 57% agree 
The prevalence of ignorance is a 
primary cause of almost everything, 
so it is also the cause of medication 
wastage 
0 4 6 9 4 57% agree 
When a person passes away, all 
his/her medication gets wasted 
0 3 7 6 7 57% agree 
Irresponsibility and carelessness of 
patients  
1 2 8 10 2 52% agree 
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Patients tend to throw away 
medication which is not expired to 
refill with ‘fresh’ stock from the 
pharmacy 
0 4 12 5 2 52% neither 
disagree nor 
agree 
Men with low pain thresholds taking 
unnecessary medication (n=22) 
1 7 10 4 0 45% neither 
disagree nor 
agree 
Overbearing mothers who mistake 
their child's mild bout of the common 
cold for Yellow Fever (n=22) 
1 3 8 7 3 45% agree 
Healthcare professionals and the 
healthcare system does not offer the 
knowledge, education, support and 
advice regarding medication to 
patients 
0 6 7 7 3 44% agree 
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C. Cultural factors 
Table 4.14 lists the statements that met consensus and Table 4.15 lists the 
statements not meeting consensus. 
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Table 4.14: Panellists responses (n=23) to cultural factors contributing to medication wastage that met consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
Patients hoard medication as they are 
afraid that the item will be out of 
stock and then they will be forced to 
buy the medication 
0 0 3 12 8 87% agree 
Medication provided freely by the 
state and not paid directly from 
patients' pockets 
0 1 3 8 11 83% agree 
Some patients believe that once they 
are entitled for a medication, it is 
theirs by right even in those cases 
when they do not need it 
0 0 5 11 7 78% agree 
 
 
 
 
  
 
  
Chapter 4: Delphi technique          116 
 
Table 4.15: Panellists responses (n=23) to cultural factors contributing to medication wastage that did not meet consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
There is lack of stock from the 
importers 
0 5 16 2 0 70% neither 
disagree nor 
agree 
Greed and hoarding situations by 
patients, on the welfare system, is a 
mentality which is difficult to 
overcome 
1 1 6 10 5 65% agree 
There should be co-payment of 
medication (that is patients must pay 
a fixed fee for their use of specific 
medication) 
0 4 4 7 8 65% agree 
Medication regularly out of stock 0 6 5 7 5 52% agree 
When entitled for free medication, 
patients reason that since the 
medication is ‘free’ it is good to have 
lots of different medication 
0 2 9 6 6 52% agree 
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Medication can be easily purchased 
without the pharmacist questioning 
the need of such medication 
0 3 11 8 1 48% neither 
disagree nor 
agree 
When entitled for free medication, 
patients believe that the medication 
has no value 
0 4 8 4 7 48% agree 
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D. Practitioner factors 
Table 4.16 lists the statements related to practitioner factors that met consensus 
and Table 4.17 those not meeting consensus.  
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Table 4.16: Panellists responses (n=22) to practitioner factors contributing to medication wastage that met consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
Overprescribing is one of the causes of 
medication wastage 
0 1 2 9 10 86% agree 
Pharmacists should be supported by 
state of the art IT to reduce 
medication wastage 
0 0 3 11 8 86% agree 
Pharmacists should have the time to 
concentrate on the patient and their 
medication usage 
0 0 3 12 7 86% agree 
GPs do not always have time to review 
all their patients' medication and so 
new medication get added to the 
patients' list 
0 2 2 11 7 82% agree 
GPs do not always have time to review 
all their patients' medication and often 
those medication that are not required 
anymore continue to be prescribed 
0 2 2 10 8 82% agree 
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When prescribing, doctors should ask 
the patients the quantity of medication 
they have left at home (n=23) 
0 
 
2 3 10 8 78% agree 
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Table 4.17: Panellists responses (n=22) to practitioner factors contributing to medication wastage that did not meet 
consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
Inadequate medication reviews at the 
point of dispensing 
1 1 4 10 6 73% agree 
Inadequate CPD of healthcare 
professionals in prescribing, 
dispensing and administration of 
medication (n=23) 
0 2 5 11 5 70% agree 
Some doctors are not aware of the 
monetary costs of medication (n=23) 
0 2 5 8 8 70% agree 
If symptoms resolve when patients 
have already collected their 
medication supply, these medication 
go wasted 
0 1 6 14 1 68% agree 
Pharmacists should be supported by 
well-trained assistants to reduce 
medication wastage 
0 0 7 9 6 68% agree 
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Prescribing antibiotics for acute 
bronchitis or mild coughs or asthma 
attacks is considered as wastage 
0 4 3 11 4 68% agree 
Doctors stop or change medication 
when patients have already collected 
their medication supply 
0 2 6 13 1 64% agree 
Inadequate stock management 
training of pharmacists and their 
assistants (n=23) 
0 2 7 8 6 61% agree 
Medication have to be changed due to 
the unexpected development of side-
effects, allergies, contra-indications or 
medication interactions during 
medication therapy 
0 3 6 10 3 59% agree 
Inadequate training of HCP students in 
prescribing, dispensing and 
administration of medication(n=23) 
0 3 7 10 3 57% agree 
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The fact that pharmacists have to 
spend their time carrying out 
bureaucratic and administrative 
chores  
1 5 4 8 4 55% agree 
Excessive volumes of medication 
supplied to patients during repeat 
prescribing and dispensing 
0 3 8 9 2 50% agree 
A large volume of medication is 
dispensed during the treatment 
initiation phase, that is when the 
patient has just started the medication 
1 3 7 8 3 50% agree 
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4.3.4 Round 3 Delphi technique 
Eighteen panellists (67%) completed round 3. A further three (two from the 
patients’ group and one Member of Parliament) answered only the first question. 
A representative from the practitioners’ group, two members of parliament 
(Government officials group), two members amongst the non-governmental 
organizations and one patient did not respond. 
 
4.3.4.1 Definition of medication wastage 
Figure 4.4 illustrates the extent of agreement with the final definition for 
medication wastage:  
 
'Medication wastage refers to any medication which expires or remains unused 
throughout the whole medicines supply chain. Medication wastage also refers to 
the unnecessary or inappropriate consumption of medication by patients, or the 
unjustified non-adherence to treatment guidelines by healthcare professionals. 
Medication wastage poses a financial burden on patients themselves and the 
state's economy and requires adequate education of all people concerned.' 
 
 
 
Figure 4.4: Extent of agreement with the definition of medication wastage during 
round 3 Delphi technique 
Consensus achieved: 86% agreement  
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4.3.4.2 Consensus on factors contributing to wastage  
Figure 4.5 illustrates the maximum range of weeks of medication supply that 
panellists found to be acceptable. 
 
 
Figure 4.5: Preferred maximum range of weeks of medication supply chosen by 
panellists during round 3 Delphi technique 
Consensus NOT achieved  
 
Potential factors for medication wastage 
A total of 16 out of 39 statements (41%) met the 75% consensus level, which 
when considered with round 2 results gives consensus achieved for 38/61 (62%) 
statements. 
 
A. Physical and environmental factors 
Statements that met consensus are shown in Table 4.18 and in Table 4.19 those 
not meeting consensus. 
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Table 4.18: Panellists responses (n=18) to physical and environmental factors contributing to medication wastage that met 
consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
Lack of medication rotation on 
pharmacy shelves 
0 0 3 9 6 83% agree 
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Table 4.19: Panellists responses (n=18) to physical and environmental factors contributing to medication wastage that did 
not meet consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
Inadequate computerised audits and 
medication consumption trends 
0 1 6 3 8 61% agree 
Medication no longer in use are not 
accepted back by pharmacies 
2 1 5 7 3 56% agree 
Government medical stores overstock 
with medication which subsequently 
expires 
1 1 7 9 0 50% agree 
There is an inadequate IT 
implementation and interoperability 
across interfaces 
0 1 8 3 6 50% agree 
Medication dispensed with short expiry 
dates 
0 3 8 7 0 44% neither 
disagree nor 
agree 
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B. Social and psychological patient factors 
Statements that met consensus are shown in Table 4.20 and in Table 4.21 those 
not meeting consensus. 
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Table 4.20: Panellists responses (n=18) to social and psychological patient factors contributing to medication wastage that 
met consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
Due to patients' expectation that 
medication will solve every problem, 
patients take medication when they 
could have modified their lifestyle 
behaviour instead 
0 2 0 11 5 89% agree 
Due to lack of communication between 
hospital and community care, patients 
continue to receive medication even if 
this has been stopped 
0 0 3 12 3 83% agree 
The healthcare system fails to support 
medication taking by vulnerable 
individuals who cannot independently 
adhere to their treatment regimens 
1 0 2 12 3 83% agree 
When a person passes away, all 
his/her medication gets wasted 
0 0 3 8 7 83% agree 
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Many people believe that once they do 
not collect all of their periodical 
medication they will automatically be 
refused the same medication in the 
future 
0 1 3 10 4 78% agree 
Patients read about illnesses on the 
internet and they subsequently take 
medication which they do not require 
0 1 3 12 2 78% agree 
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Table 4.21: Panellists responses (n=18) to social and psychological patient factors contributing to medication wastage that 
did not meet consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
Irresponsibility and carelessness of 
patients 
1 1 3 13 0 72% agree 
Patients tend to throw away 
medication not expired to refill with 
‘fresh’ stock from the pharmacy 
0 2 12 4 0 67% neither 
disagree nor 
agree 
Overbearing mothers who mistake 
their child's mild bout of the common 
cold for Yellow Fever 
0 3 11 1 3 61% neither 
disagree nor 
agree 
Patients get an oversupply of 
medication through the POYC even 
though they do not need it 
0 1 6 8 3 61% agree 
Men with low pain thresholds taking 
unnecessary medication 
2 8 8 0 0 56% 
disagree 
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The prevalence of ignorance is a 
primary cause of almost everything, 
so it is also the cause of medication 
wastage 
0 3 5 8 2 56% agree 
Healthcare professionals and the 
healthcare system does not offer the 
knowledge, education, support and 
advice regarding medication to 
patients 
0 1 8 7 2 50% agree 
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C. Cultural factors 
Statements that met consensus are shown in Table 4.22 and in Table 4.23 those 
not meeting consensus. 
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Table 4.22: Panellists responses (n=18) to cultural factors contributing to medication wastage that met consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
Greed and hoarding situations by 
patients, on the welfare system, is a 
mentality which is difficult to 
overcome 
0 1 2 12 3 83% agree 
There should be co-payment of 
medication (that is patients must pay 
a fixed fee for their use of specific 
medication) 
0 0 4 4 10 78% agree 
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Table 4.23: Panellists responses (n=18) to cultural factors contributing to medication wastage that did not meet consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
There is lack of stock from the 
importers 
0 0 13 5 0 72% neither 
disagree nor 
agree 
Medication regularly out of stock 0 1 6 9 2 61% agree 
When entitled to free medication, 
patients reason that since the 
medication is ‘free’ it is good to have 
lots of different medication 
0 1 6 8 3 61% agree 
Medication can be easily purchased 
without the pharmacist questioning 
the need of such medication 
0 1 10 6 1 56% neither 
disagree nor 
agree 
When entitled for free medication, 
patients believe that the medication 
has no value 
0 2 7 4 5 50% agree 
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D. Practitioner factors 
Statements that met consensus are shown in Table 4.24 and in Table 4.25 those 
not meeting consensus. 
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Table 4.24: Panellists responses (n=18) to practitioner factors contributing to medication wastage that met consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
If symptoms resolve when patients 
have already collected their 
medication supply, these medication 
go wasted 
0 0 2 15 1 89% agree 
Doctors stop or change medication 
when patients have already collected 
their medication supply 
0 0 3 15 0 83% agree 
Inadequate CPD of healthcare 
professionals in prescribing, 
dispensing and administration of 
medication 
0 2 1 11 4 83% agree 
Pharmacists should be supported by 
well-trained assistants to reduce 
medication wastage 
0 0 3 11 4 83% agree 
Prescribing antibiotics for acute 
bronchitis or mild coughs or asthma 
attacks is considered as wastage 
0 1 2 12 3 83% agree 
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Inadequate medication reviews at the 
point of dispensing 
1 0 3 9 5 78% agree 
Some doctors are not aware of the 
monetary costs of medication 
0 2 2 6 8 78% agree 
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Table 4.25: Panellists responses (n=18) to practitioner factors contributing to medication wastage that did not meet 
consensus 
Statement Totally 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Totally 
agree 
Percentage 
agreement 
(%) 
Inadequate stock management 
training of pharmacists and their 
assistants 
0 1 4 12 1 72% agree 
Medication changed due to the 
unexpected development of side-
effects, allergies, contra-indications or 
medication interactions during 
medication therapy 
0 1 4 11 2 72% agree 
A large volume of medication is 
dispensed during the treatment 
initiation phase (that is when the 
patient has just started the 
medication) 
0 2 4 11 1 67% agree 
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Inadequate training of HCP students in 
prescribing, dispensing and 
administration of medication 
0 2 4 9 3 67% agree 
Excessive volumes of medication 
supplied to patients during repeat 
prescribing and dispensing 
0 3 4 10 1 61% agree 
The fact that pharmacists have to 
spend their time carrying out 
bureaucratic and administrative 
chores 
1 3 4 9 1 56% agree 
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4.4 Discussion 
4.4.1 Key findings  
The aim of this phase of the research was to apply the Delphi technique in 
relation to defining ‘medication wastage’ and its contributory factors in the 
context of the Maltese population. 
 
Consensus was reached with 86% of panellists agreeing (38% of these totally 
agreeing), with the following definition: 
'Medication wastage refers to any medication which expires or remains unused 
throughout the whole medicines supply chain. Medication wastage also refers to 
the unnecessary or inappropriate consumption of medication by patients, or the 
unjustified non-adherence to treatment guidelines by healthcare professionals. 
Medication wastage poses a financial burden on patients themselves and the 
state's economy and requires adequate education of all people concerned.' 
 
During round 1, 61 possible factors leading to wastage were identified, 
categorised as: ‘physical and environmental factors’; ‘social and psychological 
patient factors’; ‘cultural factors’; and ‘practitioner factors’. A total of 38 out of 
61 statements (62%) met consensus following the three Delphi rounds. The 
cause which achieved the highest level of consensus was: 
• Patients are afraid that their medication will be unavailable when they need it 
(96% consensus). 
 
4.4.2 Strengths and weaknesses 
This study has a number of strengths and weaknesses which merit further 
discussion. This is the first study to use a robust methodological approach to 
derive a definition of ‘medication wastage’. The expert panel comprised strategic 
individuals, practising professionals and patients, thus providing vast and diverse 
expertise promoting content validity (Goodman, 1987). High levels of 
recruitment and participation were achieved throughout thus reducing the 
likelihood of recruitment and non-respondent biases. Furthermore, there was 
very little attrition between Delphi rounds. The use of electronic communication 
facilitated confidentiality (Hsu and Sandford, 2007) and could reach international 
individuals (Owens, 2002) who could participate as experts at a lower cost.  
  
Chapter 4: Delphi technique    142 
 
However, there are study limitations and hence the findings should be 
interpreted with caution. Snowball sampling, which relies on an initial group of 
participants to recruit others, could have introduced an element of bias. It is 
difficult to differentiate between panellists who rated items as ‘strongly agree’ or 
‘agree’. Moreover, this Delphi technique was conducted within Malta and given 
the differences in healthcare structures and processes between different 
countries and populations, the results are not necessarily generalizable and 
hence limited in external validity. However, it is likely that the definition and the 
panellists’ views on possibly contributory factors will resonate globally.  
 
4.4.3 Interpretation of findings  
Following a scoping review of the literature (chapter 1) followed by a systematic 
review on the possible causative factors associated with medication wastage 
(chapter 3), only two definitions of medication wastage were identified. These 
definitions are presented in Table 4.26 together with the definition generated 
from the current Delphi technique. 
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Table 4.26: Definitions of medication wastage 
Source Definition of medication wastage 
UK DoH (White, 2010, 
p.132) 
"Medicines issued to the patient but not 
consumed" 
Abou-Auda (2003, p.1277) "Any drug product either dispensed by a 
prescription or purchased over the counter (OTC) 
that is never fully consumed. Medication wastage 
may be due to poor compliance of patients, 
excessive and irrational prescribing, or the lack of 
control of the sales of prescription medications in 
the community pharmacy" 
Current Delphi technique “Medication wastage refers to any medication 
which expires or remains unused throughout the 
whole medicines supply chain. Medication wastage 
also refers to the unnecessary or inappropriate 
consumption of medication by patients, or the 
unjustified non-adherence to treatment guidelines 
by healthcare professionals. Medication wastage 
poses a financial burden on patients themselves 
and the state's economy and requires adequate 
education of all people concerned” 
 
The definition derived through this Delphi study differs in a number of respects 
from that issued by the UK DoH (White, 2010) and that of Abou-Auda (2003). 
The Delphi definition considers medication wastage at any point of the 
medication supply chain and is not restricted to the point following issue to the 
patient. The Maltese Medicines Authority states that medicines supply chain 
extends to  reaching the consumer (Medicines Authority, 2013) and therefore it 
is important that wastage is also considered at all levels. 
 
Furthermore, the Delphi definition emphasises the financial impact and 
educational relevance of wastage. Reducing wastage is a paramount objective in 
promoting appropriate utilisation of finite resources (Commission of the European 
Communities, 2005). The study commissioned by the DoH in England in 2009 
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which explored the scale and cost of medication wastage, and was described in 
chapter 1, concluded that while not all of the wastage is avoidable, or the result 
of poor practice, more than half is preventable (York Health Economics 
Consortium, School of Pharmacy University of London, 2010). 
 
The lack of coverage of inappropriate prescribing, dispensing or consumption of 
medication within the UK DoH definition has been criticised (White, 2009). 
Irrational prescribing, consistent with the current Delphi study definition, is 
considered by Abou-Auda (2003). Inappropriate prescribing and dispensing or 
consumption of inappropriate medication by patients was considered to be a 
form of medication wastage by some panellists when defining medication 
wastage. Inappropriate medication has also been seen as an indirect form of 
wastage by other authors who describe irrational use of medication such as self-
medication to be a waste of resources (Kiyingi and Lauwo, 1993; Abdo-Rabbo et 
al., 2009a). Cromarty and Downie (2001) discuss that medication wastage 
extends beyond leftover medication, but it also includes other aspects such as 
sub-optimal prescribing and failure to give out medication when really needed. In 
the current Delphi technique 89% of panellists agreed that patients' expectation 
that medication will solve every problem leads to overuse of medication when 
lifestyle modification could have been adequate. This was also a key point 
articulated by Abdo-Rabbo et al. (2009b) who claim that one reason for unused 
medication is that many patients still believe that the result of their visit to public 
health facilities must be the dispensing of a prescription. Therefore, HCPs have a 
role to play in reducing the amount of unused medication by prescribing or 
recommending medication only when necessary. 
 
As described in the ‘Introduction’ to this chapter, inconsistencies around the 
definition of ‘medication wastage’, together with the scope of wastage, limit 
direct inter-study comparisons. A clear definition and detailed scope was 
considered to be necessary to strengthen the base of this research and inform 
future directions of this doctoral research, thus directly impacting the further two 
research phases (chapter 5 and chapter 6). Moreover, whilst not considered to 
be necessarily generalizable to other countries, the standardisation of a definition 
of medication wastage has an academic impact by contributing a backbone for 
future research in this field. Ultimately, the research has also an economic and 
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societal impact, defined as “the demonstrable contribution that excellent 
research makes to society and the economy” (Research Councils UK, 2011, p.2), 
if the findings are likely to be considered by policy makers in an effort to reduce 
medication wastage.   
 
Some panellists changed their responses from the second to the third round of 
questionnaires. It is uncertain whether this alteration in the decision-making 
process is a result of careful reconsideration or the pressure to conform. 
Notwithstanding this, one can clearly conclude from this Delphi technique that 
medication wastage cannot be attributed to one single factor but is likely to be a 
very complex interplay between many, and sometimes very diverse, influencing 
factors. It is also notable that the Delphi has identified a number of potential 
factors not highlighted during the systematic review and these merit further 
consideration.  
 
This research identified a higher number of social and psychological patient and 
practitioner contributory factors towards wastage, in contrast to physical and 
cultural factors. There is a substantial volume of literature on social and 
psychological factors influencing health. Changing individuals’ behaviours is a 
prerequisite to change these contributory factors (Maio et al., 2007). Behaviour, 
characterised as the result of individual choice and personal responsibility, is 
linked to social contexts (Locker, 2008). The next phase of this research (chapter 
5) focuses in detail on awareness, perception, attitude and behaviour of different 
stakeholders (HCPs, HCP students and the public) with the support of different 
theoretical behavioural models (the Health Belief Model (HBM), the 
Transtheoretical Model of Behaviour Change (TTM) and Rogers’ Diffusion of 
Innovation theory). 
 
4.5 Conclusion 
A high level of consensus was achieved on a definition of medication wastage 
from a diverse panel of academics, practitioners, Government officials, officials 
from non-Governmental organizations and patients in Malta. The agreed 
definition was, ‘Medication wastage refers to any medication which expires or 
remains unused throughout the whole medicines supply chain. Medication 
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wastage also refers to the unnecessary or inappropriate consumption of 
medication by patients, or the unjustified non-adherence to treatment guidelines 
by healthcare professionals. Medication wastage poses a financial burden on 
patients themselves and the state's economy and requires adequate education of 
all people concerned.’ This research identified a number of potentially 
contributory factors towards wastage, ranging ‘physical and environmental 
factors’; ‘social and psychological patient factors’; ‘cultural factors’; and 
‘practitioner factors’. Fear of medication unavailability giving rise to medication 
wastage was perceived to be a contributory factor by the majority of 
participants.  
 
4.6 Reflections and future direction  
The definition of ‘medication wastage’ and potential influencing factors identified 
by the panellists were applied in all further phases of the research. A 
quantitative, cross-sectional survey of HCPs, students and the general public 
(chapter 6) was followed by qualitative focus groups to further explore these 
issues as a basis for the development of interventions with the ultimate aim of 
reducing medication wastage.  
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Chapter 5  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Attitudes are more important 
than abilities, motives are more 
important than methods, 
character is more important than 
cleverness, and the heart takes 
precedence over the head“ 
Denis Burkitt 
[Surgeon  
1911-1993] 
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The perspectives of the Maltese population, HCPs and 
students on medication wastage: cross-sectional surveys  
 
 
The systematic review of published literature, carried out in the first phase of this 
research, identified a lack of studies relating to awareness, perceptions, attitudes 
and behaviours of the general public, HCPs and students regarding medication 
wastage. This chapter provides a detailed account of research aims and 
objectives, survey methods, results and discussion. 
 
5.1 Introduction 
5.1.1 Studies employing survey methods in relation to healthcare 
wastage 
While none of the studies included in the quality assessment and data extraction 
of medication wastage literature focused on the perspectives outlined above, a 
number of studies were identified in earlier stages of the review related to other 
forms of healthcare wastage, including clinical and biomedical wastage such as 
infected sharps.  
 
Several of these employed survey approaches to research awareness of hospital 
wastage amongst HCPs. Akter et al. (2002) concluded that doctors and nurses 
were not fully aware of what constituted medical wastage and its management. 
Similar findings were reported by Massrouje (2001), Danchaivijitrmd et al. 
(2005), Pandit et al. (2005), Hassan et al. (2008), Rao (2008), Sharma and 
Chauhan (2008), Verma et al. (2008), Amanullah and Uddin (2009), Jarvis et al. 
(2009), Mostafa et al. (2009), Ramokate and Basu (2009), Chattopadhyay et al. 
(2010), Ortner and McCullagh (2010), Mochungong et al. (2010) and 
Yadavannavar et al. (2010). Jahnavi and Raju (2006), in a study of 
undergraduate medical students, suggested that appropriate training on aspects 
of wastage should be included as part of the undergraduate curriculum. 
 
Several reported aspects of medication disposal by patients highlighting poor 
awareness of proper methods of disposal and lack of awareness of the 
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implications of improper disposal (Uysal and Tinmaz, 2004; Bound et al., 2006; 
Persson et al., 2009; Abrons et al., 2010; Tong et al., 2011).   
 
5.1.2 Rationale for cross-sectional structured questionnaire 
The general aim of survey research is to predict population attributes or 
behaviours (Teddlie and Tashakkori, 2009) and was thus considered most 
appropriate to collect data to meet the study aim. 
 
5.1.3 Study aim and research questions 
The overall aim of this phase of the research was to investigate issues of 
awareness, perceptions, attitudes and behaviours regarding medication wastage 
amongst the Maltese population, HCPs and respective students.  
 
More specifically, this study sought to answer the following questions: 
1. What is the level of awareness and interest in medication wastage? 
2. Which dependent and independent variables are associated with awareness, 
attitudes, perceptions and behaviours in relation to medication wastage? 
3. Which factors are considered to be contributing towards medication wastage? 
4. Which behaviours are possibly contributing towards medication wastage? 
5. Which patient groups, classes of drugs and type of medication are considered 
priority when targeting medication wastage? 
6. Is there a need for education on issues of medication wastage? 
 
The study also sought to identify potential participants for the next phase of the 
research (focus groups). 
 
5.2 Method 
5.2.1 Inclusion criteria 
5.2.1.1 Maltese population 
Residents of Malta at the time of the study and aged 18 years and over were 
included. 
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5.2.1.2 HCPs 
All who had a license to practise in Malta and were listed in the professional 
registers of dentists, doctors, nurses or pharmacists (2013) were included. These 
professions were researched as they had direct involvement with the processes 
of medication prescribing, dispensing or administration. Due to logistical reasons 
within the newly appointed Council for Nurses and Midwives, nurses had to be 
excluded from the main study. 
 
5.2.1.3 HCP students 
All students who were pursuing a first degree undergraduate course in dentistry, 
medicine, nursing or pharmacy with the University of Malta. Students were in 
their final or pre-final year of their undergraduate course at the time of the study 
as by then they would have studied most of the curriculum. 
 
5.2.2 Exclusion criteria 
Professionals listed with other than a Maltese address were excluded, as were 
those participating in the pilot study.  
 
5.2.3 Sample size 
To determine the sample size, the following were taken into consideration: 
1. Three hundred and eighty-four responses for the public and 330 for HCPs were 
required to give 95% confidence intervals with a 5% margin of error. 
2. Response rates from pilot study (see later) [12.0% for public, 13.0% for HCPs 
and 43.0% for students, with no follow-up of non-respondents].  
3. Estimated response rates for the full study, with follow-up of non-respondents.  
 
The total Maltese population (aged 18 years and over) from the electoral register 
2013 was 332,644 (i.e. the sampling frame). Assuming a 20% response rate 
(with follow-up of non-respondents) required a sample size of 1,920 to achieve 
384 responses. 
 
There were 210 listed dental practitioners (available online) at the time of the 
study (Medical Council, 2013). Thirty-five did not have an address listed and 
eleven had a non-Maltese address thus excluded, giving 164 dentists eligible to 
participate. 
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There were 1,667 medical practitioners (available online) at the time of the study 
(Medical Council, 2013). Two hundred and forty-six did not have an address 
listed and 169 had a non-Maltese address thus were excluded, giving 1,252 
doctors eligible to participate.  
 
Eight hundred and sixteen pharmacists (excluding respondents from the pilot 
study) were registered (with an email address) with the Pharmacy Council at the 
time of the study and were eligible to participate. 
 
The total number of HCPs eligible for the study was 2,232. The minimum 
recommended sample size was 330 (as there was no intention to compare 
responses between HCP groupings). Assuming a 20% response rate required a 
sample size of 1,650 to achieve 330 responses. To achieve this: 
• All 816 pharmacists were recruited (for logistical reasons to avoid any 
sampling to be undertaken by the Pharmacy Council).  
• All 164 dentists were recruited in view of the small study population. 
• Seven hundred doctors were recruited.  
 
Four hundred and thirty-four students in their pre-final and final year who had 
previously agreed to receive emails through their university account were eligible 
to participate.  
 
5.2.4 Sampling 
5.2.4.1 General public from the Maltese population 
Participants were selected by random sampling (Random.org, 2014) of the 
Maltese electoral list 2013, obtained from the Maltese Department of 
Information.  
 
5.2.4.2 HCPs 
Doctors were selected by random sampling (Random.org, 2014) from the 
register of medical practitioners, available online (Medical Council, 2013). In view 
of the small number of practising dentists in Malta, all these were included 
without sampling. The list of dental practitioners was available online (Medical 
Council, 2013). All pharmacists were included through the Maltese Pharmacy 
Council, who held the email details of all practising pharmacists.  
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5.2.4.3 HCP students 
In Malta, the dental, medical and pharmacy undergraduate courses are of five 
years’ duration (Cauchi and Mamo, 2012). All 434 final and pre-final year 
students were included.  
 
5.2.5 Questionnaire development 
The questionnaire is the most common data collection method (Mann, 2003). 
Three similar structured self-completion questionnaires were developed for the 
Maltese population, HCPs and students.   
 
Draft questionnaires were developed with reference to three key sources: 
1. existing literature (Seehusen and Edwards, 2006; Jarvis et al., 2009; Persson 
et al., 2009; Abrons et al., 2010; Chattopadhyay et al., 2010) 
2. findings of the Delphi technique 
3. theoretical frameworks, which are described in more detail below. 
  
5.2.5.1 Awareness, perception and attitudes 
Knowledge based questions determine awareness of issues and awareness of 
desired behaviours (Sayers, 2006). Awareness is thought to occur when ‘an 
experience’ becomes ‘an individual's experience’ (LaBerge, 1998), and raising 
awareness is thought to attempt to inform attitudes, behaviours and beliefs 
(Sayers, 2006); hence these concepts are intertwined. However, it is recognised 
that possessing information and awareness does not automatically lead to 
behavioural change. Also, one has to distinguish between conscious awareness 
(explicit perception of a stimulus), that is the individual distinguishing the 
presence or absence of an issue, and unconscious awareness, that is the 
perception without awareness of the issue (implicit perception of a stimulus) 
(Dretske, 2006). 
 
Perception is when a person is confronted with a situation or stimulus, and is 
interpreted into something meaningful based on prior experiences. It is 
recognised that perception may be very different from reality (Pickens, 2005). 
Perception is the process of interpreting messages delivered from our senses to 
create order and meaning to the environment (Johns and Saks, 2013). Since 
perception is based on experiences, two individuals with different experiences 
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may view the same thing and perceive it as being different (Schiff, 1970). While 
attitudes exert a powerful influence on perception (Kuper and Kuper, 2004), 
other characteristics, such as motives, existing beliefs and personality, can 
influence perception (Pickens, 2005). 
 
In 1928, Thurstone described the concept of attitude as "the sum total of a 
man's inclinations and feelings, prejudice or bias, preconceived notions, ideas, 
fears, threats, and convictions about any specified topic" (Thurstone, 1928, p. 
531). Pickens (2005, p.44) defines attitude as “a mind-set or a tendency to act 
in a particular way due to both an individual’s experience and temperament”.   
 
5.2.5.2 Theoretical frameworks to determine behaviour  
There are a number of theoretical frameworks which try to determine individuals' 
decisions to behave in a certain way. One of the theoretical frameworks used in 
this study, the HBM, was initially based on four theoretical constructs as a basis 
for behaviour: perceived seriousness, perceived susceptibility, perceived benefits 
and perceived barriers. It has now been expanded to include cues to action, 
motivating factors and self-efficacy (Hayden, 2009). The constructs of the HBM, 
although originally used to explain public's fear to participate in health screening 
programs, are also important when dealing with other topics which are health 
related. This model takes into account the individual's past experiences and 
characteristics. Perceived seriousness gauges the feelings one has regarding the 
seriousness of the issue. Perceived susceptibility is an individual’s perception of 
his or her risk of being affected by the issue. Perceived benefits indicate an 
individual's beliefs regarding the efficacy of appropriate behaviour measures. 
Perceived barriers refer to an individual's perception of the obstacles to 
appropriate behaviour measures. Cues to action refer to events, people or things 
that move individuals to change their behaviour. Self-efficacy refers to an 
individual's beliefs regarding his or her ability to successfully do something 
(Hayden, 2009).  
 
Two other theoretical frameworks that relate to behaviours and behavioural 
change are Rogers’ Diffusion of Innovation theory and the TTM, both applied in 
the design of the survey instrument in this study. The Diffusion of Innovation 
theory, which relates to social behaviours and change, refers to the process by 
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which an innovation is communicated through certain channels over time among 
members of a social system (Valente and Rogers, 1995). Therefore, Diffusion of 
Innovation refers to the process that occurs as individuals adopt a new idea, 
product, practice or philosophy. There are five adopter categories: the 
innovators, the early adopters, early majority, late majority and laggards 
(Kaminski, 2011). Rogers identified five distinct innovation characteristics which 
include (Kaminski, 2011):  
1. observability (the extent to which the results of an innovation are visible to 
potential adopters) 
2. relative advantage (the extent to which the innovation is perceived to be 
superior to current practice) 
3. compatibility (the extent to which the innovation is perceived to be consistent 
with socio-cultural values, previous ideas and/or perceived needs) 
4. trialability (the extent to which the innovation can be experienced on a limited 
basis) 
5. complexity (the extent to which an innovation is difficult to use or 
understand).  
 
The Diffusion of Innovation model suggests five stages in the decision making 
process (Sanson-Fisher, 2004):  
1. Knowledge (the individual acquires knowledge about the proposed innovation) 
2. Persuasion (the individual is persuaded about the advantages of innovation) 
3. Decision (the individual engages in activities that will lead to a choice about 
adopting or rejecting the innovation) 
4. Implementation (the individual tries the innovation) 
5. Adoption (the individual reinforces the innovation decision). 
There are three types of knowledge that participants require to adopt the 
innovation (Wadensten and Carlsson, 2007):  
1. Awareness knowledge (provision of information whereby a person learns 
about the innovation) 
2. How-to knowledge (which is the information required to use the innovation 
properly) 
3. Principles knowledge (knowledge on the principles underlying how the 
innovation works). 
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The TTM is based on stages of change and categorises segments of the 
population based on where they are in the process of change (Prochaska and 
Prochaska, 2011). There are six stages of change:  
1. Precontemplation (the individual does not intend to take action in the near 
future, typically measured as the next six months) 
2. Contemplation (the individual intends to take action in the next six months. 
S/he is aware of the advantages of changing but is also aware of the 
disadvantages) 
3. Preparation (the individual intends to take action in the immediate future, 
typically measured as the next month) 
4. Action (the individual has already made overt modifications to his/her 
behaviour in the last six months) 
5. Maintenance (the individual has already made overt modifications to his/her 
behaviour and is working to prevent relapse) 
6. Termination (the individual is not tempted).  
 
Individuals’ progress goes through stages through a number of processes:  
1. Consciousness raising 
2. Dramatic relief 
3. Environmental re-evaluation 
4. Self-re-evaluation 
5. Self-liberation 
6. Social liberation 
7. Counter conditioning 
8. Helping relationships 
9. Reinforcement management 
10. Stimulus control  
 
Change is based on the decisional balance of reflecting the pros and cons of 
changing.  
 
5.2.5.3 Measurement scales 
There are a number of scales which are used in the construction of attitudinal 
response items, namely Thurstone scales, Likert scale, Guttman scales and the 
Semantic Differential scale (Bucci, 2003). Attitudes typically fall between two 
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extreme points ranging from extremely negative to extremely positive (Kuper 
and Kuper, 2004). The Likert scale, originally a five response format ranging 
from strongly disagree to strongly agree, was developed by Rensis Likert (Dwyer, 
1993). Semantic differential scales are concerned with the measurement of 
meaning, ideas or associations which individuals assign to words or objects. The 
scale contains two opposing adjectives separated by a range of words (Bucci, 
2003). It is reported to be a simple and economical means for obtaining data on 
people's reactions. The extent of use of both Likert and semantic differential 
scales in research studies is thought to support their validity for attitude 
measurement (Heise, 1970).  
 
The 8-item Morisky Medication Adherence Scale (MMAS-8-Item) was used to 
determine adherence to medication by those patients prescribed regular 
medication. Approval to use this scale and its equivalent Maltese translation was 
sought and obtained from Professor Donald Morisky (owner of this scale) 
(Appendix 5.1). 
 
5.2.5.4 Questionnaire sections and items 
The HCP pre-pilot questionnaire was constructed as five sections: 
• Section A requested personal and practice demographics.  
• Section B explored issues related to awareness of medication wastage. 
Questions within this section were in the form of a Likert scale with responses 
from 1= Strongly disagree to 5= Strongly agree.  
• Section C sought opinions on factors potentially leading to medication 
wastage via a semantic differential scale with bipolar adjectives, ’no 
contribution’ and ’major contribution’. 
• Section D investigated current practices, views and experiences, also in the 
form of five point Likert scales. A further scale was used with response 
options of never, infrequently, around half the time, usually, always, unsure. 
This scale was reported by Mort et al. (2010) when exploring the effect of an 
introductory pharmacy practice experience on students' performance. This 
section also contained an open response item on the medication, therapeutic 
areas or patient groups to be considered as priority for targeting strategies to 
reduce medication wastage in Malta. 
• Section E explored education and training. 
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The students’ questionnaire was similar in content to that of HCPs but questions 
from section D and E were combined as one section. 
 
The public questionnaire contained seven sections and was presented as both an 
English and Maltese version. The content was very similar to the HCP 
questionnaire, with the following differences: 
• Section A requested patient demographics. 
• Sections B to D were in the form of the five point Likert scale. Section B 
focused on awareness of medication wastage and was similar to the HCP one. 
Sections C and D were about current practices involving medication patients 
bought or obtained free of charge. 
• Section E focused on experiences with medication. 
• Section F included the MMAS-8-Item. 
• Section G contained a quality of life semantic differential scale between the 
two opposing statements: 1 = As bad as it could be and 5 = As good as it 
could be. 
 
5.2.5.5 Face and content validity testing 
Questionnaires were sent by email to a panel of ten senior colleagues and/or 
Delphi study participants for face and content validity review.  
 
Comments were received from six and these are presented in Appendix 5.2, 
highlighting subsequent changes.  
 
5.2.5.6 Pilot testing 
A pilot study was carried out for several reasons: to confirm that the research 
protocol was realistic and workable; to determine the likely study response rates 
(van Teijlingen and Hundley, 2001); to ensure that responses elicited would 
meet the aims of the study; and to refine questionnaire items (Clibbens et al., 
2012).  
  
Pilot testing was carried out using a random sample of 100 members of the 
Maltese population and 100 HCPs (30 doctors, 40 nurses and 30 pharmacists), 
and 30 recently graduated medical students who were still not included in the 
medical register. Pilot study participants were excluded from the full study. Minor 
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changes were made to the wording of questionnaire items and response options 
following the pilot study.  
 
5.2.6 Full study 
5.2.6.1 Study information 
A covering letter was included with the questionnaire (Appendices 5.3, 5.4, 5.5) 
describing: the purpose and importance of the study; sampling of study 
participants; voluntary nature; fate of results; organizer; funding body; and 
reminder of confidentiality (Raymond, 2005). 
 
To identify potential participants for the next phase of the research (focus 
groups) a separate information letter describing the planned focus groups was 
also included.  
 
5.2.6.2 Questionnaire formatting 
Questionnaires were formatted using SNAP 10 which is an integrated software 
package used to design questionnaires for either printing or for publishing on the 
web. Data generated from online questionnaires using SNAP can be transferred 
directly into Statistical Package for the Social Sciences® (SPSS®) for data 
analysis (Directorate of Information technology, University of Aberdeen, 2007). 
 
5.2.6.3 Recruitment 
The questionnaire, covering letter, focus group recruitment information letter and 
a self-addressed envelope were sent by post to the general public, dentists and 
doctors, requesting that the completed questionnaire be returned to the principal 
researcher within two weeks.  
 
An email describing the study, with a link to all study materials was sent by the 
Registrar of the Maltese Pharmacy Council to pharmacists and by the Registrar of 
the University of Malta to students. Questionnaires completed via email were 
returned through SNAP which transferred the data directly into SPSS® V21. 
Email or a postal reminder was sent to non-respondents after two to three 
weeks.  
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5.2.6.4 Maximising response rates 
Response rates may vary depending on several factors such as the length of 
questionnaire, the nature of the sponsorship, the topic and the type of 
respondent. As discussed in chapter 4, while there is no agreed acceptable 
minimum response rate, 75% and above is considered to be good (Bowling, 
2009; Williams, 2003) and below 60% sub-optimal (Bowling, 2009).  
 
Measures highlighted in a systematic review by Edwards et al. (2009) to increase 
response rates of studies employing postal questionnaires were described in 
chapter 4. The following measures were adopted in this phase: high quality, 
short, focused questionnaires with appropriate formatting; an ‘invitation to 
participate’ letter; distribution of the student questionnaire to avoid examination 
periods; support of a scholarship through the MGSS; university logos on letters 
and questionnaires; reassurance of confidentiality throughout; provision of reply 
paid envelopes for postal questionnaires; and one reminder. ‘Post-it’ notes 
stating “Your feedback will be greatly appreciated. Thank you. Lorna” were 
attached to postal questionnaires to increase further response rates (Garner, 
2005). 
 
Questionnaire data collection took place between September and November 
2013. 
  
5.2.7 Data handling and analysis 
Data were inputted into SPSS® V21, with an independent reliability check 
undertaken on a sample of 10% of entries. Data were screened for errors by 
analysing frequencies and checking for outliers. 
Data were analysed as follows: 
1. Descriptive statistics (frequency, percentage) for categorical data (e.g. 
demographic variables, Likert scale responses) 
2. Inferential statistics to explore any associations. Data from Likert scales were 
converted to binomial data by combining all agree responses, and all disagree 
and unsure responses. Chi-square was used to determine any associations 
between variables (e.g. demographics) and outcomes (e.g. awareness and 
interest in medication wastage). Variables identified as significant in univariate 
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analysis were further tested in bivariate logistic regression analysis. P-values ≤ 
0.05 were considered significant.  
3. Textual responses generated through open questions were analysed using a 
content analysis approach, as described in chapter 4. 
   
5.2.8 Promoting quality in research: validity and reliability  
A number of measures were implemented to promote validity and thus study 
robustness: 
• Face and content validity testing by a panel of expert academics, researchers 
and practitioners. The combination of experts in the field of study together 
with experts in instrument construction increased the likelihood of the 
questionnaire being both well-constructed and content-valid (Davis, 1992). 
• Questionnaire items were developed from the published literature, the Delphi 
technique and theoretical frameworks, and together with using established 
measurement scales, enhanced criterion validity. 
• A pilot study was carried out to ensure robustness. 
 
A number of measures were taken to reduce bias and thus improve validity and 
reliability. 
• Participants (general public, doctors) were randomly selected to prevent 
selection bias.  
• Questionnaires did not require participants to recall events beyond six months 
to minimise recall or memory bias.  
• Attention bias and social desirability bias were minimised through the use of 
self-administered questionnaires and by emphasising the purpose of the 
research. 
• Questionnaire items were mainly in the form of Likert scales, semantic 
differential scales and close-ended questions with standardised options to 
prevent acquiescence response set bias. 
• Questionnaires were self-administered to minimise evaluation apprehension. 
• Clear statements of the purpose of the research phase were provided to 
prevent expectancy bias. 
• Independent reliability checks were undertaken on a sample of 10% of 
entries. 
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5.2.9 Research Governance 
The study was approved by the School of Pharmacy and Life Sciences Research 
Ethics Committee, Robert Gordon University (Appendix 5.6) and the University of 
Malta Research Ethics Committee (Appendix 5.7). The UK DPA (The National 
Archives, 1998), the Maltese DPA (Information and Data Protection 
Commissioner, 2001) as well as the EU Data Protection Directive (The European 
Parliament and the Council of the European Union, 1995) were adhered to at all 
times by the use of password protected databases accessible only by the 
principal researcher.  
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5.3 Results: Maltese public questionnaire 
5.3.1 Response rate 
The response rate following the first mailing was 15.4% (295 responses), higher 
than the response rate of the pilot study (12.0%), and increased to 20.4% 
(391/1,920 responses) following one reminder sent to non-respondents. The 
number of responses exceeded the calculated sample size of 384. Figure 5.1 
illustrates the number of responses per day over a 55-day time period.  
 
 
Figure 5.1: Number of public questionnaire responses during 55-day collection 
 
5.3.2 Respondent demographics  
Table 5.1 provides a description of the respondent demographics, comparing 
these to Maltese population demographics where available (National Statistics 
Office, 2012; National Statistics Office, 2013; National Statistics Office, 2014).  
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Table 5.1: Respondent demographic data (n=391) 
Characteristic Percent (Frequency) 
% (n) 
Maltese 
Demographics 
% (n) 
Gender 
 
Male 
Female 
 
 
43.5 (170) 
56.5 (221) 
Electoral 
register 2013 
49.4 (164,370) 
50.6 (168,274) 
Age (years) 
18-24  
25-34  
35-44  
45-54  
55-64  
65-74  
75-84  
≥ 85  
 
7.2 (28) 
13.0 (51) 
17.1 (67) 
15.6 (61) 
23.5 (92) 
13.6 (53) 
7.9 (31) 
2.1 (8) 
Census 2011 
13.3 (55,312) 
14.5 (60,462) 
13.0 (54,129) 
13.8 (57,336) 
14.3 (59,470) 
(>65 years): 
16.3 (67,841) 
Highest level of education 
No schooling 
Primary 
Secondary 
Post-secondary 
Tertiary 
Post-graduate 
Missing data 
 
1.0 (4) 
17.9 (70) 
36.1 (141) 
18.9 (74) 
17.4 (68) 
8.2 (32) 
0.5 (2) 
Census 2011 
1.6 (5,948) 
20.0 (71,254) 
59.0 (209,715) 
5.3 (18,792) 
9.7 (34,306) 
4.4 (15,689) 
- 
Locality of residence 
 
Southern Harbour 
Northern Harbour 
South Eastern 
Western 
Northern 
Gozo and Comino 
Missing data 
 
 
19.4 (76) 
31.7 (124) 
15.6 (61) 
12.0 (47) 
14.1 (55) 
6.9 (27) 
0.3 (1) 
Electoral 
register 2013 
19.8 (65,843) 
28.7 (95,377) 
14.9 (49,711) 
13.9 (46,292) 
14.3 (47,734) 
8.3 (27,687) 
- 
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Labour status  
 
Employed 
Unemployed 
Inactive 
• Pensioner 
• Student 
• Other 
 
 
47.6 (186) 
6.7 (26) 
45.7 (179) 
27.6 (108) 
3.8 (15) 
14.3 (56) 
2012 Maltese 
Demographics 
48.2 (NA*) 
3.3 (NA) 
48.5 (NA) 
- 
- 
- 
Respondent or close family 
member is a dentist, doctor, 
nurse or pharmacist 
No 
Yes 
Missing data 
 
 
 
72.1 (282) 
25.8 (101) 
2.1 (8) 
 
 
 
- 
- 
- 
*NA: Not available 
 
While just over half of the respondents (56.5%, n=221) were female the 
majority (62.6%, n=245) were aged over 44 years, had a level of education of 
secondary or higher (81.1%, n=317) and were in employment (47.6%, n=186). 
Respondent demographics were similar to the Maltese population.  
 
5.3.3 Medication use 
Sixty-two percent of respondents (n=241) stated that they were taking or using 
regular medication, defined in the questionnaire as medication that they had to 
take or use every day. Of these, almost three quarters (70.5% n=170) obtained 
their medication free of charge, with 53.5% (n=129) purchasing the medication 
(respondents could have ticked both options: buying some of their regular 
medication and getting the remainder free). Free samples were given by the 
doctor to 2.5% (n=6) of respondents. 
 
Of the 150 respondents not taking or using medication every day, 62% (n=93) 
had been prescribed medication or purchased OTC medication in the previous six 
months.  
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The remainder of the questionnaire was completed only by those respondents 
either taking medication every day or had been prescribed or purchased OTC 
medication in the previous six months. 
 
Full questionnaire data was therefore obtained from the majority of respondents 
(85.7%, n=335, including one respondent not specifying regular/prescribed/ 
purchased). 
 
5.3.4 Medication adherence 
The MMAS-8-Item was completed by those either prescribed regular medication 
or who had a medication prescribed during the two weeks prior to the study 
(n=269). 
 
Responses to individual scale statements are given in Table 5.2 and summary 
scores in Table 5.3. Almost half (50.6%, n=136) self-reported forgetting to take 
their medication, one third (31.2%, n=84) considered sticking to their treatment 
plan to be a real inconvenience while three quarters (75.1%, n=202) self-
reported not being fully adherent.  
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Table 5.2: Responses to MMAS-8-Item (n=269) 
MMAS-8-Item Yes 
% (n) 
Do you sometimes forget to take your pills? 50.6 (136) 
People sometimes miss taking their medication for 
reasons other than forgetting. Thinking over the past 
two weeks, were there any days when you did not 
take your medicine?  
26.4 (71)  
Have you ever cut back or stopped taking your 
medication without telling your doctor, because you 
felt worse when you took it? 
19.0 (51)  
When you travel or leave home, do you sometimes 
forget to bring along your medication? 
18.6 (50)  
Did you take your medicine yesterday? 85.9 (231)  
When you feel like your health is under control, do 
you sometimes stop taking your medicine?  
22.3 (60)  
Taking medication everyday is a real inconvenience 
for some people. Do you ever feel hassled about 
sticking to your treatment plan? 
31.2 (84)  
How often do you have difficulty remembering to take all your 
medication? 
Never/Rarely 47.2 (127) 
Once in a while 38.7 (104) 
Sometimes 11.5 (31) 
Usually 2.2 (6) 
All the time 0.4 (1) 
 
 
Table 5.3: MMAS-8-Item score (n=269) 
Low adherence 
(score < 6) 
Medium adherence 
(6 = score < 8) 
High adherence 
(score = 8) 
43.5% (117) 31.6% (85) 24.9% (67) 
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5.3.5 General health 
Figure 5.2 illustrates respondents’ state of health, with less than one quarter 
(22.7%, n=76) stating their health to be as good as it could be. 
 
Figure 5.2: Health rating during the previous 6 months (n=335) 
 
5.3.6 Awareness of medication wastage 
Table 5.4 provides responses to statements on aspects of medication wastage. 
The majority strongly agreed/agreed that they were fully aware of the issue of 
medication wastage (70.6%, n=276), its impact on society (65.8%, n=257) and 
the economy (76.2%, n=298). Just over half were fully aware of the impact on 
patients (57.3%, n=224) and the environment (55.0%, n=215) but less on HCPs 
(38.6%, n=151). Some respondents added areas of impact, which included the 
following categories:  
• shortage of medication (n=10) 
• hospitals and health in general, tax payers (n=5 each) 
• patients who required the medication but were not entitled for free (n=3) 
• social services and social care professionals, drug abusers and any type of 
abuse (n=2 each) 
• the poor, Europe, suppliers, resistance to antibiotics, culture, animals, black 
market, respondent’s family and those who are helpless (n=1 for each). 
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Table 5.4: Awareness of medication wastage (n=391) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
 
% (n) 
I am fully aware of the issue of medication 
wastage in Malta  
5.6 
(22) 
5.9 
(23) 
15.3 
(60) 
34.8 
(136) 
35.8 
(140) 
2.6 
(10) 
I am fully aware of the impact of medication 
wastage in Malta on patients 
5.4 
(21) 
8.4 
(33) 
24.3 
(95) 
39.9 
(156) 
17.4 
(68) 
4.6 
(18) 
I am fully aware of the impact of medication 
wastage in Malta on healthcare professionals 
7.2 
(28) 
10.7 
(42) 
37.6 
(147) 
27.6 
(108) 
11.0 
(43) 
5.9 
(23) 
I am fully aware of the impact of medication 
wastage in Malta on society  
4.6 
(18) 
6.1 
(24) 
18.9 
(74) 
42.5 
(166) 
23.3 
(91) 
4.6 
(18) 
I am fully aware of the impact of medication 
wastage in Malta on the economy  
2.3 
(9) 
5.4 
(21) 
12.5 
(49) 
40.4 
(158) 
35.8 
(140) 
3.6 
(14) 
I am fully aware of the impact of medication 
wastage in Malta on the environment 
4.1 
(16) 
6.1 
(24) 
29.2 
(114) 
35.8 
(140) 
19.2 
(75) 
5.6 
(22) 
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Table 5.5 provides responses to statements relating to interest in the impact of 
medication wastage.  
 
The majority strongly disagreed/disagreed that they had no interest in the issue 
of medication wastage (71.9%, n=281), and its impact on patients (73.9%, 
n=289), HCPs (69.1%, n=270), society (75.7%, n=296), the economy (77.5%, 
n=303), and the environment (72.9%, n=285). 
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Table 5.5: Interest in the impact of medication wastage (n=391) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
 
% (n) 
I have no interest in the issue of medication 
wastage in Malta 
40.4 
(158) 
31.5 
(123) 
5.6 
(22) 
7.4 
(29) 
5.6 
(22) 
9.5 
(37) 
I have no interest in the impact of medication 
wastage in Malta on patients 
37.1 
(145) 
36.8 
(144) 
9.7 
(38) 
6.4 
(25) 
2.0 
(8) 
7.9 
(31) 
I have no interest in the impact of medication 
wastage in Malta on healthcare professionals 
32.5 
(127) 
36.6 
(143) 
13.0 
(51) 
5.6 
(22) 
2.8 
(11) 
9.5 
(37) 
I have no interest in the impact of medication 
wastage in Malta on society 
38.6 
(151) 
37.1 
(145) 
8.2 
(32) 
5.6 
(22) 
2.3 
(9) 
8.2 
(32) 
I have no interest in the impact of medication 
wastage in Malta on the economy 
40.9 
(160) 
36.6 
(143) 
7.7 
(30) 
3.8 
(15) 
3.3 
(13) 
7.7 
(30) 
I have no interest in the impact of medication 
wastage in Malta on the environment 
37.6 
(147) 
35.3 
(138) 
12.5 
(49) 
3.8 
(15) 
2.6 
(10) 
8.2 
(32) 
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Table 5.6 provides responses to statements on contribution towards medication 
wastage in Malta. 
 
Whilst a little more than a quarter of respondents (27.2%, n=106) felt that they 
contributed to the issue of medication wastage, the majority (69.3%, n=271) 
stated that they felt that other people were contributing to medication wastage. 
Respondents strongly agreed/agreed that, of all the HCPs, doctors were 
contributing most to medication wastage (35.0%, n=137), followed by 
pharmacists (16.6%, n=65), nurses (16.1%, n=63) and dentists (8.2%, n=32). 
Almost half of respondents (42.4%, n=166) strongly agreed/agreed that the free 
healthcare system was contributing towards the issue of medication wastage.  
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Table 5.6: Contribution towards medication wastage (n=391) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
 
% (n) 
I feel that I contribute to the issue of medication 
wastage in Malta 
35.8 
(140) 
21.0 
(82) 
9.5 
(37) 
18.2 
(71) 
9.0 
(35) 
6.6 
(26) 
I feel that other people are contributing to the 
issue of medication wastage in Malta 
3.6 
(14) 
3.6 
(14) 
17.9 
(70) 
44.0 
(172) 
25.3 
(99) 
5.6 
(22) 
I feel that the free health system is contributing 
to the issue of medication wastage in Malta 
14.3 
(56) 
18.7 
(73) 
18.9 
(74) 
24.0 
(94) 
18.4 
(72) 
5.6 
(22) 
I feel that dentists are responsible for the issue 
of medication wastage in Malta 
25.1 
(98) 
34.8 
(136) 
27.4 
(107) 
5.1 
(20) 
3.1 
(12) 
4.6 
(18) 
I feel that doctors are responsible for the issue 
of medication wastage in Malta 
14.1 
(55) 
21.5 
(84) 
25.1 
(98) 
27.1 
(106) 
7.9 
(31) 
4.3 
(17) 
I feel that nurses are responsible for the issue of 
medication wastage in Malta 
19.2 
(75) 
34.5 
(135) 
25.3 
(99) 
12.8 
(50) 
3.3 
(13) 
4.9 
(19) 
I feel that pharmacists are responsible for the 
issue of medication wastage in Malta 
18.9 
(74) 
34.0 
(133) 
25.8 
(101) 
11.0 
(43) 
5.6 
(22) 
4.6 
(18) 
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Table 5.7 provides responses to statements on the ability to reduce medication 
wastage in Malta. 
 
While little more than one third (38.6%, n=151) strongly agreed/agreed that 
they could do more to reduce medication wastage in Malta, only a similar 
proportion (35.6%, n=139) were confident in their ability to reduce medication 
wastage. The majority (71.3%, n=279) strongly agreed/agreed that the state 
could do more to reduce medication wastage. 
 
Some respondents commented on what the state could do to reduce medication 
wastage, including:  
• exercise more control checks (n=35)  
• educate (n=20) 
• revise the free healthcare system (n=17) 
• medication should always be available (n=11) 
• there should be payment for medication (n=10) 
• patients should be made aware of cost of free medication (n=2) 
• patients should be able to exchange closed package medication for other 
useful medication, the state should give more free medication, the state 
should enforce more patient reviews, abuse should be penalised, medication 
should be packed in smaller amounts, the state should ask patients to return 
unused medication, the state has to understand the Maltese population, the 
state should enforce laws, introduce policies and have more restrictions, the 
state should supply good medication, and medication should be delivered to 
those who need them (n=1 for each) 
 
Respondents strongly agreed/agreed that, of all the HCPs, doctors could do more 
to reduce medication wastage (62.1%, n=243), followed by pharmacists (46.8%, 
n=183), nurses (40.4%, n=158) and dentists (19.7%, n=77).  
 
Some respondents commented on HCPs’ contributions towards wastage. Themes 
derived using a content analysis approach included:  
• doctors should not issue prescriptions unnecessarily (n=38 [7 of whom 
commented on the unnecessary prescribing of antibiotics]) 
• doctors should carry out medication reviews more regularly (n=17)  
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• doctors are the ones who prescribe medication mostly, therefore they should 
do this cautiously (n=8) 
• the need for doctors to educate patients (n=7)  
• doctors “do whatever the patient tells them to do”, “doctors should not 
succumb to patients' pressure, who take medicines that they do not need any 
longer” and nurses should not make mistakes when administering medication 
(n=1 each) 
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Table 5.7: Confidence in ability (n=391) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
 
% (n) 
I feel that I could do more to reduce 
medication wastage in Malta 
9.0 
(35) 
15.6 
(61) 
28.4 
(111) 
29.4 
(115) 
9.2 
(36) 
8.4 
(33) 
I feel confident in my ability to reduce 
medication wastage in Malta 
6.4 
(25) 
12.5 
(49) 
37.1 
(145) 
24.3 
(95) 
11.3 
(44) 
8.4 
(33) 
Dentists could do more to reduce medication 
wastage in Malta 
6.6 
(26) 
16.9 
(66) 
48.3 
(189) 
15.9 
(62) 
3.8 
(15) 
8.4 
(33) 
Doctors could do more to reduce medication 
wastage in Malta 
3.1 
(12) 
6.9 
(27) 
19.7 
(77) 
43.7 
(171) 
18.4 
(72) 
8.2 
(32) 
Nurses could do more to reduce medication 
wastage in Malta 
5.9 
(23) 
14.1 
(55) 
30.7 
(120) 
32.7 
(128) 
7.7 
(30) 
9.0 
(35) 
Pharmacists could do more to reduce 
medication wastage in Malta 
4.9 
(19) 
13.3 
(52) 
25.8 
(101) 
35.8 
(140) 
11.0 
(43) 
9.2 
(36) 
The state could do more to reduce medication 
wastage in Malta 
1.5 
(6) 
3.8 
(15) 
13.8 
(54) 
36.8 
(144) 
34.5 
(135) 
9.5 
(37) 
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5.3.7 Association between demographic characteristics and outcomes 
This section provides analysis of associations between a number of demographic 
variables and key outcome measures of: awareness of medication wastage in 
Malta; no interest in medication wastage; contribution towards medication 
wastage; and confidence in ability to reduce medication wastage. 
 
5.3.7.1 Awareness of medication wastage 
Demographics and other variables were tested for association with the outcome 
of awareness of medication wastage. Awareness was collapsed into those 
agreeing/strongly agreeing, and those uncertain/disagreeing/strongly 
disagreeing as given in Table 5.8. 
 
Association of data for demographic characteristics and awareness of issues of 
medication wastage (statement in questionnaire: “I am fully aware of the issue 
of medication wastage in Malta”), revealed that: 
• age and awareness of medication wastage were significantly related 
χ2=21.223, p=0.003. Younger respondents were much less likely to self-
report awareness of issues of medication wastage.  
• type of occupation and awareness of medication wastage were significantly 
related χ2=13.111, p=0.011, with pensioners more likely to self-report 
awareness of issues of medication wastage and students self-reporting the 
least. 
• whether patients were on regular medication and awareness of medication 
wastage were significantly related χ2=5.334, p=0.021. Respondents who were 
on regular medication were much more likely to self-report awareness of 
issues of medication wastage. 
• whether patients were obtaining their medication for free and awareness of 
medication wastage were significantly related χ2=4.962, p=0.026. 
Respondents who were obtaining their medication for free were more likely to 
self-report awareness of issues of medication wastage. 
 
Variables identified as significant in univariate analysis (p≤0.05) were entered 
into bivariate logistic regression. There were no strong predictor(s) for the given 
outcome. 
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Table 5.8: Association of data for demographic characteristics and awareness of issues of medication wastage  
Variable Strongly agree/agree 
% (n) 
Uncertain/disagree/strongly disagree 
% (n) 
Test value (p) 
Gender 
   Female 
   Male 
72.4 (276) 
71.8 (153)  
73.2 (123)  
27.6 (105) 
28.2 (60)  
26.8 (45)  
0.090 (0.764) 
Age (years) 
   18-24  
   25-34    
   35-44  
   45-54  
   55-64  
   65-74  
   75-84  
   ≥ 85 
72.4 (276) 
39.3 (11) 
64.7 (33) 
74.2 (49) 
75.9 (44) 
79.8 (71) 
76.9 (40) 
72.4 (21) 
87.5 (7) 
27.6 (105) 
60.7 (17) 
35.3 (18) 
25.8 (17) 
24.1 (14) 
20.2 (18) 
23.1 (12) 
27.6 (8) 
12.5 (1) 
21.223 (0.003) 
Level of education 
   No schooling 
   Primary 
   Secondary 
   Post-secondary 
   Tertiary 
   Post-graduate 
72.3 (274) 
75.0 (3) 
78.3 (54) 
72.6 (98) 
70.8 (51) 
65.7 (44) 
75.0 (24) 
27.7 (105) 
25.0 (1) 
21.7 (15) 
27.4 (37) 
29.2 (21) 
34.3 (23) 
25.0 (8) 
2.908 (0.714) 
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Type of occupation 
   Employed 
   Unemployed 
   Pensioner 
   Student 
   Other 
72.4 (276) 
70.7 (130) 
64.0 (16) 
76.9 (80) 
40.0 (6) 
83.0 (44) 
27.6 (105) 
29.3 (54) 
36.0 (9) 
23.1 (24) 
60.0 (9) 
17.0 (9) 
13.111 (0.011) 
Locality of residency 
   Southern Harbour 
   Northern Harbour 
   South Eastern 
   Western 
   Northern 
   Gozo & Comino 
72.4 (275) 
73.7 (56) 
70.5 (86) 
70.0 (42) 
76.1 (35) 
73.1 (38) 
75.0 (18) 
27.6 (105) 
26.3 (20) 
29.5 (36) 
30.0 (18) 
23.9 (11) 
26.9 (14) 
25.0 (6) 
0.863 (0.973) 
Family member – HCP 
   No 
   Yes 
72.4 (270) 
71.2 (195) 
75.8 (75) 
27.6 (103) 
28.8 (79) 
24.2 (24) 
0.766 (0.381) 
On regular medicines 
   No 
   Yes 
72.4 (275) 
65.8 (98) 
76.6 (177) 
27.6 (105) 
34.2 (51) 
23.4 (54) 
5.334 (0.021) 
Free:yellow or pink card 
No 
Yes 
72.5 (274) 
68.1 (147) 
78.4 (127) 
27.5 (104) 
31.9 (69) 
21.6 (35) 
4.962 (0.026) 
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Pay for them 
No 
Yes 
72.5 (274) 
70.2 (179) 
77.2 (95) 
27.5 (104) 
29.8 (76) 
22.8 (28) 
2.062 (0.151) 
MMAS-8-Item score 
   Low adherence 
   Medium adherence 
   High adherence 
74.6 (194) 
68.4 (80) 
81.3 (65) 
77.8 (49) 
25.4 (66) 
31.6 (37) 
18.7 (15) 
22.2 (14) 
4.597 (0.100) 
General health 
   As bad as it could be 
   2 
   3 
   4 
   As good as it could be 
74.3 (226) 
60.0 (3) 
77.8 (7) 
78.3 (72) 
73.6 (92) 
71.2 (52) 
25.7 (78) 
40.0 (2) 
22.2 (2) 
21.7 (20) 
26.4 (33) 
28.8 (21) 
1.742 (0.783) 
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5.3.7.2 No interest in medication wastage 
Demographics and other variables were tested for association with the outcome 
of no interest in medication wastage. Interest was collapsed into those 
agreeing/strongly agreeing, and those uncertain/disagreeing/strongly 
disagreeing as given in Table 5.9. 
 
Association of data for demographic characteristics and interest in issues of 
medication wastage (statement in questionnaire: “I have no interest in the issue 
of medication wastage in Malta”), revealed that: 
• whether patients were obtaining their medication for free and no interest in 
medication wastage were significantly related χ2=5.254, p=0.022. 
Respondents who were obtaining their medication for free were more likely to 
self-report no interest of issue of medication wastage. 
• whether patients were purchasing their medication and interest in medication 
wastage were significantly related χ2=4.809, p=0.028. Respondents who were 
paying for their medication were less likely to self-report no interest of issue 
of medication wastage. 
 
The fact that those patients paying for their medication were less likely to self-
report no interest of issue of medication wastage is in line with the finding that 
those patients obtaining their medication for free were more likely to self-report 
no interest of issue of medication wastage. 
 
Variables identified as significant in univariate analysis (p≤0.05) were entered 
into bivariate logistic regression. Both variables were retained as significant, as 
follows: 
 
• medication for free, odds ratio 2.280 (95% CI 1.093-4.758) 
• paying for medication, odds ratio 2.041 (95% CI 1.15-3.731) 
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Table 5.9: Association of data for demographic characteristics and no interest in issues of medication wastage 
Variable Strongly agree/agree 
% (n) 
Uncertain/disagree/strongly disagree 
% (n) 
Test value  
(p) 
Gender 
   Female 
   Male 
14.4 (51) 
14.5 (29) 
14.3 (22) 
85.6 (303) 
85.5 (171) 
85.7 (132) 
0.003 (0.955) 
Age (years) 
   18-24  
   25-34 
   35-44 
   45-54 
   55-64 
   65-74 
   75-84 
   ≥ 85  
14.4 (51) 
17.9 (5) 
11.7 (6) 
7.9 (5) 
14.5 (8) 
12.7 (10) 
25.6 (11) 
21.4 (6) 
0.0 (0) 
85.6 (303) 
82.1 (23) 
88.2 (45) 
92.1 (58) 
85.5 (47) 
87.3 (69) 
74.4 (32) 
78.6 (22) 
100.0 (7) 
9.547 (0.216) 
Level of education 
   No schooling 
   Primary 
   Secondary 
   Post-secondary 
   Tertiary 
   Post-graduate 
14.4 (51) 
0.0 (0) 
18.3 (11) 
19.2 (23) 
11.3 (8) 
7.6 (5) 
12.9 (4) 
85.6 (301) 
100.0 (4) 
81.7 (49) 
80.8 (97) 
88.7 (63) 
92.4 (61) 
87.1 (27) 
6.716 (0.243) 
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Type of occupation 
   Employed 
   Unemployed 
   Pensioner 
   Student 
   Other 
14.4 (51) 
11.9 (21) 
14.3 (3) 
21.7 (20) 
20.0 (3) 
8.2 (4) 
85.6 (303) 
88.1 (156) 
85.7 (18) 
78.3 (72) 
80.0 (12) 
91.8 (45) 
6.869 (0.143) 
Locality of residency 
   Southern Harbour 
   Northern Harbour 
   South Eastern 
   Western 
   Northern 
   Gozo & Comino 
14.4 (51) 
17.6 (12) 
13.7 (16) 
8.8 (5) 
24.4 (10) 
10.6 (5) 
13.0 (3) 
85.6 (302) 
82.4 (56) 
86.3 (101) 
91.2 (52) 
75.6 (31) 
89.4 (42) 
87.0 (20) 
5.973 (0.309) 
Family member – HCP 
   No 
   Yes  
14.1 (49) 
14.5 (37) 
13.0 (12) 
85.9 (298) 
85.5 (218) 
87.0 (80) 
0.120 (0.729) 
On regular medicines 
   No 
   Yes 
14.4 (51) 
12.6 (18) 
15.7 (33) 
85.6 (302) 
87.4 (125) 
84.3 (177) 
0.673 (0.412) 
Free:yellow or pink card 
No 
Yes 
14.5 (51) 
11.0 (23) 
19.7 (28) 
85.5 (301) 
89.0 (187) 
80.3 (114) 
5.254 (0.022) 
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Pay for them 
No 
Yes 
14.5 (51) 
17.4 (41) 
8.6 (10) 
85.5 (301) 
82.6 (195) 
91.4 (106) 
4.809 (0.028) 
MMAS-8-Item score 
   Low adherence 
   Medium adherence 
   High adherence 
15.6 (37) 
14.8 (16) 
20.3 (14) 
11.7 (7) 
84.4 (200) 
85.2 (92) 
79.7 (55) 
88.3 (53) 
1.907 (0.385) 
General health 
   As bad as it could be 
   2 
   3 
   4 
   As good as it could be 
14.7 (41) 
20.0 (1) 
14.3 (1) 
18.6 (16) 
13.0 (15) 
12.1(8) 
85.3 (238) 
80.0 (4) 
85.7 (6) 
81.4 (70) 
87.0 (100) 
87.9 (58) 
1.761 (0.780) 
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5.3.7.3 Contribution towards medication wastage 
Demographics and other variables were tested for association with the outcome 
of contribution towards medication wastage. Contribution was collapsed into 
those agreeing/strongly agreeing, and those uncertain/disagreeing/strongly 
disagreeing as given in Table 5.10. 
 
Association of data for demographic characteristics and contribution towards 
medication wastage (statement in questionnaire: “I feel that I contribute to the 
issue of medication wastage in Malta”), revealed that: 
• type of occupation and contribution towards medication wastage were 
significantly related χ2=13.274, p=0.010, with unemployed respondents much 
more likely to report contribution towards medication wastage. 
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Table 5.10: Association of data for demographic characteristics and contribution towards medication wastage 
Variable Strongly agree/agree 
% (n) 
Uncertain/disagree/strongly disagree 
% (n) 
Test value  
(p) 
Gender 
   Female 
   Male 
29.0 (106) 
29.4 (60) 
28.6 (46) 
71.0 (259) 
70.6 (144) 
71.4 (115) 
0.031 (0.861) 
Age (years) 
   18-24  
   25-34  
   35-44  
   45-54  
   55-64  
   65-74 
   75-84 
  ≥ 85  
29.0 (106) 
33.3 (9) 
36.0 (18) 
18.8 (12) 
41.8 (23) 
24.4 (21) 
31.2 (15) 
17.9 (5) 
42.9 (3) 
71.0 (259) 
66.7 (18) 
64.0 (32) 
81.2 (52) 
58.2 (32) 
75.6 (65) 
68.8 (33) 
82.1 (23) 
57.1 (4) 
12.416 (0.088) 
Level of education 
   No schooling 
   Primary 
   Secondary 
   Post-secondary 
   Tertiary 
   Post-graduate 
28.9 (105) 
75.0 (3) 
31.7 (20) 
26.4 (34) 
22.9 (16) 
37.3 (25) 
23.3 (7) 
71.1 (258) 
25.0 (1) 
68.3 (43) 
73.6 (95) 
77.1 (54) 
62.7 (42) 
76.7 (23) 
8.791 (0.118) 
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Type of occupation 
   Employed 
   Unemployed 
   Pensioner 
   Student 
   Other 
29.0 (106) 
32.8 (58) 
54.5 (12) 
23.2 (23) 
26.7 (4) 
17.3 (9) 
71.0 (259) 
67.2 (119) 
45.5 (10) 
76.8 (76) 
73.3 (11) 
82.7 (43) 
13.274 (0.010) 
Locality of residency 
   Southern Harbour 
   Northern Harbour 
   South Eastern 
   Western 
   Northern 
   Gozo & Comino 
29.1 (106) 
28.6 (20) 
27.1 (32) 
27.6 (16) 
41.9 (18) 
23.1 (12) 
34.8 (8) 
70.9 (258) 
71.4 (50) 
72.9 (86) 
72.4 (42) 
58.1 (25) 
76.9 (40) 
65.2 (15) 
4.964 (0.420) 
Family member – HCP 
   No 
   Yes 
29.0 (104) 
28.3 (75) 
31.2 (29) 
71.0 (254) 
71.7 (190) 
68.8 (64) 
0.277 (0.599) 
On regular medicines 
   No 
   Yes 
29.1 (106) 
27.5 (39) 
30.2 (67) 
70.9 (258) 
72.5 (103) 
69.8 (155) 
0.309 (0.578) 
Free:yellow or pink card 
No 
Yes 
29.0 (105) 
27.9 (58) 
30.5 (47) 
71.0 (257) 
72.1 (150) 
69.5 (107) 
0.298 (0.585) 
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Pay for them 
   No 
   Yes 
29.0 (105) 
28.2 (68) 
30.6 (37) 
71.0 (257) 
71.8 (173) 
69.4 (84) 
0.218 (0.640) 
MMAS-8-Item score 
   Low adherence 
   Medium adherence 
   High adherence 
31.5 (79) 
38.4 (43) 
28.6 (22) 
22.6 (14) 
68.5 (172) 
61.6 (69) 
71.4 (55) 
77.4 (48) 
5.060 (0.080) 
General health 
   As bad as it could be 
   2 
   3 
   4 
   As good as it could be 
29.3 (86) 
40.0 (2) 
44.4 (4) 
30.7 (27) 
27.3 (33) 
28.2 (20) 
70.7 (208) 
60.0 (3) 
55.6 (5) 
69.3 (61) 
72.7 (88) 
71.8 (51) 
1.639 (0.802) 
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5.3.7.4 Confidence in ability to medication wastage 
Demographics and other variables were tested for association with the outcome 
of confidence in ability to reduce medication wastage. Confidence was collapsed 
into those agreeing/strongly agreeing, and those uncertain/disagreeing/strongly 
disagreeing as given in Table 5.11. 
 
Association of data for demographic characteristics and confidence in ability to 
reduce medication wastage (statement in questionnaire: “I feel confident in my 
ability to reduce medication wastage in Malta”), revealed that: 
• the presence of a HCP as a family member (dentist, doctor, nurse and/or 
pharmacist) of respondent and confidence in ability to reduce medication 
wastage were significantly related χ2=6.807, p=0.009, with respondents who 
had a HCP as a family member self-reporting a higher confidence in ability to 
reduce medication wastage. 
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Table 5.11: Association of data for demographic characteristics and confidence in ability to reduce medication wastage 
Variable Strongly agree/agree 
% (n) 
Uncertain/disagree/strongly disagree 
% (n) 
Test value  
(p) 
Gender 
   Female 
   Male 
38.8 (139) 
40.1 (79) 
37.3 (60) 
61.2 (219) 
59.9 (118) 
62.7 (101) 
0.300 (0.584) 
Age (years) 
   18-24  
   25-34  
   35-44  
   45-54  
   55-64  
   65-74  
   75-84  
   ≥ 85  
38.8 (139) 
25.0 (7) 
39.2 (20) 
34.4 (21) 
39.3 (22) 
49.4 (41) 
32.6 (15) 
38.5 (10) 
42.9 (3) 
61.2 (219) 
75.0 (21) 
60.8 (31) 
65.6 (40) 
60.7 (34) 
50.6 (42) 
67.4 (31) 
61.5 (16) 
57.1 (4) 
7.462 (0.382) 
Level of education 
   No schooling 
   Primary 
   Secondary 
   Post-secondary 
   Tertiary 
   Post-graduate 
39.0 (139) 
75.0 (3) 
42.1 (24) 
40.2 (51) 
37.1 (26) 
40.3 (27) 
25.8 (8) 
71.0 (217) 
25.0 (1) 
57.9 (33) 
59.8 (76) 
62.9 (44) 
59.7 (40) 
74.2 (23) 
4.897 (0.429) 
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Type of occupation 
   Employed 
   Unemployed 
   Pensioner 
   Student 
   Other 
38.8 (139) 
37.7 (66) 
58.3 (14) 
40.4 (38) 
33.3 (5) 
32.0 (16) 
61.2 (219) 
62.3 (109) 
41.7 (10) 
59.6 (56) 
66.7 (10) 
68.0 (34) 
5.209 (0.267) 
Locality of residency 
   Southern Harbour 
   Northern Harbour 
   South Eastern 
   Western 
   Northern 
   Gozo & Comino 
38.7 (138) 
38.8 (26) 
40.9 (47) 
35.2 (19) 
45.7 (21) 
36.5 (19) 
26.1 (6) 
61.3 (219) 
61.2 (41) 
59.1 (68) 
64.8 (35) 
54.3 (25) 
63.5 (33) 
73.9 (17) 
3.093 (0.686) 
Family member – HCP 
   No 
   Yes 
38.4 (135) 
34.2 (88) 
49.5 (47) 
61.6 (217) 
65.8 (169) 
50.5 (48) 
6.807 (0.009) 
On regular medicines 
   No 
   Yes 
38.7 (138) 
36.4 (52) 
40.2 (86) 
61.3 (219) 
63.6 (91) 
59.8 (128) 
0.528 (0.467) 
Free:yellow or pink card 
No 
Yes 
38.3 (136) 
37.2 (77) 
39.9 (59) 
61.7 (219) 
62.8 (130) 
60.1 (89) 
0.260 (0.610) 
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Pay for them 
   No 
   Yes 
38.3 (136) 
37.4 (89) 
40.2 (47) 
61.7 (219) 
62.6 (149) 
59.8 (70) 
0.256 (0.613) 
MMAS-8-Item score 
   Low adherence 
   Medium adherence 
   High adherence 
38.9 (95) 
42.9 (48) 
41.9 (31) 
27.6 (16) 
61.1 (149) 
57.1 (64) 
58.1 (43) 
72.4 (42) 
4.139 (0.126) 
General health 
   As bad as it could be 
   2 
   3 
   4 
   As good as it could be 
38.7 (111) 
60.0 (3) 
25.0 (2) 
44.7 (38) 
37.0 (44) 
34.3 (24) 
61.3 (176) 
40.0 (2) 
75.0 (6) 
55.3 (47) 
63.0 (75) 
65.7 (46) 
3.607 (0.462) 
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5.3.8 Current practices with medication that patients buy or get for free 
Table 5.12 illustrates the current practices with medication that patients 
purchased against a prescription or OTC. Twenty-seven respondents stated that 
this section was not applicable. 
 
Almost one-fifth of respondents (16.9%, n=52) strongly agreed/agreed that they 
bought all of their medication regularly whether or not they had run out. While 
15.9% of respondents (n=49) strongly agreed/agreed that they passed 
medication that they bought for themselves to other persons, such as relatives, 
neighbours and friends, only 5.5% (n=17) accepted medication from other 
people. 
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Table 5.12: Practice with medication that are purchased against a prescription or OTC (n=308) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
data 
% (n) 
I buy all my medication regularly whether 
or not I have run out of them 
34.1 
(105) 
31.8 
(98) 
2.3 
(7) 
10.1 
(31) 
6.8 
(21) 
14.9 
(46) 
I buy all my medication only when I run 
out of them 
5.2 
(16) 
9.7 
(30) 
1.3 
(4) 
43.2 
(133) 
28.2 
(87) 
12.3 
(38) 
I buy more medication than I need 47.7 
(147) 
31.8 
(98) 
0.6 
(2) 
2.9 
(9) 
1.6 
(5) 
15.3 
(47) 
I buy medication without checking if I 
already have a supply at home 
46.8 
(144) 
32.1 
(99) 
2.3 
(7) 
2.9 
(9) 
1.9 
(6) 
14.0 
(43) 
I pass medication that I buy for myself to 
other persons, such as relatives, 
neighbours and friends 
43.5 
(134) 
25.3 
(78) 
3.2 
(10) 
12.7 
(39) 
3.2 
(10) 
12.0 
(37) 
I buy different medication for the same 
condition as I follow the advice of 
different people 
54.9 
(169) 
26.0 
(80) 
1.9 
(6) 
2.9 
(9) 
1.3 
(4) 
13.0 
(40) 
When I visit the dentist, doctor, 
pharmacist, nurse, I put them under 
pressure to supply me medication 
55.2 
(170) 
26.3 
(81) 
1.3 
(4) 
3.2 
(10) 
2.3 
(7) 
11.7 
(36) 
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I buy medication depending on what I 
read in books, magazines, internet 
61.0 
(188) 
21.4 
(66) 
2.6 
(8) 
2.3 
(7) 
1.0 
(3) 
11.7 
(36) 
I get medication from other people 59.1 
(182) 
21.8 
(67) 
1.3 
(4) 
3.9 
(12) 
1.6 
(5) 
12.3 
(38) 
I am aware of the approximate costs of 
the medication that I buy 
3.2 
(10) 
5.8 
(18) 
10.7 
(33) 
41.2 
(127) 
26.9 
(83) 
12.0 
(37) 
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Table 5.13 illustrates the current practices with medication that patients are 
entitled to get free of charge through the Maltese NHS. One hundred and forty-
five respondents stated that this section was not applicable to them. 
 
While slightly more than a quarter of respondents (26.9%, n=51) strongly 
agreed/agreed that they obtained all their free medication regularly whether or 
not they had run out, only 4.2% (n=8) of respondents strongly agreed/agreed 
that they obtained more free medication than needed. The majority of 
respondents (65.3%, n=124) felt that they were aware of the approximate costs 
of the medication that they obtained free of charge from the NHS. 
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Table 5.13: Practice with medication obtained free of charge through the Maltese NHS (n=190) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
 
% (n) 
I get all my free medication regularly 
whether or not I have run out of them 
24.7 
(47) 
25.8 
(49) 
2.1 
(4) 
21.1 
(40) 
5.8 
(11) 
20.5 
(39) 
I get all my free medication only when I run 
out of them 
4.7 
(9) 
13.7 
(26) 
2.1 
(4) 
35.8 
(68) 
25.8 
(49) 
17.9 
(34) 
I get more free medication than I need  48.9 
(93) 
25.3 
(48) 
2.1 
(4) 
2.6 
(5) 
1.6 
(3) 
19.5 
(37) 
I get free medication from the pharmacy 
without checking if I already have a supply 
at home 
45.3 
(86) 
28.9 
(55) 
1.1 
(2) 
4.2 
(8) 
2.1 
(4) 
18.4 
(35) 
I pass medication that I get for free to other 
persons, such as relatives, neighbours and 
friends 
54.7 
(104) 
18.9 
(36) 
1.1 
(2) 
3.2 
(6) 
2.1 
(4) 
20.0 
(38) 
I am aware of the approximate costs of the 
medication that I get for free from the NHS 
1.6 
(3) 
3.7 
(7) 
11.6 
(22) 
33.7 
(64) 
31.6 
(60) 
17.9 
(34) 
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5.3.9 Experiences with medication  
The majority of all respondents (92.8%, n=311) replied that they were aware 
that all medication have an expiry date, with only one respondent stating that he 
was not aware of the ‘use-by date’. One-fifth of respondents (21.5%, n=72) 
either stated that they encountered a problem when trying to read the expiry 
date, or failed to respond (Figure 5.3). 
 
 
Figure 5.3: Problem reading expiry date (n=335) 
 
Figure 5.4 illustrates responses relating to the reuse of medication. Only half 
(51.5%, n=201) agreed/strongly agreed that medication supplied to patients and 
returned within expiry dates to HCPs should be reused. One stated that “this will 
reduce the hazard of unused medication being flushed down toilets”. However, 
others were not in favour of medication redistribution.  
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Figure 5.4: Responses relating to the reuse of medication returned within expiry 
dates (n=391) 
 
Table 5.14 presents responses relating to locations where respondents stored 
medication. 
 
Table 5.14: Medication storage (n=335) 
Storage location Percent (%) Frequency 
Medication cabinets in kitchen 30.7 103 
Medication cabinets in bedroom 18.5 62 
Medication cabinets in bathroom 28.4 95 
Medication cabinets in garage 0.9 3 
Cupboard in kitchen 30.7 103 
Cupboard in bedroom 14.0 47 
Cupboard in bathroom 12.5 42 
Cupboard in garage 0.9 3 
Office 3.6 12 
Car 2.4 8 
Fridge 26.6 89 
Carried around by individual 13.7 46 
Other 9.2 31 
Missing data 7.2 24 
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‘Other’ included: the dining room, boardroom, box room, hall, in cool places, 
cupboard in the corridor, cupboard in the showcase, drawers, in a tin on the 
fridge, dresser, study cabinet, “in a fruit bowl on the bench”, “next to bedside 
the ones I take everyday”, in a box in the wall unit, “always under lock and key”, 
in a pouch in the wardrobe, “in bag (travel) to find them ready”, in bulky bags, 
“where I can find them most accessible” and “the way I think best”. 
 
Table 5.15 presents the sources of information on medication storage. More than 
half of respondents (56.4%, n=189) stated that they had never been given any 
information on medication storage. 
 
Table 5.15: Information regarding storage (n=335) 
Information regarding storage Percent (%) Frequency 
No one 56.4 189 
Information leaflet supplied with medication 26.0 87 
Pharmacist 19.4 65 
Doctor 18.2 61 
Other 5.4 18 
Nurse 3.9 13 
Television/Radio 3.0 10 
Magazines/Newspapers 2.7 9 
Internet 2.4 8 
Friend 1.2 4 
Dentist 0.9 3 
Missing data 7.8 26 
 
Respondents got information from ‘other’ sources, including: 
• “From common sense” 
• “My mother” 
• “Nursing school” 
 
Figure 5.5 illustrates whether respondents had any unused medication in their 
household in the six months prior to the study. Figure 5.6 depicts the reasons 
why this medication remained unused. 
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Figure 5.5: Unused medication in household in the last 6 months (n=335) 
 
 
Figure 5.6: Reasons for unused medication (n=335) 
 
‘Other’ reasons included:  
• “Can't use more than doctor tells you” 
• “Samples given were not used” 
• “Stopped by the doctor” 
• “Stopped by the doctor as they were both for the same condition” 
• “Sometimes you have to buy more than you require” 
• “Sometimes when you buy certain things like eye drops or ointment you have 
to use them within 3 weeks” 
• “Forgot to check what I had in travel bag” 
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• “Got allergy to medication” 
 
Table 5.16 shows the method of disposal respondents employed for unused and 
expired medication. 
 
Table 5.16: Methods of medication disposal used by respondents (n=335) 
Disposal of medication Unused  
% (n) 
Expired 
% (n) 
Throw them away with the household rubbish 5.1 (17) 46.6 (156) 
Throw them down the toilet or sink 6.6 (22) 33.7 (113) 
Give them to a pharmacy to give them to 
someone else 
14.9 (50) 1.2 (4) 
Give them to another person or friend 9.6 (32) 1.2 (4) 
Take them to a medication disposal bring-in-site 2.7 (9) 6.6 (22) 
Give them to a pharmacy to dispose of them 8.4 (28) 8.1 (27) 
Keep them for possible future use 57.3 (192) 3.3 (11) 
Sell these medication 0.0 (0) 0.0 (0) 
Give to charity 2.1 (7) 0.6 (2) 
None of the above 0.0 (0) 0.0 (0) 
I do not know 2.1 (7) 3.0 (10) 
Other 8.1 (27) 3.6 (12) 
Missing data 9.0 (30) 9.2 (31) 
 
‘Other’ means of disposal included: 
• “Burn them” 
• “Give them to a family doctor”  
• “When I'm due for medicines I calculate the difference” 
• “Use cardboard box for education purposes” 
• “Give them to some old people's home” 
 
Table 5.17 presents the source from where respondents obtained information on 
medication disposal. Two thirds of respondents (66.6%, n=223) claimed that 
they had never been given this information. 
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Table 5.17: Information regarding disposal (n=335) 
Information regarding disposal Percent (%) Frequency 
No one 66.6 223 
Pharmacist 6.9 23 
Information leaflet supplied with medication 6.0 20 
Doctor 5.7 19 
Television/Radio 4.2 14 
Other 3.9 13 
Magazines/Newspapers 2.4 8 
Nurse 2.4 8 
Friend 1.2 4 
Internet 0.6 2 
Dentist 0.0 0 
Missing data 11.0 37 
 
Respondents got information from ‘other’ sources, including: 
• “From common sense” 
• “This is the way I think” 
• “Education” 
• “My mother” 
• “Nursing school” 
• “My sister”  
• “What I feel on the spur of the moment” 
 
Table 5.18 shows whether respondents felt that they had enough information on 
how to take medication to get most benefit and least side-effects, while Table 
5.19 presents the source from where respondents obtained this information. 
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Table 5.18: Information regarding use of medication (n=335) 
 Yes 
% (n) 
No 
% (n) 
I am not 
sure 
% (n) 
Missing 
data 
% (n) 
Do you feel you have enough 
information on how to take all of 
your medication to get the most 
benefit from them (including 
medication which is used only 
occasionally)? 
64.5 
(216) 
17.6 
(59) 
9.2 
(31) 
8.7 
(29) 
Do you feel you have enough 
information on how to take all of 
your medication to get the least 
side-effects from them (including 
medication which is used only 
occasionally)?  
56.4 
(189) 
 
23.6 
(79) 
11.9 
(40) 
8.1 
(27) 
 
Table 5.19: Information on use of medication (n=335) 
Information on use of medication Percent (%) Frequency  
Doctor 42.4 142 
Information leaflet supplied with medication 36.1 121 
Pharmacist 24.5 82 
Internet 7.8 26 
Nurse 5.4 18 
I do not know 3.6 12 
Dentist 2.7 9 
Other 2.7 9 
Television/Radio 2.4 8 
Magazines/Newspapers 2.1 7 
Friend 0.9 3 
Missing data 9.6 32 
 
Respondents got information from ‘other’ sources, including: 
• “Education” 
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• “My mother” 
• “Nursing school” 
 
5.3.10 Factors contributing towards medication wastage 
Analysis of responses (n=391) to the open question on the factors or reasons 
that could be leading to medication wastage in Malta identified ten key themes. 
The most commonly cited contributory factor for wastage was the ‘free 
healthcare system’, mentioned by 15.6% (n=61) of respondents. The key 
themes which emerged from the reasons for wastage provided by respondents 
included:  
• The free healthcare system (n=61) 
• Collecting/buying medication that you do not need or more than you need 
(n=29) 
• Overprescribing/incorrect prescribing (n=24) 
• Lack of education/information (n=20) 
• Medication shortages (n=19) 
• Large pack sizes (n=18) 
• Non-adherence/inappropriate use of medication (n=17) 
• Abuse of the free healthcare system (n=12) 
• Mismanagement of stock (n=11) 
• Lack of responsibility/carelessness by patients (n=10) 
 
5.3.11 Consequences of medication wastage  
Analysis of responses (n=391) to the open question on the consequences of 
medication wastage identified three key themes. The most commonly cited was 
the ‘financial’ one, mentioned by 37.0% (n=145) of respondents. The key 
themes which emerged from the consequences for wastage provided by 
respondents included:  
• Financial consequences (n=145) 
• Medication shortages (n=95) 
• Environmental consequences (n=34) 
 
5.3.12 Potential solutions to reduce medication wastage 
Analysis of responses (n=391) to the open question on the potential solutions 
which could reduce medication wastage identified nine key themes. The most 
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commonly cited solutions were ‘education’ and ‘more control checks of 
medication given to patients’, both mentioned by 7.4% (n=29) of respondents. 
The key themes which emerged were:  
• Education of HCPs and patients (n=29) 
• More control checks of medication given to patients (n=29) 
• Medication reviews by HCPs (n=26) 
• Careful and accurate prescribing and dispensing of medication (n=21) 
• By introducing a small fee on free medication or prescriptions or paying for 
medication (n=17) 
• Better prescribing (n=17) 
• More awareness by patients (n=11) 
• Patients should return unused sealed medication (n=10) 
• Medication should always be available (n=10) 
 
5.3.13 General comments on medication wastage listed by respondents 
Respondents were given the option to add any additional comments. Some re-
emphasised contributory factors and consequences. Analysis of these comments 
identified five key themes, which were: 
• General comments on causes and consequences of medication wastage that 
were already highlighted above, including free medication through POYC 
scheme (n=55) 
• More information and awareness by patients on medication use, storage, 
disposal and wastage (n=23) 
• More control or reviews by HCPs (n=22) 
• Medication shortages, with comments discussing the resultant hoarding, with 
one respondent suggesting that when medication has to be purchased as a 
result of an out-of-stock situation, one should not pay the full price (n=16) 
• There is no wastage or they do not feel that they are wasting (n=10) 
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5.4 Results: HCP questionnaire 
5.4.1 Response rate 
The response rate following the first mailing was 17.4% (293 responses, 
exceeding the response rate of the pilot study which was 13.0%) and increased 
to 26.4% (444/1680 responses) following one reminder sent to non-respondents. 
This exceeded the calculated sample size of 330 responses. The highest response 
rate was obtained from doctors (32.0%, n=224/700), followed by dentists 
(27.4%, n=45/164) and pharmacists (21.4%, n=175/816). As 1.3% (n=21) of 
doctors returned the questionnaire incomplete with a statement indicating that 
they lived or worked overseas, the response rate is an underestimate. Figure 5.7 
illustrates the number of daily responses that were obtained over the 55-day 
collection period. 
 
Figure 5.7: Number of HCP questionnaire responses during the 55-day data 
collection 
 
5.4.2 Demographic characteristics 
Table 5.20 gives the demographic characteristics of respondents.  
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Table 5.20: Demographic data of HCP respondents (n=444) 
Demographics Percent (Frequency) 
% (n) 
Gender 
Male 
Female 
Missing data 
 
50.0 (222) 
49.1 (218) 
0.9 (4) 
Age (years) 
20-29  
30-39  
40-49  
50-59  
> 59  
Missing data 
 
22.5 (100) 
27.5 (122) 
22.3 (99) 
16.0 (71) 
11.3 (50) 
0.4 (2) 
Profession 
Dentist 
Doctor 
Pharmacist 
 
10.1 (45) 
50.5 (224) 
39.4 (175) 
Main place of work 
Government services/Public sector 
Private sector 
Self-employed 
 
51.1 (227) 
27.3 (121) 
18.7 (83) 
  
Chapter 5: Cross-sectional surveys          208 
 
Other:  
• Academic 
• Research 
Missing data 
2.2 (10) 
 
 
0.7 (3) 
Years practising in profession 
≤ 5 
6-10  
11-15  
16-20  
21-25  
26-30  
31-35  
> 35  
Missing data 
 
18.5 (82) 
17.1 (76) 
14.9 (66) 
10.1 (45) 
13.0 (58) 
11.3 (50) 
3.6 (16) 
11.3 (50) 
0.2 (1) 
Undergraduate training 
Malta 
Other  
• Albania, Bulgaria, Czech Republic, Germany, Ireland, 
Kiev, Moscow, UK 
Missing data 
 
95.7 (425) 
4.1 (18) 
 
 
0.2 (1) 
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Postgraduate training 
Yes  
• Malta 
• Other: Belgium, Bulgaria, Czech Republic, France, 
Hungary, Italy, Malta, UK, USA 
No 
Missing data 
 
51.6 (229) 
31.0 (71) 
69.0 (158) 
 
44.8 (199) 
3.6 (16) 
Practised in other countries 
Yes  
• Australia, Belgium, Bulgaria, Canada, Czech Republic, 
Denmark, Emirates, France, Germany, Ghana, Italy, 
Kenya, Libya, Mozambique, Northeast and West Africa, 
Saudi Arabia, Spain, Sweden, Switzerland, The 
Netherlands, UK, Ukraine, USA, Zimbabwe 
No 
Missing data 
 
20.7 (92) 
 
 
 
 
 
78.2 (347) 
1.1 (5) 
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5.4.3 Rogers’ Diffusion of Innovation theory 
Table 5.21 shows the respondents’ self-reported innovativeness, with over half 
(54.5%, n=242) stating that they deliberate for some time before adopting 
change. 
 
Table 5.21: Willingness of HCPs to adopt change (n=444) 
Rogers’ Diffusion of Innovation 
theory 
Percentage (%) Number of 
respondents (n) 
I resist any change 0.2 1 
I am cautious in relation to change; 
I tend to change once most peers 
have done so 
6.8 30 
I deliberate for some time before 
adopting change 
54.5 242 
I serve as a role model for others in 
relation to change 
8.3 37 
I am venturesome and willing to be 
innovative with change 
29.3 130 
Missing data 0.9 4 
 
5.4.4 Definition of medication wastage 
The four statements which composed the definition of medication wastage 
developed in the Delphi technique stage of the research (chapter 4) were 
presented separately to respondents. Three out of the four statements exceeded 
the consensus level of 75.0% stipulated in the Delphi technique (Table 5.22). 
Almost all respondents (97.7%, n=434) agreed that medication wastage poses a 
financial burden on patients, the state's economy and requires adequate 
education of all people concerned. There was less agreement with the statement 
that ‘medication wastage encompasses the unjustified non-adherence to 
treatment guidelines by HCPs’, with around a quarter of respondents (25.9%, 
n=115) disagreeing or unsure. 
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Table 5.22: Definition of medication wastage (n=444) 
Statements 
 
Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
data 
% (n) 
Medication wastage encompasses any medication 
which expires or remains unused throughout the 
medication supply chain (manufacturing, storage, 
transport and handling of medication until these 
reach the consumer) and during use by the patient 
0.7 
(3) 
2.0 
(9) 
1.6 
(7) 
44.4 
(197) 
51.1 
(227) 
0.2 
(1) 
Medication wastage encompasses unnecessary or 
inappropriate consumption of medication by 
patients 
1.6 
(7) 
5.2 
(23) 
6.3 
(28) 
46.6 
(207) 
39.9 
(177) 
0.5 
(2) 
Medication wastage encompasses the unjustified 
non-adherence to treatment guidelines by 
healthcare professionals 
1.6 
(7) 
9.9 
(44) 
14.4 
(64) 
45.9 
(204) 
27.5 
(122) 
0.7 
(3) 
Medication wastage poses a financial burden on 
patients themselves, the state's economy and 
requires adequate education of all people concerned 
0.7 
(3) 
0.2 
(1) 
0.7 
(3) 
24.5 
(109) 
73.2 
(325) 
0.7 
(3) 
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Respondents commented on other issues which should be considered within the 
scope of medication wastage as follows:  
• The use of medication when equally effective cheaper alternatives are 
available (n=2) 
• Sharing of medication, short expiry dates or labels without expiry dates, free 
medication, aggressive treatment in terminal patients, poor quality of generic 
medication leading to higher dose usage, lack of communication between 
HCPs, inappropriate medication storage, poor transportation and handling of 
medication, medication shortages, lack of medication inventories on hospital 
wards, unused medication from clinical trials, HCPs and patients dropping 
medication and throwing away, and problems with wastage related to 
cytotoxic/radioactive treatment and industrial medication wastage (n=1 
each). 
 
One pharmacist commented, “if Maltese Governments in the past were unable to 
control wastage from 7 or so government pharmacies how could wastage ever be 
controlled from over 200 private pharmacies that have adopted the POYC 
scheme?!!” One doctor stated that “stand by emergency drugs that expire 
without use are not WASTE”. 
 
5.4.5 Awareness of issues related to medication wastage 
Table 5.23 gives the extent of awareness on issues related to medication 
wastage. Less than half of respondents (42.1%, n=187) agreed/strongly agreed 
that they were fully aware of the extent of medication wastage in Malta.  
 
The majority strongly agreed/agreed that they were fully aware of the 
consequences of medication wastage on the economy (69.4%, n=308) and on 
society (60.3%, n=268). Just over half were fully aware of the consequences on 
patients (54.8%, n=243), the environment (53.4%, n=197), and less on HCPs 
(40.1%, n=178). Respondents also stated that they were aware of other 
consequences of medication wastage, including:  
• medication shortages (n=6) 
• global economy and tax payers, pharmaceutical industry (n=3 each) 
• microbial resistance, medical ethics and morality (n=2 each) 
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• consequences on elderly and vulnerable groups, psychological well-being, free 
health service, policy makers, and the greater chance of massive doses being 
ingested in cases of parasuicides (n=1 each) 
 
Only 15.1% (n=67) agreed/strongly agreed that they were fully aware of laws, 
procedures and policies relating to medication wastage in Malta and just over 
half (54.0%, n=240) agreed/strongly agreed that they were fully aware of 
factors potentially leading to medication wastage. 
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Table 5.23: Awareness of the extent of medication wastage in Malta (n=444) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
data 
% (n) 
I am fully aware of the extent of medication 
wastage in Malta 
5.9 
(26) 
18.5 
(82) 
32.9 
(146) 
25.7 
(114) 
16.4 
(73) 
0.7 
(3) 
I am fully aware of the consequences of medication 
wastage in Malta on patients 
3.4 
(15) 
16.0 
(71) 
25.2 
(112) 
37.2 
(165) 
17.6 
(78) 
0.7 
(3) 
I am fully aware of the consequences of medication 
wastage in Malta on healthcare professionals 
3.6 
(16) 
18.5 
(82) 
37.6 
(167) 
28.2 
(125) 
11.9 
(53) 
0.2 
(1) 
I am fully aware of the consequences of medication 
wastage in Malta on society 
2.5 
(11) 
15.3 
(68) 
20.5 
(91) 
37.8 
(168) 
22.5 
(100) 
1.4 
(6) 
I am fully aware of the consequences of medication 
wastage in Malta on the economy 
3.6 
(16) 
13.7 
(61) 
13.1 
(58) 
36.7 
(163) 
32.7 
(145) 
0.2 
(1) 
I am fully aware of the consequences of medication 
wastage in Malta on the environment 
4.3 
(19) 
16.0 
(71) 
25.7 
(114) 
35.6 
(118) 
17.8 
(79) 
0.7 
(3) 
I am fully aware of factors potentially leading to 
medication wastage in Malta 
1.6 
(7) 
15.5 
(69) 
27.9 
(124) 
43.2 
(192) 
10.8 
(48) 
0.9 
(4) 
I am fully aware of laws, procedures and policies 
relating to medication wastage in Malta 
14.2 
(63) 
28.6 
(127) 
41.9 
(186) 
11.7 
(52) 
3.4 
(15) 
0.2 
(1) 
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5.4.6 Interest in issues related to medication wastage 
Table 5.24 gives the extent of interest in issues related to medication wastage. 
Only 3.2% (n=14) stated that they had no interest in the extent of medication 
wastage in Malta.  
 
The majority strongly disagreed/disagreed that they had no interest in the 
consequences of medication wastage on the economy (97.0%, n=431), on 
society (97.1%, n=431), the environment (95.5%, n=424), patients (94.4%, 
n=419) and HCPs (93.4%, n=415). 
 
Only a small minority (2.3%, n=10) agreed/strongly agreed that they had no 
interest in laws, procedures and policies relating to medication wastage in Malta 
and 2.5% (n=11) no interest in factors potentially leading to medication 
wastage. 
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Table 5.24: Interest in the extent of medication wastage in Malta (n=444) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
data 
% (n) 
I have no interest in the extent of medication 
wastage in Malta 
55.4 
(246) 
38.7 
(172) 
2.3 
(10) 
1.4 
(6) 
1.8 
(8) 
0.5 
(2) 
I have no interest in the consequences of 
medication wastage in Malta on patients 
60.4 
(268) 
34.0 
(151) 
1.6 
(7) 
0.7 
(3) 
0.7 
(3) 
2.7 
(12) 
I have no interest in the consequences of 
medication wastage in Malta on healthcare 
professionals 
56.5 
(251) 
36.9 
(164) 
3.6 
(16) 
0.9 
(4) 
0.7 
(3) 
1.4 
(6) 
I have no interest in the consequences of 
medication wastage in Malta on society 
62.6 
(278) 
34.5 
(153) 
0.5 
(2) 
0.9 
(4) 
0.5 
(2) 
1.1 
(5) 
I have no interest in the consequences of 
medication wastage in Malta on the economy 
66.4 
(295) 
30.6 
(136) 
0.5 
(2) 
0.5 
(2) 
0.7 
(3) 
1.4 
(6) 
I have no interest in the consequences of 
medication wastage in Malta on the environment 
62.4 
(277) 
33.1 
(147) 
2.5 
(11) 
0.7 
(3) 
0.5 
(2) 
0.9 
(4) 
I have no interest in the factors potentially leading 
to medication wastage in Malta 
51.6 
(229) 
43.9 
(195) 
1.8 
(8) 
1.8 
(8) 
0.7 
(3) 
0.2 
(1) 
I have no interest in laws, procedures and policies 
relating to medication wastage in Malta 
48.2 
(214) 
44.1 
(196) 
5.2 
(23) 
1.8 
(8) 
0.5 
(2) 
0.2 
(1) 
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5.4.7 Factors potentially leading to medication wastage 
Table 5.25 shows responses relating to factors which potentially lead to 
medication wastage. Respondents attributed the free healthcare system (86.7%, 
n=385) and the overstocking of medication by patients due to previous or 
potential out of stock situation (83.1%, n=369) as the two major contributing 
factors. The factors considered to be contributing least were ‘medication stopped 
by HCP due to ineffectiveness of the medication (21.0%, n=93), ‘medication 
stopped by HCP due to adverse events of the medication’ (20.5%, n=91), and 
‘medication stopped by HCP due to resolution of patients’ symptoms/conditions’ 
(18.3%, n=81). 
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Table 5.25: Factors which potentially lead to medication wastage (1=No contribution at all; 5=Major contribution) (n=444) 
Statements 1 
% (n) 
2 
% (n) 
3 
% (n) 
4 
% (n) 
5 
% (n) 
Missing 
data 
% (n) 
Short medication expiry dates  1.6 
(7) 
9.2 
(41) 
27.9 
(124) 
34.7 
(154) 
25.7 
(114) 
0.9 
(4) 
Large pack sizes when patients need smaller 
quantities of medication, particularly when starting 
new medication  
1.1 
(5) 
10.1 
(45) 
19.8 
(88) 
41.4 
(184) 
27.3 
(121) 
0.2 
(1) 
Inadequate audit of medication prescribing  0.7 
(3) 
4.3 
(19) 
20.5 
(91) 
33.8 
(150) 
39.2 
(174) 
1.6 
(7) 
Medication that remain unused within their expiry 
dates are not accepted for reuse by healthcare 
professionals 
8.1 
(36) 
12.6 
(56) 
27.3 
(121) 
30.6 
(136) 
20.5 
(91) 
0.9 
(4) 
Inappropriate storage of medication 3.4 
(15) 
18.0 
(80) 
31.3 
(139) 
28.8 
(128) 
17.6 
(78) 
0.9 
(4) 
Patients' expectations to receive a prescription for 
medication 
4.1 
(18) 
12.6 
(56) 
25.7 
(114) 
27.9 
(124) 
28.4 
(126) 
1.4 
(6) 
Lack of patient education/ knowledge about 
medication in general 
2.0 
(9) 
6.1 
(27) 
18.2 
(81) 
34.2 
(152) 
38.5 
(171) 
0.9 
(4) 
Lack of patient education/ knowledge about 
monetary cost of medication 
1.8 
(8) 
5.4 
(24) 
14.2 
(63) 
30.9 
(137) 
46.6 
(207) 
1.1 
(5) 
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Statements 1 
% (n) 
2 
% (n) 
3 
% (n) 
4 
% (n) 
5 
% (n) 
Missing 
data 
% (n) 
Overstocking of medication by patients due to 
previous or potential out of stock situation 
0.7 
(3) 
3.4 
(15) 
11.9 
(53) 
24.5 
(109) 
58.6 
(260) 
0.9 
(4) 
Overstocking of medication by patients due to 
dependency on others to collect medication supply  
1.6 
(7) 
7.7 
(34) 
21.8 
(97) 
35.8 
(159) 
32.2 
(143) 
0.9 
(4) 
Overstocking by patients due to fear of refusal of 
medication supply due to entitlement problems 
0.2 
(1) 
5.6 
(25) 
14.6 
(65) 
30.2 
(134) 
48.9 
(217) 
0.5 
(2) 
Other family members or carers obtaining 
medication on behalf of patient unaware of stock at 
home 
1.4 
(6) 
8.1 
(36) 
25.2 
(112) 
38.7 
(172) 
25.5 
(113) 
1.1 
(5) 
Patients getting advice form more than one HCP, 
family and friends regarding use of medication 
2.3 
(10) 
13.1 
(58) 
32.4 
(144) 
32.4 
(144) 
19.1 
(85) 
0.7 
(3) 
Non-adherence to medication regimens by patients 1.8 
(8) 
7.7 
(34) 
20.9 
(93) 
42.3 
(188) 
26.1 
(116) 
1.1 
(5) 
Medication stopped by patient due to perceived 
ineffectiveness 
2.7 
(12) 
11.7 
(52) 
23.2 
(103) 
41.9 
(186) 
20.0 
(89) 
0.5 
(2) 
Medication stopped by patient due to perceived 
adverse events 
3.6 
(16) 
14.9 
(66) 
25.9 
(115) 
38.7 
(172) 
16.0 
(71) 
0.9 
(4) 
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Statements 1 
% (n) 
2 
% (n) 
3 
% (n) 
4 
% (n) 
5 
% (n) 
Missing 
data 
% (n) 
Medication stopped by patient due to perceived 
resolution of their symptoms/medical condition 
2.0 
(9) 
13.5 
(60) 
21.6 
(96) 
43.7 
(194) 
18.9 
(84) 
0.2 
(1) 
Patient's death  15.8 
(70) 
26.1 
(116) 
23.9 
(106) 
20.5 
(91) 
13.1 
(58) 
0.7 
(3) 
Lack of education and training of HCP students 
about medication wastage  
3.8 
(17) 
15.3 
(68) 
33.3 
(148) 
32.4 
(144) 
14.0 
(62) 
1.1 
(5) 
Lack of education and training of HCP students 
about monetary cost of medication 
4.1 
(18) 
14.0 
(62) 
28.4 
(126) 
36.5 
(162) 
16.7 
(74) 
0.5 
(2) 
Lack of CPD of healthcare professionals about 
medication wastage 
4.7 
(21) 
15.1 
(67) 
30.6 
(136) 
34.7 
(154) 
14.2 
(63) 
0.7 
(3) 
Lack of CPD of healthcare professionals about 
monetary cost of medication 
4.7 
(21) 
17.1 
(76) 
30.0 
(133) 
34.2 
(152) 
13.1 
(58) 
0.9 
(4) 
Healthcare professionals lack of awareness of 
monetary cost of medication 
5.4 
(24) 
18.2 
(81) 
30.4 
(135) 
31.5 
(140) 
14.0 
(62) 
0.5 
(2) 
Lack of communication about medication between 
primary and secondary healthcare 
2.3 
(10) 
13.1 
(58) 
28.4 
(126) 
34.5 
(153) 
20.5 
(91) 
1.4 
(6) 
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Statements 1 
% (n) 
2 
% (n) 
3 
% (n) 
4 
% (n) 
5 
% (n) 
Missing 
data 
% (n) 
Lack of communication about medication between 
healthcare providers and patients 
1.4 
(6) 
15.3 
(68) 
26.6 
(118) 
39.2 
(174) 
17.1 
(76) 
0.5 
(2) 
Medication stopped by HCP due to ineffectiveness 
of the medication 
7.2 
(32) 
36.3 
(161) 
34.2 
(152) 
15.8 
(70) 
5.2 
(23) 
1.4 
(6) 
Medication stopped by HCP due to adverse events 
of the medication 
9.5 
(42) 
38.3 
(170) 
30.6 
(136) 
16.4 
(73) 
4.1 
(18) 
1.1 
(5) 
Medication stopped by HCP due to resolution of 
patients’ symptoms/conditions  
12.6 
(56) 
35.6 
(158) 
33.1 
(147) 
14.2 
(63) 
4.1 
(18) 
0.5 
(2) 
Over-prescribing by healthcare professional 2.5 
(11) 
13.5 
(60) 
25.5 
(113) 
33.8 
(150) 
23.6 
(105) 
1.1 
(5) 
Extra medication supply dispensed to patients 7.0 
(31) 
21.2 
(94) 
27.7 
(123) 
27.3 
(121) 
16.2 
(72) 
0.7 
(3) 
Medication prescribed for no indication 10.8 
(48) 
25.2 
(112) 
23.0 
(102) 
20.5 
(91) 
19.8 
(88) 
0.7 
(3) 
Healthcare professionals’ perceptions that patients 
expect to receive a medication 
4.1 
(18) 
16.0 
(71) 
27.7 
(123) 
29.3 
(130) 
22.1 
(98) 
0.9 
(4) 
Inadequate medication reviews by healthcare 
professionals  
1.8 
(8) 
17.1 
(76) 
28.6 
(127) 
27.0 
(120) 
24.8 
(110) 
0.7 
(3) 
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Statements 1 
% (n) 
2 
% (n) 
3 
% (n) 
4 
% (n) 
5 
% (n) 
Missing 
data 
% (n) 
Free healthcare system 2.3 
(10) 
2.7 
(12) 
7.4 
(33) 
20.0 
(89) 
66.7 
(296) 
0.9 
(4) 
Medication which are obtained free through the 
National Health System are regularly out of stock in 
the pharmacy 
4.3 
(19) 
10.8 
(48) 
26.1 
(116) 
27.3 
(121) 
29.1 
(129) 
2.5 
(11) 
Medication that legally require a prescription are 
easily purchased from pharmacies without the need 
for a valid prescription 
11.9 
(53) 
18.5 
(82) 
32.0 
(142) 
20.3 
(90) 
16.0 
(71) 
1.4 
(6) 
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5.4.8 Current practices, views, experiences 
Table 5.26 shows the current practices, views and experiences of HCPs. Just over 
half of respondents (52.2%, n=232) strongly agreed/agreed that they played an 
important part in reducing medication wastage in Malta. A similar proportion 
(59.2%, n=263) noted that they could be more active in reducing wastage. 
While only 7.0% (n=31) felt that there was little scope for them to further 
reduce medication wastage, less than half (46.6%, n=207) strongly 
agreed/agreed that they felt confident in their ability to reduce wastage.  
 
The majority of respondents (66.3%, n=294) stated that they reviewed 
medication for the management of chronic conditions to ensure their continued 
indication. Some felt under pressure by patients (35.0%, n=155) or family 
members of patients (27.5%, n=122) to supply medication they considered 
unnecessary.  
 
A little more than one third (37.2%, n=165) strongly agreed/agreed that other 
HCPs had more responsibility in advising patients on use of their medication, and 
almost half strongly agreed/agreed that other HCPs had more responsibility to 
advise patients on medication storage (46.0%, n=204) and disposal (43.9%, 
n=195). Only half (50.5%, n=224) strongly agreed/agreed that medication 
supplied to patients and returned within their expiry dates to HCPs should be 
reused. The majority (91.5%, n=406) stated that the provision of medication to 
patients free of charge could lead to medication wastage. 
 
Table 5.27 shows the responses given by HCPs on advice regarding use, storage 
and disposal of medication. Whilst 68.0% (n=302) claimed that they always 
advised their patients on the use of medication, only 16.7% (n=74) and 4.5% 
(n=20) respectively stated that they always advised on storage and disposal. 
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Table 5.26: Current practices, views and experiences of HCPs (n=444) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
data 
% (n) 
I currently play an important part in reducing 
medication wastage in Malta 
4.3 
(19) 
18.7 
(83) 
24.1 
(107) 
44.8 
(199) 
7.4 
(33) 
0.7 
(3) 
I could be more active in reducing medication 
wastage in Malta 
3.4 
(15) 
12.8 
(57) 
23.2 
(103) 
48.2 
(214) 
11.0 
(49) 
1.4 
(6) 
There is little scope for me to further reduce 
medication wastage in Malta 
28.8 
(128) 
49.1 
(218) 
14.2 
(63) 
5.4 
(24) 
1.6 
(7) 
0.9 
(4) 
I feel confident in my ability to reduce medication 
wastage in Malta 
2.3 
(10) 
12.6 
(56) 
36.7 
(163) 
40.5 
(180) 
6.1 
(27) 
1.8 
(8) 
Healthcare professionals other than me have more 
responsibility in advising patients on use of their 
medication 
8.6 
(38) 
33.3 
(148) 
20.7 
(92) 
26.4 
(117) 
10.8 
(48) 
0.2 
(1) 
Healthcare professionals other than me have more 
responsibility in advising patients on storage of 
their medication 
11.0 
(49) 
27.9 
(124) 
14.6 
(65) 
34.7 
(154) 
11.3 
(50) 
0.5 
(2) 
Healthcare professionals other than me have more 
responsibility in advising patients on disposal of 
unused medication 
10.1 
(45) 
26.4 
(117) 
19.1 
(85) 
31.3 
(139) 
12.6 
(56) 
0.5 
(2) 
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Patient information leaflets, available in the 
medication package, are a good source of 
information for patients on use of their medication 
2.7 
(12) 
13.1  
(58) 
16.4       
(73) 
50.5 
(224) 
16.4 
(73) 
0.9 
(4) 
Patient information leaflets are a good source of 
information for patients on storage of their 
medication 
2.5 
(11) 
12.6 
(56) 
16.2 
(72) 
52.0 
(231) 
16.2 
(72) 
0.5 
(2) 
Patient information leaflets are a good source of 
information for patients on disposal of unused 
medication 
11.7 
(52) 
32.9 
(146) 
24.1 
(107) 
23.4 
(104) 
7.4 
(33) 
0.5 
(2) 
Patients put me under pressure to supply 
medication which I consider to be unnecessary 
16.4 
(73) 
31.5 
(140) 
15.8 
(70) 
26.4 
(117) 
8.6 
(38) 
1.4 
(6) 
Family members of patients put me under pressure 
to supply medication which I consider unnecessary 
18.9 
(84) 
37.2 
(165) 
15.3 
(68) 
21.4 
(95) 
6.1 
(27) 
1.1 
(5) 
Other HCPs put me under pressure to supply 
medication which I consider to be unnecessary 
17.6 
(78) 
28.6 
(127) 
7.2 
(32) 
6.5 
(29) 
1.8 
(8) 
38.3 
(170) 
I am fully aware of the costs of medication I supply 3.4 
(15) 
13.1 
(58) 
19.8 
(88) 
40.1 
(178) 
22.5 
(100) 
1.1 
(5) 
I review medication for the management of chronic 
conditions to ensure their continued indication 
4.1 
(18) 
10.1 
(45) 
16.4 
(73) 
52.3 
(232) 
14.0 
(62) 
3.2 
(14) 
Patients often bring me unwanted or unused 
medication 
19.1 
(85) 
27.3 
(121) 
9.5 
(42) 
35.1 
(156) 
6.3 
(28) 
2.7 
(12) 
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Medication supplied to patients and returned to me 
within their expiry dates should be reused 
11.3 
(50) 
15.5 
(69) 
20.9 
(93) 
31.8 
(141) 
18.7 
(83) 
1.8 
(8) 
I have insufficient time in my daily practise to 
reduce the extent of medication wastage in Malta 
12.2 
(54) 
38.7 
(172) 
21.4 
(95) 
21.4 
(95) 
4.3 
(19) 
2.0 
(9) 
There is little incentive for me to reduce the extent 
of medication wastage in Malta 
14.0 
(62) 
32.2 
(143) 
15.8 
(70) 
26.4 
(117) 
10.4 
(46) 
1.4 
(6) 
Provision of medication to patients free of charge 
can lead to medication wastage in Malta 
1.1 
(5) 
2.7 
(12) 
4.1 
(18) 
30.9 
(137) 
60.6 
(269) 
0.7 
(3) 
 
Table 5.27: Advice provided by HCPs on use, storage and disposal of medication (n=444) 
Statements Never 
% (n) 
Infrequently 
% (n) 
Around 
half the 
time 
% (n) 
Usually 
% (n) 
Always 
% (n) 
Unsure 
% (n) 
Missing 
data 
% (n) 
I advise patients on use of their 
medication 
1.1 
(5) 
4.3 
(19) 
4.1 
(18) 
20.9 
(93) 
68.0 
(302) 
0.7 
(3) 
0.9 
(4) 
I advise patients on storage of 
their medication 
7.2 
(32) 
32.0 
(142) 
10.1 
(45) 
32.4 
(144) 
16.7 
(74) 
0.7 
(3) 
0.9 
(4) 
I advise patients on disposal of 
their medication 
29.9 
(132) 
43.0 
(190) 
9.0 
(40) 
10.6 
(47) 
4.5  
(20) 
1.8 
(8) 
1.1 
(5) 
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5.4.9 Association between demographic characteristics and outcomes 
This section provides analysis of associations between a number of demographic 
variables and key outcome measures of: awareness of medication wastage in 
Malta; no interest in medication wastage; and confidence in ability to reduce 
medication wastage.  
 
5.4.9.1 Awareness of medication wastage 
Demographics and other variables were tested for association with the outcome 
of awareness of medication wastage. Awareness was collapsed into those 
agreeing/strongly agreeing, and those uncertain/disagreeing/strongly 
disagreeing as given in Table 5.28. 
 
Association of data for demographic characteristics and awareness of issues of 
medication wastage (statement in questionnaire: “I am fully aware of the extent 
of medication wastage in Malta”), revealed that: 
• age and awareness of medication wastage were significantly related 
χ2=31.555, p<0.001, with the older age groups much more likely to self-
report awareness of issues of medication wastage than their younger 
counterparts.  
• number of years practising in profession and awareness of medication 
wastage were significantly related χ2=36.929, p<0.001. The longer HCPs 
were in practice, the more likely they self-reported awareness of issues of 
medication wastage. 
• Rogers’ Diffusion of Innovation theory and awareness of medication wastage 
were significantly related χ2=20.147, p<0.001. HCPs that resisted or were 
cautious in relation to new ways of working were more likely to self-report 
awareness of issues of medication wastage. 
 
Variables identified as significant in univariate analysis (p≤0.05) were entered 
into bivariate logistic regression. The only variable retained as significant was 
Rogers’ Diffusion of Innovation theory, with those more venturesome being less 
likely to be aware, odds ratio 2.268 (95% CI 1.429-3.598). 
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Table 5.28: Association of data for demographic characteristics and awareness of issues of medication wastage 
Variable Strongly 
agree/agree 
% (n) 
Uncertain/disagree
/strongly disagree 
% (n) 
Test value  
(p) 
Gender 
   Female 
   Male 
42.1 (184) 
59.4 (129) 
56.4 (124) 
57.9 (253) 
40.6 (88) 
43.6 (96) 
0.426 (0.514) 
Age (years) 
   20-29  
   30-39  
   40-49  
   50-59  
   > 59  
42.3 (186) 
31.3 (31) 
32.0 (39) 
46.5 (46) 
48.6 (34) 
73.5 (36) 
57.6 (253) 
68.7 (68) 
68.0 (83) 
53.5 (53) 
51.4 (36) 
26.5 (13) 
31.555 
(<0.001) 
Profession 
   Dentist 
   Doctor 
   Pharmacist 
42.4 (187) 
35.6 (16) 
38.3 (85) 
49.4 (86) 
57.6 (254) 
64.4 (29) 
61.7 (137) 
50.6 (88) 
5.916 (0.052) 
Main place of work 
   Government services/public sector 
   Private sector 
   Self-employed 
   Other 
42.0 (184) 
38.1 (86) 
40.3 (48) 
55.4 (46) 
40.0 (4) 
58.0 (254) 
61.9 (140) 
59.7 (71) 
44.6 (37) 
60.0 (6) 
7.734 (0.052) 
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Years in profession 
≤ 5 
6-10  
11-15 
16-20 
21-25 
26-30 
31-35 
> 35  
42.5 (187) 
32.1 (26) 
27.6 (21) 
36.4 (24) 
48.9 (22) 
45.6 (26) 
42.0 (21) 
62.5 (10) 
75.5 (37) 
57.5 (253) 
67.9 (55) 
72.4 (55) 
63.6 (42) 
51.1 (23) 
54.4 (31) 
58.0 (29) 
37.5 (6) 
24.5 (12) 
36.929 
(<0.001) 
Rogers’ Diffusion of Innovation theory 
I resist new ways of working 
I am cautious in relation to new ways of working; I tend 
to change once most peers have done so 
I deliberate for some time before adopting new ways of 
working 
I serve as a role model for others in relation to new ways 
of working 
I am venturesome and willing to be innovative with new 
ways of working 
(185) 
100.0 (1) 
69.0 (20) 
 
34.2 (82) 
 
43.2 (16) 
 
50.8 (66) 
(252) 
0.0 (0) 
31.0 (9) 
 
65.8 (158) 
 
56.8 (21) 
 
49.2 (64) 
20.147 
(<0.001) 
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5.4.9.2 No interest in medication wastage 
Demographics and other variables were tested for association with the outcome 
of no interest in medication wastage (statement in questionnaire: “I have no 
interest in the extent of medication wastage in Malta”). Interest was collapsed 
into those agreeing/strongly agreeing, and those uncertain/disagreeing/strongly 
disagreeing as given in Table 5.29. No statistically significant associations were 
identified.  
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Table 5.29: Association of data for demographic characteristics and no interest in issues of medication wastage 
Variable Strongly 
agree/agree 
% (n) 
Uncertain/disagree
/strongly disagree 
% (n) 
Test value  
(p) 
Gender 
   Female 
   Male 
3.2 (14) 
3.7 (8) 
2.7 (6) 
96.8 (424) 
96.3 (210) 
97.3 (214) 
0.314 (0.575) 
Age (years) 
   20-29 
   30-39 
   40-49 
   50-59 
   > 59  
3.0 (13) 
3.0 (3) 
0.8 (1) 
4.0 (4) 
4.2 (3) 
4.1 (2) 
97.0 (427) 
97.0 (97) 
99.2 (120) 
96.0 (95) 
95.8 (68) 
95.9 (47) 
2.936 (0.569) 
Profession 
   Dentist 
   Doctor 
   Pharmacist 
3.2 (14) 
4.4 (2) 
1.8 (4) 
4.6 (8) 
96.8 (428) 
95.6 (43) 
98.2 (219) 
95.4 (166) 
2.772 (0.250) 
Main place of work 
   Government services/public sector 
   Private sector 
   Self-employed 
   Other 
3.0 (13) 
1.8 (4) 
5.8 (7) 
1.2 (1) 
10.0 (1) 
97.0 (426) 
98.2 (222) 
94.2 (114) 
98.8 (81) 
90.0 (9) 
7.064 (0.070) 
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Years in profession 
≤ 5 
6-10  
11-15 
16-20 
21-25 
26-30 
31-35 
> 35  
3.2 (14) 
3.7 (3) 
2.7 (2) 
0.0 (0) 
4.4 (2) 
3.4 (2) 
6.0 (3) 
0.0 (0) 
4.1 (2) 
96.8 (427) 
96.3 (79) 
97.3 (73) 
100.0 (66) 
95.6 (43) 
96.6 (56) 
94.0 (47) 
100.0 (16) 
95.9 (47) 
4.494 (0.721) 
Rogers’ Diffusion of Innovation theory 
I resist new ways of working 
I am cautious in relation to new ways of working; I tend 
to change once most peers have done so 
I deliberate for some time before adopting new ways of 
working 
I serve as a role model for others in relation to new ways 
of working 
I am venturesome and willing to be innovative with new 
ways of working 
3.2 (14) 
0.0 (0) 
3.3 (1) 
 
2.9 (7) 
 
5.6 (2) 
 
3.1 (4) 
96.8 (424) 
100.0 (1) 
96.7 (29) 
 
97.1 (234) 
 
94.4 (34) 
 
96.9 (126) 
0.755 (0.944) 
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5.4.9.3 Confidence in ability to reduce medication wastage 
Demographics and other variables were tested for association with the outcome 
of confidence in ability to reduce medication wastage (statement in 
questionnaire: “I feel confident in my ability to reduce medication wastage in 
Malta”). Confidence was collapsed into those agreeing/strongly agreeing, and 
those uncertain/disagreeing/strongly disagreeing as given in Table 5.30. No 
statistically significant associations were identified. 
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Table 5.30: Association of data for demographic characteristics and confidence in ability to reduce medication wastage 
Variable Strongly 
agree/agree 
% (n) 
Uncertain/disagree
/strongly disagree 
% (n) 
Test value  
(p) 
Gender 
   Female 
   Male 
47.0 (203) 
42.7 (91) 
51.1 (112) 
53.0 (229) 
57.3 (122) 
48.9 (107) 
3.072 (0.080) 
Age (years) 
   20-29  
   30-39  
   40-49  
   50-59  
   > 59  
47.5 (206) 
42.4 (42) 
45.5 (55) 
50.5 (49) 
50.0 (37) 
50.0 (20) 
52.5 (228) 
57.6 (57) 
54.5 (66) 
49.5 (48) 
50.0 (37) 
50.0 (20) 
3.873 (0.423) 
Profession 
   Dentist 
   Doctor 
   Pharmacist 
47.5 (207) 
54.5(24) 
42.5 (94) 
52.0 (89) 
52.5 (229) 
45.5 (20) 
57.5 (127) 
48.0 (82) 
4.479 (0.107) 
Main place of work 
   Government services/public sector 
   Private sector 
   Self-employed 
   Other 
47.8 (207) 
46.0 (104) 
42.2 (49) 
61.0 (50) 
44.4 (4) 
52.2 (226) 
54.0 (122) 
57.8 (67) 
39.0 (32) 
55.6 (5) 
7.470 (0.058) 
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Years in profession 
≤ 5  
6-10 
11-15 
16-20 
21-25 
26-30 
31-35 
> 35  
47.5 (207) 
44.4 (36) 
41.3 (31) 
48.5 (32) 
47.7 (21) 
45.6 (26) 
51.0 (25) 
43.7 (7) 
60.4 (29) 
52.5 (229) 
55.6 (45) 
58.7 (44) 
51.5 (34) 
52.3 (23) 
54.4 (31) 
49.0 (24) 
56.3 (9) 
39.6 (19) 
5.100 (0.648) 
Rogers’ Diffusion of Innovation theory 
I resist new ways of working 
I am cautious in relation to new ways of working; I tend 
to change once most peers have done so 
I deliberate for some time before adopting new ways of 
working 
I serve as a role model for others in relation to new ways 
of working 
I am venturesome and willing to be innovative with new 
ways of working 
47.5 (205) 
0.0 (0) 
41.4 (12) 
 
46.4 (110) 
 
43.2 (16) 
 
52.3 (67) 
52.5 (227) 
100.0 (1) 
58.6 (17) 
 
53.6 (127) 
 
44.7 (21) 
 
47.7 (61) 
2.926 (0.570) 
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5.4.10 Therapeutic areas, patient groups and other areas 
Analysis of responses to the open question on the therapeutic areas, patient 
groups or other areas which, in the respondents’ opinion, should be considered 
as priority for targeting strategies to reduce medication wastage identified three 
key themes. The most frequently reported was the ‘patient group’ receiving free 
medication, mentioned by 21.0% (n=93) of respondents. This was followed by 
elderly patients (17.8%, n=79) and patients on chronic medication (13.1%, 
n=58).  
 
Respondents also listed the classes of drugs that should be considered as priority 
for targeting strategies to reduce medication wastage. The most common classes 
of drugs to be targeted were the cardiovascular (13.5%, n=60) and antibiotics 
(12.6%, n=56).  
 
The classes of medication were:  
• Cardiovascular medication (n=60) 
o Antihypertensives (n=31) 
o Cardiovascular medication in general (n=15) 
o Statins (n=8) 
o Medication for ischaemic heart disease (n=4) 
o Medication for congestive heart failure (n=2) 
• Antibiotics (n=56) 
• Medication for diabetes (n=35) 
• Respiratory (n=29) 
o Medication for asthma (n=15) 
o Respiratory in general (n=10) 
o Medication for chronic obstructive pulmonary disease (n=4) 
• Analgesics (n=24) 
• Antidepressants/anxiolytics (psychiatric treatment) (n=19) 
• Oncology medication (n=10) 
• Gastrointestinal tract medication (n=6) 
• Vitamins and minerals (n=5) 
• OTC medication and ophthalmic/ear nose throat medication (n=3 each) 
• Warfarin/aspirin and rheumatoid arthritis/orthopaedics (n=2 each) 
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• Auto-immune disease medication, medication for osteoporosis, medication for 
menopause, and vaccines (n=1 each) 
 
The type of medication that should be targeted to reduce wastage included: 
• High cost medication (n=15) 
• Cheap medication and medication used in large volumes (n=7 each) 
• Medication with short expiry date (n=4) 
• Medication hazardous to the environment (n=3) 
• Ointments and creams (n=3) 
• Medication rare or hard to source (n=2) 
• New medication, tablet and liquid formulations, dressings, and emergency 
medication (n=1 each) 
 
Other areas or groups that should be targeted were: 
• HCPs (n=15) 
o GPs (n=11) 
o HCPs in general (n=2) 
o Pharmacists and community nurses (n=1 each) 
• Health centres (n=5) 
• Medication shortages (n=3) 
• Storage/disposal (n=3) 
• Prevention of illnesses (n=2) 
• The general public (n=2) 
• Medication returns (n=2) 
• Political interference, coherence between primary and secondary care, 
medication pack size, and higher level of education of patients and carers 
(n=1 each) 
 
5.4.11 Education and training 
Table 5.31 indicates that although 71.0% (n=315) of HCPs had never thought 
about undertaking further education and training in relation to medication 
wastage, 79.3% (n=352) felt that they required more education and training. 
Table 5.31 also indicates clearly that respondents did not view that current 
undergraduate and postgraduate training has sufficient coverage of medication 
wastage.  
  
Chapter 5: Cross-sectional surveys          238 
 
Table 5.31: Responses to issues of education and training (n=444) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
data 
% (n) 
I have never thought about undertaking further 
education and training relating to medication 
wastage 
1.6 
(7) 
14.4 
(64) 
12.6 
(56) 
55.9 
(248) 
15.1 
(67) 
0.5 
(2) 
My undergraduate education and training had 
sufficient emphasis on medication wastage 
33.1 
(147) 
45.0 
(200) 
9.5 
(42) 
7.9 
(35) 
3.6 
(16) 
0.9 
(4) 
Current HCP undergraduate education and training 
in Malta has sufficient emphasis on medication 
wastage 
21.6 
(96) 
36.5 
(162) 
33.8 
(150) 
5.9 
(26) 
1.1 
(5) 
1.1 
(5) 
Current HCP postgraduate education and training in 
Malta has sufficient emphasis on medication 
wastage 
16.2 
(72) 
32.4 
(144) 
43.0 
(191) 
5.9 
(26) 
0.7 
(3) 
1.8 
(8) 
I require more education and training to further 
reduce medication wastage in Malta 
2.5 
(11) 
6.1 
(27) 
11.3 
(50) 
59.0 
(262) 
20.3 
(90) 
0.9 
(4) 
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Figure 5.8 illustrates the form of education and training that respondents were 
mostly interested in. 
 
 
Figure 5.8: Form of education and training of most interest 
 
The ‘other’ option (0.2%, n=1) was the use of social media. Some recommended 
multidisciplinary education. 
 
5.4.12 Additional comments on medication wastage  
Respondents were given the option to add any additional comments. Some re-
emphasised causes and consequences of medication wastage. Analysis identified 
two key themes: 
• Need for education and information for HCPs and patients (n=19) 
• Introduction of payment in the free healthcare system (n=12) 
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5.5 Results: Student questionnaire 
5.5.1 Response rate 
The response rate following the first mailing was 11.5% (50 responses), which 
increased to 15.4% (67/434 responses) following one reminder (this is lower 
than the response rate of the pilot study which was 43.0%). Figure 5.9 illustrates 
the number of daily responses that were obtained over a 30-day collection 
period. 
 
 
Figure 5.9: Number of student questionnaire responses during 30-day data 
collection 
 
5.5.2 Demographic characteristics 
Table 5.32 presents the demographic characteristics of student respondents. 
Twenty-one percent (n=14) stated that they were taking regular medication at 
the time of the study. Eleven of these bought their medication, two students got 
them free of charge on entitlement cards (yellow or pink card) through the 
Maltese NHS, and one student obtained regular medication both against payment 
and free of charge. In the six months prior to completion of the questionnaire, 
80.6% of respondents (n=54) had a prescribed or OTC medication. 
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Table 5.32: Demographic characteristics of HCP students (n=67) 
Demographics Frequency 
% (n) 
Gender 
Male 
Female 
 
26.9 (18) 
73.1 (49) 
Age (years) 
18-21 
22-25 
26-29 
30-33 
> 33 
 
64.2(43) 
32.8 (22) 
1.5 (1) 
0.0 (0) 
1.5 (1) 
Course of study 
Dentistry 
Medicine 
Nursing 
Pharmacy 
 
3.0 (2) 
41.8 (28) 
38.8 (26) 
16.4 (11) 
Year of study 
Second 
Third 
Fourth 
Fifth 
Missing data 
 
35.8 (24) 
7.5 (5) 
37.3 (25) 
17.9 (12) 
1.5 (1) 
Nationality 
Maltese  
Other 
• Kuwaiti 
Missing data 
 
94.0 (63) 
3.0 (2) 
 
3.0 (2) 
 
5.5.3 Rogers’ Diffusion of Innovation theory 
Table 5.33 shows the perceived innovativeness of respondents, with over half 
(59.7%, n=40) stating that they deliberated for some time before adopting 
change. 
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Table 5.33: Willingness of HCP students to adopt change  
Rogers’ Diffusion of Innovation 
theory 
Percentage (%) Number of 
respondents (n) 
I resist any change 0.0 0 
I am cautious in relation to change; 
I tend to change once most peers 
have done so 
14.9 10 
I deliberate for some time before 
adopting change 
59.7 40 
I serve as a role model for others in 
relation to change 
3.0 2 
I am venturesome and willing to be 
innovative with change 
20.9 14 
Missing data 1.5 1 
 
5.5.4 Definition of medication wastage 
All four statements relating to the definition of medication wastage developed in 
the previous stage of the research (chapter 4) exceeded the consensus level of 
75.0% (Table 5.34). One respondent commented that medication wastage 
should encompass medication produced but is too expensive to be accessible to 
the target population. 
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Table 5.34: Responses by HCP students to the definition of medication wastage (n=67) 
Statements 
 
Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
data 
% (n) 
Medication wastage encompasses any medication 
which expires or remains unused throughout the 
medication supply chain (manufacturing, storage, 
transport and handling of medication until these 
reach the consumer) and during use by the patient 
3.0 
(2) 
6.0 
(4) 
7.5 
(5) 
37.3 
(25) 
46.3 
(31) 
0.0 
(0) 
Medication wastage encompasses unnecessary or 
inappropriate consumption of medication by 
patients 
3.0 
(2) 
4.5 
(3) 
6.0 
(4) 
40.3 
(27) 
46.3 
(31) 
0.0 
(0) 
Medication wastage encompasses the unjustified 
non-adherence to treatment guidelines by 
healthcare professionals 
1.5 
(1) 
4.5 
(3) 
16.4 
(11) 
41.8 
(28) 
35.8 
(24) 
0.0 
(0) 
Medication wastage poses a financial burden on 
patients themselves, the state's economy and 
requires adequate education of all people concerned 
1.5 
(1) 
0.0 
(0) 
1.5 
(1) 
19.4 
(13) 
73.1 
(49) 
4.5 
(3) 
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5.5.5 Awareness of issues related to medication wastage 
Table 5.35 gives the extent of awareness of issues related to medication 
wastage. Only one fifth of students (20.9%, n=14) stated that they were fully 
aware of the extent of medication wastage in Malta. 
 
Slightly more than half of respondents (59.7%, n=40) strongly agreed/agreed 
that they were fully aware of the consequences of medication wastage on the 
economy. Less than half were fully aware of the consequences on society 
(47.8%, n=32), patients (38.8%, n=26), the environment (38.8%, n=26) and 
HCPs (28.4%, n=19). Respondents also stated that they were aware of other 
consequences of medication wastage including:  
• future generations, industry, natural resources, patient comprehension, 
unequal resource sharing, and water purity (n=1 each). 
 
A little more than one third of respondents (35.8%, n=24) were fully aware of 
factors potentially leading to medication wastage and only 10.4% (n=7) 
agreed/strongly agreed that they were fully aware of laws, procedures and 
policies relating to medication wastage in Malta. 
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Table 5.35: Awareness of the extent of medication wastage in Malta (n=67) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
data 
% (n) 
I am fully aware of the extent of medication 
wastage in Malta 
11.9 
(8) 
26.9 
(18) 
40.3 
(27) 
14.9 
(10) 
6.0 
(4) 
0.0 
(0) 
I am fully aware of the consequences of medication 
wastage in Malta on patients 
6.0 
(4) 
17.9 
(12) 
34.3 
(23) 
34.3 
(23) 
4.5 
(3) 
3.0 
(2) 
I am fully aware of the consequences of medication 
wastage in Malta on healthcare professionals 
9.0 
(6) 
23.9 
(16) 
37.3 
(25) 
25.4 
(17) 
3.0 
(2) 
1.5 
(1) 
I am fully aware of the consequences of medication 
wastage in Malta on society 
7.5 
(5) 
13.4 
(9) 
29.9 
(20) 
38.8 
(26) 
9.0 
(6) 
1.5 
(1) 
I am fully aware of the consequences of medication 
wastage in Malta on the economy 
4.5 
(3) 
14.9 
(10) 
19.4 
(13) 
41.8 
(28) 
17.9 
(12) 
1.5 
(1) 
I am fully aware of the consequences of medication 
wastage in Malta on the environment 
7.5 
(5) 
20.9 
(14) 
31.3 
(21) 
28.4 
(19) 
10.4 
(7) 
1.5 
(1) 
I am fully aware of factors potentially leading to 
medication wastage in Malta 
9.0 
(6) 
14.9 
(10) 
40.3 
(27) 
35.8 
(24) 
0.0 
(0) 
0.0 
(0) 
I am fully aware of laws, procedures and policies 
relating to medication wastage in Malta 
22.4 
(15) 
34.3 
(23) 
32.8 
(22) 
10.4 
(7) 
0.0 
(0) 
0.0 
(0) 
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5.5.6 Interest in issues related to medication wastage 
Table 5.36 gives the extent of interest in issues related to medication wastage. 
Only 4.5% (n=3) stated that they had no interest in the extent of medication 
wastage in Malta.  
 
The majority strongly disagreed/disagreed that they had no interest in the 
consequences of medication wastage on patients (98.5%, n=66), HCPs (98.5%, 
n=66), society (98.5%, n=66), the economy (94.0%, n=63) and the 
environment (94.0%, n=63). 
 
None stated that they agreed/strongly agreed that they had no interest in factors 
potentially leading to medication wastage and only 1.5% (n=1) had no interest 
in laws, procedures and policies relating to medication wastage in Malta. 
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Table 5.36: Interest in extent of medication wastage in Malta (n=67) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
data 
% (n) 
I have no interest in the extent of medication 
wastage in Malta 
38.8 
(26) 
52.2 
(35) 
4.5 
(3) 
3.0 
(2) 
1.5 
(1) 
0.0 
(0) 
I have no interest in the consequences of 
medication wastage in Malta on patients 
68.7 
(46) 
29.8 
(20) 
1.5 
(1) 
0.0 
(0) 
0.0 
(0) 
0.0 
(0) 
I have no interest in the consequences of 
medication wastage in Malta on healthcare 
professionals 
67.2 
(45) 
31.3 
(21) 
0.0 
(0) 
1.5 
(1) 
0.0 
(0) 
0.0 
(0) 
I have no interest in the consequences of 
medication wastage in Malta on society 
59.7 
(40) 
38.8 
(26) 
1.5 
(1) 
0.0 
(0) 
0.0 
(0) 
0.0 
(0) 
I have no interest in the consequences of 
medication wastage in Malta on the economy 
61.2 
(41) 
32.8 
(22) 
4.5 
(3) 
0.0 
(0) 
0.0 
(0) 
1.5 
(1) 
I have no interest in the consequences of 
medication wastage in Malta on the environment 
62.7 
(42) 
31.3 
(21) 
3.0 
(2) 
0.0 
(0) 
0.0 
(0) 
3.0 
(2) 
I have no interest in the factors potentially leading 
to medication wastage in Malta 
56.7 
(38) 
37.3 
(25) 
4.5 
(3) 
0.0 
(0) 
0.0 
(0) 
1.5 
(1) 
I have no interest in laws, procedures and policies 
relating to medication wastage in Malta 
37.3 
(25) 
46.3 
(31) 
9.0 
(6) 
1.5 
(1) 
0.0 
(0) 
6.0 
(4) 
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5.5.7 Factors potentially leading to medication wastage 
Table 5.37 shows responses to statements on factors which potentially lead to 
medication wastage. Respondents attributed the lack of patient education/ 
knowledge about medication in general (83.6%, n=56) and the overstocking of 
medication by patients due to previous or potential out of stock situation 
(80.6%, n=54) as the two major contributing factors. The factor which was 
considered to be contributing the least towards medication wastage was 
‘patient's death’ (23.8%, n=16). 
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Table 5.37: Factors which potentially lead to medication wastage (1=No contribution at all; 5=Major contribution) (n=67) 
Statements 1 
% (n) 
2 
% (n) 
3 
% (n) 
4 
% (n) 
5 
% (n) 
Missing 
data 
% (n) 
Short medication expiry dates  3.0 
(2) 
11.9 
(8) 
29.9 
(20) 
37.3 
(25) 
17.9 
(12) 
0.0 
(0) 
Large pack sizes when patients need smaller 
quantities of medication, particularly when starting 
new medication  
1.5 
(1) 
6.0 
(4) 
13.4 
(9) 
34.3 
(23) 
44.8 
(30) 
0.0 
(0) 
Inadequate audit of medication prescribing  0.0 
(0) 
10.4 
(7) 
25.4 
(17) 
44.8 
(30) 
16.4 
(11) 
3.0 
(2) 
Medication that remain unused within their expiry 
dates are not accepted for reuse by healthcare 
professionals 
9.0 
(6) 
11.9 
(8) 
29.9 
(20) 
26.9 
(18) 
19.4 
(13) 
3.0 
(2) 
Inappropriate storage of medication 3.0 
(2) 
10.4 
(7) 
22.4 
(15) 
28.4 
(19) 
34.3 
(23) 
1.5 
(1) 
Patients' expectations to receive a prescription for 
medication 
6.0 
(4) 
13.4 
(9) 
25.4 
(17) 
26.9 
(18) 
26.9 
(18) 
1.5 
(1) 
Lack of patient education/knowledge about 
medication in general 
0.0 
(0) 
4.5 
(3) 
9.0 
(6) 
34.3 
(23) 
49.3 
(33) 
3.0 
(2) 
Lack of patient education/knowledge about 
monetary cost of medication 
0.0 
(0) 
1.5 
(1) 
22.4 
(15) 
32.8 
(22) 
40.3 
(27) 
3.0 
(2) 
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Statements 1 
% (n) 
2 
% (n) 
3 
% (n) 
4 
% (n) 
5 
% (n) 
Missing 
data 
% (n) 
Overstocking of medication by patients due to 
previous or potential out of stock situation 
1.5 
(1) 
3.0 
(2) 
13.4 
(9) 
35.8 
(24) 
44.8 
(30) 
1.5 
(1) 
Overstocking of medication by patients due to 
dependency on others to collect medication supply  
1.5 
(1) 
7.5 
(5) 
11.9 
(8) 
55.2 
(37) 
22.4 
(15) 
1.5 
(1) 
Overstocking by patients due to fear of refusal of 
medication supply due to entitlement problems 
1.5 
(1) 
4.5 
(3) 
23.9 
(16) 
44.8 
(30) 
23.9 
(16) 
1.5 
(1) 
Other family members or carers obtaining 
medication on behalf of patient unaware of stock at 
home 
1.5 
(1) 
3.0 
(2) 
26.9 
(18) 
43.3 
(29) 
23.9 
(16) 
1.5 
(1) 
Patients getting advice form more than one HCP, 
family and friends regarding use of medication 
1.5 
(1) 
3.0 
(2) 
32.8 
(22) 
29.9 
(20) 
29.9 
(20) 
3.0 
(2) 
Non-adherence to medication regimens by patients 1.5 
(1) 
1.5 
(1) 
19.4 
(13) 
32.8 
(22) 
43.3 
(29) 
1.5 
(1) 
Medication stopped by patient due to perceived 
ineffectiveness 
0.0 
(0) 
3.0 
(2) 
19.4 
(13) 
41.8 
(28) 
32.8 
(22) 
3.0 
(2) 
Medication stopped by patient due to perceived 
adverse events 
1.5 
(1) 
9.0 
(6) 
20.9 
(14) 
40.3 
(27) 
26.9 
(18) 
1.5 
(1) 
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Statements 1 
% (n) 
2 
% (n) 
3 
% (n) 
4 
% (n) 
5 
% (n) 
Missing 
data 
% (n) 
Medications stopped by patient due to perceived 
resolution of their symptoms/medical condition 
0.0 
(0) 
10.4 
(7) 
16.4 
(11) 
34.3 
(23) 
37.3 
(25) 
1.5 
(1) 
Patient's death  13.4 
(9) 
32.8 
(22) 
28.4 
(19) 
11.9 
(8) 
11.9 
(8) 
1.5 
(1) 
Lack of education and training of HCP students 
about medication wastage  
0.0 
(0) 
4.5 
(3) 
22.4 
(15) 
34.3 
(23) 
34.3 
(23) 
4.5 
(3) 
Lack of education and training of HCP students 
about monetary cost of medication 
0.0 
(0) 
9.0 
(6) 
25.4 
(17) 
37.3 
(25) 
25.4 
(17) 
3.0 
(2) 
Lack of CPD of healthcare professionals about 
medication wastage 
0.0 
(0) 
9.0 
(6) 
28.4 
(19) 
38.8 
(26) 
20.9 
(14) 
3.0 
(2) 
Lack of CPD of healthcare professionals about 
monetary cost of medication 
1.5 
(1) 
7.5 
(5) 
40.3 
(27) 
29.9 
(20) 
17.9 
(12) 
3.0 
(2) 
Healthcare professionals’ lack of awareness of 
monetary cost of medication 
4.5 
(3) 
16.4 
(11) 
23.9 
(16) 
32.8 
(22) 
20.9 
(14) 
1.5 
(1) 
Lack of communication about medication between 
primary and secondary healthcare 
1.5 
(1) 
9.0 
(6) 
19.4 
(13) 
41.8 
(28) 
26.9 
(18) 
1.5 
(1) 
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Statements 1 
% (n) 
2 
% (n) 
3 
% (n) 
4 
% (n) 
5 
% (n) 
Missing 
data 
% (n) 
Lack of communication about medication between 
healthcare providers and patients 
0.0 
(0) 
10.4 
(7) 
16.4 
(11) 
40.3 
(27) 
31.3 
(21) 
1.5 
(1) 
Medication stopped by HCP due to ineffectiveness 
of the medication 
3.0 
(2) 
32.8 
(22) 
38.8 
(26) 
14.9 
(10) 
7.5 
(5) 
3.0 
(2) 
Medication stopped by HCP due to adverse events 
of the medication 
10.4 
(7) 
25.4 
(17) 
38.8 
(26) 
16.4 
(11) 
7.5 
(5) 
1.5 
(1) 
Medication stopped by HCP due to resolution of 
patients’ symptoms/conditions  
11.9 
(8) 
26.9 
(18) 
35.8 
(24) 
17.9 
(12) 
4.5 
(3) 
3.0 
(2) 
Over-prescribing by HCP 1.5 
(1) 
11.9 
(8) 
14.9 
(10) 
37.3 
(25) 
32.8 
(22) 
1.5 
(1) 
Extra medication supply dispensed to patients 1.5 
(1) 
11.9 
(8) 
22.4 
(15) 
29.9 
(20) 
32.8 
(22) 
1.5 
(1) 
Medication prescribed for no indication 3.0 
(2) 
13.4 
(9) 
16.4 
(11) 
22.4 
(15) 
43.3 
(29) 
1.5 
(1) 
Healthcare professionals’ perceptions that patients 
expect to receive a medication 
0.0 
(0) 
10.4 
(7) 
25.4 
(17) 
37.3 
(25) 
23.9 
(16) 
3.0 
(2) 
Inadequate medication reviews by healthcare 
professionals  
1.5 
(1) 
10.4 
(7) 
46.3 
(31) 
20.9 
(14) 
19.4 
(13) 
1.5 
(1) 
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Statements 1 
% (n) 
2 
% (n) 
3 
% (n) 
4 
% (n) 
5 
% (n) 
Missing 
data 
% (n) 
Free healthcare system 6.0 
(4) 
13.4 
(9) 
14.9 
(10) 
9.0 
(6) 
55.2 
(37) 
1.5 
(1) 
Medication obtained free through the National 
Health System are regularly out of stock in the 
pharmacy 
4.5 
(3) 
9.0 
(6) 
35.8 
(24) 
20.9 
(14) 
26.9 
(18) 
3.0 
(2) 
Medication that legally require a prescription are 
easily purchased from pharmacies without the need 
for a valid prescription 
3.0 
(2) 
25.4 
(17) 
35.8 
(24) 
11.9 
(8) 
22.4 
(15) 
1.5 
(1) 
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5.5.8 Current practices, views, experiences 
Table 5.38 shows the current views of HCP students regarding the role of HCPs in 
reducing medication wastage in Malta. In the students’ opinions, doctors (91.0%, 
n=61), pharmacists (88.0%, n=59) and nurses (77.7%, n=52) play an 
important part in reducing medication wastage. The majority also strongly 
agreed/agreed that doctors (94.0%, n=63), pharmacists (85.1%, n=57) and 
nurses (85.1%, n=57) could play a more active role in reducing medication 
wastage. 
 
A little more than one third of respondents (38.8%, n=26) strongly agreed/ 
agreed that they felt confident in their abilities to reduce medication wastage.  
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Table 5.38: Current views regarding the role of HCPs in reducing medication wastage in Malta (n=67) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
data 
% (n) 
Dentists play an important part in reducing 
medication wastage in Malta 
6.0 
(4) 
22.4 
(15) 
56.7 
(38) 
6.0 
(4) 
7.5 
(5) 
1.5 
(1) 
Doctors play an important part in reducing 
medication wastage in Malta 
0.0 
(0) 
1.5 
(1) 
6.0 
(4) 
31.3 
(21) 
59.7 
(40) 
1.5 
(1) 
Nurses play an important part in reducing 
medication wastage in Malta 
3.0 
(2) 
3.0 
(2) 
13.4 
(9) 
47.8 
(32) 
29.9 
(20) 
3.0 
(2) 
Pharmacists play an important part in reducing 
medication wastage in Malta 
1.5 
(1) 
0.0 
(0) 
6.0 
(4) 
17.9 
(12) 
70.1 
(47) 
4.5 
(3) 
Dentists could play a more active role in reducing 
medication wastage in Malta 
1.5 
(1) 
0.0 
(0) 
49.3 
(33) 
31.3 
(21) 
11.9 
(8) 
6.0 
(4) 
Doctors could play a more active role in reducing 
medication wastage in Malta 
0.0 
(0) 
0.0 
(0) 
1.5 
(1) 
31.3 
(21) 
62.7 
(42) 
4.5 
(3) 
Nurses could play a more active role in reducing 
medication wastage in Malta 
0.0 
(0) 
0.0 
(0) 
10.4 
(7) 
38.8 
(26) 
46.3 
(31) 
4.5 
(3) 
Pharmacists could play a more active role in 
reducing medication wastage in Malta 
0.0 
(0) 
0.0 
(0) 
9.0 
(6) 
28.4 
(19) 
56.7 
(38) 
6.0 
(4) 
There is little scope for dentists to further reduce 
medication wastage in Malta 
13.4 
(9) 
37.3 
(25) 
41.8 
(28) 
4.5 
(3) 
1.5 
(1) 
1.5 
(1) 
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There is little scope for doctors to further reduce 
medication wastage in Malta 
47.8 
(32) 
38.8 
(26) 
7.5 
(5) 
1.5 
(1) 
1.5 
(1) 
3.0 
(2) 
There is little scope for nurses to further reduce 
medication wastage in Malta  
38.8 
(26) 
44.8 
(30) 
10.4 
(7) 
3.0 
(2) 
0.0 
(0) 
3.0 
(2) 
There is little scope for pharmacists to further 
reduce medication wastage in Malta 
46.3 
(31) 
35.8 
(24) 
11.9 
(8) 
0.0 
(0) 
1.5 
(1) 
4.5 
(3) 
I feel confident in my ability to reduce medication 
wastage in Malta  
7.5 
(5) 
10.4 
(7) 
41.8 
(28) 
31.3 
(21) 
7.5 
(5) 
1.5 
(1) 
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Table 5.39 shows the current views of HCP students regarding the provision of 
advice to patients on use, storage and disposal of medication. Respondents 
reported that doctors routinely advise patients on use of their medication 
(85.1%, n=57), followed by pharmacists (80.6%, n=54). Pharmacists were 
considered the most appropriate profession to give advice on storage (73.1%, 
n=49) and disposal (43.2%, n=29) of medication. 
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Table 5.39: Current views regarding advice to patients on use, storage and disposal of medication (n=67) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
data 
% (n) 
To my knowledge, dentists routinely advise patients 
on use of their medication 
3.0 
(2) 
9.0 
(6) 
56.7 
(38) 
25.4 
(17) 
4.5 
(3) 
1.5 
(1) 
To my knowledge, dentists routinely advise patients 
on storage of their medication 
10.4 
(7) 
28.4 
(19) 
53.7 
(36) 
6.0 
(4) 
0.0 
(0) 
1.5 
(1) 
To my knowledge, dentists routinely advise patients 
on disposal of unused medication 
14.9 
(10) 
22.4 
(15) 
58.2 
(39) 
1.5 
(1) 
0.0 
(0) 
3.0 
(2) 
To my knowledge, doctors routinely advise patients 
on use of their medication 
0.0 
(0) 
4.5 
(3) 
9.0 
(6) 
58.2 
(39) 
26.9 
(18) 
1.5 
(1) 
To my knowledge, doctors routinely advise patients 
on storage of their medication 
4.5 
(3) 
32.8 
(22) 
25.4 
(17) 
28.4 
(19) 
6.0 
(4) 
3.0 
(2) 
To my knowledge, doctors routinely advise patients 
on disposal of unused medication 
16.4 
(11) 
41.8 
(28) 
23.9 
(16) 
10.4 
(7) 
4.5 
(3) 
3.0 
(2) 
To my knowledge, nurses routinely advise patients 
on use of their medication 
1.5 
(1) 
7.5 
(5) 
19.4 
(13) 
44.8 
(30) 
25.4 
(17) 
1.5 
(1) 
To my knowledge, nurses routinely advise patients 
on storage of their medication 
3.0 
(2) 
25.4 
(17) 
34.3 
(23) 
19.4 
(13) 
16.4 
(11) 
1.5 
(1) 
To my knowledge, nurses routinely advise patients 
on disposal of unused medication 
11.9 
(8) 
35.8 
(24) 
34.3 
(23) 
9.0 
(6) 
7.5 
(5) 
1.5 
(1) 
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To my knowledge, pharmacists routinely advise 
patients on use of their medication 
0.0 
(0) 
1.5  
(1) 
14.9 
(10) 
37.3 
(25) 
43.3 
(29) 
3.0 
(2) 
To my knowledge, pharmacists routinely advise 
patients on storage of their medication 
1.5 
(1) 
3.0 
(2) 
19.4 
(13) 
40.3 
(27) 
32.8 
(22) 
3.0 
(2) 
To my knowledge, pharmacists routinely advise 
patients disposal of unused medication 
7.5 
(5) 
13.4 
(9) 
32.8 
(22) 
31.3 
(21) 
11.9 
(8) 
3.0 
(2) 
To my knowledge, other healthcare professionals 
have more responsibility than people of my same 
profession to advise patients on use of their 
medication 
17.9 
(12) 
35.8 
(24) 
25.4 
(17) 
13.4 
(9) 
4.5 
(3) 
3.0 
(2) 
To my knowledge, other healthcare professionals 
have more responsibility than people of my same 
profession to advise patients on storage of their 
medication 
14.9 
(10) 
34.3 
(23) 
28.4 
(19) 
16.4 
(11) 
4.5 
(3) 
1.5 
(1) 
To my knowledge, other healthcare professionals 
have more responsibility than people of my same 
profession to advise patients on disposal of unused 
medication 
13.4 
(9) 
35.8 
(24) 
28.4 
(19) 
13.4 
(9) 
6.0 
(4) 
3.0 
(2) 
Patient information leaflets, available in the 
medication package, are a good source of 
information for patients on use of their medication 
1.5 
(1) 
6.0 
(4) 
10.4 
(7) 
44.8 
(30) 
34.3 
(23) 
3.0 
(2) 
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Patient information leaflets are a good source of 
information for patients on storage of their 
medication 
1.5 
(1) 
7.5 
(5) 
14.9 
(10) 
40.3 
(27) 
34.3 
(23) 
1.5 
(1) 
Patient information leaflets are a good source of 
information for patients on disposal of unused 
medication 
9.0 
(6) 
25.4 
(17) 
19.4 
(13) 
32.8 
(22) 
11.9 
(8) 
1.5 
(1) 
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Table 5.40 shows the current practices, views and experiences of HCP students 
regarding medication wastage in Malta. Almost three quarters of respondents 
(70.2%, n=47) felt concerned that when they graduate, patients would put them 
under pressure to supply medication which they consider unnecessary, 67.2% 
(n=45) were concerned that patients’ family members would put them under 
pressure and 65.7% (n=44) were concerned that other HCPs would put them 
under pressure to supply medication which they consider unnecessary. 
 
Only one third (35.8%, n=24) strongly agreed/agreed that medication supplied 
to patients and returned to the HCPs within their expiry dates should be reused. 
Two thirds (65.7%, n=44) strongly agreed/agreed that the provision of 
medication to patients free of charge could lead to medication wastage. Almost 
half (44.8%, n=30) strongly agreed/agreed that as a consumer of healthcare, 
they contributed to medication wastage. Only one tenth (10.5%, n=7) strongly 
agreed/agreed that current undergraduate training had sufficient emphasis on 
medication wastage and 86.5% (n=58) felt that they required more education 
and training on how to reduce medication wastage. 
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Table 5.40: Current practices, views and experiences regarding medication wastage in Malta (n=67) 
Statements Strongly 
disagree 
% (n) 
Disagree 
 
% (n) 
Unsure 
 
% (n) 
Agree 
 
% (n) 
Strongly 
agree 
% (n) 
Missing 
data 
% (n) 
When I graduate, I intend considering medication 
wastage when supplying medication 
0.0 
(0) 
0.0 
(0) 
6.0 
(4) 
65.7 
(44) 
26.9 
(18) 
1.5 
(1) 
When I graduate, I intend to regularly educate 
patients about medication wastage 
1.5 
(1) 
1.5 
(1) 
6.0 
(4) 
56.7 
(38) 
31.3 
(21) 
3.0 
(2) 
Dentists can make little difference to reduce the 
extent of medication wastage in Malta 
13.4 
(9) 
34.3 
(23) 
34.3 
(23) 
10.4 
(7) 
3.0 
(2) 
4.5 
(3) 
Doctors can make little difference to reduce the 
extent of medication wastage in Malta 
43.3 
(29) 
40.3 
(27) 
3.0 
(2) 
7.5 
(5) 
3.0 
(2) 
3.0 
(2) 
Nurses can make little difference to reduce the 
extent of medication wastage in Malta 
38.8 
(26) 
44.8 
(30) 
3.0 
(2) 
9.0 
(6) 
3.0 
(2) 
1.5 
(1) 
Pharmacists can make little difference to reduce the 
extent of medication wastage in Malta 
56.7 
(38) 
28.4 
(19) 
3.0 
(2) 
9.0 
(6) 
1.5 
(1) 
1.5 
(1) 
I am concerned that when I graduate, patients will 
put me under pressure to supply medication which 
I consider unnecessary 
1.5 
(1) 
10.4 
(7) 
14.9 
(10) 
40.3 
(27) 
29.9 
(20) 
3.0 
(2) 
I am concerned that when I graduate, family 
members of patients will put me under pressure to 
supply medication which I consider unnecessary 
3.0 
(2) 
10.4 
(7) 
17.9 
(12) 
41.8 
(28) 
25.4 
(17) 
1.5 
(1) 
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I am concerned that when I graduate, other 
healthcare professionals will put me under pressure 
to supply medication which I consider unnecessary  
0.0 
(0) 
16.4 
(11) 
16.4 
(11) 
43.3 
(29) 
22.4 
(15) 
1.5 
(1) 
I am fully aware of the costs of medication 
commonly used in Malta 
7.5 
(5) 
28.4 
(19) 
19.4 
(13) 
32.8 
(22) 
9.0 
(6) 
3.0 
(2) 
Medication supplied to patients and returned to me 
within their expiry dates should be reused  
11.9 
(8) 
10.4 
(7) 
40.3 
(27) 
25.4 
(17) 
10.4 
(7) 
1.5 
(1) 
Dentists have insufficient time in their daily practise 
to reduce the extent of medication wastage in Malta 
25.4 
(17) 
25.4 
(17) 
43.3 
(29) 
4.5 
(3) 
0.0 
(0) 
1.5 
(1) 
Doctors have insufficient time in their daily practise 
to reduce the extent of medication wastage in Malta 
26.9 
(18) 
37.3 
(25) 
17.9 
(12) 
11.9 
(8) 
4.5 
(3) 
1.5 
(1) 
Nurses have insufficient time in their daily practise 
to reduce the extent of medication wastage in Malta 
29.9 
(20) 
40.3 
(27) 
14.9 
(10) 
10.4 
(7) 
1.5 
(1) 
3.0 
(2) 
Pharmacists have insufficient time in their daily 
practise to reduce the extent of medication wastage 
34.3 
(23) 
41.8 
(28) 
14.9 
(10) 
4.5 
(3) 
3.0 
(2) 
1.5 
(1) 
Provision of medication to patients free of charge 
can lead to medication wastage in Malta  
4.5 
(3) 
10.4 
(7) 
16.4 
(11) 
29.9 
(20) 
35.8 
(24) 
3.0 
(2) 
As a consumer of healthcare, I contribute to 
medication wastage in Malta 
10.4 
(7) 
16.4 
(11) 
26.9 
(18) 
35.8 
(24) 
9.0 
(6) 
1.5 
(1) 
My undergraduate training has sufficient emphasis 
on medication wastage 
23.9 
(16) 
50.7 
(34) 
11.9 
(8) 
9.0 
(6) 
1.5 
(1) 
3.0 
(2) 
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I require more education and training on how to 
reduce medication wastage in Malta  
1.5 
(1) 
6.0 
(4) 
3.0 
(2) 
55.2 
(37) 
31.3 
(21) 
3.0 
(2) 
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5.5.9 Therapeutic areas, patient groups and other areas 
Respondents listed the therapeutic areas, patient groups or other areas which 
should be considered as priority for targeting strategies to reduce medication 
wastage. The most commonly listed was the ‘elderly patient group’, mentioned by 
31.3% (n=21) of respondents.  
 
The patient groups/therapeutic areas were:  
• Elderly patients (n=21) 
• Patients receiving free medication (n=4) 
• Polypharmacy (n=3) 
• Patients on chronic medication and young adults/children (n=2 each) 
• Non-adherence, patients on acute medication, patients with multiple co-
morbidities, patients with chronic pain, patients dealing with their own 
medication independently, and middle-aged groups (n=1 each) 
 
Respondents also listed the classes of medication that should be considered as 
priority for targeting. The most common class of drugs was cardiovascular (17.9%, 
n=12).  
 
The classes of drugs were:  
• Cardiovascular medication (n=12) 
o Antihypertensives (n=7) 
o Cardiovascular medication in general (n=4) 
o Statins (n=1) 
• Antibiotics and medication for diabetes (n=4 each) 
• Respiratory and analgesics (n=3 each) 
• Antidepressants/anxiolytics (psychiatric treatment), warfarin/aspirin, and OTC 
medication (n=2 each) 
• Ophthalmic, ear nose throat medication and steroids (n=1 each) 
 
The types of medication that should be targeted were: 
• Medication commonly prescribed (n=5) 
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• Special medication formulations, high cost medication, and ointments and 
creams (n=1 each) 
 
Other areas or groups listed were: 
• HCPs (n=3) 
• General public, family member, and carers and parents (n=2 each) 
• Medication disposal, adults, primary healthcare flu season, and immigrants (n=1 
each) 
 
5.6 Discussion 
5.6.1 Key findings in relation to the research aim and questions 
The overall aim of this phase of the research was to investigate issues of 
awareness, perceptions, attitudes and behaviours regarding medication wastage 
amongst the Maltese population, HCPs and respective students. 
 
In general, there were clear deficiencies in the awareness in relation of issues of 
medication wastage amongst the general population, HCPs and students, with the 
general public self-reporting highest level of awareness. There were also clear 
deficiencies in the public, as well as HCPs and students’, confidence in ability to 
reduce medication wastage. 
 
Awareness amongst the general public was significantly associated, in univariate 
analysis, with the following variables: age, type of occupation, whether the person 
was on regular medication, and whether the person was using medication obtained 
free. Bivariate logistic analysis did not yield any significant findings.  
 
Interest amongst the general public was significantly associated, in univariate 
analysis, with the following variables: whether the person was using medication 
obtained free and whether the medication was purchased. Both variables were 
significant in bivariate logistic analysis.   
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Contribution towards medication wastage by the general public was significantly 
associated with the type of occupation of the participant. 
 
Confidence in ability to reduce medication wastage by the general public was 
significantly associated with the presence of a HCP as a family member. 
 
Awareness amongst HCPs was significantly associated with the following variables: 
age, number of years practising in profession, and Rogers’ Diffusion of Innovation 
theory (the only variable retained in bivariate logistic analysis). 
 
A variety of factors were suggested as contributing to medication wastage, although 
there were some differences in responses from the general public, HCPs and 
students. In general, key areas were: the free healthcare system; the overstocking 
of medication by patients due to previous or potential out of stock situations; the 
fact that patients collect free medication or purchase medication that they do not 
need, or more than they need; and lack of patient education/knowledge about 
medication. 
 
A number of behaviours were suggested as contributing to medication wastage, 
namely non-adherence; and contribution towards medication wastage by other 
people, by doctors and by the free healthcare system. The public also felt that 
doctors principally could do more to reduce medication wastage, followed by 
pharmacists and nurses. More than half of HCPs noted that they could be more 
active in reducing wastage. HCP students strongly agreed/agreed that doctors could 
play a more active role in reducing medication wastage in Malta, followed by nurses 
and pharmacists. The majority of the public felt that the state could do more to 
reduce medication wastage in Malta. 
 
A number of patient groups were considered as priority when targeting medication 
wastage. Key patient groups mostly cited by HCPs were: patients receiving free 
medication, elderly patients (which was the most cited group by students) and 
patients on chronic medication.  
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The most common classes of drugs that HCPs felt that needed to be targeted to 
reduce medication wastage were the cardiovascular (also cited by students) and 
antibiotics. The most common type of medication that, in HCPs’ opinion, should be 
targeted to reduce medication wastage was high cost medication, whilst students 
mentioned mostly commonly prescribed medication.  
 
In general, there were clear deficiencies in terms of advice to patients by HCPs 
related to storage and disposal, with the majority of HCPs and students voicing the 
need for more education and training in relation to this area. 
 
5.6.2 Strengths and weaknesses of questionnaires 
This is the first study to report the perspectives of the Maltese (or indeed any) 
general population, HCPs and students on medication wastage and associations 
between different variables and outcomes of awareness, interest, contribution and 
confidence in ability to reduce medication wastage. The questionnaires were 
developed from evidence generated through previous research phases of the 
systematic review and the Delphi technique. Furthermore, the questionnaire items 
were grounded in several key theoretical frameworks. The draft questionnaires 
underwent pre-testing in terms of face and content validity followed by piloting. The 
evidence base around maximising response rates was employed and the 
questionnaires were distributed amongst HCPs who had the greatest involvement in 
prescribing, dispensing or administration of medication. One further strength was 
the collection of data from the general public, allowing description and 
understanding of their perspectives.  
 
There are, however, several weaknesses and hence the results should be 
interpreted with caution. Despite recruiting HCPs who had the greatest involvement 
in prescribing and dispensing of medication, the exclusion of nurses limited 
researching an important perspective. The response rates were low and hence may 
limit the generalizability of the results to the general public, HCPs and students in 
Malta and elsewhere. Regardless of the number of measures taken to enhance 
response rates, non-respondent bias could not be eliminated and the differences (or 
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similarities) between those who responded and those who did not respond to the 
survey could not be established. However, for the general public, the respondents 
were similar in terms of demographics to the general population. One further key 
limitation is the self-reported nature of the data which could not be validated. 
Moreover, relying on self-reporting meant that individuals amongst the public who 
were unable to read or write could not possibly participate in this study unless 
helped by others, thus potentially creating a selection bias. In fact, only four 
members of the public with no schooling completed the questionnaire. The sequence 
between the exposure and the outcome (i.e. any cause and effect), although a 
limitation of all cross-sectional surveys, could not be determined (Ho et al., 2008). 
A core weakness of this study was the lack of internal reliability and test-retest 
reliability testing. All of these weaknesses and biases are potential threats to 
internal validity and limit the degree of generalizability of the findings (external 
validity). Moreover, while respondents appear to be similar to other populations, 
caution should be exercised in extrapolating the results beyond Malta in view of the 
differences in healthcare systems, practices and cultures. 
 
5.6.3 Importance of findings  
The survey results highlight key issues of lack of awareness of medication wastage, 
levels of individual contribution to wastage and capability to reduce wastage for 
HCPs, students and the general public. Further understanding these issues will aid 
in the development of strategies to reduce wastage and hence the results are of 
importance to HCPs, professional bodies, organizations, policy makers, patients and 
the general public.  
 
While multivariate analysis failed to identify key, consistent predictors of variables 
related to the outcomes studied, univariate analysis for the public questionnaire 
findings identified the potential importance of age, type of occupation, whether the 
person was on regular medication, whether the person was using medication 
obtained free, and the presence of a HCP as a family member. Age has been shown 
to be a significant factor in relation to awareness in other areas, such as awareness 
of and attitudes towards the avoidance of skin cancer (Butler et al., 2013), 
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awareness of early signs and symptoms and prevention of oral cancer (Ghani et al., 
2013) and awareness of the patients’ rights by subjects on admission to a tertiary 
university hospital in Poland (Krzych and Ratajczyk, 2013). Therefore, different age 
groups should be targeted in different ways when implementing strategies to reduce 
medication wastage. 
 
Considering the significant associations observed between general public occupation 
and outcomes of awareness of medication wastage and individual contribution 
towards medication wastage, it is important for healthcare policy makers and HCPs 
to consider occupation when targeting medication wastage reduction. Occupation 
has also been shown to significantly impact areas of healthcare, such as the level of 
satisfaction with physicians’ services in primary healthcare (Al-Doghaither et al., 
2000) and the level of self-medication usage (Selvaraj et al., 2014). Occupation was 
also found to play a role in terms of awareness of existing medical conditions, such 
as the existence of hypertension (Davila et al., 2012). 
 
Measures to target patients on regular medication should perhaps differ to those 
prescribed acute medication as those on regular medication were much more likely 
to self-report awareness of issues of medication wastage. In contrast, Wan-kin Chan 
et al. (2013) argued that patients taking chronic medication generally lack 
knowledge of their medication, albeit not specifically relating to wastage. Notably, 
data from the public survey failed to identify any association between the level of 
adherence and outcomes relating to medication wastage. However, self-reported 
adherence levels were sub-optimal, a result which is also important in relation to 
medication wastage if patient health outcomes are adversely affected. It is 
important for HCPs to adopt models of concordance which truly engage patients, 
providing opportunities for informed discussion and decision-making. Bond et al. 
(2012) argued that the goals of best outcomes and reducing medication wastage 
can only be achieved by significant involvement of the patient and by the provision 
of suitable and accessible information. Study findings highlight that one quarter of 
patients perceived that they lacked information on how to make the most of their 
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medication, and one third lacked information on how to take their medication to get 
the least possible side-effects.  
 
Those members of the public obtaining free medication reported a lower interest in 
issues of medication wastage compared to those paying for their medication. The 
reason for this result is unknown but could perhaps be related to paying for 
medication engendering a greater respect in medication in general, appropriate use 
and minimising wastage. This finding is important in terms of national policy 
development and review around medication supplies, and targeting medication 
wastage. Richardson et al. (2014), in a study on the effect of free healthcare on 
polypharmacy, suggested that the effects of the free healthcare system need to be 
fully explored and recognised before informing policy debates. 
 
Interestingly, one quarter (25.8%) of general public respondents had a HCP as one 
of their close family members (dentist, doctor, nurse or pharmacist). A statistically 
significant association was observed between this family link and confidence in own 
ability to reduce medication wastage. One possible interpretation is due to the direct 
access to professional support, which should be extended to all. 
 
Univariate analysis for the HCP questionnaire findings identified the potential 
importance of age, number of years of practise, and Rogers’ Diffusion of Innovation 
theory (the only variable retained in bivariate logistic analysis). Number of years of 
practise has also been shown to statistically significantly impact other areas of 
healthcare. Gill et al. (2013) found that consultants who have been practising for 
longer conduct faster post-take medical ward rounds with no negative outcomes for 
the patients. A study by Green et al. (2014) on the attitudes of medical practitioners 
to both whole body donation to medical science and organ donation at time of death 
shows that attitudes change as their clinical experience grows. HCPs’ age has also 
been shown to be an important factor in other studies. For example, Lewthwaite et 
al. (2014) found that senior doctors were more willing to be vaccinated with the 
seasonal influenza vaccine. This difference in attitudes indicates that future 
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strategies targeting HCPs to reduce wastage should consider using different 
approaches depending on the age and number of years in practise. 
 
Innovation is recognised in society as a main keyword in pursuing new ideas and 
practices (Baek et al., 2013). Rogers’ Diffusion of Innovation theory was applied in 
this study to further our understanding of HCPs and students in relation to 
outcomes related to medication wastage. This study identified a statistically 
significant association between the Diffusion of Innovation categories and 
awareness of medication wastage. Interestingly, those more venturesome were less 
likely to be aware of medication wastage. Again, the reason for this result is not 
clear but could perhaps be related to ‘venturesome characteristics’ of risk takers not 
being bound by issues, such as compatibility of change with work practices, which 
may worry others. Moreover, based on the three types of knowledge described 
above that participants require to adopt the innovation, while the ‘less venturesome’ 
have the awareness knowledge, they might lack the ‘how-to knowledge’ required to 
use the innovation properly. 
 
The public and HCP variables identified as significant in either univariate and 
bivariate analysis provide a framework for potentially targeting medication wastage 
reduction strategies and are thus important for policy makers, organizations, 
educators and practitioners. However, further qualitative research is required to 
provide more in-depth understanding to aid the development of these strategies.  
 
Factors perceived by the general public and HCPs as contributing to medication 
wastage were highlighted, with the free healthcare system and previous or potential 
out of stock situations as two major factors. These results are consistent with those 
of the Delphi technique (chapter 4). Patients’ fear of medication unavailability was 
the factor which achieved the highest level of consensus in the Delphi technique 
with almost all panellists (96.0%) in agreement. The issue of medication shortages 
is a global problem, with the Food and Drug Administration (FDA) in the US 
expressing concern that shortages have been increasing each year since 2006 
(Haninger et al., 2011). In contrast to the key findings of the systematic review, the 
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survey data indicate that factors of change in medication, patient’s death, and 
resolution of patient’s conditions were not considered to be major contributors to 
wastage. These differences may be due to the largely dated studies identified in the 
systematic review, most of which preceded the shortage issues.  
 
Elderly patients were cited as an important priority group for targeting medication 
wastage reduction. The need for rational prescribing, particularly in the elderly, 
given population demographic changes and increasing prescribing patterns and 
volumes, has been recognised since the 1980s and is still a global priority (Duerden 
et al., 2013). A very recent paper commissioned by the WHO Collaborating Centre 
for Pharmaceutical Policy and Regulation, ‘Priority Medicines for Elderly’ discusses 
inappropriate prescribing and polypharmacy in the elderly and possible interventions 
to improve it (Martial et al., 2013). HCP respondents in this study largely considered 
inappropriate prescribing to be encompassed within a definition of medication 
wastage. Nationally a number of measures have been taken to improve awareness 
on issues related to medication use in the elderly. These include the establishment 
of the International Institute on Ageing (INIA) in Malta in 1988 under the auspices 
of the United Nations (International Institute on Ageing, 2001), a conference on 
Medication Management in Older Patients hosted by INIA and held in Malta in 2004 
(Azzopardi, 2005), and a multi-disciplinary focus group held in 2012 followed by a 
full-day national conference for HCPs in 2013 (Office of the Commissioner for Mental 
Health and Older Persons, 2013). Survey results appear to suggest a maintained 
need to prioritise the elderly when targeting medication wastage.  
 
Both HCPs and students agreed that cardiovascular medication should be considered 
as a priority when targeting medication wastage. The need to target cardiovascular 
medication is reflected in the findings of a number of studies identified in the 
systematic review (chapter 3). In a cross-sectional study of 29 pharmacies, Boivin 
(1997) recorded that the medication categorised as cardiovascular constituted the 
highest monetary value of medication wastage. Many other studies throughout the 
world have replicated this finding (Henderson, 1984; Longmore et al., 1995; 
Isacson and Olofsson 1999; Grant, 2001; Langley et al., 2005; Al Siyabi and Al 
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Riyami, 2007; Mackridge and Marriott, 2007; James et al., 2009; Guirguis, 2010). 
There may be many reasons for this finding, including the very large volume of 
cardiovascular medication prescribing. However, in a cross-sectional study of 24 
community pharmacies, James et al. (2009) found that the cardiovascular group 
was mainly wasted due to very frequent medication changes. There may be merit in 
developing guidance on prescribing quantities and monitoring response when 
initiating cardiovascular medication. 
 
HCPs and students clearly indicated the need for education in the field of medication 
wastage, which may be considered as a key step in reducing and preventing 
medication wastage. Insufficient emphasis on wastage as part of HCPs’ CPD was 
also noted as part of the Delphi technique. In addition, the fact that less than one-
fifth of HCPs agreed that they were fully aware of laws, procedures and policies 
relating to medication wastage in Malta further supports the need for further 
education and CPD related to medication wastage. 
 
5.7 Conclusion 
The quantitative data from these cross-sectional studies have demonstrated that 
more effort is warranted to raise awareness and education of the public, HCPs and 
students as an initial step in promoting behavioural change. This study has also 
presented major contributory factors which merit considerable attention (the free 
healthcare system; the overstocking of medication by patients due to previous or 
potential out of stock situations; the fact that patients collect free medication or 
purchase medication that they do not need, or more than they need), as well as 
patient groups and classes of drugs that require prioritisation when targeting 
medication wastage. Significant associations of data for demographic characteristics 
and awareness of issues and behaviours in relation to medication wastage provide 
an insight on important aspects that need to be considered when developing 
strategies to reduce wastage. 
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5.8 Reflections and future direction  
Survey results informed the next phase of the research, which employed a 
qualitative methodology of interpretative phenomenology to allow in-depth 
description and understanding of the issues of medication wastage, again from the 
perspectives of the general public and HCPs. Emphasis was placed on discussing the 
potential for development and implementation of strategies to reduce medication 
wastage.  
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Chapter 6  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Experience has shown, and a 
true philosophy will always show, 
that a vast, perhaps the larger 
portion of the truth arises from 
the seemingly irrelevant” 
Edgar Allan Poe 
[Author, poet, editor, and literary critic 
1809-1849] 
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The perspectives of the Maltese population and HCPs on 
medication wastage: focus groups  
 
 
To date, no published literature has employed a qualitative approach to provide 
in-depth exploration of the causes and potential solutions to the issue of 
medication wastage. The questionnaire results presented in the previous chapter 
provide a quantitative perspective, with less emphasis on richness of data. This 
chapter describes the research aims and questions, and provides a detailed 
account of focus group method, findings and discussion. 
 
6.1 Introduction 
6.1.1 Behaviour 
This section provides a brief overview of the concept of behaviour. Attitudes are 
linked to some extent to their behavioural intentions and these in turn are 
thought to be related to some extent to actual behaviours (Bradburn et al., 
2004). Intention is made up of three types of things:  
1. Attitude towards performing a particular behaviour 
2. Perceived injunctive, the expected social pressure from important social 
networks regarding performing the behaviour; and perceived descriptive norm, 
the extent to which members of the social network perform the behaviour 
themselves 
3. Self-efficacy, the extent to which a person regards his or her ability to 
successfully do something.  
 
Targeting specific messages may not always lead to individual behaviour change 
as intended. Behaviour is based on four components: the action which is directed 
at a target which is performed in a certain context and at certain point in time 
(Fishbein and Ajzen, 2010). Therefore, all these aspects are important to 
consider when researching behaviours and are ideally aligned to qualitative 
modes of enquiry. 
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6.1.2 Rationale for Focus Groups 
The Delphi technique identified a number of potential factors amongst the 
Maltese population which give rise to medication wastage. Cross-sectional 
questionnaires elicited awareness, perceptions, attitudes and behaviours in 
relation to medication wastage. Focus groups conducted amongst samples of 
questionnaire respondents could provide a more in-depth examination of 
participants' beliefs and behaviours. Furthermore, this approach could allow 
exploration of possible barriers and facilitators to aid development of strategies 
aiming to reduce medication wastage. 
 
6.1.3 Study aim and research questions 
The overall aims of this phase of the research were to describe and understand 
the beliefs and behaviours regarding medication wastage of the Maltese public 
and HCPs and to explore potential solutions to reduce medication wastage. 
 
More specifically, this study sought to answer the following questions: 
1. What are the beliefs and behaviours of participants regarding medication 
wastage?  
2. What are the potential solutions to reducing medication wastage? 
3. Which are the key facilitators and barriers?  
 
6.2 Method 
6.2.1 Inclusion criteria 
Those individuals from the general public and HCPs who completed the 
questionnaire declaring interest in participating in a focus group were included.  
 
6.2.2 Exclusion criteria 
Members of the general public not receiving prescription medication or not 
purchasing medication in the six months prior to completing the questionnaire 
were excluded.  
 
HCP students were not included in this phase of the research due to the low 
questionnaire response. 
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6.2.3 Sample size  
There are no specific guidelines on the optimal number of focus groups to be 
conducted (Bowling, 2009). Focus group studies can consist of anything from a 
few to over fifty groups (Kitzinger, 2006). As a general rule of thumb, three to 
five groups per project are considered acceptable (Morgan, 1997).  
 
Similarly, there is little evidence on the appropriate group size, with Kitzinger 
(2006) suggesting four to eight members whilst Bowling (2009) recommends 
that each group typically contains between six and twelve. Morgan (1997) states 
that as a general rule of thumb each focus group should have six to ten 
participants. However, Morgan (1997) also notes that consideration should be 
given to the criterion of saturation to determine whether members are reiterating 
what was said in earlier groups. Yzer (2012), using the integrative model of 
behavioural prediction, suggests a total sample size of about 30 participants to 
be adequate to produce an exhaustive list of prominent beliefs. Taking all of this 
into consideration, this phase planned to recruit five focus groups each 
containing six participants: three HCPs and two general public. To allow for 
refusals to participate, a 20% over-recruitment target was set. 
 
6.2.4 Sampling  
Morgan (1997) suggests that focus groups should be homogeneous, for example 
participants with similar occupations, social classes, educational levels and ages, 
to lessen the potential for some participants feeling inhibited and hence not 
expressing their views. The groups were therefore homogenous in terms of being 
separate for HCPs (dentists, doctors and pharmacists) and the public. 
Multiprofessional rather than uniprofessional focus groups were planned to 
enhance discussion, reflecting the multidisciplinary nature of patient care. Groups 
contained an equal number of males and females whenever possible. Purposive 
sampling was used to select participants. 
 
Participants for the public focus groups were systematically selected in two 
groups according to the following criteria: 
Group 1 – those who preferred to participate in the morning; age of 50 years and 
over (there were more in the ≥ 50 years who preferred morning); secondary 
education level or lower (in the ≥ 50 years group participants all happened to 
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have attended till primary or secondary school); gender (until five females and 
five males were reached). 
Group 2 – those who preferred to participate in the evening; age less than 50 
years (there were more amongst those less than 50 years who preferred 
evening); tertiary or higher level of education; gender (until five females and five 
males were reached). 
 
The list of potential participants was filtered according to the exclusion criteria 
described and then selected according to the sequence of response (who replied 
first was chosen first) aiming for a group of 10 participants.  
 
Participants for the HCP focus groups were systematically selected in three 
groups according to the following criteria: 
Group 1 - those who preferred afternoon; mixed aged group 
Group 2 - those who preferred evening; mixed aged group 
Group 3 - those who preferred evening; age less than 40 years 
 
The target was four doctors, four pharmacists and two dentists for each group 
(five females and five males). As none of the HCPs who specified morning were 
able to participate, the morning group was removed.  
 
6.2.5 Topic guide development 
A topic guide was developed to promote a consistent and systematic approach 
during the focus group discussions and to ensure that all study research 
questions were adequately covered. The focus group guide was based on: 
1. the questionnaire results 
2. the Theoretical Domains Framework (TDF) 
 
The topic guides for the HCP groups (Appendix 6.1) and the general public 
groups (Appendix 6.2) were very similar, with the public one also translated into 
Maltese. 
 
An opening ice breaker question allowed participants to introduce themselves, 
create a comfortable environment, while at the same time gathering 
demographic data. This was followed by discussions around medication wastage 
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and minimisation based on TDF domains of: knowledge, intentions, beliefs about 
capabilities, social/professional role and identity, skills, beliefs about 
consequences and social influences. The final section focused on beliefs of: 
reinforcement, environmental context and resources, emotion, optimism, 
behavioural regulation and goals. The guide was reviewed by members of the 
supervisory team to promote credibility. 
 
6.2.5.1 TDF 
Theories of behaviour and behaviour change should be the first step when 
designing interventions, to facilitate the understanding of causal determinants, to 
test the theory in question and to improve theory across different contexts, 
populations, and behaviours (Cane et al., 2012). Designing interventions solely 
on the basis of the researcher or participants’ perceptions rather than theory 
prevents the understanding of behaviour change processes that underlie effective 
interventions and of applying the findings to inform the design of future 
interventions (Cane et al., 2012).  
 
The TDF was developed by 18 psychological theorists together with 16 health 
service researchers and 30 health psychologists to simplify and integrate a 
number of behaviour change theories which can then be exploited by other 
disciplines. The group applied a six stage consensus approach which included the 
identifying of theories and theoretical constructs relevant to behaviour change; 
simplifying the resulting constructs into overarching theoretical domains; 
evaluating the importance of the theoretical domains; conducting an 
interdisciplinary evaluation and synthesis of these domains and constructs; 
validating the domain list; and piloting interview questions relevant to these 
constructs and domains. Thirty-three theories and 128 key theoretical constructs 
were recognised and a 12 TDF emerged which explains implementation problems 
and inform implementation interventions. Following this, the framework was 
refined to include 14 domains and 84 component constructs. The domains are 
(Cane et al., 2012):  
1. Knowledge: “An awareness of the existence of something” 
2. Skills: “An ability or proficiency acquired through practice”  
3. Social/Professional Role and Identity: “A coherent set of behaviours and 
displayed personal qualities of an individual in a social or work setting”  
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4. Beliefs about Capabilities: “Acceptance of the truth, reality, or validity about 
an ability, talent, or facility that a person can put to constructive use” 
5. Optimism: “The confidence that things will happen for the best or that desired 
goals will be attained” 
6. Beliefs about Consequences: “Acceptance of the truth, reality, or validity 
about outcomes of a behaviour in a given situation” 
7. Reinforcement: “Increasing the probability of a response by arranging a 
dependent relationship, or contingency, between the response and a given 
stimulus” 
8. Intentions: “A conscious decision to perform a behaviour or a resolve to act in 
a certain way” 
9. Goals: “Mental representations of outcomes or end states that an individual 
wants to achieve” 
10. Memory, Attention and Decision Processes: “The ability to retain information, 
focus selectively on aspects of the environment and choose between two or more 
alternatives”  
11. Environmental Context and Resources: “Any circumstance of a person's 
situation or environment that discourages or encourages the development of 
skills and abilities, independence, social competence, and adaptive behaviour” 
12. Social Influences: “Those interpersonal processes that can cause individuals 
to change their thoughts, feelings, or behaviours” 
13. Emotion: “A complex reaction pattern, involving experiential, behavioural, 
and physiological elements, by which the individual attempts to deal with a 
personally significant matter or event” 
14. Behavioural Regulation: “Anything aimed at managing or changing 
objectively observed or measured actions”. 
 
The advantages of the TDF lie within its comprehensive coverage of possible 
influences on behaviour, the clarity of each domain being specified by component 
constructs and the association between theories of behaviour change and 
techniques of behaviour change with the aid of the TDF to address 
implementation problems (Cane et al., 2012). The TDF has been used in several 
studies to explain implementation problems and inform implementation 
interventions, such as the interview guide constructed by Squires et al. (2013) 
which applied the TDF to obtain a better understanding of the barriers and 
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enablers to physician hand hygiene compliance; the TDF based semi structured 
interviews by Duncan et al. (2012) to investigate prescribing errors in the 
hospital context among a sample of trainee doctors; and the focus group study 
by Bussières et al. (2012) which used the TDF to identify chiropractors’ beliefs 
about managing uncomplicated back pain without X-rays and to explore barriers 
and facilitators to implementing evidence-based recommendations on lumbar 
spine x-rays. 
 
6.2.5.2 Pilot testing 
A pilot focus group process was carried out to familiarise the researcher with 
focus group processes (e.g. topic guide content, audio-recording), and identify 
any logistical issues and solutions. The pilot focus group was carried out amongst 
HCPs following the same recruitment process as per actual study. Feedback on 
the topic guide and the process of the focus group was obtained. As no changes 
to the topic guide were necessary, data were included in the analysis.  
 
6.2.6 Full study 
6.2.6.1 Study information 
An ‘invitation to participate letter’ (Appendix 6.3) was sent with each 
questionnaire (chapter 5). Individuals interested in participation were asked to 
complete and return an ‘expression of interest form’ (Appendix 6.4) indicating 
the most preferred time of the day to attend a focus group.  
 
6.2.6.2 Sampling and recruitment 
Of those expressing interest, potential participants were sampled as described in 
section 6.2.4. They were contacted by telephone by the principal researcher to 
confirm that they were still interested in participating. Those confirming 
participation were assigned to a group as described above.  
 
6.2.6.3 Focus group process 
The focus group process is depicted in Figure 6.1 and described in detail below. 
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Figure 6.1: Focus group discussion process [Adapted from Fern, 2001] 
 
6.2.6.4 Focus group setting 
Focus groups were carried out at three different times of the day, morning, 
afternoon and evening, to provide the most possible convenient time frames for 
participants. Groups were timed as follows: 
• public focus groups between 9am and 11am; and between 7pm and 9 pm 
• HCP focus groups between 3pm and 5pm; and between 7pm and 9pm (two 
groups) 
The focus groups lasted approximately 90 minutes and were conducted in a 
conference room of a centrally located hotel. 
  
6.2.6.5 Moderator involvement 
The funnel strategy (Morgan, 1997) of moderator involvement was applied, with 
minimal involvment from the outset to encourage free and open discussion, 
transitioning to a more structured discussion of specific issues. This approach 
allowed the researcher to obtain the participants' perspectives and setting their 
priorities (Kitzinger, 1994), as well as their responses to the researcher's specific 
interests.  
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6.2.6.6 Role of assistant moderator 
The assistant moderator complemented the moderator by taking notes of 
discussions, including non-verbal responses, eye contact, pauses in interactions, 
patterns of speech and turn-taking of discussion.  
 
6.2.6.7 Focus group discussion 
Participants were asked to complete a consent form (Appendix 6.5) on the day of 
the focus group. Each focus group was audiorecorded using two recorders, one 
as back up in case of system failure. Participants were allowed to speak in 
Maltese or English, whichever language they felt more comfortable with, to aid 
better expression of experiences, ideas and opinions. Focus group discussions 
were held in March 2014. 
 
6.2.7 Data handling and analysis 
Focus group recordings were transcribed verbatim and supplemented with non-
verbal material noted by the assistant moderator. Maltese statements were 
translated into English by the principal researcher. Analysis was carried out using 
the framework approach, with the coding frame developed independently by two 
researchers. 
  
6.2.7.1 Framework approach 
The guidelines by Smith and Firth (2011) and Spencer et al. (2014) were applied 
as follows:  
• Transcripts were read and reread to promote researcher immersion in the 
data.  
• Preliminary codes were identified through detailed consideration of each 
phrase, sentence and paragraph; each code was defined. 
• A coding matrix was developed in Microsoft® Excel 2010 using participants' 
own words ('in-vivo' codes) to stay 'true' to the data. The coding matrix 
contained a row for each respondent's statements and a column for a 
separate sub code. Data were assigned to the coding matrix.  
• The coding framework was constructed independently by the principal 
researcher and the principal supervisor promoting confirmability. 
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• Preliminary codes were refined; links between codes were identified until the 
'whole picture' emerged.  
• Similarity in statements was identified, amongst other methods, by the use 
of: word repetitions, keywords, indigenous typologies, similarities and 
differences, metaphors and analogies (Ryan and Bernard, 2003).  
• Codes were translated to final themes and subthemes. 
• Themes and sub-themes were mapped to the TDF domains. 
• A narrative of the themes and sub-themes was constructed, using 
participants’ quotes.  
• Interpretation of the themes and sub-themes was grounded in participants’ 
contributions, with supporting illustrative quotes. The most representative 
quotes were selected. Quotes for different participants’ arguments under the 
same theme were all included. Each quote was labelled by the participants’ 
demographics (Anderson, 2010). 
 
6.2.7.2 Focus group ‘utterances’ 
The number of utterances for each participant was counted and subsequently 
mapped to the specific domains within the TDF framework (Bussières et al., 
2012). For each utterance, this was counted as to whether the utterance related 
directly or indirectly to 'reduce wastage' or 'increase wastage'. ‘No influence’ was 
assigned if an utterance was: unrelated to the topic of discussion; did not 
affect medication wastage directly or indirectly; and/or the speaker felt that 
whatever was being discussed had no influence on wastage. An utterance is an 
indicative count of what participants discussed most and should not be confused 
with quantifying in quantitative research.  
 
6.2.8 Promoting quality in research: trustworthiness 
A number of measures were implemented to promote trustworthiness and thus 
study rigour: 
• The topic guide was developed from the published literature, the Delphi 
process and theoretical frameworks to promote credibility. 
• A pilot study was carried out to ensure rigour. 
• Although the study was limited in geographical location to Malta, a detailed 
decision trail, as suggested by Sandelowski (1986), was kept throughout all 
the focus group research to ensure dependability and transferability. 
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• Trustworthiness in interpreting the focus group data was promoted by 
presenting interpretations using participants’ own words and concepts as 
much as possible (Chioncel et al., 2003). 
 
A number of measures were taken to reduce bias and thus improve 
trustworthiness. 
• Potentially dominant or reluctant focus group participants were managed 
through effective moderation to prevent dominance/shyness bias. Rules of 
behaviour were established at the outset. 
• During focus groups, attention bias was minimised by following a topic guide. 
• Clear statements of the purpose of the research study were provided at the 
start of each focus group to reduce expectancy bias. 
• Focus group moderator facilitated rather than led the discussions to prevent 
interviewer bias. 
 
6.2.9 Research Governance 
The study was approved by the School of Pharmacy and Life Sciences Research 
Ethics Committee, Robert Gordon University (Appendix 6.6) and the University of 
Malta Research Ethics Committee (Appendix 6.7). The focus group study and 
cross-sectional survey study were submitted to the ethics committees in one 
application. The UK DPA (The National Archives, 1998), the Maltese DPA 
(Information and Data Protection Commissioner, 2001) as well as the EU Data 
Protection Directive (The European Parliament and the Council of the European 
Union, 1995) were adhered to at all times by the use of password protected 
databases accessible only by the principal researcher. Complete confidentiality 
can never be guaranteed in focus group discussions and hence care was taken to 
minimise risk to participants. Ground rules were set at the outset and 
participants were instructed and reminded several times that discussions should 
not be shared outwith the groups. Anonymity was considered in transcribing and 
reporting through the use of codes rather than divulging names and identities.
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6.3 Findings 
6.3.1 Participant demographics 
Eleven pharmacists, six doctors and six members of the general public, one of 
whom was a nurse, participated in the focus groups. 
 
6.3.2 Focus group ‘utterances’ 
Table 6.1 indicates the counts of utterances for each theoretical domain, as 
described in the analysis section. 
 
Table 6.1: The counts of utterances for each theoretical domain, combined for 
focus groups 
Theoretical domain Topic guide 
question 
number 
Utterances Reduce 
wastage 
Increase 
wastage 
No 
influence 
Knowledge Introductory 
question 
65 1 36 28 
Intentions Question 1 35 2 13 20 
Beliefs about capabilities 
and social and professional 
role and identity 
Questions 2 
and 3 
23 16 1 6 
Skills Question 4 32 7 14 11 
Beliefs about consequences Question 5 44 1 26 17 
Social influences Probe 49 0 36 13 
Reinforcement Probe 10 0 0 10 
Environmental context and 
resources 
Question 7 528 11 309 208 
Emotion Probe 38 1 15 22 
Optimism Question 8 6 4 2 0 
Behavioural regulation Questions 6 
and 9 
560 329 3 228 
Goals Question 10 
and ending 
question 
141 70 0 71 
Total   1,531 442 455 634 
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6.3.2.1 Focus group 1: HCPs 
Focus group duration was 94 minutes, with five participants (one doctor and four 
pharmacists) and work experience ranging from 1-24 years (Table 6.2). All 
engaged in the discussions, with one participant (P1) slightly more dominant, 
and a high level of agreement throughout. Table 6.3 shows the number of 
utterances for each domain and participants in this group. 
 
Table 6.2: Participant demographics for focus group 1 
Participant Age Sex Profession Years in 
profession 
Main role Other 
experience 
1 47 F Pharmacist 24 Hospital 
pharmacist 
  
2 23 M Pharmacist 1 Hospital 
pharmacist 
Community 
pharmacist 
3 31 M Pharmacist 8 Community 
pharmacist 
  
4 35 M Pharmacist 12 Hospital 
pharmacist 
Community 
pharmacist 
5 28 M Doctor 5 Hospital 
doctor 
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Table 6.3: Number of utterances for each domain and participants, focus group 1 
Theoretical domain Questions Utterances Reduce 
wastage 
Increase 
wastage 
No 
influence 
Participants 
      1 2 3 4 5 
Knowledge Introductory 
question 
6 1 3 2 1 1 1 0 3 
Intentions Question 1 0 0 0 0 0 0 0 0 0 
Beliefs about capabilities and social 
and professional role and identity 
Questions 2 and 3 9 5 0 4 1 3 3 1 1 
Skills Question 4 0 0 0 0 0 0 0 0 0 
Beliefs about consequences Question 5 7 1 2 4 0 0 3 0 4 
Social influences Probe 2 0 1 1 0 0 1 0 1 
Reinforcement Probe 0 0 0 0 0 0 0 0 0 
Environmental context and resources Question 7 96 0 48 48 24 24 20 11 17 
Emotion Probe 19 0 10 9 5 2 9 0 3 
Optimism Question 8 0 0 0 0 0 0 0 0 0 
Behavioural regulation Questions 6 and 9 94 50 1 43 27 14 8 26 19 
Goals Question 10 and 
ending question 
8 8 0 0 1 2 3 1 1 
Total   241 65 65 111 59 46 48 39 49 
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6.3.2.2 Focus group 2: HCPs 
Focus group duration was 92 minutes, with five participants (two doctors and 
three pharmacists) and work experience ranging from 4-20 years (Table 6.4). All 
engaged in the discussions, with two participants (P4 and P5) slightly more 
dominant, and a high level of agreement throughout. Table 6.5 shows the 
number of utterances for each domain and participant in this group. 
 
Table 6.4: Participant demographics for focus group 2 
Participant Age Sex Profession Years in 
profession 
Main role Other 
experience 
1 38 M Pharmacist 15 Hospital pharmacist Medical 
representative 
2 32 M Pharmacist 9 Responsible 
person/regulatory 
affairs pharmacist 
  
3 27 F Doctor 4 Hospital doctor   
4 28 F Pharmacist 5 Hospital pharmacist Community 
pharmacist 
5 43 F Doctor 20 Hospital doctor   
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Table 6.5: Number of utterances for each domain and participant in focus group 2 
Theoretical domain Questions Utterances Reduce 
wastage 
Increase 
wastage 
No 
influence 
Participants 
      1 2 3 4 5 
Knowledge Introductory 
question 
7 0 6 1 2 0 0 2 3 
Intentions Question 1 4 0 0 4 0 1 0 1 2 
Beliefs about capabilities and social 
and professional role and identity 
Questions 2 and 3 0 0 0 0 0 0 0 0 0 
Skills Question 4 5 3 2 0 1 0 0 2 2 
Beliefs about consequences Question 5 5 0 3 2 0 1 2 1 1 
Social influences Probe 20 0 18 2 2 2 5 7 4 
Reinforcement Probe 0 0 0 0 0 0 0 0 0 
Environmental context and resources Question 7 108 0 72 36 30 16 15 28 19 
Emotion Probe 0 0 0 0 0 0 0 0 0 
Optimism Question 8 1 0 1 0 0 0 0 0 1 
Behavioural regulation Questions 6 and 9 74 60 1 13 12 5 17 16 24 
Goals Question 10 and 
ending question 
4 4 0 0 1 1 0 1 1 
Total   228 67 103 58 48 26 39 58 57 
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6.3.2.3 Focus group 3: HCPs 
Focus group duration was 102 minutes, with seven participants (three doctors 
and four pharmacists) and work experience ranging from 3-17 years (Table 6.6). 
All engaged in the discussions, with one participant (P4) more dominant. 
Participant 7 joined after 20 minutes and participant 6 joined after 30 minutes 
following commencement of the focus group. A number of disagreements 
emerged during the course of this focus group. Since both participant 4 and 6 
are male hospital doctors with 4 years’ work experience, these are distinguished 
as hospital doctor ‘A’ (participant 4) and hospital doctor ‘B’ (participant 6) when 
quoting their utterances. Table 6.7 shows the number of utterances for each 
domain and participant in this group. 
 
Table 6.6: Participant demographics for focus group 3 
Participant Age Sex Profession Years in 
profession 
Main role Other 
experience 
1 35 M Pharmacist 12 Hospital 
pharmacist 
  
2 32 F Pharmacist 9 Hospital 
pharmacist 
Community 
pharmacist 
3 36 F Pharmacist 13 Hospital 
pharmacist 
Community 
pharmacist 
4 26 M Doctor 4 Hospital 
doctor 
  
5 38 F Doctor 17 Hospital 
doctor 
  
6 26 M Doctor 4 Hospital 
doctor 
  
7 26 F Pharmacist 3 Hospital 
pharmacist 
Community 
pharmacist 
 
 
 
  
Chapter 6: Focus groups         294 
 
Table 6.7: Number of utterances for each domain and participant in focus group 3 
Theoretical domain Questions Utterances Reduce 
wastage 
Increase 
wastage 
No 
influence 
Participants 
      1 2 3 4 5 6 7 
Knowledge Introductory  12 0 11 1 0 2 4 2 1 0 3 
Intentions Question 1 1 1 0 0 0 0 0 0 1 0 0 
Beliefs about capabilities and social 
and professional role and identity 
Questions 2 
and 3 
4 4 0 0 1 0 0 1 1 0 1 
Skills Question 4 9 4 0 5 0 0 3 1 2 2 1 
Beliefs about consequences Question 5 11 0 11 0 4 1 1 3 2 0 0 
Social influences Probe 19 0 13 6 1 5 4 2 0 3 4 
Reinforcement Probe 0 0 0 0 0 0 0 0 0 0 0 
Environmental context and resources Question 7 73 3 57 13 8 5 8 22 9 16 5 
Emotion Probe 13 0 3 10 3 2 3 2 2 0 1 
Optimism Question 8 4 3 1 0 0 1 2 0 0 1 0 
Behavioural regulation Questions 6 
and 9 
121 60 0 61 7 14 19 27 33 9 12 
Goals Question 10 
and ending 
question 
6 6 0 0 1 1 1 1 0 1 1 
Total   273 81 96 96 25 31 45 61 51 32 28 
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6.3.2.4 Focus group 4: Public 
Focus group duration was 100 minutes, with four participants (two males and 
two females) all under the age of 40 years, and with post-graduate qualifications 
(Table 6.8). All engaged in the discussions, with one participant (P3) more 
dominant, and a high level of agreement throughout. Table 6.9 shows the 
number of utterances for each domain and participant in this group. 
 
Table 6.8: Participant demographics for focus group 4 
Participant Age Gender Profession Level of education 
1 34 M PhD Nursing Postgraduate 
2 24 M Accountant Postgraduate 
3 36 F Director Postgraduate 
4 32 F Assistant 
director 
Postgraduate 
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Table 6.9: Number of utterances for each domain and participant in focus group 4 
Theoretical domain Questions Utterances Reduce 
wastage 
Increase 
wastage 
No 
influence 
Participants 
      1 2 3 4 
Knowledge Introductory 
question 
17 0 11 6 4 2 5 6 
Intentions Question 1 0 0 0 0 0 0 0 0 
Beliefs about capabilities and social and 
professional role and identity 
Questions 2 and 3 5 4 1 0 1 1 1 2 
Skills Question 4 14 0 12 2 6 2 4 2 
Beliefs about consequences Question 5 9 0 7 2 2 3 4 0 
Social influences Probe 3 0 3 0 0 1 1 1 
Reinforcement Probe 10 0 0 10 0 2 5 3 
Environmental context and resources Question 7 48 0 36 12 10 14 14 10 
Emotion Probe 0 0 0 0 0 0 0 0 
Optimism Question 8 0 0 0 0 0 0 0 0 
Behavioural regulation Questions 6 and 9 117 84 0 33 25 29 45 18 
Goals Question 10 and 
ending question 
4 4 0 0 1 1 1 1 
Total   227 92 70 65 49 55 80 43 
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6.3.2.5 Focus group 5: Public 
Focus group duration was 123 minutes, with two participants (two females) both 
over the age of 40 years, and with a secondary level of education or less (Table 
6.10). Both engaged in the discussions, with one participant (P1) more 
dominant, and a high level of agreement throughout. Table 6.11 shows the 
number of utterances for each domain and participant in this group. 
 
Table 6.10: Participant demographics for focus group 5 
Participant Age Gender Profession Level of education 
1 63 F Housewife Primary 
2 56 F Housewife Secondary 
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Table 6.11: Number of utterances for each domain and participant in focus group 5 
Theoretical domain Questions Utterances Reduce 
wastage 
Increase 
wastage 
No 
influence 
Participants 
      1 2 
Knowledge Introductory 
question 
23 0 5 18 17 6 
Intentions Question 1 30 1 13 16 15 15 
Beliefs about capabilities and social 
and professional role and identity 
Questions 2 and 3 5 3 0 2 2 3 
Skills Question 4 4 0 0 4 2 2 
Beliefs about consequences Question 5 12 0 3 9 7 5 
Social influences Probe 5 0 1 4 1 4 
Reinforcement Probe 0 0 0 0 0 0 
Environmental context and resources Question 7 203 8 96 99 116 87 
Emotion Probe 6 1 2 3 1 5 
Optimism Question 8 1 1 0 0 1 0 
Behavioural regulation Questions 6 and 9 154 75 1 78 85 69 
Goals Question 10 and 
ending question 
119 48 0 71 63 56 
Total   562 137 121 304 310 252 
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6.3.3 Key themes identified within TDF domains  
Key themes and sub-themes identified from the focus group data analysis were 
mapped to TDF domains as listed in Table 6.12. 
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Table 6.12: Key themes and sub-themes mapped to TDF domains 
Theoretical Domain Key themes (sub-themes) 
Knowledge 1. Knowledge of the consequences of medication wastage (economy, staff resources) 
Skills 1. Practitioner effects (ability) 
2. Suboptimal use of medication by patients (non-adherence) 
Beliefs about 
capabilities and their 
social/professional 
role and identity 
1. Overstocking of medication by HCPs 
2. Social influences (global force) 
3. Educational influences (HCPs as educators) 
4. System influences (failing system, time constraints) 
Optimism 1. Psychological influences (stress, obsessed, discouraged, optimistic) 
Beliefs about 
consequences 
1. Consequences of inappropriate prescribing/dispensing (financial, consequences of medication 
unavailability, unawareness of consequences of unused returned medication) 
Reinforcement 1. HCP incentive (uphill battle, professionalism) 
Intentions 
 
1. Sustainability of the current free healthcare system 
2. Medication unavailability (fear) 
3. Unclear goals within the Government health system 
Environmental 
context and 
resources 
1. Issues of resources and organization (lack of resources, lack of harmonisation) 
2. The free healthcare system (abuse of free healthcare system) 
3. Lack of review of doctors’ prescribing (lack of patient review, lack of patient information, multiple 
prescribers, lack of patient registration, lack of treatment management guidelines) 
4. Patient effects (selfish practices, confrontation, vulnerability) 
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5. Lack of education (social class) 
Social influences 
 
 
1. Pressure to prescribe or dispense (pressure by patients, pressure by work colleagues, pharmaceutical 
lobbying) 
2. Attitudes of HCPs (mentality, communication, power) 
Emotion 1. Psychological effects (fear) 
Behavioural 
regulation 
1. System effects (stock management, budgeting, independent body governing free healthcare system, 
pharmaceutical identity card, infrastructure, incentives, medication fee, reimbursement, compulsory 
private insurance, medication take-back scheme with cash card, high consumption medication, disease 
prevention) 
2. Practitioner effects (correct prescribing and accountability, medication use reviews (MURs), improved 
documentation, improved communication) 
3. Patients effects (increase patient reassurance, patient empowerment) 
4. Political effects (reduce political interference) 
5. Awareness and educational effects (increase awareness, strategies and settings to deliver education) 
Goals 1. Need for education (HCP and patient education) 
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6.3.3.1 Domain: Knowledge 
The theme which emerged in terms of knowledge regarding medication wastage 
was the knowledge of the consequences of medication wastage. 
 
1. Knowledge of the consequences of medication wastage 
Participants demonstrated knowledge of the wide ranging consequences of 
medication wastage, with particular emphasis on economy and staff time. One 
member of the public described the high cost of expired medication within 
Governmental entities and stores, 
 
"…1 ’cause there were cases where they opened out some warehouses, I don’t know 
where, in Madliena [stores]2, just kilometres away from the hospital, and there were 
tens of thousands of euro worth of expired medicine, and even at Boffa [hospital] if 
I recall well which is quite a laughing stock". 
(Male, accountant, 24 years, post-graduate qualifications) 
 
while another member of the public described the cost to an individual patient,  
 
"First of all if he’s buying it [the medication] privately, it’s an expense for him, 
himself, secondly it’s a complete waste of resources". 
(Female, Director, 36 years, post-graduate qualifications) 
 
Cost was also described by HCPs,  
 
"So sometimes you end up having to discard treatment that could be quite 
expensive that had been ordered on a named-patient basis". 
 (Female, hospital doctor, 17 years in profession) 
 
along with the consequences in terms of staff resources dealing with expired 
medication,  
                                                 
1 “… “ at the start of a quotation indicates that the participant interrupted another participant and started speaking. 
2 [] indicate words that were not articulated by the participant but have been included by the researcher for clarity. 
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"Human resources wasted to do that process [boarding out of expired medications 
for disposal]. Waste of time which could be invested in maybe more useful 
processes". 
(Female, hospital pharmacist, part-time-community pharmacist, 13 years in profession) 
 
6.3.3.2 Domain: Skills  
Two themes emerged in terms of HCP and patient skills to reduce medication 
wastage.  
 
1. Practitioner effects 
When discussing issues relating to prescribing or dispensing, participants described 
a number of practitioner effects, notably pharmacists’ skills to reduce medication 
wastage,  
 
"So even pharmacists are at a point that they can reduce this wastage. They can do 
it". 
(Female, hospital pharmacist, part-time-community pharmacist, 5 years in profession) 
 
One of the doctors highlighted the need to be aware of limitations and refer to 
others to optimise medication use, 
 
"I think it is then where they should refer to a specialist, if they go outside the 
guidelines. Anyone can adhere to guidelines and then when the guidelines aren’t 
simple enough, you need expert advice, you refer to expert advice". 
(Male, hospital doctor B, 4 years in profession) 
 
2. Suboptimal use of medication by patients 
Several issues were perceived as influencing the skills of patients which could 
impact medication wastage. Non-adherence leading to wastage was attributed to 
issues such as poor education amongst certain patients, 
  
"Yes because their education is low, so they won’t take their medication properly". 
(Female, hospital pharmacist, 24 years in profession) 
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lack of information, 
 
"They just stop it, they don’t care and I think lack of information is huge in Malta 
regarding everything, but regarding medication and their health it’s incredible". 
(Male, Nurse, 34 years, post-graduate qualifications) 
 
adverse effects, 
 
"Yes but you can have situations where they stop the medicines and then they will 
remain extra in their ...3 and even if you have a new patient, all right, a patient 
getting new medicines, this we didn’t mention. I think patients get side effects from 
medicines and they decide to stop them because of side effects in the initial period". 
(Female, hospital pharmacist, 24 years in profession) 
 
improvement in patient’s condition, 
 
"... but I think one other reason maybe people stop before they should stop, maybe 
they start feeling better and they start thinking ‘ok, I’m better now so I don’t need 
to take the rest’ ”. 
(Female, Assistant Director, 32 years, post-graduate qualifications) 
 
and issues of personality, intellect and previous experiences, 
 
"Very individual I think. There’s varying factors depending on their level of IQ, their 
personality, their willingness to listen to a medical health professional, their 
previous experience with people". 
(Female, Director, 36 years, post-graduate qualifications) 
 
 
 
                                                 
3 “… “ as part of a quotation indicates that in the original focus group transcript, the citations divided by the “ …” 
were separated by other words not recounted in this quotation. 
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6.3.3.3 Domains: Beliefs about capabilities and their social/professional role and 
identity 
Several themes were apparent in term of beliefs of capabilities to reduce medication 
wastage, from the perspectives of the patients, HCPs and organizations. 
 
1. Overstocking of medication by HCPs 
A nurse participating in the public focus group highlighted the fact that HCPs have a 
tendency to stockpile medication and therefore was sceptical of his own ability to 
reduce wastage, 
 
"I would like to say that I’m confident to make wastage less. But I‘m a HCP, so I 
tend to hoard some medication for myself but individually I will try definitely but as 
a HCP, every HCP that I know, they tend to stockpile some medication. I don’t know 
why, maybe because we see a lot of things, maybe we see a lot of out of stock, but 
everyone has in my opinion, as a HCP, something at home, stock pile somewhere. I 
don’t know why". 
(Male, Nurse, 34 years, post-graduate qualifications) 
 
2. Social influences 
Some participants felt that their individual ability and effort to reduce medication 
wastage was not sufficient and required joint and co-ordinated effort by all, 
 
"But to reduce wastage, overall wastage, my part is not enough. It has to be done 
as a whole team, a global force. So everyone has to contribute to the same effect". 
(Male, hospital pharmacist, part-time-community pharmacist, 12 years in profession) 
 
3. Educational influences 
HCPs described confidence to educate others, 
 
"If I feel confident, I feel confident in addressing areas where I can affect sort of, 
areas where I can make a difference: patient education and maybe prescribing". 
(Male, hospital doctor, 5 years in profession) 
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A community pharmacist described asthma management educational sessions, 
 
"For example education. For example people were taking the salbutamol without 
taking the preventer. Now I am educating them to take the preventer. Maybe it’s 
more costly. So I educate people a lot". 
(Male, community pharmacist, 8 years in profession) 
 
4. System influences 
When discussing capabilities, one of the doctors felt that his efforts in promoting 
appropriate prescribing and medication use were nullified by the failing system, 
 
“Personally, most of the time I try to reduce medication, especially of patients I 
know. The problem I find is the next time they come back they’d still be on that 
medication because other doctor would have prescribed it back or they would have 
an out-patients’ appointment and be back on it as if nothing changed”. 
(Male, hospital doctor A, 4 years in profession)  
 
One of the hospital doctors noted time constraints which sometimes hindered efforts 
to reduce medication wastage, 
 
"Because what we can, we as prescribers, we accepted and we do prescribe 
randomly and like Speaker 2 said, as we are busy. And I see the previous one, one 
year ago, and I continue the same [medication] ‘cause I don’t have the time to 
review the patient". 
(Female, hospital doctor, 20 years in profession) 
 
6.3.3.4 Domain: Optimism 
There were various psychological influences which appeared to impact optimism 
around efforts to reduce medication wastage. 
 
1. Psychological influences 
Participants ranged from those stressed, obsessed, discouraged and optimistic, 
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"I mean the prescriber, the doctor, the physician, they are too much stressed". 
(Female, hospital doctor, 20 years in profession) 
 
"Where I work we are a bit obsessed with not wasting, not wasting chemotherapy 
because we suffer the impact of drug shortages a lot". 
(Female, hospital pharmacist, part-time community pharmacist, 9 years in practice) 
 
"But I think sometimes I do get discouraged like most of us do probably when you 
work in a system where you see it failing a lot of times, you get discouraged". 
(Female, hospital pharmacist, part-time-community pharmacist, 13 years in profession) 
 
"Perhaps I am a bit optimistic but I believe that yes I try to go through medication 
wastage". 
(Male, hospital doctor B, 4 years in profession) 
 
6.3.3.5 Domain: Beliefs about consequences 
The theme related to the consequences of inappropriate prescribing and dispensing 
impacting medication wastage. 
 
1. Consequences of inappropriate prescribing/dispensing  
The financial consequences of pharmacy overstocking medication was highlighted by 
a member of the public, 
 
"No I won’t say it would be waste but then again striking a balance between 
maintaining a business, ‘cause at the end of the day, pharmacies are, it’s a 
business. So they must be sustainable, they’re financed through a cycle so 
maintaining a balance between financial and education, I think is a very difficult 
task and I don’t think it can be achieved". 
(Male, accountant, 24 years, post-graduate qualifications) 
 
One of the hospital doctors, who also practised as a GP, felt that the beliefs of 
consequences of medication unavailability impacted decision making. Prescribing 
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patients medication at double the actual doses resulted in higher dispensed 
amounts thus ensuring that patients always had adequate supplies, 
 
"I feel that if I really know my patients, ok, and I know that she is really dependent 
on that medication, I mean sometimes I wrote double the dose yes". 
(Male, hospital doctor A, 4 years in profession) 
 
A hospital doctor noted that patients were generally unaware of the consequences 
of unused returned medication, believing that these could be recycled,  
 
"If they have surplus stocks of medication at home, and then they stop taking them 
because they don’t need them anymore, they think that you can just bring them 
back to hospital and that medication can be distributed to another patient". 
(Female, hospital doctor, 17 years in profession) 
 
6.3.3.6 Domain: Reinforcement 
The lack of incentives to reduce medication wastage was noted by participants. 
  
1. HCP incentive 
While a pharmacist described that the lack of any incentive to reduce wastage 
resulted to be “an uphill battle”,  
 
"When it comes to HCPs, in order to be incentivized in reducing wastage, I think 
then again it’s quite an uphill battle". 
(Female, hospital pharmacist, part-time community pharmacist, 9 years in practice) 
 
one of the doctors suggested that professionalism should be the key incentive and 
hence should be continually reinforced, 
  
"But doctors took an oath to look after their patient, and part of that should be, in 
my opinion, looking after the general consensuses, to help become you know, 
doctors I’d like to think, because they have this sense of helping society, that’s 
maybe my being idealistic. And even a nurse, you go into it ‘cause it’s more partly 
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vocational, you love what you do. Yes you need a salary, but you do it ‘cause it’s 
something that you enjoy". 
(Female, hospital doctor, 17 years in profession) 
 
6.3.3.7 Domain: Intentions 
The three themes which emerged in terms of impacting intentions of reducing 
medication wastage were sustainability of the healthcare system, medication 
unavailability and unclear goals. 
 
1. Sustainability of the current free healthcare system 
The need to reduce medication wastage to ensure sustainability of the current free 
healthcare system was highlighted by a hospital pharmacist, 
 
"Because it is not sustainable any more. And I think we can see it because many 
medications are out-of-stock and this reflects that the system is not sustainable". 
(Female, hospital pharmacist, part-time-community pharmacist, 5 years in profession) 
 
2. Medication unavailability 
Participants described the patients’ fear of unavailability of medication as a major 
obstacle to their desire to reduce wastage. As noted by one hospital pharmacist,  
 
"It [unavailability of medication] is a problem, a major one". 
(Female, hospital pharmacist, part-time-community pharmacist, 5 years in profession) 
 
In fact one of the pharmacists pointed out that patients explicitly expressed   
concerns about medication shortages, 
 
"We see it, I mean quite frequently, people you know, they just tell us outright 
‘because I don’t really need this medication, I have at home you know. But will it be 
available the next time I collect my medicines?’ I mean we’ve all heard this I think, 
those of us who were at the dispensing window basically".  
(Male, hospital pharmacist, 12 years in profession) 
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and one member of the public considered overstocking to be justified in the context 
of medication being unavailable,  
 
"The problem I used to see is the huge amounts patients collect. That yes, I became 
aware of it long time ago. And I have come across people; especially the elderly 
who pass away and you find full drawers packed with medicines. But then I started 
to notice that people take a lot and hoard, then I started thinking that they are right 
so that if there aren’t any I will have". 
(Female, housewife, 63 years, primary level of education) 
 
There were instances where fear of unavailability had led to medication sharing,  
 
"I know a family that even certain types of blood pressure pills, for example, let's 
say the mother and son take the same medicine. So when any of them runs short, 
one assists the other ‘Give me some of yours, I will give you when I get mine’ ”. 
(Female, housewife, 56 years, secondary level of education) 
 
and one pharmacist who encouraged overstocking,  
 
"... in a period when there is no doubt of stocks, people are really nice. They tell 
you ‘Look I don’t need it’. But when they see rainy days they say ‘Why should I give 
it to him?’ Sometimes I tell them ‘Listen it’s a bit shaky right now, it’s better if you 
keep it because next 2 months I don’t think I might have’. So I mean I do it myself. 
They tell me ‘Don’t give me this time’. I tell her ‘Look I don’t have’ ".  
(Male, community pharmacist, 8 years in profession) 
 
3. Unclear goals within the Government health system 
Unclear goals within the Government health system were seen to be critical in 
improving intentions to reduce medication wastage, 
 
"It’s, I see a difference between, as a part-time I go to a private hospital, there’s a 
huge difference between a private hospital mentality to a Government hospital 
mentality. Everything is accountable in a private hospital; everyone is working to a 
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goal. Whereas Government, there is not a clear goal. So if there is something, an 
independent body that gives goals, that gives, especially in this medicines wastage, 
and how strategies how to go around it and how to target this wastage, it would be 
much better". 
(Male, Nurse, 34 years, post-graduate qualifications) 
 
6.3.3.8 Domain: Environmental context and resources 
While several of these sub-themes also aligned to other TDF domains, several 
aligned to only this theme.  
 
1. Issues of resources and organization 
The lack of adequate resources, notably an integrated computerised system was 
strongly emphasised,  
 
"That is what we’re saying; the IT system is so bad that you cannot give the 
forecast [of medication requirements]". 
(Male, community pharmacist, 8 years in profession) 
 
The lack of harmony between computerised systems of different Governmental 
pharmacy institutions was also critical,  
 
"Because sometimes I know what my stock position is but I don’t know, there is no 
clear IT system between all the healthcare, so I don’t know what Boffa [a 
governmental oncology and dermatology hospital] hoards, I have to ask. Where I 
work there is no critical level, there is no threshold, and the system does not 
advise, boom, you have to order". 
(Male, hospital pharmacist, part-time-community pharmacist, 1 year in profession) 
 
2. The free healthcare system 
The free healthcare system, particularly free medication was perceived to have a 
negative effect on behaviour, as described for psychiatric patients and patients in 
general,  
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"But having said that, I am also aware that between psychiatric patients there is 
kind of a black market when it comes to pills. So if I get them for free because, I 
don’t know, if I get them for free and I know someone who needs them, they sell 
them between themselves". 
(Female, Assistant Director, 32 years, post-graduate qualifications) 
 
"One other way of abusing entitlement, when people come with their own pink 
cards, and if they have children they ask for the medicines to be written on their 
card so that they can get them for free, for example. So they’re using, the one 
person in the family who has a card, that card is used for everyone else". 
(Female, hospital doctor, 4 years in profession) 
 
One hospital pharmacist remarked that patients perceived free medication to be 
comparable to their wage or pension, 
 
"I think a lot of people have the mentality, and this is a core issue I think, they have 
the mentality that once they are entitled to their free medicines, it’s like they are 
entitled to their pension and they have to get it every month. And if something is 
missing or they get it late they want it back dated. Do you understand? So it’s this 
sort of thing. They don’t see it as their treatment. It’s their entitlement, number of 
pills, that’s it, it’s like they’re getting their wage. So that amounts to wastage. They 
go to the doctor every time and request whatever they need without being 
reviewed". 
(Male, hospital pharmacist, part-time-community pharmacist, 12 years in profession) 
 
3. Lack of review of doctors’ prescribing 
Participants cited the issue of the lack of patient reviews, 
 
"... patients are not being reviewed. They keep getting the repeat prescription 
because they have seen a doctor years ago and they keep getting the same thing 
for ages". 
(Male, hospital pharmacist, part-time-community pharmacist, 12 years in profession) 
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Lack of consultant review was also discussed, 
 
"Most of the patients are not seen by the consultant. They’re seen by the junior 
doctors who are not able to change the medication. Sometimes you just continue 
the same because you’d see that there are, it’s stable ok, but there could be 
something, say the guidelines, it could be something you need to change and you 
don’t know what’s going on and the consultant is aware. But he doesn’t see 
everyone". 
(Female, hospital doctor, 20 years in profession) 
 
The lack of review was thought to be due to several factors including lack of patient 
information,  
 
"But the problem is that if the pharmacist doesn’t do any review is because of lack 
of information". 
(Female, hospital pharmacist, 24 years in profession) 
 
multiple doctors prescribing medication for the same patient, 
 
"And sometimes you’ll find patients shopping around where they would go first to 
their GP, then to another GP for prescriptions". 
(Male, hospital doctor A, 4 years in profession) 
 
lack of patient registration, 
 
"... but I agree with all of you. But I think the biggest problem in Malta is we have 
no GP registration. A patient can go to a GP, prescribe, ask for a medicine, the GP 
can refuse, go to another GP and he can prescribe it. And he can go to another GP 
and prescribe another medication". 
(Male, Nurse, 34 years, post-graduate qualifications) 
 
and an absence of treatment management guidelines, 
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"And we don’t have first line, second line, third line". 
(Female, hospital pharmacist, part-time-community pharmacist, 13 years in profession) 
 
4. Patient effects 
Participants perceived patients to have selfish practices,  
 
"So I am taking this sort of from the Government even if I throw it down the bin. 
There are some people who reason with this mentality". 
(Male, Responsible Person/Regulatory Affairs Pharmacist, 9 years in profession) 
 
One of the pharmacists, however, felt that a possible explanation for these selfish 
practices was past negative experiences,  
 
"I think that this problem is that big because patients are sometimes very selfish. 
So they become very selfish and very possessive of their medications. But maybe 
they are that way through experience, through negative experience". 
(Female, hospital pharmacist, part-time-community pharmacist, 13 years in profession) 
 
with one of the public describing the need for confrontation with pharmacists to get 
the medication that one needs, 
 
"... yes most of the times, people have to shout and fight with them [pharmacists] 
sometimes. Like certain people".  
(Female, housewife, 63 years, primary level of education) 
 
One of the members of the public explained that sick patients would be miserable 
and vulnerable, 
 
"Let’s not forget that this woman would be miserable ... because a person is 
vulnerable". 
(Female, housewife, 56 years, secondary level of education) 
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5. Lack of education 
In addition to the influence of lack of education to support medication adherence, 
this lack was also noted to more generally impact behaviour leading to wastage. 
This was thought to be a particular issue amongst those of a low socio-economic 
class, as highlighted by one of the pharmacists, 
 
"Those who are in low social class are always the ones who suffer from whatever 
entitlement system there is. And because they are the ones who get, don’t get 
access to medicine because of their intellectuality, because obviously also their 
education, all right, their level of education, it plays an important role. Yes because 
their education is low, so they won’t take their medication properly". 
(Female, hospital pharmacist, 24 years in profession) 
 
6.3.3.9 Domain: Social influences 
Two themes emerged in terms of social influences regarding medication wastage, 
the pressure to prescribe and dispense, and HCP attitudes. 
 
1. Pressure to prescribe or dispense 
There was much discussion on social influences, particularly the pressure by 
patients on doctors to prescribe,  
 
"At out-patient clinics, especially at free healthcare centres, doctors, from junior 
doctors to consultants, they are harassed to give [prescribe to] patients free 
medication". 
(Male, hospital doctor B, 4 years in profession) 
 
and on pharmacists to dispense, 
 
"It happens also between the patient and the community pharmacist because they 
sometimes put pressure on the community pharmacist to dispense medication". 
(Female, hospital pharmacist, part-time-community pharmacist, 5 years in profession) 
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These pressures were felt to be compounded by Malta being a small country,  
 
"So we have the pressure from the patients, ‘cause it’s a small country and you 
know each other and they want to be nice with patients". 
(Female, hospital doctor, 20 years in profession) 
 
This was also reiterated by a member of the public, 
 
"The problem in Malta, I think, is that people develop very close relationships with 
their family doctors as well. Often you choose your family doctor based on the fact 
that it was your father’s family doctor or something similar. So there is a very 
strong bond. And I do feel that sometimes perhaps doctors do feel that pressure 
sort of to acquiesce and help out the patient". 
(Female, Director, 36 years, post-graduate qualifications) 
 
Pressure from work colleagues to prescribe for their relatives was discussed, 
 
"Pressures will not always be from patients, it might be from staff. And then you are 
put in a more uncomfortable situation. For example they ask you to write for their 
relatives and you don’t know their relatives. And to say no to a staff ...4" 
(Female, hospital doctor, 4 years in profession) 
 
Pressure from the pharmaceutical industry was also mentioned by one of the 
members of the public, 
 
"So easily the pharmaceutical lobbying will pressure out the doctors to dish out 
certain amounts of drugs, or particular drugs, through the pharmacist". 
(Male, accountant, 24 years, post-graduate qualifications) 
 
 
 
                                                 
4 “… “ at the end of a quotation indicates that the participant has been interrupted by another participant at that 
point of the conversation. 
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2. Attitudes of HCPs 
HCPs’ attitudes were felt to regulate their behaviours, as described by a member of 
the public, 
 
"There is a category of professionals within the medical field that I think; yes 
they’ve got this mentality. It’s either old-school mentality that the doctor just 
prescribes anything and even the pharmacies just dish out pills for the sake of ..." 
(Male, accountant, 24 years, post-graduate qualifications) 
 
As noted earlier, poor communication at all levels impacted wastage and it was 
emphasised that this poor communication affected practice leading to wastage,  
 
"The patient basically there is lack of communication with the patient, all right, 
possibly by the consultant or between the consultant and his GP, and the patient 
ends up for example then taking more than, taking the medicine because he does 
not want to say “I do not need that medicine” for example". 
(Female, hospital pharmacist, 24 years in profession) 
 
The position of ‘power’, mainly relating to consultants, affected behaviour of HCPs 
and patients, 
 
"But I think what has happened as well locally is that instead of the NHS setting its 
own rules and then implementing it across the board, the NHS asks for consultants 
opinion, and then they adapt the formulary according to what the consultant have 
said. So as Speaker 1 said, I think consultants still have a lot of power". 
(Female, hospital pharmacist, part-time-community pharmacist, 13 years in profession) 
  
6.3.3.10 Domain: Emotion 
Different aspects of fear emerged within this domain from the perspectives of 
patients and HCPs.  
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1. Psychological effects 
Participants spoke about patients’ fear surrounding their entitlement to free 
medication if they do not collect these regularly, so they end up overstocking 
unnecessary medication,  
 
"Sometimes they think that if they don’t actually pick up their usual medication, if 
they are entitled to 6 medication and they collect just 3, they won’t be entitled".  
(Male, hospital pharmacist, 12 years in profession) 
 
On the other hand one of the community pharmacists stated that pharmacists 
experience fear that they will remain with unused stock which is not sold and thus 
wasted, 
 
"But then the pharmacists have some fear that if we open the box, the agent. Now 
again it’s stocking, we cannot give packs. The problem is there. So we are tempted 
to sell it just not to lose the money".  
(Male, community pharmacist, 8 years in profession) 
 
One of the hospital doctors emphasised on the importance of eliminating the fear of 
medication unavailability by changing the patients’ perspective which in turn will 
have an influence on the HCPs and policy makers’ perspectives. 
 
"I think that ultimately what we need to change is the patients’ perspective. 
Because if you change that perspective, obviously you’d change the doctors’ 
perspective, the policy makers’ perspectives. And by doing so, in the sense both 
media, both by increasing their confidence in the delivery system, in the sense 
reducing these out-of-stock." 
(Male, hospital doctor, 5 years in profession) 
 
6.3.3.11 Domain: Behavioural regulation 
Behavioural regulation was articulated throughout the discussions of both HCPs and 
members of the public. The themes within this section were discussed in the context 
of reducing medication wastage. 
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1. System effects 
Numerous solutions to medication wastage, particularly in relation to the healthcare 
system in Malta, were discussed. HCPs and the public described the importance of 
stock management and forecasting of medication requirements,  
 
"Even for example between entities [different Government hospitals] they should 
make clear their stock positions". 
(Male, hospital pharmacist, part-time-community pharmacist, 1 year in profession) 
 
"But I’m not suggesting not maintaining any stock level at Mater Dei. What I’m 
suggesting is, if we can stock let’s say 100 which will last us for 3 months, I’m just 
inventing, if that level will last us 3 months, what’s the need for the Government to 
stock pile for 6? And then that will put the risk on the supplier, and it is the 
supplier’s responsibility to maintain the stock in an adequate environment". 
(Male, accountant, 24 years, post-graduate qualifications) 
 
"Sure. So we need to have a simple system which is continuously updated by the 
HCPs and even GPs who are seeing trends coming, at the general practice and even 
at hospital, and this system is being updated by the doctors and even by 
professionals who are reading papers about upcoming medicines that are going to 
be launched on the market. It can, let’s say, if a new drug is being developed but I 
don’t know, and that drug can help in substituting another drug and through that 
drug it’s going to end in less consumption, the Government can shift trends". 
(Male, accountant, 24 years, post-graduate qualifications) 
 
Focusing attention around highly prevalent medical conditions and hence budgeting 
was suggested,  
 
"Exactly, I mean we are talking about every day condition. We are talking about 
cardiovascular; it’s a huge chunk of our budget, cardiovascular medications and 
diabetes. I think if we are more selective in the medications we use in those two 
groups; the cost savings will be quite significant". 
(Female, hospital pharmacist, part-time-community pharmacist, 13 years in profession) 
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One member of the public proposed establishing an independent body to finance 
healthcare, which would be subject to audit, and which would in turn be financed by 
the Government,  
 
"I would say that, would make the healthcare financed through some external body 
which is privately run and independent from the Government, so I would say that if 
I need a healthcare service, I need to get prescribed drugs from the state hospital, I 
would go and get it and I would need to present some sort of receipt to an 
independent insurance company. And then this insurance company is financed by 
the Government. So at the end of the day there is an independent body in between 
the patient and the Government ... no then again it must go down to ethics, but 
given that you’re segregating power from the Government and giving it to an 
independent body, this independent body is going to be audited so on and so forth, 
I think". 
(Male, accountant, 24 years, post-graduate qualifications) 
 
Another member of the public suggested the introduction of a patient specific 
pharmaceutical identity card containing all medication history for both privately 
purchased medication and those obtained for free to prevent redispensing, 
 
"I thought if they had an ID card, sort of pharmaceutical ID with, you know, you’ve 
got your history, what you’ve been prescribed, on a chip. Something like our ID 
card where the patient carries it around you know, and get plugged in ... yes, so 
that you can see what they’ve been prescribed previously as well and even for 
repeat prescription abuse or over, you know people, over, stock piling. Because you 
can see, look, they just came in and had this". 
(Female, Director, 36 years, post-graduate qualifications) 
 
A number discussed the importance of a good infrastructure, 
 
"A computerised system would solve the thing. The same thing is with stocks, 
‘cause for example if you have 10% left you rebuy. So really and truly the 
centralised IT system should be from the Government’s point, by who buys the 
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medicine and all the outlying pharmacies. So I think they should have the same or a 
connected IT system. Now from where they buy etc., that’s up to them". 
(Male, hospital doctor, 5 years in profession) 
 
with one participant adding the importance of a centralised patient medication 
record,  
 
"One thing I was going to mention is that in the community there should be an IT 
system where you, where if I go to a doctor and maybe next month I don’t find my 
own doctor, and I have to go to another doctor, then there should be a record. My 
information, my medication record should be recorded yes". 
(Female, hospital pharmacist, part-time-community pharmacist, 5 years in profession) 
 
Incentives for HCP to reduce wastage were suggested, 
 
"If not, there should be steps that are taken where if they don’t want to take that 
responsibility, there is no incentive, they need to be incentivised somehow". 
(Female, Director, 36 years, post-graduate qualifications) 
 
There was much discussion around patients paying for medication, with one 
pharmacist suggested implementing a payment system similar to electricity 
supplies,  
 
"People who can’t afford buying the medicines or paying prescription fees, we 
already have a system in place. Everybody pays the electricity. Some people do not 
afford to pay the electricity bills and they get the voucher system. So same thing 
can be implemented". 
(Male, hospital pharmacist, part-time medical representative, 15 years in profession) 
 
Some recommended a system of those patients eligible for free medication, initially 
paying, then being reimbursed and that this could reduce system abuse and hence 
wastage, 
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"Because let me tell you, ‘cause there is a system that if it happens in Malta, do you 
know why they do not have any extra, I do not know why it was never implemented 
in Malta, abroad first you buy the medicines, at the end of the year you have all the 
receipts, that is what they do abroad, and you would sort the whole problem. It’s 
true not everyone could afford these medicines but that is what they do".  
(Female, housewife, 63 years, primary level of education) 
 
One of the hospital doctors proposed a compulsory private insurance as a means of 
regulating the free healthcare system,  
 
"I think you have to, probably it has to be included in policy. When you start 
working, you should pay, you should choose your own private insurance and you 
should pay the insurance scheme. You know there are so many private insurances". 
(Female, hospital doctor, 20 years in profession) 
 
One of the pharmacists was not in total agreement with the introduction of a 
compulsory private insurance if people still have to pay the full National Insurance,  
 
"But would the young people, if I am understanding well this argument, the younger 
people would be made, forced to pay for a national insurance sort of, a national 
insurance to cover their medicines and all health. But would the young people be 
charged less because nowadays everyone pays national insurance who works. And a 
part of it goes to the [health system] ..." 
(Male, Responsible Person/Regulatory Affairs Pharmacist, 9 years in profession) 
 
Following this disagreement the hospital doctor suggested that the use of half of the 
National Insurance money should go to a private insurance company who will be 
responsible for paying health related bills, 
 
"Or maybe the Government I don’t know, when you pay National insurance, maybe 
the Government half of it has to give it to a private insurance and the private 
insurance will be responsible for the use of it. Something similar I think".  
(Female, hospital doctor, 20 years in profession) 
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Other participants felt that having a medication take back scheme, whereby unused 
medication can be returned to pharmacies, was another possibility to regulate the 
free healthcare system,  
 
"By having a take back scheme". 
(Male, hospital doctor A, 4 years in profession) 
 
One of the hospital pharmacists suggested the implementation of a cash card as an 
incentive to return unused medication to pharmacies,  
 
"I think a different mechanism would work; they’ll give you a cash card for 
returning your medication. If we could test those medications and reuse them that 
would make sense but if we cannot". 
(Female, hospital pharmacist, part-time-community pharmacist, 13 years in profession) 
 
A hospital pharmacist mentioned the need to regulate use of high consumption, low 
cost medication which could result in a higher total cost compared to low 
consumption, high cost medication, 
 
"When you mention high cost medication, we tend to go see one tablet, how much 
that costs. But really when you have high consumption items their cost might 
actually be higher than the high cost". 
(Male, hospital pharmacist, 12 years in profession) 
 
The aim of disease prevention with resultant decrease in the need for medication 
was discussed. The employment of more nutritionists in hospitals was suggested,  
 
"Because this is like a chain, ‘cause if I am eating for my health, I will not get high 
cholesterol. Sometimes it could be age related; I inherited the genes from my 
family. Even the Government would save a lot of money". 
(Female, housewife, 56 years, secondary level of education) 
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Others suggested the employment of psychologists in schools, leading to reduced 
need for medication, thus indirectly reducing wastage, 
 
"I am in favour as well with the introduction in schools, maybe this is related or not, 
that we have psychologists for children so that from a young age, there are 
counsellors at the moment, I know that in a lot of schools there is a counsellor. But 
when the counsellor doesn’t manage, if we have a psychologist. Because at the end 
of the day, this poor boy or girl, if he gets ill he will end up using medicines at a 
young age, tender, from a young age". 
(Female, housewife, 56 years, secondary level of education) 
 
2. Practitioner effects 
Several noted the need to engender a culture of accountability in HCPs, particularly 
in relation to prescribing,  
 
"I think that correct prescribing in that case would be of paramount importance to 
do, because procurement will be linked directly to this". 
 (Male, hospital pharmacist, 12 years in profession) 
 
"... so if we are going to invest in an IT system and we are not going to make 
anybody accountable for the cost, we are just going to spend money on an IT 
system". 
(Female, hospital pharmacist, part-time community pharmacist, 9 years in practice) 
 
MURs were discussed as a potential for HCPs and patients to optimise medication 
and reduce wastage, 
 
"In the UK patients are even reviewed by the pharmacist, the MURs. And that has 
reduced a great deal of costs for the NHS. Reviews are then every year for 
example". 
(Male, hospital pharmacist, part-time-community pharmacist, 12 years in profession) 
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Others suggested involving different HCPs, 
 
"Or they should have a consultant review, yearly consultant review for chronic 
conditions". 
(Female, hospital doctor, 20 years in profession) 
 
"I think a GP can do the work [MURs] effectively". 
(Female, hospital doctor, 4 years in profession) 
 
A standardised patient review template was suggested, which would be mandatory 
and updated regularly following patient assessment prior to prescribing, 
 
"What if they have to like you said a reassessment? So together with the 
prescription, every 6 months they have to show something given to the, by the 
doctor, of what the examination found. Maybe the blood pressure, the treatment 
they are on. Maybe every 6 months something is filled in as proof that the patient 
was examined. It’s an idea". 
(Female, hospital doctor, 4 years in profession) 
 
The nurse within the public focus group discussed prescribing guidelines, 
 
"More guidelines. Guidelines, if for example a patient is on certain medication, you 
can prescribe for certain amount, for certain time. Yes, not for the patient, but for 
the GP and the system, protocol system, not for the patients". 
(Male, Nurse, 34 years, post-graduate qualifications) 
 
while others stressed the need for better communication between the private and 
public health sector, 
 
"There is no contact between the private sector and the NHS, that is all the 
problem". 
 (Female, hospital pharmacist, part-time-community pharmacist, 3 years in profession) 
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and at all levels of the medication supply chain, 
 
"I, the way I see it, it is like a chain, right? From the manufacturer, to the agent, to 
the wholesaler, to the pharmacy and eventually to the patient. And between the 
pharmacy and the patient there is the doctor prescribing. Now if there is more 
communication between each level, maybe on consumptions, prescribing trends, 
etc., I think that wastage could be reduced at each level, which means between the 
manufacturer and the agent, the agent and the wholesaler". 
(Male, hospital pharmacist, part-time-community pharmacist, 12 years in profession) 
 
3. Patients effects 
A hospital pharmacist suggested that patient groups and organizations could 
support, encourage and reassure patients around appropriate medication ordering 
and use, 
 
"And the coeliac association had created a system whereby every patient collects his 
stock, whatever he is entitled to but then if you feel you have excess stock of 
something, maybe you can share this, you know, they had like a support group, 
they could meet or there was a liaising person and you know that you could go 
there and maybe they could spare you a packet of gluten free flour. And I used to 
feel that that system was a bit of like a reassurance to those patients". 
(Female, hospital pharmacist, part-time-community pharmacist, 13 years in profession) 
 
The need for reassurance was reiterated by a member of the public, 
 
"Basically I think what you first need is peace of mind, that if I become anxious, I 
went to a pharmacy and I was assisted. Now if it’s close by in the village or 
wherever you are all the better, but if there is no alternative, you have to go to 
hospital, you don’t have a choice, as long as your mind is at rest that you will find 
help". 
(Female, housewife, 56 years, secondary level of education) 
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Patient empowerment was also noted, 
 
"I think we go too often to the doctor so that he doesn’t give you a plan ... for 
example, not now ‘cause now they’re grown-ups, when I used to take my son, he 
used to tell me ‘look these two days leave him on this only, if you see that the 
symptoms have increased buy him this antibiotic’ ". 
(Female, housewife, 56 years, secondary level of education) 
 
4. Political effects 
The need to reduce political interference in the organization and delivery of health 
services, leaving strategy and decision making to HCPs, was discussed at length 
especially amongst HCPs, 
 
"The politicians need to relinquish power and willingly". 
(Male, hospital pharmacist, part-time medical representative, 15 years in profession) 
 
"They [politicians] have to stop being scared of what the public thinks ... the only 
way it will work if both [political] parties or 3 or whatever agree, and state that they 
agree and sign a document that they agree that this is the way it’s going to be. So 
it’s not this party or that party, it’s the way it has to be. That’s the only way it will 
work". 
(Female, hospital doctor, 4 years in profession) 
 
As a member of the public commented, 
 
"Yes I agree. Health I think, health is a sector that needs to be separated from 
politics. The administrative side of it is one thing, the medical side of it is another 
thing, the regulating is another thing. So I think the health sector needs to be 
separate. I don’t know how it can be done; it needs to be separated from the 
Government. If we need to get anywhere I mean". 
(Female, Assistant Director, 32 years, post-graduate qualifications) 
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5. Awareness and educational effects 
Making patients more aware of the cost of medication, particularly those supplied at 
no cost, was highlighted as a positive move in reducing wastage,  
 
"…when some get free medication, even if they’re getting it free, there should be a 
price to make a person aware how much they are spending. Some medicines are 
extremely expensive. And the patient has no idea how much they are wasting. I 
think it would be very valuable if prices are present". 
(Female, hospital doctor, 4 years in profession) 
 
A hospital pharmacist working in oncology, stated that patients who were aware of 
the high cost of treatment were less selfish, 
 
"We, for chemotherapy, not specifically to a support group but many patients know 
about the cost of treatment and usually it’s a smaller group and discuss things 
between them, especially in-patients. So they understand that some drugs are 
difficult to procure, some drugs are bought for them on a named-patient basis. But 
they are not usually very selfish because they understand about the high cost of 
treatment and they understand that if I’m taking all this drug for myself, I’m not 
leaving enough drug for another person with the same condition". 
(Female, hospital pharmacist, part-time community pharmacist, 9 years in practice) 
 
This was also suggested as being important for HCPs,  
 
"I think we need to increase awareness amongst the physicians as well. Tell them 
there is wastage. Because we know there is wastage but we don’t know by how 
much". 
(Female, hospital doctor, 20 years in profession) 
 
One of the members of the public felt that everyone, especially politicians, should 
be made aware of the extent of medication wastage to be able to regulate 
behaviour, 
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"Malta, I don’t know how much it is in Malta, but I think if we make people aware, 
especially politicians and doctors, how much it is, I think there will be much more 
awareness, as money, as pills. I don’t know the exact amount ... yes but especially 
politicians, I think they don’t know the extent so they do not know if it is a problem. 
They know there is a problem, like in a hospital, a big problem with beds. It’s been 
like that ages but now because it’s a critical issue on the news and everything, they 
will target it. I think the politicians do not know the extent of the problem". 
(Male, Nurse, 34 years, post-graduate qualifications) 
 
One of the hospital doctors thought that the cost of medication wastage should be 
more apparent, 
 
"Because when you present patients with a figure, they become more aware of 
wastage. Because for them being prescribed this packet of paracetamol which 
maybe the Government buys for one euro, for the individual patient he is only 
wasting one euro. But if they have an idea of what is being wasted nationally, even 
if it’s a fraction, sometimes you know it’s a reality". 
(Female, hospital doctor, 17 years in profession) 
 
which was reiterated by one of the members of the public, who also added that 
these costs could be translated to finance further research, 
 
"... because if it [medication wastage] can be costed, then it can be linked maybe to 
targets and this target can maybe finance more research. ‘Cause it is a well-known 
fact when it comes to research, there is never enough finance for research, we 
finance everything but research, in every area. So maybe that can be linked. 
Costing, targets ..." 
(Female, Assistant Director, 32 years, post-graduate qualifications) 
 
Another hospital doctor suggested the awareness of the humane aspect of wastage, 
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"Maybe not just tell them how much it costs. Maybe they get the point that if 
they’re using more and wasting, they’re taking from other patients, sort of the 
humane point. Em you try to focus on this". 
(Male, hospital doctor, 5 years in profession) 
 
Several suggested more education on appropriate medication use, starting with the 
very young,  
 
"Maybe target young children in school even education wise. Why you take 
medication, how you take medication, how to store medication, how to get rid of 
excess medication. Ehe, I think maybe from 9 years, 10 years old. I mean they 
start sexual education, why don’t they start about ..." 
(Female, Assistant Director, 32 years, post-graduate qualifications) 
 
and using different targeting strategies,  
 
"But I think, it’s very good to educate, but it depends which target, which people we 
need to target. For example if you need the youngsters, there is the social media, 
Facebook, Twitter, everything, computer, Facebook. If you need elderly people, it’s 
useless. But it depends who you want to target because elderly people you will do 
educational session during for example news. Something like that. It depends, it 
depends which age you want to go". 
(Male, Nurse, 34 years, post-graduate qualifications) 
 
and settings such as the workplace,  
 
"And with all due respect even at workplaces, during this time of year we have lent 
talks ... like a retreat. So why shouldn’t we educate people at the workplace? If 
nowadays women are working outside the house and maybe she is in a hotel. You 
would tell me maybe not all workers can attend. No, but we should try to do it even 
in their breaks, get someone who is competent". 
(Female, housewife, 56 years, secondary level of education) 
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The local council was also considered to be an important setting when delivering 
educational sessions, 
 
"I will mention the same thing, I think you will agree with me, housewives, and 
there should be meetings like the meetings held in local councils". 
(Female, housewife, 63 years, primary level of education) 
 
A medication education campaign amongst patients was also proposed as a 
measure to regulate behaviours, 
 
"Launch a medication education campaign. You have to tell the patient that if they 
stop wasting the medication, to tell the patient, you have to tell the patient that if 
they stop wasting medication, that money can go somewhere else which can end up 
helping them". 
(Female, hospital doctor, 17 years in profession) 
 
This suggestion evoked some disagreement with one of the participants about 
whether a campaign would help to reduce medication wastage. Some participants 
also suggested that education campaigns amongst both doctors and pharmacists 
can help regulate behaviours to minimise wastage, 
 
"And not just a patient education campaign, it has to be a doctor education 
campaign as well. Because I don’t think we are blaming all of this on, we are not 
saying the patient is to blame". 
(Female, hospital doctor, 17 years in profession) 
 
"Campaigns are you train the pharmacists so that then they can educate the 
patients because then when it’s one to one it sinks in more". 
(Female, hospital pharmacist, part-time-community pharmacist, 13 years in profession) 
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6.3.3.12 Domain: Goals 
At the end of the focus groups, participants reiterated behavioural regulation which 
they felt was important to reduce wastage and suggested their main goal to support 
appropriate use of medication and reduce medication wastage. 
 
1. Need for education 
Behavioural change around education and communication in general was seen as 
the main goal to moving forward and for maintaining long term change,  
 
"I think what is really important is that we should move forward towards, patients 
should have, should be more understanding and maybe more respectful of doctors, 
pharmacists when they dispense the medication. And they should understand their 
decisions, of the doctors and of the pharmacists. And maybe in that way, education, 
it boils down to education I think at the end of the day". 
(Female, hospital pharmacist, part-time-community pharmacist, 5 years in profession) 
 
"I think with medication wastage you have to go to the individual, not just the 
patient but also the HCP. So I think it should be a system where, as Speaker 2 said, 
everyone is involved but it should target the individuals, not just throw something 
at the general population like that". 
(Female, hospital pharmacist, part-time-community pharmacist, 13 years in profession) 
 
6.4 Discussion 
6.4.1 Key findings  
The aims of this phase of the research were to describe and understand the beliefs 
and behaviours regarding medication wastage of the Maltese public and HCPs and to 
explore potential solutions to reduce medication wastage. 
 
The TDF was used to guide the topic guide content and coding during data analysis. 
Key themes were identified around behavioural domains of:  
1. knowledge (knowledge of the consequences of medication wastage) 
2. skills (practitioner effects, suboptimal use of medication by patients)  
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3. beliefs about capabilities and their social/professional role and identity 
(overstocking of medication by HCPs; social influences, educational influences, 
system influences) 
4. optimism (psychological influences) 
5. beliefs about consequences (consequences of inappropriate prescribing/ 
dispensing) 
6. reinforcement (HCP incentive) 
7. intentions (sustainability of the current free healthcare system, medication 
unavailability, unclear goals within the Government health system) 
8. environmental context and resources (issues of resources and organization, the 
free healthcare system, lack of review of doctors’ prescribing, patient effects, lack of 
education) 
9. social influences (pressure to prescribe or dispense, attitudes of HCPs) 
10. emotion (psychological effects) 
11. goals (need for education) 
 
In terms of potential solutions to reduce wastage, these were described under the 
domain of behavioural regulation in terms of facilitators to alter behaviour. The key 
emerging themes were: 1) system effects (stock management, budgeting, 
independent body governing free healthcare system, pharmaceutical identity card, 
infrastructure, incentives, medication fee, reimbursement, compulsory private 
insurance, medication take-back scheme with cash card, high consumption 
medication, disease prevention); 2) practitioner effects (correct prescribing and 
accountability, MURs, improved documentation, improved communication); 3) 
patients effects (increase patient reassurance, patient empowerment); 4) political 
effects (reduce political interference); 5) awareness and educational effects 
(increase awareness, strategies and settings to deliver education). 
 
6.4.2 Strengths and weaknesses of focus groups 
To the researcher’s knowledge this is the first interpretivist phenomenological study 
providing a detailed description of behaviours around medication wastage and 
particularly on solutions and facilitators of behavioural change. The focus group 
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guide method was designed according to best practice. The use of a theoretical 
basis, the TDF and associated domains to aid the construction of the topic guide and 
coding framework, ensured that the research and outputs were grounded in 
behavioural theories which also focus on change. Furthermore, this approach 
provided a very systematic approach to data generation and analysis. Importantly, 
focus group participants were not aware of the theoretical assumptions.  
 
The focus groups were part of a mixed methods sequential explanatory design 
which provided triangulation of data from the cross-sectional questionnaires and 
also the opportunity to explore areas in greater depth (Morgan, 1997). Perspectives 
of HCPs and the general public were researched through homogenous focus groups 
to allow broad consideration of issues and potential solutions. Attention was paid to 
the issue of data trustworthiness at all stages.  
 
However, there are limitations to the research and the data generated and hence 
the findings should be interpreted with caution. Despite employing purposive 
sampling, a wider range of participants, such as unemployed or less educated 
members of the general public, dentists, pharmacists from the pharmaceutical 
industry or more GPs, may have impacted the findings. The inability to capture the 
views of nurses or HCP students is a key limitation, given their roles or future roles 
in patient care. While it is possible that data saturation was not achieved, a number 
of important themes and potential solutions were identified. While not attempting to 
be generalizable, it is possible that the research findings have limited transferability 
outwith the study population.  
 
6.4.3 Interpretation of findings  
Study findings confirm the usefulness of the TDF to guide the research and 
comprehensively describe behaviours and generate ideas. A better understanding of 
behaviours of HCPs and the public in relation to medication wastage will provide a 
greater probability of developing successful interventions to reduce wastage 
compared to researching without a comprehensive theoretical framework (Squires 
et al., 2013). It is worth noting that whilst this study employed the 14 domains TDF, 
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the domain ‘memory, attention and decision porcesses’ was not retained as it was 
not relevant to this study. 
 
This study has provided valuable in-depth description and understanding of a 
number of behaviours which may lead to medication wastage and in doing so act as 
barriers or hindrances to all stakeholders striving to reduce wastage. Key issues 
such as the lack of resources and organization factors should not be overlooked and 
are fundamental to the development of strategies for change. Adequate resources 
are essential for the management of any system. Maltese Government policies are 
based on quality, affordability and sustainability (Superintendence of Public Health, 
2012) and hence the need to optimise limited resources is imperative. The 
perspectives of participants in this study on disease prevention should also be 
considered as a means of saving on limited resources, including HCPs’ time and 
healthcare expenditures. Notably, the EU Commission staff working document 
‘Investing in Health’ very recently reported that only approximately three percent of 
the current health expenditure is earmarked for public health and prevention 
programmes amongst Member States (European Commission, 2013). 
 
The fact that the Maltese free healthcare system as a possible major barrier to 
medication wastage reduction was identified in the focus groups discussions 
triangulates this key finding of all previous phases of this research (Delphi technique 
and cross-sectional survey). Politicians, healthcare organizations and HCPs have the 
responsibility and a societal duty in providing healthcare services to everyone, 
regardless of the patients’ ability to pay (Department of Health, 2010). The free 
healthcare system is provided by the Maltese state Government and therefore the 
state is duty-bound to ensure the sustainable and just provision of health services. 
Yet, the Maltese Ministry for Resources and Rural Affairs (2009, p.37-38) states that 
“all actors need to respect public funds as if they were their own and hence 
contribute towards their effective management”. There is therefore an urgent need 
to fully explore the healthcare system.  
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There is some evidence (albeit limited) that those patients entitled to free 
medication are more likely to receive polypharmacy, traditionally defined as “the 
concurrent use of five or more medications” (Richardson et al., 2014, p.656). Whilst 
providing free medication could be viewed as a positive step in terms of patient 
equality of care, there is a need to research the impact of no charge on patient 
request for and use of prescribed medication. It could be hypothesised that patients 
receiving free medication are more prone to wastage. The findings of the 
questionnaire in the previous phase of this study also drew attention to the 
significant difference between respondents who were obtaining their medication for 
free and those who were buying the medication. Those who were obtaining their 
medication for free were more likely to self-report no interest of issue of medication 
wastage. Hence the effects of the free healthcare system need to be fully explored 
and recognised to fully inform policy debates (Richardson et al., 2014). 
 
Sub-optimal use (misuse, underuse and overuse) of medication amongst the 
Maltese population was investigated in the previous phase of the research using the 
MMAS-8-Item and found that three quarters self-reported not being fully adherent. 
Medication non-adherence was also discussed at length during the focus groups and 
was considered to be one of the key barriers hindering resolution of medication 
wastage. Notable, the WHO, in its report on the world’s medicines situation, states 
that globally it is estimated that half of all patients fail to take medication correctly 
(World Health Organization, 2004b). Identifying factors which contribute to 
medication non-adherence is fundamental in obtaining satisfactory clinical patient 
outcomes (Al-Dabbagh and Aswad, 2010), as well as humanistic and economic 
patient outcomes. A very recent review of 51 systematic reviews of the 
determinants of adherence identified 771 individual factors for non-adherence to 
medicines for chronic conditions. These factors were grouped into eight clusters, 
two of which were the patients (key issue in the elderly) and the medicine (key 
issue with polypharmacy) (Kardas et al., 2013).  
 
While this research does not focus exclusively on non-adherence, paying attention 
to these factors could positively impact medication wastage. Furthermore, 
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medication non-adherence can lead to leftover unused medication in households 
which can be later used for an inappropriate indication or may expire and hence 
pose a public health issue, including environmental implications through improper 
disposal. Despite advice provided by the FDA on medication disposal with only a 
short-list of medications recommended for disposal by flushing down the toilet or 
sink (US Food and Drug Administration, 2014), participants also felt that there is 
inadequate knowledge and practices with regards to medication disposal. Lack of 
legal framework and local policies are likely to be impacting medication disposal 
behaviour (Vogler et al., 2014) and could be the reason for lack of advice by HCPs. 
 
The lack of awareness and the existence of knowledge gaps in relation to 
medication wastage both amongst the public and HCPs emerged in focus group 
discussions. Participants felt that the main goal to reduce medication wastage in the 
long term revolves around education and communication to bring about behavioural 
change. Overcoming the knowledge-behaviour gap through different programs 
designed to educate were discussed at length by participants. However, this 
knowledge-behaviour gap cannot be seen as a standalone barrier in the issue of 
medication wastage but has to be seen in the context of all the other factors elicited 
by participants, such as psychological factors in terms of fear of medication 
unavailability. 
 
Political interference contributing to wastage and as a potential barrier to 
implementing wastage reduction strategies was discussed in all groups and by 
almost all participants. Undermining of HCPs and scientific experts by political 
influence has been described elsewhere (Check, 2003; Mckee and Novotny, 2003; 
Baum et al., 2009; Roth-Deubel and Molina-Marín, 2013). In a commentary, Rest 
and Halpern (2007) argue that public policy decisions need to be informed by 
independent scientists rather than through political interference if one wants to 
ensure a good government and a functioning democracy. Pham et al. (2009) 
describe the importance of segregating ‘macro-level decisions’ generated at a 
political debate level from ‘micro-level decisions’. This is in line with participants’ 
suggestions around the need to redefine political will. Consistent with the 
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arguments by Post et al. (2010), that political will should be a group-level concept 
rather than stemming from an individual, participants emphasised that the 
healthcare system should be at health department level and not the individual 
Minister level. 
 
While the issue of medication shortages was clearly demonstrated during the Delphi 
technique and the surveys, it was discussed in depth during the focus groups as a 
key cause of unnecessary hoarding and stocking by patients and also recommended 
to patients at times by HCPs. As discussed in chapter 5, medication shortages are a 
global problem with all medication classes being affected (European Association of 
Hospital Pharmacists, 2013; Dill and Ahn, 2014) and have been described for more 
than a decade (Charatan, 2001). This issue has also been recognised as causing 
great distress to patients, their carers and families (European Association of 
Hospital Pharmacists, 2013). There are many and complex reasons for medication 
shortages including manufacturing quality problems, the increased demand of 
medication and changes in regulatory standards of manufacturing plants, amongst 
others (Gray and Manasse, 2012). Following a reflection paper on the issue of 
medication shortages by the European Medicines Agency, the European Association 
of Hospital Pharmacists (2013) issued a number of recommendations. One key 
recommendation is the collaborative involvement of patients’ organizations, using 
their expertise to issue guidelines for patients and HCPs to promote rational 
medication use. Interestingly focus group participants were in accord with this 
recommendation, proposing one solution involving collaborating with patient groups 
to provide guidance, support and reassurance. 
 
A comprehensive description of strategies to potentially reduce wastage was 
elicited. These will require intervention at macro-contextual levels (e.g. the need to 
implement public policies and to reduce political interference), meso-transactional 
level (e.g. the need discussed to purchase medication according to supply and 
demand) and at the micro-organizational level (e.g. the resources and services 
discussed). Implementation of any of these strategies is likely to be an iterative 
process, especially since each and every strategy merits further consideration which 
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will generate its own multifaceted challenges. Nonetheless, implementation of some 
strategies might not be as simple or straightforward as one might think. In a 
qualitative study employing photo-elicitation to identify different types of wastage, 
Goff et al. (2013) discuss the need to re-engineer systems to target all different 
types of wastage, and this requires the involvement of multiple stakeholders. 
Moreover, Goff et al. (2013) added that whilst attempting to reduce medication 
wastage one needs to be careful so as not to generate other forms of wastage, such 
as the time and money invested in implementing a specific intervention which may 
not always outweigh the benefits of introducing the intervention. 
 
The literature indicates that success of implementation depends on a number of 
inter-related factors, with some factors more prominent than others. Key success 
factors include the need of adequate human and financial resources available for 
implementation and desirable implementation factors defined as “effective planning; 
project management; communication; collaboration; useful tools; clear 
implementation strategy; teamwork; champions; monitoring, evaluation and 
feedback; incentives; flexibility; autonomy; standardization; tailoring 
implementations to the local context” and the actual preparation for change 
(Braithwaite et al., 2014, p.324). Behavioural change theories that promote uptake 
and optimal use of strategies are discussed further in chapter 7.  
 
Some of the strategies suggested by participants have been used elsewhere with 
positive outcomes. Health education campaigns have reduced the level of antibiotic 
prescribing both in Malta (The Malta Independent, 2013) and elsewhere 
(Chahwakilian et al., 2011; Formoso et al., 2013; National Institute for Health and 
Care Excellence, 2014). Patient education delivered through health promotion 
leaflets, patient medication reviews and attention to prescribing, have also been 
discussed (Jesson et al., 2005). Some of the solutions from the current study are 
also in line with recommendations formulated during workshops throughout a 
Maltese conference on improving medication use in older persons (Office of the 
Commissioner for Mental Health and Older Persons, 2013). Overlap in 
recommendations emerging from this conference include: the need to increase 
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education and awareness amongst patients and HCPs; to use various forms of 
media education including social media; the need for a holistic and integrated IT 
system between different sectors; the need to empower different HCPs and 
patients; the need for clear management pathways; the importance of 
communication and adequate documentation; interdisciplinary teams conducting 
regular medication reviews;  encouraging evidence-based prescribing; and patient 
registration with GPs. The similarity in these findings strengthens the evidence 
towards the need to utilise these solutions to target appropriate medication use and 
thus prevent wastage. The importance of some of these solutions, such as 
communication and documentation, has already been recognised at a national level 
(Superintendence of Public Health, 2012). However, it is clear that there remains a 
need for further action to implement and sustain change.  
 
Novel suggestions from focus group participants include: the introduction of a 
patient specific pharmaceutical identity card containing all medication history for 
both privately purchased medication and those obtained for free to prevent 
redispensing; and the establishment of a healthcare intermediary independent body 
for Government subsidised medication. Maltese health authorities should consider 
each solution in turn and determine the societal and economic ramifications of each 
and subsequently underpin those strategies which can have a national impact. 
 
6.5 Conclusion 
To date there is paucity of studies employing a theoretical framework to identify key 
underlying medication wastage related behaviours. This study has employed the 14 
domain TDF to provide new insight into beliefs and behaviours in relation to 
medication wastage (such as system, practitioner and patient effects) which require 
attention (e.g. lack of education and information, and political interference) as part 
of strategic development. Relevant TDF domains which generated strong beliefs and 
lengthy discussions included ‘behavioural regulation’, ‘environmental context and 
resources’ and ‘goals’. Findings may also assist health authorities when designing 
tailored interventions to minimise medication wastage. 
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Chapter 7  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“The improvement of 
understanding is for two ends: 
first, our own increase of 
knowledge; secondly, to enable 
us to deliver that knowledge to 
others” 
John Locke 
[Philosopher, physician  
1632-1704] 
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Discussion 
 
 
This chapter reiterates the research aims, design and key findings, emphasising 
the novel contribution to knowledge. Potential impact on policy and practice is 
discussed in the context of Malta and beyond. Further research aims, 
methodologies and outcome measures are articulated. 
  
7.1 Aims and key findings  
The need for the implementation of a generic waste management strategy was 
recognised by the Maltese Government who stated that “the success of the waste 
management strategy is not solely dependent on Government’s commitment and 
resourcing. It depends also on the contribution and commitment of each and 
every one of us, being in our capacity as entrepreneurs, administrators, 
politicians and above all citizens of the Maltese islands” (Ministry for Resources 
and Rural Affairs, 2009, p.7). The need to undertake a systematic, research 
focused development of strategy to reduce medication wastage was therefore 
highly topical.  
 
7.1.1 Flow of ideas 
The overall aim of this research was: 
• To investigate aspects of medication wastage in Malta by applying mixed 
methods research 
 
The following aims for each phase of this research emerged: 
 
 
• Chapter 3: To appraise critically, synthesize and present the available 
evidence on the possible causative factors associated with medication 
wastage in all populations and settings and the effectiveness of any 
interventions focusing on wastage reduction as an outcome measure 
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Key findings: The systematic review identified 42 published papers, only one of 
which reported a definition of medication wastage. The main factors contributing 
to wastage were ‘change in medication’, ‘patient's death’, ‘resolution of patient's 
condition’ and ‘passed expiry date’. Very few studies reported medication 
wastage as an outcome measure. 
 
 
• Chapter 4: To apply the Delphi technique to define ‘medication wastage’ and 
its contributory factors in the context of the Maltese population 
 
Key findings: The Delphi technique generated the following definition for 
medication wastage, with 86% of panellists agreeing/totally agreeing (exceeding 
the predefined consensus value of 75%). 
 
‘Medication wastage refers to any medication which expires or remains unused 
throughout the whole medicines supply chain. Medication wastage also refers to 
the unnecessary or inappropriate consumption of medication by patients, or the 
unjustified non-adherence to treatment guidelines by healthcare professionals. 
Medication wastage poses a financial burden on patients themselves and the 
state's economy and requires adequate education of all people concerned’. 
 
Sixty-one possible factors leading to wastage were identified by the panellists, 
categorised as: ‘physical and environmental factors’; ‘social and psychological 
patient factors’; ‘cultural factors’; and ‘practitioner factors’. A total of 38 out of 
61 (62%) statements of factors leading to wastage met consensus following the 
three Delphi rounds. 
 
 
• Chapter 5: To investigate issues of awareness, perceptions, attitudes and 
behaviours regarding medication wastage amongst the Maltese population, 
HCPs and respective students 
 
Key findings: Surveys of HCPs, students and the general public identified key 
factors contributing to wastage being: lack of patient education/knowledge; the 
free healthcare system; the overstocking of medication by patients due to 
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previous or potential out of stock situations; and the fact that patients collected 
free medication or purchased medication not needed, or more than they needed. 
There were clear deficiencies in the awareness of medication wastage amongst 
the general population, HCPs and students.  
 
 
• Chapter 6: To describe and understand the beliefs and behaviours regarding 
medication wastage of the Maltese public and HCPs and to explore potential 
solutions to reduce medication wastage 
 
Key findings: Focus groups conducted with HCPs and the general public identified 
the following five key themes which were proposed as solutions to minimise 
medication wastage: 1) system effects (stock management, budgeting, 
independent body governing free healthcare system, pharmaceutical identity 
card, infrastructure, incentives, medication fee, reimbursement, compulsory 
private insurance, medication take-back scheme with cash card, high 
consumption medication, disease prevention); 2) practitioner effects (correct 
prescribing and accountability, MURs, improved documentation, improved 
communication); 3) patients effects (increase patient reassurance, patient 
empowerment); 4) political effects (reduce political interference); 5) awareness 
and educational effects (increase awareness, strategies and settings to deliver 
education). 
 
7.2 Use of theory in research 
One of the strengths of this research is the use of theory of behaviours in the 
development of data collection and generation tools, analysis and interpretation. 
Theory, as defined by Meleis (2012, p.29) is: 
 
“an organized, coherent, and systematic articulation of a set of statements 
related to significant questions in a discipline and communicated in a meaningful 
whole. It is a symbolic depiction of those aspects of reality that are discovered or 
invented for describing, explaining, predicting, or prescribing responses, events, 
situations, conditions, or relationships. Theories have concepts that are related to 
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the discipline's phenomena. These concepts are related to each other to form 
theoretical statements.” 
 
In essence, the importance of theory in research lies within the systematic 
framework it provides for analysis and in its efficiency in incorporating literature 
into a single, integrated consistent body of knowledge (Wacker, 1998). 
Furthermore, theory provides both explanations and predictions in a deductive 
approach (Gilbert, 2007). Theories of behaviours and behavioural change 
employed in this research will aid the systematic development of complex 
interventions to support medication wastage reduction. Such an approach is in 
line with the recommendations of the UK MRC (Research Councils UK, 2011).  
 
7.3 Promoting quality in research 
This research was conducted according to highest of ethical and scientific 
principles and standards of conduct as described in chapter 2. Studies were 
designed so as to promote research robustness and rigour hence maximising the 
quality of evidence while minimising the potential for systematic error. Strengths 
and limitations of the research data obtained from each phase have been 
highlighted throughout.  
 
7.4 Contribution to knowledge  
This body of research is an original contribution to scholarly knowledge, 
providing results and generating findings which will aid the development of 
strategies and solutions to reduce medication wastage. Reducing medication 
wastage is a complex task and will require interventions at the macro-contextual, 
meso-transactional and micro-organizational levels, as has been described in 
chapter 6.  
 
The pragmatic approach adopted in this research captured a broad range of 
behaviours. The development and subsequent implementation of interventions 
are based on theories of behavioural change. Michie et al. (2011, p.1) defined 
behaviour change interventions as “coordinated sets of activities designed to 
change specified behaviour patterns”. This research has applied systematic 
review, consensus study and sequential explanatory mixed methods approach of 
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surveys followed by focus groups. The latter research phases allowed an 
understanding of the nature of behaviours around the issue of medication 
wastage. 
 
Recommended interventions and policies to change behaviour within this 
research fit well with the ‘Behaviour Change Wheel’ (BCW), which promotes 
uptake and optimal use of strategies. As depicted by Figure 7.1, at the centre of 
the BCW lies the foundation of the framework of capability, opportunity and 
motivation. The intervention functions and ultimately policy categories are built 
on this foundation (Michie et al., 2011). 
 
 
Figure 7.1: The BCW [Source: Michie et al., 2011] 
 
The TDF domains have provided an accepted theoretical approach to identifying 
the behavioural determinants in relation to medication wastage. The different 
elements of the BCW relate to the different solutions proposed throughout the 
research, especially in terms of ‘education’ and ‘training’ (Michie et al., 2011). 
Education as a means of imparting knowledge and developing understanding of 
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the factors leading to medication wastage, as well as training to develop skills to 
minimise and prevent wastage were both strongly highlighted in this research 
under different TDF domains. If seen as a complex adaptive system, healthcare 
organizations have diverse parties that learn, including patients, HCPs and other 
stakeholders (McDaniel et al., 2009). Therefore, educational effect interventions 
need to be targeted at the organizational, professional and individual (HCP, 
patient) levels. 
 
The need to improve communication, highlighted under many domains and 
particularly ‘social influences’, maps to the BCW ‘persuasion’, defined as the 
“communication to induce positive or negative feelings or stimulate action” 
(Michie et al., 2011, p.7). The free healthcare system, which was highlighted 
repeatedly throughout the survey and focus group phases as a contributory 
factor to wastage should be recognised by the government/organization as an 
embedded barrier within the social and cultural context of Malta. This also relates 
to the need for ‘environmental restructuring’ in the BCW, defined as “changing 
the physical or social context” (Michie et al., 2011, p.7). This is in line with the 
NHS strategy issued by the Government, describing objectives relating to 
ensuring a sustainable healthcare system (Ministry for Health, 2014b). 
 
A change in attitudes of HCPs is also crucial, evidenced by some HCPs 
unnecessarily stockpiling medication, rather than leading by example. This 
highlights the importance of ‘modelling’ as described in the BCW, and defined as 
the provision of an example “for people to aspire or to imitate” (Michie et al., 
2011, p.7). This also has relevance to reinforcing professionalism, which can be 
encouraged through ‘incentives’ as well as ‘restrictions’ by using rules to 
minimize the opportunity of creating wastage (Michie et al., 2011). This research 
highlights the need for the Maltese healthcare system to be seen as a complex 
adaptive system where the managerial positions should practice influence rather 
than power, with command and control being replaced with incentives and 
inhibitions (Rouse, 2008). 
 
Many of the solutions proposed in this research align to the BCW ‘enablement’ 
aspect of increasing means and minimising barriers to increase both capabilities 
and opportunities. ‘Coercion’, defined as the “expectation of punishment or cost” 
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(Michie et al., 2011, p.7), was proposed by some focus group participants 
through introducing a medication fee to replace the current free of charge 
medication system. The need for the healthcare system and organization to 
provide clear goals relating to medication use and wastage, aligning to the 
‘Intentions’ was discussed. 
 
When discussing the BCW, Michie et al. (2011) distinguish between the 
interventional solutions aimed at changing behaviour discussed above and the 
actions taken by authorities in the form of policies to support those interventions. 
This study clearly highlights the fact that policy makers need to address not only 
the legislative aspects described within this study but also the social, economic 
and environmental factors that affect people's aptitude to change their behaviour 
(National Institute for Health and Care Excellence, 2007). 
 
The BCW aims to change behaviour. However, interventions need to become 
accepted and integrated into routine practices. Therefore, novel explanatory 
frameworks, such as the Normalisation Process Theory (NPT), can aid in the 
understanding of the barriers and facilitators described within this research and 
inform future implementation, and thus should be used with the BCW to bring 
about the desired change. The NPT is a theory of action (May and Finch, 2009) 
which targets social processes and work that individuals carry out alone and in 
conjunction with others to make an intervention work (Bamford et al., 2012). 
Therefore it targets implementation of an intervention to bring a practice into 
action through four generative mechanisms: coherence; cognitive participation; 
collective action; and reflexive monitoring. NPT is concerned with embedding 
practice in the everyday work of individuals and groups and with the integration 
of practice which is sustained within an organization or institution, as shown in 
Figure 7.2 (May and Finch, 2009). This requires continuous investment in terms 
of commitment, effort, meaning and appraisal (Finch et al., 2013). 
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Figure 7.2: Components of NPT [Source: May and Finch, 2009]
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7.5 Implications of research 
The results and findings of this research are of direct relevance and have potential 
to impact a range of key stakeholders with the overall goals of achieving wastage 
minimisation and compliance with EU regulations as per strategic objectives of the 
Maltese Government (Ministry for Resources and Rural Affairs, 2009). Complex and 
multimodal interventions are required to promote behavioural change at individual, 
population and organizational levels. These interventions have implications for 
members of the public, patients, HCPs, students, educators, policy makers and 
many others. 
 
Policy makers, service providers, practitioners and patients need to be partners in 
this mission to bring about the necessary change. As one of the participating 
doctors in the focus group discussed, altering patients’ perspectives will have an 
influence on the HCPs and policy makers’ perspectives.  
 
7.6 Recommendations to policy makers and other 
stakeholders and suggested future research 
7.6.1 Need for policy and guidelines 
Findings generated from the mixed methods studies in this PhD emphasise strongly 
the need for policy and guidelines in a number of areas related to medication 
wastage. Evidence generated and collated from all the four studies within this 
research present contributory factors of wastage and call for urgent assessment of 
these factors and implementation of policies and guidelines to overcome them. As 
discussed in the paper by Dingfelder and Mandell (2011), contextual factors are 
critical variables when adopting and sustaining new strategies, interventions or 
practices. 
 
Areas requiring prioritisation when developing policies in line with the BCW are:  
• promoting awareness of medication wastage and information-sharing through 
communication (such as mass media campaigns) 
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• implementing educational measures regarding medication waste minimisation for 
all HCPs 
 
Other areas that need to be addressed when developing policies are: 
• issues of environmental and social planning (such as controlling the physical and 
social environment through the proposed solutions within this research) 
• service provision (such as policies on the return of unused medication by 
patients and disposal of unused medication)  
• establishing rules of behaviour of practice to regulate the current health system, 
including guidelines for HCPs with clear procedures on the prescribing of 
medication which are supplied free of charge, with links to the GFL 
• guidelines for the public around storage of medication 
 
Development of policies should follow the policy cycle depicted in Figure 7.3 (World 
Health Organization, 2014) in relation to the NPT described above which will aid to 
review and evaluate the implementation process. Participants in this research, 
representing key stakeholders in the Maltese healthcare system, have played a 
crucial role in the policy process by portraying an understanding of the present 
issues and establishing a vision to reduce medication wastage (Step 1 in Figure 
7.3).  
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Figure 7.3: The policy cycle [Adapted from World Health Organization, 2014] 
 
To promote uptake and sustainability, all stakeholders and stakeholder groups need 
to be involved in policy development, planning and implementation. This may help 
to ensure that the policy is not rejected at implementation stage and, once 
implemented, it is not opposed due to misunderstandings or lack of communication 
(Schmeer, 1999). Current literature lacks clarity on how to identify stakeholders 
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and establish their importance to policy decision and policy making (Jepsen and 
Eskerod, 2009).  
 
The Maltese Government currently aims to apply a people-centred concept which 
recognizes four major groups of stakeholders of 1) individuals, families and 
communities; 2) health practitioners; 3) healthcare organizations; and 4) health 
authorities (Ministry for Health, 2014b). In a healthcare system, which can be 
considered as a complex adaptive system with strong tendencies to learn, adapt, 
and self-organize (Rouse, 2008), change depends on each individual being 
empowered to act autonomously and in an informed way (Innes and Booher, 1999). 
Schiller et al. (2013) provide a broader framework as depicted in Figure 7.4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.4: Framework of stakeholder categories [Adapted from Schiller et al., 
2013] 
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7.6.2 Need for education and training 
Attention needs to be given to aspects of medication wastage within undergraduate 
healthcare student educational programmes and CPD for professionals. Recognising 
the factors giving rise to wastage, evidenced throughout this research, will help to 
define the learning outcomes for both students and HCPs. Quality improvement 
measures such as lean thinking could be deployed as educational and interventional 
measures which can result in wastage minimisation. Lean thinking, which adapts 
from the five principles of Lean (Figure 7.5), is a quality improvement philosophy 
originally formulated for manufacturing by Ohno Taichi of Toyota, and attempts to 
improve value and remove wastage. The concept of Lean has been applied into 
different healthcare settings, with the resultant delivery of excellent and efficient 
care in a safe environment which benefits patients, employees and tax-payer 
(Rexhepi and Shrestha, 2011; McDermott et al., 2013).  
 
 
Figure 7.5: The five principles of Lean [Adapted from Lean Enterprise Institute, 
2009] 
 
A goal arising from the current research is to plan and deliver appropriate education 
and training for HCPs and students with the aim of knowledge and skills 
development around effective and efficient medication usage hence minimising 
wastage. The need to implement different educational measures, such as education 
on appropriate medication use for the general public and patients in different 
settings, has also been recognised within this research. 
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7.6.3 Future research 
One of the benefits of this research is the linkage to practice developments. While 
there are many future research areas and questions which emerge from this 
research, this section focuses on key priority areas. It is also recommended that the 
views of stakeholders are sought in further developing these suggestions.  
 
7.6.3.1 The effect of policy implementation on practice from the HCP perspective 
As discussed above, implementing policies requires the engagement of a wide range 
of stakeholders and relies on various disciplines in order to address complex 
implementation challenges (Peters et al., 2013). Policies can modify the role of 
different stakeholders, including HCPs, change the relationships among them, and 
change the resources available to them. 
 
Research question: What are the effects of policy implementation on practice from 
HCP perspectives? 
 
Research philosophy: This study adapts with the interpretivist paradigm in that it 
explores in-depth effects from the perspectives of HCPs. 
 
Methodology and methods: A phenomenological methodology of focus group studies 
with different HCPs (dentists, doctors, nurses and pharmacists) identified through 
purposive sampling to explore the policy implementation and impact. 
 
Outcome measures around policy implementation and impact are complex and will 
include perspectives and experiences of: acceptability, adoption, appropriateness, 
feasibility, practice impact, and sustainability. 
 
7.6.3.2 Effects of education 
The European Commission recognises the importance of education for the 
achievement of a sustainable future and proposes education as one of the 
measurable targets for 2020 (European Commission, 2010). Therefore, measuring 
the effects of education is imperative to determine its success. 
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Research question: What are the effects of education on the public, patients, HCPs, 
students and educators in relation to medication waste minimisation? 
 
Research philosophy: This study takes a pragmatic approach in that it both 
measures as well as explores the effects of education on different stakeholders. 
 
Methodology and methods: Survey and phenomenological methodologies to 
determine the effects of education, using a mixed methods approach with samples 
of the public, patients, HCPs, students and educators. An explanatory sequential 
approach could be adopted with a quantitative design followed by qualitative 
methods. The quantitative element, pre and post intervention questionnaires, would 
be distributed to random samples to determine their self-reported perspectives. 
Results could be further explored through qualitative interviews or focus groups with 
purposive samples. 
 
Outcome measures around policy implementation:  
Quantitative: self-reported skills pre and post the educational intervention. 
Qualitative: experiences of their adoption of educational interventions and the 
facilitators and barriers encountered to adopting such interventions. 
 
7.6.3.3 Overall impact of the interventions on medication wastage 
Determining the impact of interventions will establish the success or otherwise of 
these interventions and hence is the most important area of research. 
 
Research question: What is the overall impact of the interventions on medication 
wastage? This will apply the definition of medication wastage and outcome 
measures derived through this doctoral research. 
 
Research philosophy: This study takes a positivist approach in that it determines 
impact of interventions and attempts to quantify waste reduction. 
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Methodology and methods: Quantitative tools will be developed, validated and 
piloted to quantify amount of expired and unused medication and its cost, to 
determine patient medication adherence and medication appropriateness before and 
after the intervention.  
 
Outcome measures relate to each element of the definition: 
Medication wastage refers to any medication which expires or remains unused 
throughout the whole medicines supply chain: amount of expired and unused 
medication before and after the intervention. 
Medication wastage also refers to the unnecessary or inappropriate consumption of 
medication by patients: patient medication adherence (measured using MMAS-8-
Item) before and after the intervention in a sufficiently powered sample of patients. 
Medication wastage also refers to the unjustified non-adherence to treatment 
guidelines by HCPs: clinical audit of HCP adherence to clinical guidelines in 
therapeutic target areas highlighted by stakeholder group; medication 
appropriateness, measured using a scale such as the Medication Appropriateness 
Index (Hanlon et al., 1992), before and after the intervention in a sufficiently 
powered sample of patients. 
Medication wastage poses a financial burden on patients themselves and the state's 
economy and requires adequate education of all people concerned: medication 
costs, acknowledging that a pharmacoeconomic assessment is likely to be complex 
requiring health economic modelling (and thus health economist input to research 
design) from many perspectives. 
 
7.7 Conclusion 
This body of work has identified a paucity of published literature on medication 
wastage, particularly around interventions using wastage as an outcome measure. A 
consensus based definition of medication wastage was derived and used in later 
research phases.  
 
The cross-sectional questionnaires, based on selected theoretical frameworks, 
namely Rogers’ Diffusion of Innovation theory, the HBM and the TTM, have 
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demonstrated that more effort is warranted to raise awareness and educate the 
public, HCPs and students as initial steps in promoting behavioural change. The TDF 
was applied to design the focus group guide and to systematically interpret findings 
of the focus group discussions and to identify key underlying medication wastage 
related behaviours which required attention (e.g. lack of education and information, 
and political interference) as part of strategic development. This research has 
highlighted the areas requiring prioritisation when developing and implementing 
policies and strategies.  
 
While the research was conducted within Malta and notwithstanding limitations such 
as low response rates, it is likely that results and findings are generalizable and 
transferrable to other countries and settings. 
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Appendix 3.1: Search strategy 
 
Box 1: Search terms and search strings 
Medic* wast* or unwanted medic* or unwanted pharm* or unwanted drug* or 
unused medic* or unused pharm* or unused drug* or drug wast* or pharm* 
wast* or prescription* wast* or unnecessary medic* or unnecessary drug* or 
unnecessary pharm* or extra medic* or extra drug* or extra pharm* or surplus 
medic* or surplus drug* or surplus pharm* or untouched medic* or untouched 
drug* or untouched pharm* or remaining medic* or remaining drug* or 
remaining pharm* or returned medic* or returned drug or returned pharm* 
COMBINED with (1) Patient* or pharmacist* or doctor* or prescriber* or 
student* (2) Perception* or opinion* or belief* or awareness or attitude* or 
concept* or knowledge (3) Solution* or reduc* (4) Medic* appropriate* or 
medic* manage* or appropriate* or medic* review* or drug review* 
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Search terms for Medline and CINAHL 
Search Combination 1:  
S1. medic* wast* 
S2. unwanted medic* OR unwanted pharm* OR unwanted drug* 
S3. unused N1 medic* OR unused N1 pharm* OR unused N1 drug* 
S4. pharm* wast* 
S5. prescription* wast* 
S6. unnecessary N1 medic* OR unnecessary N1 pharm* OR unnecessary N1 
drug* 
S7. extra N1 medic* OR extra N1 pharm* OR extra N1 drug* 
S8. surplus N1 medic* OR surplus N1 pharm* OR surplus N1 drug* 
S9. untouched N1 medic* OR untouched N1 pharm* OR untouched N1 drug* 
S10. remaining medic* OR remaining pharm* OR remaining drug* 
S11. returned medic* OR returned pharm* OR returned drug* 
S12. S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 
S13. S12 AND patient* 
S14. S12 AND pharmacist* 
S15. S12 AND doctor* 
S16. S12 AND prescriber* 
S17. S12 AND nurse* 
S18. S12 AND student* 
S19. S13 OR S14 OR S15 OR S16 OR S17 OR S18 
Search Combination 2: 
S20. S12 AND perception*  
S21. S12 AND opinion*  
S22. S12 AND belief*  
S23. S12 AND awareness  
S24. S12 AND attitude*  
S25. S12 AND concept*  
S26. S12 AND knowledge 
S27. S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 
Search Combination 3: 
S28. S12 AND solution* 
S29. S12 AND reduction 
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S30. S28 OR S29 
Search Combination 4:  
S31. S12 AND medic* appropriate*  
S32. S12 AND medic* manage*  
S33. S12 AND appropriate*  
S34. S12 AND medic* review*  
S35. S12 AND drug review* 
S36. S31 OR S32 OR S33 OR S34 OR S35 
 
Search terms for the Cochrane Library 
Search Combination 1:  
#1. medic* wast* 
#2. unwanted medic* OR unwanted pharm* OR unwanted drug* 
#3. unused NEXT medic* OR unused NEXT pharm* OR unused NEXT drug* 
#4. pharm* wast* 
#5. prescription* wast* 
#6. unnecessary NEXT medic* OR unnecessary NEXT pharm* OR unnecessary 
NEXT drug* 
#7. extra NEXT medic* OR extra NEXT pharm* OR extra NEXT drug* 
#8. surplus NEXT medic* OR surplus NEXT pharm* OR surplus NEXT drug* 
#9. untouched NEXT medic* OR untouched NEXT pharm* OR untouched NEXT 
drug* 
#10. remaining medic* OR remaining pharm* OR remaining drug* 
#11. returned medic* OR returned pharm* OR returned drug* 
#12. #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR 
#11 
#13. #12 AND patient* 
#14. #12 AND pharmacist* 
#15. #12 AND doctor* 
#16. #12 AND prescriber* 
#17. #12 AND nurse* 
#18. #12 AND student* 
#19. #13 OR #14 OR #15 OR #16 OR #17 OR #18 
Search Combination 2: 
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#20. #12 AND perception*  
#21. #12 AND opinion*  
#22. #12 AND belief*  
#23. #12 AND awareness  
#24. #12 AND attitude*  
#25. #12 AND concept*  
#26. #12 AND knowledge 
#27. #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 
Search Combination 3: 
#28. #12 AND solution* 
#29. #12 AND reduction 
#30. #28 OR #29 
Search Combination 4:  
#31. #12 AND medic* NEAR/5 appropriate*  
#32. #12 AND medic* NEAR/5 manage*  
#33. #12 AND appropriate*  
#34. #12 AND medic* NEAR/5 review*  
#35. #12 AND drug NEAR/5 review* 
#36. #31 OR #32 OR #33 OR #34 OR #35 
 
Search terms for Embase 
Search Combination 1: 
#1. medic* wast* 
#2. unwanted medic* OR unwanted pharm* OR unwanted drug* 
#3. unused adj medic* OR unused adj pharm* OR unused adj drug* 
#4. pharm* wast* 
#5. prescription* wast* 
#6. unnecessary adj medic* OR unnecessary adj pharm* OR unnecessary adj 
drug* 
#7. extra adj medic* OR extra adj pharm* OR extra adj drug* 
#8. surplus adj medic* OR surplus adj pharm* OR surplus adj drug* 
#9. untouched adj medic* OR untouched adj pharm* OR untouched adj drug* 
#10. remaining medic* OR remaining pharm* OR remaining drug* 
#11. returned medic* OR returned pharm* OR returned drug* 
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#12. #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR 
#11 
#13. #12 AND patient* 
#14. #12 AND pharmacist* 
#15. #12 AND doctor* 
#16. #12 AND prescriber* 
#17. #12 AND nurse* 
#18. #12 AND student* 
#19. #13 OR #14 OR #15 OR #16 OR #17 OR #18 
Search Combination 2: 
#20. #12 AND perception*  
#21. #12 AND opinion*  
#22. #12 AND belief*  
#23. #12 AND awareness  
#24. #12 AND attitude*  
#25. #12 AND concept*  
#26. #12 AND knowledge 
#27. #20 OR #21 OR #22 OR #23 OR #24 OR #25 
Search Combination 3: 
#28. #12 AND solution* 
#29. #12 AND reduction 
#30. #28 OR #29 
Search Combination 4: 
#31. #12 AND medic* adj5 appropriate*  
#32. #12 AND medic* adj5 manage*  
#33. #12 AND appropriate*  
#34. #12 AND medic* adj5 review*  
#35. #12 AND drug adj5 review* 
#36. #31 OR #32 OR #33 OR #34 OR #35 
 
Search terms for PubMed 
Search Combination 1:  
#1. medic* wast* 
#2. unwanted medic* OR unwanted pharm* OR unwanted drug* 
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#3. unused medic* OR unused pharm* OR unused drug* 
#4. pharm* wast* 
#5. prescription* wast* 
#6. unnecessary medic* OR unnecessary pharm* OR unnecessary drug* 
#7. extra medic* OR extra pharm* OR extra drug* 
#8. surplus medic* OR surplus pharm* OR surplus drug* 
#9. untouched medic* OR untouched pharm* OR untouched drug* 
#10. remaining medic* OR remaining pharm* OR remaining drug* 
#11. returned medic* OR returned pharm* OR returned drug* 
#12. #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR 
#11 
#13. #12 AND patient* 
#14. #12 AND pharmacist* 
#15. #12 AND doctor* 
#16. #12 AND prescriber* 
#17. #12 AND nurse* 
#18. #12 AND student* 
#19. #13 OR #14 OR #15 OR #16 OR #17 OR #18 
Search Combination 2: 
#20. #12 AND perception*  
#21. #12 AND opinion*  
#22. #12 AND belief*  
#23. #12 AND awareness  
#24. #12 AND attitude*  
#25. #12 AND concept*  
#26. #12 AND knowledge 
#27. #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 
Search Combination 3: 
#28. #12 AND solution* 
#29. #12 AND reduction 
#30. #28 OR #29 
Search Combination 4:  
#31. #12 AND medic* appropriate*  
#32. #12 AND medic* manage*  
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#33. #12 AND appropriate*  
#34. #12 AND medic* review*  
#35. #12 AND drug review* 
#36. #31 OR #32 OR #33 OR #34 OR #35 
 
Search terms for SCI Expanded - Web of Science 
Search Combination 1: 
#1. TS=(medic* SAME wast*) 
#2. TS=(unwanted SAME medic* OR unwanted SAME pharm* OR unwanted 
SAME drug*) 
#3. TS=(unused SAME medic* OR unused SAME pharm* OR unused SAME 
drug*) 
#4. TS=(pharm* SAME wast*) 
#5. TS=(prescription* SAME wast*) 
#6. TS=(unnecessary SAME medic* OR unnecessary SAME pharm* OR 
unnecessary SAME drug*) 
#7. TS=(extra SAME medic* OR extra SAME pharm* OR extra SAME drug*) 
#8. TS=(surplus SAME medic* OR surplus SAME pharm* OR surplus SAME 
drug*) 
#9. TS=(untouched SAME medic* OR untouched SAME pharm* OR untouched 
SAME drug*) 
#10. TS=(remaining SAME medic* OR remaining SAME pharm* OR remaining 
SAME drug*) 
#11. TS=(returned SAME medic* OR returned SAME pharm* OR returned SAME 
drug*) 
#12. #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR 
#11  
#13. TS=(#12 AND patient*) 
#14. TS=(#12 AND pharmacist*) 
#15. TS=(#12 AND doctor*) 
#16. TS=(#12 AND prescriber*) 
#17. TS=(#12 AND nurse*) 
#18. TS=(#12 AND student*) 
#19. #13 OR #14 OR #15 OR #16 OR #17 OR #18 
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Search Combination 2: 
#20. TS=(#12 AND perception*) 
#21. TS=(#12 AND opinion*) 
#22. TS=(#12 AND belief*) 
#23. TS=(#12 AND awareness) 
#24. TS=(#12 AND attitude*) 
#25. TS=(#12 AND concept*) 
#26. TS=(#12 AND knowledge) 
#27. #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 
Search Combination 3: 
#28. TS=(#12 AND solution*) 
#29. TS=(#12 AND reduction) 
#30. #28 OR #29 
Search Combination 4: 
#31. TS=(#12 AND medic* SAME appropriate*) 
#32. TS=(#12 AND medic* SAME manage*)  
#33. TS=(#12 AND appropriate*)  
#34. TS=(#12 AND medic* SAME review*)  
#35. TS=(#12 AND drug SAME review*) 
#36. #31 OR #32 OR #33 OR #34 OR #35 
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Appendix 3.2: Quality assessment tools 
 
Quality Assessment Tool for Quantitative Research 
Question Yes No Partial Unclear Not 
applicable 
1. Did the study ask a clearly-focused and relevant question(s) (aims, 
objectives)? 
          
2. Was a definition of waste described?           
3. Was the definition of waste for this study clearly explained?           
4. Was ethics approval reported?           
5. Was the study design/method justified and appropriate for the 
research question(s)? 
          
6. Were limitations of study design/method considered?           
7. Was the sampling population and strategy clear and justified?           
8. Was the sample size justified?           
9. Were participant recruitment strategies clearly described?           
10. Were the data collection tools described, piloted and validated?           
11. Were analysis strategies (quantitative and any open comments) 
clear and justified? 
          
12. Were participant characteristics sufficiently described?           
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13. Is the loss of any of the participants explained?           
14. Are the results of the study clearly explained and do the results 
address the original research question? 
          
15. Were limitations (bias, confounders, generalizability etc.) of 
findings considered? 
          
16. Were all important outcomes considered so the results can be 
applied? 
          
17. Are the conclusions supported by the findings?           
18. Is conflict of interest reported?           
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Quality Assessment Tool for Systematic Reviews 
Question Yes No Partial Unclear Not 
applicable 
1. Did the review ask a clearly-focused question?          
2. Was a definition of waste described?          
3. Was the definition of waste for this study clearly explained?         
4. Did the review include the right type of study?          
5. Did the reviewers try to identify all relevant studies?        
6. Did the reviewers assess the quality of the included studies?        
7. If the results of the studies have been combined, was it reasonable 
to do so? Are the results of each individual study clearly displayed? 
       
8. Do the results address the original research question?          
9. How precise are these results?         
10. Can the results be applied to the local population?         
11. Were all important outcomes considered?         
12. Should policy or practice change as a result of the evidence 
contained in this review? 
        
13. Is conflict of interest reported?         
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Appendix 3.3: Data extraction tool 
 
Publication Details 
Author 
Year 
Stated Aims/Objectives 
  
Participants 
Total number of participants recruited 
Age 
Gender 
Ethnicity 
Education 
Any other socioeconomic or cultural data 
How were the participants recruited 
Were there any inclusion or exclusion criteria 
  
The Intervention 
Study design 
Country 
Setting 
Description of intervention 
Delivered by 
Length of study 
  
Outcomes 
Description of outcomes 
  
Results 
Number of participant loss 
Reasons for dropping out 
Details of statistical analysis 
Key findings 
Results: 
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Definition of medication wastage 
Total wasted medication 
Quantity: Tablets and Capsules 
Quantity: Syrups (oral liquids) 
Quantity: Creams/ ointments 
Quantity: Inhalers 
Quantity: Injections 
Quantity: Other 
Type: Prescribed 
Type: Pharmacy medicine 
Type: Over-the-counter or General Sales List medicine 
Type: Other including samples and unclear origin 
Pharmacological characteristics: Drugs 
Pharmacological characteristics: Drug classes 
Expiration date 
Cost of medication wastage 
Causes of medication wastage 
Awareness of issues relating to medication wastage amongst patients 
Awareness of issues relating to medication wastage amongst HCPs 
Awareness of issues relating to medication wastage amongst healthcare students 
Approaches to reduce medication wastage 
Storage 
Disposal 
  
Author’s Conclusion 
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Appendix 4.1: Invitation to Participate Letter 
 
Dear Government Official/ Professional Organization/ Practitioner, 
 
Re: Definition of medication wastage amongst the Maltese population 
 
I am a senior clinical pharmacist currently pursuing a PhD at the Robert Gordon 
University, Aberdeen, Scotland, about medication wastage in Malta. This study will seek 
to determine the influential factors which have the potential to create medication 
wastage in Malta, and is being financially supported, and considered as high priority by 
the Malta Government Scholarship Scheme. A systematic review identified a lack of 
standard definition for medication wastage. It is therefore the aim of the next phase of 
the study to formulate a standard definition for medication wastage with the help of a 
panel of "experts."   
 
I would therefore like to invite you to form part of this panel and participate in a Delphi 
questionnaire. The expert panel is composed of a combination of Government officials, 
professional organizations, academics, practitioners, and patients. The Delphi 
questionnaire involves a number of questionnaire rounds. The first round consists of a 
questionnaire with open-ended questions where your expertise will be sought. 
Subsequent rounds will consist of questionnaires containing statements from previous 
rounds and you will be asked to rate these statements on a Likert scale. There are no 
right or wrong answers in these questionnaires. Consensus between panellists for the 
rating of these statements will be sought. It is estimated that consensus will be reached 
with 3 rounds.  
 
Anonymity and confidentiality between members of the panel will be maintained 
throughout. The undersigned researcher will be the only person who has access to the 
individual members and their respective responses, as feedback of the individual and the 
overall group responses from previous rounds will have to be provided to each member. 
However, the provided feedback will not disclose names of members who made the 
attributed response. The study has obtained approval from the Robert Gordon University 
Ethics Committee and the Maltese Government Research Ethics Committee and is in 
conformity with the UK Data Protection Act (1998) and the Maltese Data Protection Act 
(2001) as well as European Union Data Protection Directive (1995). 
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Questionnaire compilation takes approximately 20 minutes and each round takes place 
approximately 3 weeks apart. Participation requires an element of commitment as drop 
out during the study compromises the final results. Medication wastage has been 
identified to be a major problem amongst many countries. Therefore, completion of this 
study is the first step towards identifying the root cause of this problem and your 
expertise would be of great help in achieving this. Findings of this study will inform the 
next phase of my PhD study which will involve questionnaires amongst healthcare 
professionals and respective students and case studies with patients. 
 
Whilst I understand your various commitments and busy schedule, I would greatly 
appreciate your participation. However, this letter carries no obligation on your part to 
participate and once you enrol in the study you can withdraw whenever you want. If you 
do accept to participate in the Delphi questionnaire please endorse the attached consent 
form and kindly email back the scanned copy. As part of the expert panel I would also 
like you to recommend and provide contact details (as per hereunder) of an individual to 
participate as well as part of the expert panel. The nominee must be a person working 
within your organization and who is considered to be most suitable due to him/her 
working directly with medication wastage or indirectly through experience with 
medications. 
 
For further clarifications, please do not hesitate to contact me on 99893001 or send me 
an email on l.m.west@rgu.ac.uk. Whilst hoping for a favourable reply, I would like to 
thank you in advance for your time. Kindly accept or decline participation by not later 
than _____________.  
 
Yours sincerely, 
 
Lorna Marie West 
Senior Clinical Pharmacist 
B. Pharm (Hons) MSc (Aberdeen) 
 
Name of Nominee: _________________________________ 
 
Position: _________________________________________ 
 
Contact details: ___________________________________ 
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Dear Voluntary Patient Association, 
 
Re: Definition of medication wastage amongst the Maltese population 
 
I am a senior clinical pharmacist currently pursuing a PhD at the Robert Gordon 
University, Aberdeen, Scotland, about medication wastage in Malta. This study will seek 
to determine the influential factors which have the potential to create medication 
wastage in Malta, and is being financially supported, and considered as high priority by 
the Malta Government Scholarship Scheme. A systematic review identified a lack of 
standard definition for medication wastage. It is therefore the aim of the next phase of 
the study to formulate a standard definition for medication wastage with the help of a 
panel of "experts."   
 
I would therefore like you to recommend and provide contact details below of a patient to 
form part of the expert panel and participate in a Delphi questionnaire. The nominee 
must be a person with good English language writing skills, must be suffering from a 
chronic condition for at least the past two years which requires medication treatment, 
and should be of male/female gender and must be part of _________________ 
association. Since the 2012 estimated gender ratio in Malta for the total population is 
0.99 male/ female an equal amount of male is to female patients will be recruited. This 
explains why a specific gender is being requested. 
 
The expert panel is composed of a combination of Government officials, professional 
organizations, academics, practitioners, and patients. The Delphi questionnaire involves a 
number of questionnaire rounds. The first round consists of a questionnaire with open-
ended questions where the patient's expertise will be sought. Subsequent rounds will 
consist of questionnaires containing statements from previous rounds and the panellist 
will be asked to rate these statements on a Likert scale. There are no right or wrong 
answers in these questionnaires. Consensus between panellists for the rating of these 
statements will be sought. It is estimated that consensus will be reached with 3 rounds.  
 
Anonymity and confidentiality between members of the panel will be maintained 
throughout. The undersigned researcher will be the only person who has access to the 
individual members and their respective responses, as feedback of the individual and the 
overall group responses from previous rounds will have to be provided to each member. 
However, the provided feedback will not disclose names of members who made the 
attributed response. The study has obtained approval from the Robert Gordon University 
Ethics Committee and the Maltese Government Research Ethics Committee and is in 
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conformity with the UK Data Protection Act (1998) and the Maltese Data Protection Act 
(2001) as well as European Union Data Protection Directive (1995). 
 
Questionnaire compilation takes approximately 20 minutes and each round takes place 
approximately 3 weeks apart. Participation requires an element of commitment as drop 
out during the study compromises the final results. Medication wastage has been 
identified to be a major problem amongst many countries. Therefore, completion of this 
study is the first step towards identifying the root cause of this problem and your 
expertise would be of great help in achieving this. Findings of this study will inform the 
next phase of my PhD study which will involve questionnaires amongst healthcare 
professionals and respective students and case studies with patients. 
 
Whilst I understand your various commitments and busy schedule, I would greatly 
appreciate your help in selecting a suitable patient for participation. Moreover, once 
enrolled in the study the participant can withdraw whenever he/she wants.  
 
For further clarifications, please do not hesitate to contact me on 99893001 or send me 
an email on l.m.west@rgu.ac.uk 
 
Whilst hoping for a favourable reply, I would like to thank you in advance for your time. 
Kindly accept or decline the nomination of a patient by not later than _____________. 
 
Yours sincerely 
 
Lorna Marie West 
Senior Clinical Pharmacist 
B. Pharm (Hons) MSc (Aberdeen) 
 
Name of Nominee: _________________________________ 
 
Contact details: ___________________________________ 
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Dear Academic, 
 
Re: Definition of medication wastage amongst the Maltese population 
 
I am a senior clinical pharmacist currently pursuing a PhD at the Robert Gordon 
University, Aberdeen, Scotland, about medication wastage in Malta. This study will seek 
to determine the influential factors which have the potential to create medication 
wastage in Malta, and is being financially supported, and considered as high priority by 
the Malta Government Scholarship Scheme. A systematic review identified a lack of 
standard definition for medication wastage. It is therefore the aim of the next phase of 
the study to formulate a standard definition for medication wastage with the help of a 
panel of "experts."  
 
From the list of included references in the systematic review you were one of the main 
authors that published most in the area of medication wastage. I would therefore like to 
invite you to form part of this panel and participate in a Delphi questionnaire. The expert 
panel is composed of a combination of Government officials, professional organizations, 
academics, practitioners, and patients. The Delphi questionnaire involves a number of 
questionnaire rounds. The first round consists of a questionnaire with open-ended 
questions where your expertise will be sought. Subsequent rounds will consist of 
questionnaires containing statements from previous rounds and you will be asked to rate 
these statements on a Likert scale. There are no right or wrong answers in these 
questionnaires. Consensus between participants for the rating of these statements will be 
sought. It is estimated that consensus will be reached with 3 rounds. 
 
Anonymity and confidentiality between members of the panel will be maintained 
throughout. The undersigned researcher will be the only person who has access to the 
individual members and their respective responses, as feedback of the individual and the 
overall group responses from previous rounds will have to be provided to each member. 
However, the provided feedback will not disclose names of members who made the 
attributed response. The study has obtained approval from the Robert Gordon University 
Ethics Committee and the Maltese Government Research Ethics Committee and is in 
conformity with the UK Data Protection Act (1998) and the Maltese Data Protection Act 
(2001) as well as European Union Data Protection Directive (1995). 
 
Questionnaire compilation takes approximately 20 minutes and each round takes place 
approximately 3 weeks apart. Participation requires an element of commitment as drop 
out during the study compromises the final results. Medication wastage has been 
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identified to be a major problem amongst many countries. Therefore, completion of this 
study is the first step towards identifying the root cause of this problem and your 
expertise would be of great help in achieving this. Findings of this study will inform the 
next phase of my PhD study which will involve questionnaires amongst healthcare 
professionals and respective students and case studies with patients. 
 
Whilst I understand your various commitments and busy schedule, I would greatly 
appreciate your participation. However, this letter carries no obligation on your part to 
participate and once you enrol in the study you can withdraw whenever you want. If you 
do accept to participate in the Delphi questionnaire please endorse the attached consent 
form and kindly email back the scanned copy.  
 
For further clarifications, please do not hesitate to contact me on 99893001 or send me 
an email on l.m.west@rgu.ac.uk 
 
Whilst hoping for a favourable reply, I would like to thank you in advance for your time. 
Kindly accept or decline the nomination of a patient by not later than _____________. 
 
 
Yours sincerely 
 
Lorna Marie West 
Senior Clinical Pharmacist 
B. Pharm (Hons) MSc (Aberdeen) 
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Appendix 4.2: Consent Form 
 
Consent Form 
 
Definition of medication wastage amongst the Maltese population 
 
I, the undersigned, confirm that I have read and understood the Invitation to 
Participate letter and that I have had a chance to have my questions answered.  
 
I agree to participate as part of the panel of experts in all the rounds of the 
Delphi questionnaire regarding medication wastage.  
 
I also agree that the findings of this Delphi technique will be utilized for research 
purposes only and that anonymity to attributed responses will be kept at all 
times, except from the principal researcher.  
 
I am also aware that my participation is voluntary and that I can withdraw from 
the study whenever I would like to. 
 
For any queries or clarifications, the principal researcher can be contacted on 
00356 99893001 or an email can be sent to l.m.west@rgu.ac.uk 
 
Name of participant: _______________________ 
 
Date: ___________________ 
 
Participant's Signature: ____________________ 
 
Principal Researcher's Signature: ____________________ 
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Appendix 4.3: Covering Letters: Covering letter round 1 
 
Dear ,  
 
I would like to take this opportunity to thank you for accepting to participate as part of 
the expert panel in the Delphi technique. This is the first questionnaire which consists of 
open-ended questions where your expertise will be sought. Questionnaire compilation 
takes approximately 20 minutes. Subsequent questionnaires will contain statements from 
previous rounds and you will be asked to rate these statements on a Likert scale. 
Consensus between participants for the rating of these statements will be sought. It is 
estimated that consensus will be reached with 3 rounds. Completion of this study is the 
first step towards identifying the root cause of medication wastage and your expertise 
would be of great help in achieving this.  
 
Here is a link to the survey: 
[SurveyLink] 
 
This link is uniquely tied to this survey and your email address. Please do not forward 
this message. 
 
Anonymity and confidentiality between members of the panel will be maintained 
throughout. The undersigned researcher will be the only person who has access to the 
individual members and their respective responses, as feedback of the individual and the 
overall group responses from previous rounds will have to be provided to each member. 
 
Should you wish to withdraw your participation from this research study, please click the 
link below: 
[RemoveLink] 
 
For further clarifications, please do not hesitate to contact me on 99893001 or send me 
an email on l.m.west@rgu.ac.uk 
I would like to thank you once again for your support and contribution towards this 
research study. Kindly complete the questionnaire by not later than 17th August 2012. 
 
Yours sincerely, 
 
Lorna Marie West 
Senior Clinical Pharmacist 
B.Pharm (Hons.) MSc Clin Pharm (Aberdeen) 
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Covering letter Round 2 
 
Dear , 
 
I would like to take this opportunity to thank you for participating as part of the expert 
panel in the Round 1 Delphi questionnaire. Generated opinions during the first 
questionnaire were used to develop Round 2 Delphi questionnaire regarding medication 
wastage. 
 
Compilation of this second questionnaire takes approximately 20 minutes, during which 
you will be asked to rank or rate statements on a Likert scale. Consensus between 
participants for the rating of these statements will be sought. It is estimated that 
consensus will be reached with 3 rounds of questionnaires. Completion of this study is 
the first step towards identifying the root cause of medication wastage and your 
expertise would be of great help in achieving this.  
 
Here is a link to the survey: 
[SurveyLink] 
 
This link is uniquely tied to this survey and your email address. Please do not forward 
this message. Anonymity and confidentiality between members of the panel will be 
maintained throughout. The undersigned researcher will be the only person who has 
access to the individual members and their respective responses, as feedback of the 
individual and the overall group responses from previous rounds will have to be provided 
to each member. 
 
Should you wish to withdraw your participation from this research study, please click the 
link below: 
[RemoveLink] 
 
For further clarifications, please do not hesitate to contact me on 99893001 or send me 
an email on l.m.west@rgu.ac.uk. I would like to thank you once again for your constant 
support and contribution towards this research study. Kindly complete the questionnaire 
by not later than 21st September 2012. 
 
Yours sincerely, 
 
Lorna Marie West 
Senior Clinical Pharmacist 
B.Pharm (Hons.) MSc Clin Pharm (Aberdeen) 
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Covering letter Round 3 
 
Dear , 
 
I would like to take this opportunity to thank you for participating as part of the expert 
panel in the Round 2 Delphi questionnaire. The results you have provided have been 
analysed and assessed for degree of consensus. The consensus level chosen for this 
Delphi technique is 75%. You are now invited to complete the third Delphi round. This 
third questionnaire will include only statements which have not achieved consensus in 
Round 2.  
 
Compilation of this third questionnaire takes approximately 20 minutes, during which you 
will be asked to reconsider your original response in view of the group response. 
However, you do not have to change your original response if you do not wish to. Next to 
each statement, you will also find the percentage of participants who marked “Totally 
disagree”, “Disagree”, “Neither disagree nor agree”, “Agree” and “Totally agree” in round 
2, your response to the statement in Round 2 and the comments given by all the 
participants in Round 2. The abbreviations used next to each statement in this Delphi 
questionnaire refer to the following: "TD" = Totally Disagree, "D" = Disagree, "N" = 
Neither disagree nor agree, "A" = Agree, "TA" = Totally agree, "P" = Participant’s (your) 
response from Round 2. Completion of this study is the first step towards identifying the 
root cause of medication wastage and your expertise would be of great help in achieving 
this.  
 
Here is a link to the survey: 
[SurveyLink] 
 
This link is uniquely tied to this survey and your email address. Please do not forward 
this message. 
 
Anonymity and confidentiality between members of the panel will be maintained 
throughout. The undersigned researcher will be the only person who has access to the 
individual members and their respective responses, as feedback of the individual and the 
overall group responses from previous rounds will have to be provided to each member. 
 
Should you wish to withdraw your participation from this research study, please click the 
link below: 
[RemoveLink] 
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For further clarifications, please do not hesitate to contact me on 99893001 or send me 
an email on l.m.west@rgu.ac.uk 
 
I would like to thank you once again for your constant support and contribution towards 
this research study. Kindly complete the questionnaire by not later than 19th October 
2012. 
 
Yours sincerely, 
 
Lorna Marie West 
Senior Clinical Pharmacist 
B.Pharm (Hons.) MSc Clin Pharm (Aberdeen) 
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Appendix 4.4: Round 1 Delphi Questionnaire 
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Appendix 4.5: Round 2 Delphi Questionnaire 
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Appendix 4.6: Round 3 Delphi Questionnaire 
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Appendix 4.7: Robert Gordon University Ethics Approval 
 
 
 
 
30th April 2012 
 
Dear Lorna 
 
 
We have reviewed your ethics application for your project ‘Definition of 
medication wastage amongst the Maltese population ‘and it has been approved 
with no changes. The panel recommends that it is of sufficient standard for you 
to proceed to your local ethical review process.  
I attach a copy of our completed review for your files but we do not need you to 
comment formally on any of them but just to consider any of the committee’s 
comments. 
If there are any questions on our response to the ethics submission please do 
not hesitate to get in touch. 
Regards 
 
 
 
Dr Lesley Diack* 
Chair of the School Ethics Review Panel 
 
 
 
 
*In view of potential conflict of interest Prof Diack did not participate in 
discussions for the approval of this research but acted only as endorser and 
signatory as Chair of the School Ethics Review Panel  
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Appendix 4.8: Maltese University Research Ethics 
Committee Approval 
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Appendix 5.1: Approval letter MMAS-8-Item 
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Appendix 5.2: Content Validity of Questionnaires 
 
Content validity overall comments 
 
1. Content validators’ comments in black 
2. Lorna West’s comments in red 
3. Derek Stewart’s comments in purple. No comment means that he agrees with 
Lorna’s comments 
4. Lesley Diack’s comments in green 
 
My comment: Medication samples are not mentioned anywhere in the 
questionnaires. We might want to consider them too and other issues within the 
scope of medication wastage. 
 
Maltese population questionnaire 
Section Validator 1 
A. 
Demographics 
Should this come at end. Discuss with DS but perhaps the more 
“engaging” questionnaires should be at start and demographic at end? 
To be discussed 
Suggest leave as is for the population survey 
I think with population better at the beginning 
Level of education: How about college, technical institute like MCAST 
etc? 
I agree. We can write Sixth form/College/MCAST 
Locality of residence: Is this relevant? Will it add anything else? 
We can correlate our questions to area of residence. Although in Malta 
measure of deprivation cannot be directly linked to locality, it would be 
interesting to correlate results of different areas. I would NOT change 
Occupation: Would it be appropriate to expand this further? E.g. labour 
work, skilled, unskilled 
We are asking for the type of employment. I am afraid that the more we 
add the more we have to define. What is skilled for them. Also 
Employment question was based on the Malta Demographic Review 
2010. So I would NOT change 
I agree and you can justify 
Family members in household: Why only these HCPs? How about physios 
etc? 
These are the same healthcare professionals that we are including as 
participants in the questionnaires. We decided to include only professions 
who either prescribe, dispense or administer medicines. Therefore I 
would NOT include other HC professionals 
This is quite difficult – does prescribing make a difference or having an 
HCP in family make a difference. This is a tricky one 
Question 7: Perhaps note here if yes go to Q8 if no go to Q9? 
I agree 
Question 9: Does this need to be clarified to “privately”? 
I don't think it matters whether it was privately or not. I would NOT 
change 
B. Awareness Questions in this section are about your awareness of and interest in 
medication wastage in Malta: Not sure right word? Attitudes perhaps 
seeing use of Likert scales? 
To a certain extent 'interest' could be seen as a form of 'attitudes'. So  
guess we can change this to 'attitudes' 
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Yes what is interest in this context – how do you quantify it. Attitude 
seems better  
Is statement 6 "I feel that the Government is contributing to the problem 
of medication wastage in Malta" related/covered by statement 5 " I feel 
that the free health system is contributing to the problem of medication 
wastage in Malta"? 
I agree. People in Malta tend to see the free health system as the 
Government. Therefore, I would remove the Government statement 
In bullet questions ? include 'other' category 
I agree 
Should this question "Are you aware of the approximate costs of ALL the 
medication that you take, including any medication that were obtained 
for free from the National Health Service?" be here seeing that those not 
on medicines have also been asked to answer Section B? 
I agree. Probably we should put it as "Are you aware of the approximate 
costs of ALL the medication that you buy?" in Section C and "Are you 
aware of the approximate costs of ALL the medication that you get for 
free from the National Health Service?" in Section D 
C. Current 
practice with 
medication that 
you buy 
"I buy medication from the pharmacy without checking if I already have 
a supply at home": What if a one-off medicine? Perhaps statement 
should be reworded to a more general one? 
I am not sure of this 
I think you should leave as is and see what we get in the pilot 
"I pass medication that I buy to other persons, such as relatives and 
friends": And neighbours? 
I agree. I would change statement to "I pass medication that I buy to 
other persons, such as relatives, neighbours and friends" 
D. Current 
practice with 
medication that 
you get for free 
Title "Current practice with medication that you get for free": ?involving 
instead of with 
I agree 
 
E. Experiences 
with medication 
"use-by" date: How about best before? 
'Best before' date is more connoted with food. I would NOT change 
"Please tell me where in a medication package that you can find the 
expiry date": Reword. Also what is this telling you? 
I would reword to "Please tell me where on a medication package you 
can find the expiry date". I think that this can potentially tell us a lot: if 
patients cannot reply to this then they do not even look at the package 
or do not know that it is there 
"In the last 6 months, did you ever check the expiry date before taking 
any medication?": What about medicines like antibiotic syrups, eye-
drops? 
We can ask if they have any opened antibiotic syrup or eye drops which 
they are not using.  
I would change the wording of this to have you checked the expiry date 
(did you ever – is pejorative) Sorry for not picking this up earlier 
Question 4: "Throw them away": ?dispose 
Since the questionnaire is for the public I would leave as 'throw them 
away' as it is more easy to understand than 'dispose'. i would NOT 
change 
Question 12: "On person": ?reword to “carried around by individual" 
I agree to change this 
F. Taking your 
medication 
Does this section give you any information on wastage? What I mean is, 
is it worth going through all this process for the information that this will 
give you? 
Medication non-adherence can lead to wastage. Therefore, this can help 
in determining the aspect of non-adherence as an indirect link to 
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wastage. However, if we have to decrease the length of questionnaire we 
will remove then this section. For now I would NOT change 
G. Your overall 
health 
Perhaps needs more explanation of the scale? 
I agree. We can add 'Choose a point between 1 and 5' 
 
Section Validator 2 
A. 
Demographics 
"Age category in years": Would ‘what is your age? Be more relevant for 
general population? 
I am not sure  
Suggest leave as is and see what pilot gets 
Between 18 –and 24 years 
I am not sure 
"Gender": change to What is your Gender? 
I am not sure 
"Occupation": Include Self-employed 
Does it really matter for us if they are self-employed or not? I think we 
would complicate things further for nothing. I would NOT add 
I think that might be of interest  
"Are you, or one of your family members living in your household, any of 
the following?": Any other health professional 
We decided to include only professions who either prescribe, dispense or 
administer medicines. Therefore I would NOT include other HC 
professionals 
Will the general public make this distinction – will it matter to them?  
B. Awareness I am not sure how the general public will interpret this. 
To discuss 
Suggest leave for pilot 
"I am fully aware of the extent of medication wastage in Malta": Change 
'extent' to 'issue' 
I agree 
"I feel that I contribute to the problem of medication wastage in Malta": 
Clarify 
I am not sure 
Perhaps leave 
"I feel that dentists are contributing to the problem of medication 
wastage in Malta": ??? Isn’t this a complex term for the general public- 
may be say responsible or partly responsible??? 
I am not sure. To discuss 
Think the suggestion is good – change to responsible 
"I feel that doctors are contributing to the problem of medication 
wastage in Malta": same as above 
I am not sure. To discuss 
"I am fully aware of the consequences of medication wastage in Malta 
on": consequences????? 
I agree that these statements are probably too general and people might 
have different interpretations of them. What could one see as a 
consequence someone else might not. Shall we be more specific? 
Perhaps change to impact 
"I have no interest in the consequences as above of medication wastage 
in Malta on": as above 
I agree that these statements are probably too general and people might 
have different interpretations of them. What could one see as a 
consequence someone else might not. Shall we be more specific? 
What do you want to find out with these questions and then try and 
tailor the question accordingly 
"Pharmacists could do more to reduce medication wastage in Malta": 
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May be will it be worth having some space for open ended comments 
boxes after these? 
I agree 
"Are you aware of the approximate costs of ALL the medication that you 
take, including any medication that were obtained for free from the 
National Health Service?": Costs ??? To whom? 
Probably we should put it as "Are you aware of the approximate costs of 
ALL the medication that you buy?" in Section C and "Are you aware of 
the approximate costs of ALL the medication that you get for free from 
the National Health Service?" in Section D 
C. Current 
practice with 
medication that 
you buy 
 
D. Current 
practice with 
medication that 
you get for free 
 
E. Experiences 
with medication 
"In the last 6 months, do you recall if there were any unused medication  
(medication that a person does not take any longer) in your household?  
Yes (if you ticked this go to question….) No (go to…) I am not sure 
I agree 
F. Taking your 
medication 
"Are you careless at times about taking your medication?": Add regularly 
This is taken from the Morisky medication adherence scale. Therefore, I 
would NOT change 
I really hate this Morisky question and feel that it is not a good question 
and actually asks the wrong question as well as being pejorative. 
However it would give you lots to write about! 
G. Your overall 
health 
 
 
Section Validator 3 
A. 
Demographics 
 
B. Awareness   
C. Current 
practice with 
medication that 
you buy 
 
D. Current 
practice with 
medication that 
you get for free 
 
E. Experiences 
with medication 
"If yes to either questions 9 or 10, where did you get the information 
from? Tick as many responses as you feel necessary.": Will you include 
magazines/ newspaper - sometimes there are these A&H magazine 
which have some information 
I agree 
F. Taking your 
medication 
 
G. Your overall 
health 
 
 
Section Validator 4 
A. 
Demographics 
You would need to make a short introduction to the general public of 
what the study is about (even for HCPs and students). Include definition 
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of medication in your introduction. 
Participants will receive a covering letter including details of the study. I 
agree that we can include a short introduction with glossary of terms. 
Question 7: If no (go to question 9) 
I agree 
"If no, in the last 6 months, have you had a medicine prescribed or have 
you bought any medicines?": change to "If your answer to question 7 is 
no, in the last 6 months, have you had a medicine prescribed or have 
you bought any medicines?" 
I agree 
B. Awareness Is it possible to use some questions the same as for healthcare 
professionals and then compare responses? Only as relevant of course. 
Depending on the number of questionnaires which you intend to send, it 
may be recommendable to add a few open questions to get some in 
depth information which supports the quantitative e.g. What are the 
consequences of wastage (if any)? How can wastage be reduced? 
I agree 
"Are you aware of the approximate costs of ALL the medication that you 
take, including any medication that were obtained for free from the 
National Health Service?": change 'were' to 'are'. 
I agree 
C. Current 
practice with 
medication that 
you buy 
I understand why you do sections C and D but make sure you guide 
patients clearly 
We can give a brief introduction to the section 
Possibly ask whether they buy medicines over the internet - what doctor 
prescribes - they decide on what they need 
I agree 
D. Current 
practice with 
medication that 
you get for free 
 
E. Experiences 
with medication 
"Please tell me where in a medication package that you can find the 
expiry date": Remove that ? question 
Include 'do you have problems with reading the expiry date for eye drops 
etc?' 
I agree 
Ask them an open question - how they dispose of medicines 
We did interviews with patients at two points in time. If you want you 
can use some of our questions and then compare the responses which 
you get with ours. 
I agree. We can adapt some questions from this questionnaire interview 
F. Taking your 
medication 
Storage of medicines, difficulty with taking medicines, do they read the 
information on patient leaflet 
This is taken from the Morisky medication adherence scale. Therefore, I 
would NOT change 
G. Your overall 
health 
 
 
 
Section Validator 5 
A. 
Demographics 
These questionnaires have been well thought out but they look 
intimidatingly long as they are, and when properly formatted, will 
probably span close to ten pages ... People may just not bother. 
I agree. Will decide after formatting of questionnaires and possibly 
piloting 
B. Awareness  
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C. Current 
practice with 
medication that 
you buy 
 
D. Current 
practice with 
medication that 
you get for free 
 
E. Experiences 
with medication 
 
F. Taking your 
medication 
 
G. Your overall 
health 
 
 
Section Validator 6 
A. 
Demographics 
Age: It would be interesting exploring what late teens (16+) think. Many 
countries are increasingly considering 16 year olds as adults e.g. Austria, 
Brazil, Argentina and Nicaragua 
Inclusion criteria state that "Participants must be adults aged 18 years 
and over". Also electoral list contains details of participants aged 18 
years and over. Therefore, I would NOT change 
I agree but the roll will also give you some 17 year old people able to 
vote at next election – so you have to be careful with this. But agree do 
not get side-tracked into the 16+ question 
"Are you, or one of your family members living in your household, any of 
the following?": Can you add also ‘Other Healthcare Professional' 
We decided to include only professions who either prescribe, dispense or 
administer medicines. Therefore I would NOT include other HC 
professionals 
B. Awareness  
C. Current 
practice with 
medication that 
you buy 
 
D. Current 
practice with 
medication that 
you get for free 
 
E. Experiences 
with medication 
 
F. Taking your 
medication 
"Do you ever forget to take your medication?": Shouldn’t we make a 
distinction between someone who forgets on a regular basis and 
someone who forgets only rarely 
This is taken from the Morisky medication adherence scale. Therefore, I 
would NOT change 
G. Your overall   
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HCP questionnaire 
Section Validator 1 
A. Demographics Footer: Does this need to be a footnote? Also does “drugs” need to be 
included too? 
Probably we can remove the term "drugs" since it's never mentioned in 
the questionnaire 
I think still keep drugs in case respondents think about drug wastage 
Age: Needs further break down to cover >65 separately? 
I doubt there are many HC professionals >65 years. Therefore I would 
NOT change 
Profession: How about allied healthcare professionals? Any reason why 
not included? 
We decided to include only professions who either prescribe, dispense 
or administer medicines. Therefore I would NOT include other allied HC 
professionals  
Number of years in profession: ? Needs further breakdown? than 
greater than 20 years 
Possibly right since participants in their 40s would have 20 years’ 
experience. I agree to change 
Question 6: ?Need anything re postgraduate educations 
We could ask them whether they have postgraduate education and 
from where. They might have got their awareness, knowledge, etc 
through post-graduate. I agree to change 
If you are going to put this in – would that be enough? What do we 
want from the question? 
Question 8: Does this question need anything to indicate it is about 
change? 
We can change the statement in line with the student questionnaire to 
read "Please tick one of the following which best describes you in 
relation to how you change in your professional practice:" 
Perhaps reword ‘in relation to changes to your professional practice’ 
B. Awareness Scale: Why not have these as a number and they just rank putting no 
in? 
We are testing each and every statement not ranking them in order of 
preference. Therefore I would NOT change 
"Medication wastage encompasses any medication which expires or 
remains unused throughout the whole medicines supply chain 
(medicines supply chain refers to the manufacturing, storage, transport 
and handling of medicines until these reach the consumer) and during 
use by the patient": Why not put the definition as a footnote? Overall I 
think this statement is very cumbersome and needs rewording 
We are actually testing this definition which was derived from the 
Delphi study. So cannot put as footnote or simplify it. I would NOT 
change. 
"Medication wastage encompasses the unnecessary or inappropriate 
consumption of medication by patients": Is the patient not part of the 
chain? Is this part of medication wastage? By inappropriate I would 
understand even inappropriate dosing etc…. 
Whilst I agree with the comment, we are actually testing this definition 
which was derived from the Delphi study. I would NOT change. 
"Medication wastage encompasses the unjustified non-adherence to 
treatment guidelines by healthcare professionals": Reword 
We are actually testing this definition which was derived from the 
Delphi study. So cannot reword. I would NOT change. 
Bullet point questions: Add 'other' category 
I agree 
C. Perception "Perceptions regarding factors potentially leading to medication 
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wastage": Or is it views and attitudes? I would associate perceptions as 
qualitative methods 
I am not sure about this comment 
I think that ‘perceptions’ is OK 
Nor am I – not sure you need to do anything? 
" For each statement listed below, rate in your opinion the level of 
contribution each factor  has towards medication wastage.": Would 
take out – is it not their opinion you are seeking? 
I agree to remove the term 'in your opinion' 
I agree it is superfluous 
Headings: Do you need these headings? 
I think the headings give a more systematic layout to the questionnaire 
therefore I do NOT agree in removing them 
"Unused medication within expiry dates not accepted by for reuse": 
Unclear statement - reword 
We can change to "Medication that remain unused within their expiry 
dates are not accepted  for reuse" 
"Inappropriate storage of medication": Medicines such as eye drops – 
“Use within----- days of opening?” 
We can ask this but I think we will complicate the questionnaire. To 
discuss 
I agree that this could complicate things so suggest leave 
I think this is quite an important issue but is it one that you want to 
address in your research? 
"Hoarding by patients due to dependency on others to collect 
medication supply": Reword to include “access problems?” 
I am not sure 
Perhaps there are 2 issues here. Suggest change to - hoarding by 
patients (there could be lots of reasons) 
I must admit I don’t like the word ‘hoarding’ it has connotations to it – 
it could be seen as pejorative and even biased. Would storage be 
appropriate? 
How about patient’s beliefs in all this? 
I am not sure 
Perhaps you could include a statement on patients’ beliefs around 
wastage 
You can only ask Patient’s beliefs in their questionnaire not the HCPs or 
student one? Do you want to do that in the questionnaire?  
Inadequate training of healthcare professional students about monetary 
cost of medication": Delete all 
I am not sure that we need to delete this. I believe if students knew 
more about costs of medication it can make a difference. I would NOT 
delete 
"Medication easily purchased from pharmacies": Prescription only 
medicines. Perhaps include without the need for a valid prescriptions 
We can add 'without the need for a valid prescription' 
D. Current 
practice, views 
and experiences 
Does attitudes come into this? 
This includes attitudes 
Is an “other” point required in all bullet point questions? 
I agree 
E. Education and 
training 
Scale: Why not have these as a number and they just rank putting no 
in? 
We are testing each and every statement not ranking them in order of 
preference. Therefore I would NOT change 
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Section Validator 2 
A. 
Demographics 
Is wastage the same as waste? 
Yes. We can include this in the footnote too 
"Age category in years": change to Your Age category in years: 
I prefer just 'age' rather than 'Your age'. I would NOT change 
"Gender": change to Your gender 
I prefer just 'gender' rather than 'Your gender'. I would NOT change 
"Profession": change to Your profession 
I prefer just 'profession' rather than 'Your profession'. I would NOT 
change 
"Government post": change to Government post or public sector 
I agree 
"Employed privately": change to Private sector 
I agree 
B. Awareness "Questions in this section are about your awareness of and interest in 
medication wastage in Malta and your professional practice": This 
instruction should be reworded for clarity 
We could change to "Questions in this section are about your awareness 
of/interest in medication wastage in Malta and in relation to your 
professional practice" 
"For each statement listed below, rate your level of agreement." 
State as please rate 
I agree 
For bullet point questions: Will they rank for individual bullet points here 
or for number 7 as a whole? 
They will rank for each bullet point 
The reviewers have not really understood this perhaps the instructions 
need more clarity 
For bullet point questions: how is public health different to society, 
patients and environment? 
I agree with comment. Although it can be considered differently it is not 
clear. I would remove it  
"I have no interest in the factors potentially leading to medication waste 
in Malta": waste versus wastage I agree; Do you need to define 
medication wastage right at the beginning although you have asked to 
rank their agreement with your definition, some of them won't know 
about this. 
We are actually testing the definition. Therefore, cannot define 
medication wastage at the beginning. Therefore I would NOT change 
"I have no interest in laws, procedures and policies relating to 
medication waste in Malta": Are these same or different terms- seems 
quite a lot asked- procedure regarding what? 
These are different terms 
C. Perception In general, you could reduce the number of items, some of them could 
be merged- those will similar themes. 
I am not sure we can merge further 
I agree with you and we can try this in the analysis of the data 
Titles such as "Physical and environmental factors": I don’t think these 
titles should be there- these could bias opinions. 
I think the headings give a more systematic layout to the questionnaire. 
However, it is true these can possibly bias opinions. Shall we remove? 
Agree with you to keep 
I would leave these as they add structure 
"Unused medication within expiry dates not accepted by for reuse": by 
whom? 
Remove the word 'by' 
"Patients getting advice form more than one healthcare professional, 
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family and friends": regarding what? 
Shall we add 'regarding use of medication'? 
Agree with you to add 
Happy to do this 
"Medication non-adherence to medication regimens by patients": remove 
first medication 
I agree 
"Medication stopped by patient due to perceived ineffectiveness": This 
could be difficult for patients to understand. 
This questionnaire will be completed by healthcare professionals 
"Inadequate training of healthcare professional students about 
medication wastage" and   
"Inadequate training of healthcare professional students about monetary 
cost of medication": Revise these sentences 
I am not sure 
I think they are OK 
I wonder if instead of inadequate you use lack of.  
"Healthcare professionals unaware of cost of medication": change to 
"Healthcare professionals lack of awareness of cost of medication" 
I agree 
"Lack of communication about medication between healthcare system 
and patients": healthcare system???? 
I agree that it is not clear. We can change 'healthcare system' to 
'healthcare provider' 
"Medication stopped by doctor due to ineffectiveness": Unclear 
We can change to "Medication stopped by doctor due to ineffectiveness 
of the medication" 
"Over-dispensing": I do not understand this 
Change to "extra medication supply dispensed to patients" 
"Healthcare professional perceptions of patients' expectations to receive 
medication": Unclear 
We can change to "Healthcare professional perceiving that patients 
expect to receive a medication" 
"Medication obtained for free through the National Health System are 
regularly out of stock": How is this different to "free healthcare system" 
The first includes only the free healthcare system, the second includes 
the out of stock situation of free medication 
D. Current 
practice, views 
and 
experiences 
Scale: How about – never, hardly ever……mostly, always 
Although different scales are suitable, the one chosen followed a 
reference 
"I could be more active in reducing medication wastage in Malta": This 
sentences and some below do not align to the options [scale] above. 
To discuss 
"I routinely advise patients on": Again does it align to above [scale] 
To discuss 
I think these are OK 
E. Education 
and training 
" I have had sufficient education and training related to medication 
wastage": ?chances of double positive if participants choose agree option 
I agree. However, I am not sure if it makes sense separating education 
and training in two statements 
I would leave as these 2 are usually considered together 
I would separate as they are different but you could just ask it slightly 
differently 
"The next phase of the research will involve focus groups...": Will they 
understand this? 
Together with the questionnaire they will receive a covering letter giving 
details about the focus group study 
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Section Validator 3 
A. 
Demographics 
"Government post": should it be public sector? 
I agree 
Question 8 "Please tick one of the following which best describes you in 
relation to your professional practice: I resist new ways of working ...": 
Maybe it’s me but I’m not sure i understand “new ways of working” well 
– is it referring to changing your practice in your current post or with 
relation to other people and new positions?  
To discuss 
B. Awareness Some of the statements have full stops, others not. Also will these be 
spaced out a bit more in the actual questionnaire? 
There will be formatting of questionnaires using SNAP® 
C. Perception "Medication non-adherence to medication regimens by patients": I think 
I would remove the first medication and state: Non-adherence to 
medication regimens by patients 
I agree 
"Unnecessary sold-medication": Meaning the pharmacist sold the 
incorrect medication or he sold a medication that the patient didn’t need? 
We can change to "medication sold unnecessarily without an indication to 
a patient " 
D. Current 
practice, views 
and 
experiences 
"Family members put me under pressure to 
prescribe/dispense/administer medication which I consider to be 
unnecessary": Family members of the patients or of the professional? 
I agree. I would change to 'family members of patients' 
E. Education 
and training 
Will you be putting boxes next to each response 
Yes 
"If you have responded 'Yes' to the above question, please refer to the 
enclosed invitation to participate letter for further details about this 
study": This will be separate to ensure confidentiality 
Yes 
 
Section Validator 4 
A. 
Demographics 
General comment: For most questions I would also include 'Other' at the 
end so that maybe they come up with other ideas rather than just being 
restrained by your list 
I agree 
Make footer smaller font and clearly a footer. Refer to it in text - e.g. by 
1 superscript 
I agree. There will be formatting of questionnaires using SNAP® 
I would put footer in the front page too - possibly make a short glossary? 
E.g. what do you mean by healthcare professionals? 
"Government post": change to Government services 
I agree 
"Other countries where you have practiced": Why do you assume that 
they practised in Malta? 
Inclusion criteria state that participants must have a license to practise 
in Malta 
"I am venturesome and willing to take risks with new ways of working": I 
would not use the word risk. Risk has a negative connotation. 'Be 
innovative' with new ways of working 
I agree. I would change 'risk' to 'be innovative' 
B. Awareness Comment: Medication wastage also refers to inappropriate prescribing by 
doctor, taking of medicines by patient 
Whilst I fully agree with this comment we are actually testing the 
definition. Therefore I would NOT change 
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"Medication wastage encompasses the unjustified non-adherence to 
treatment guidelines by healthcare professionals": What makes it 
justifiable - to whom? 
We are actually testing the definition. Therefore I would NOT change 
"Medication wastage poses a financial burden on patients themselves, 
the state's economy and requires adequate education of all people 
concerned": Have you defined the people concerned? Who is concerned? 
Whilst I fully agree with this comment we are actually testing the 
definition. Therefore I would NOT change 
" I am fully aware of the extent of medication wastage in Malta": ? 
knowledge of the extent? 
Different participants might have a different opinion of what extent is for 
them. Maybe we need to reword 
I suggest we leave as it is – we are interested in their perceptions rather 
than if they actually know the extent 
I agree – this is a difficult question to get the wording  
I am not sure whether these questions [5, 7 and 9] reflect the [Health 
Belief] model - achieve the intentions of the mode - check this 
I need to check this. To discuss 
I think it is OK – you could do an entire PhD on the health belief model 
"I have no interest in laws, procedures and policies relating to 
medication waste in Malta": Ask them what the laws/procedures are too 
- as another question and thus correlate what they belief and what they 
know correlate well 
I agree 
C. Perception "Unused medication within expiry dates not accepted by for reuse": by 
whom? 
I agree. To remove word 'by' or else say by whom 
"Patients' expectations to receive medication": To be prescribed? To be 
supplied with medication? 
We can change to "Patients' expectations to receive a prescription for 
medication" 
"Hoarding by patients due to fear of refusal of medication supply by 
healthcare professionals": ? refuse to prescribe? problems with 
entitlement? 
I agree. We can change to "Hoarding by patients due to fear of refusal of 
medication supply due to entitlement problems by healthcare 
professionals" 
This seems to be very long now – are there 2 statements here? 
"Medication non-adherence to medication regimens by patients": remove 
first medication 
I agree 
"Unnecessary sold-medication": ? or dispensed 
I agree. We can change to "Medication dispensed unnecessarily" 
"Medication stopped by doctor due to resolution of patient's symptoms": 
response to treatment  
I agree. We can change to "Medication stopped by doctor due to 
patient's response to treatment" 
D. Current 
practice, views 
and 
experiences 
"Patients bring me unwanted or unused medication" 
I agree 
"Medication supplied to patients and returned to me within their expiry 
dates should be reused": Why did you choose this rather than 'should 
not be reused' 
Using the word not can lead to double negatives and confusion. So I 
would NOT change 
"As a consumer of healthcare, I contribute to medication wastage in 
Malta": ? this is for healthcare professional 
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I agree. Probably we should remove this statement 
Yes I agree unless you feel that they would have a different view as a 
consumer from their professional life – and are interested in capturing 
the dichotomy 
E. Education 
and training 
You should leave the scale consistent for all questions as much as 
possible 
I agree 
I think/ consider that training in medication wastage is useful   essential 
"Dentistry/ Medicine/ Nursing/ Pharmacy": Determine a system for order 
e.g. alphabetical and keep it throughout 
I agree 
 
Section Validator 5 
A. 
Demographics 
These questionnaires have been well thought out but they look 
intimidatingly long as they are, and when properly formatted, will 
probably span close to ten pages ... People may just not bother. 
I agree. Will decide after formatting of questionnaires and possibly 
piloting 
Snap should help with this 
B. Awareness  
C. Perception  
D. Current 
practice, views 
and 
experiences 
 
E. Education 
and training 
 
 
Section Validator 6 
A. 
Demographics 
I find the questionnaire comprehensive and in essence excellent. I made 
some minor corrections 
Spelling mistakes corrected 
B. Awareness  
C. Perception  
D. Current 
practice, views 
and 
experiences 
 
E. Education 
and training 
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HCP student questionnaire 
Section Validator 1  
A. 
Demographics 
Should this come at end. Discuss with DS but perhaps the more 
“engaging” questionnaires should be at start and demographic at end? 
To be discussed 
Don’t think really matters 
Footer: Does this need to be a footnote? Also does “drugs” need to be 
included too? 
Probably we can remove the term "drugs" since it's never mentioned in 
the questionnaire.  
Age: > 33 years: Does there need to be an older categories too such as 
mature nursing students? 
Not sure of this 
Course of study: How about allied healthcare professionals? Any reason 
why not included? 
We decided to include only professions who either prescribe, dispense or 
administer medicines. Therefore I would NOT include other HC 
professionals 
Year of study: Any reason why first year omitted? 
Inclusion criteria states that "Students must be in their final or pre-final 
year of their undergraduate course as most of the topics in the 
curriculum would have been covered by then". All course have five years 
(therefore fourth and fifth year will be included), except nursing which 
has three years (therefore second year and third year will be included).  
"Are you, yourself , currently on any regular medication?": Remove 
'yourself' 
I agree 
"If no, in the last 6 months, have you had a medicine prescribed or have 
you bought any medicines?": Do you need to include “over-the-counter 
from a pharmacy”? 
I agree 
"Please tick one of the following which best describes you in relation to 
how you change, for example ways of working or studying:": Or how do 
you react/adjust to change? 
I agree 
B. Awareness "If yes, where did you hear about 'medication wastage'?": Discussion 
with peers? Social media? 
I agree 
"What does 'medication wastage' mean to you?": Maybe reword to” what 
do you understand by the term medication wastage? 
I agree 
Scale: Why not have these as a number and they just rank putting no 
in? 
We are testing each and every statement not ranking them in order of 
preference. Therefore I would NOT change 
"Medication wastage encompasses any medication which expires or 
remains unused throughout the whole medicines supply chain (medicines 
supply chain refers to the manufacturing, storage, transport and 
handling of medicines until these reach the consumer) and during use by 
the patient": Why not put the definition as a footnote? Overall I think 
this statement is very cumbersome and needs rewording 
We are actually testing this definition which was derived from the Delphi 
study. So cannot put as footnote or simplify it. I would NOT change. 
"Medication wastage encompasses the unnecessary or inappropriate 
consumption of medication by patients": Is the patient not part of the 
chain? Is this part of medication wastage? By inappropriate I would 
understand even inappropriate dosing etc…. 
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Whilst I agree with the comment, we are actually testing this definition 
which was derived from the Delphi study. I would NOT change. 
"Medication wastage encompasses the unjustified non-adherence to 
treatment guidelines by healthcare professionals": Reword 
We are actually testing this definition which was derived from the Delphi 
study. So cannot reword. I would NOT change. 
Bullet point questions: Add 'other' category 
I agree 
C. Perception "Perceptions regarding factors potentially leading to medication 
wastage": Or is it views and attitudes? I would associate perceptions as 
qualitative methods 
I am not sure about this comment 
Perhaps this indicates that there needs to be discussion somewhere 
about why perceptions??  
" For each statement listed below, rate in your opinion the level of 
contribution each factor  has towards medication wastage.": Would take 
out – is it not their opinion you are seeking? 
I agree to remove the term 'in your opinion' 
Headings: Do you need these headings? 
I think the headings give a more systematic layout to the questionnaire 
therefore I do NOT agree in removing them 
"Unused medication within expiry dates not accepted by for reuse": 
Unclear statement - reword 
We can change to "Medication that remain unused within their expiry 
dates are not accepted  for reuse" 
"Inappropriate storage of medication": Medicines such as eye drops – 
“Use within----- days of opening?” 
We can ask this but I think we will complicate the questionnaire. To 
discuss 
"Hoarding by patients due to dependency on others to collect medication 
supply": Reword to include “access problems?” 
I am not sure 
How about patient’s beliefs in all this? 
I am not sure 
Inadequate training of healthcare professional students about monetary 
cost of medication": Delete all 
I am not sure that we need to delete this. I believe if students knew 
more about costs of medication it can make a difference. I would NOT 
delete 
"Medication easily purchased from pharmacies": Prescription only 
medicines. Perhaps include without the need for a valid prescriptions 
We can add 'without the need for a valid prescription' 
D. Current 
practice, views 
and 
experiences 
I find this overall very long – will this influence questionnaire 
completion? 
I agree. Will decide after formatting of questionnaires and possibly 
piloting 
"Dentists could be more active in reducing medication wastage in Malta": 
Reword to: take on a more active role? 
I agree 
"In my view, dentists routinely advise patients on:": Reword to “to my 
knowledge 
I am not sure 
Agree that this is better 
"In my view, other health professionals have more responsibility than 
dentists to advise patients on:": Why specifically dentists? 
This will be specific to each profession depending on who is filling in the 
questionnaire 
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"When I graduate, I intend considering medication wastage when 
prescribing/dispensing/administering medication": How about patient 
education? 
We can add another statement "When I graduate, I intend to regularly 
educate patients about medication wastage" 
Agree 
Check number ordering. Statements 21-24 perhaps better placed after 
statement 14 
To be discussed 
E. Education 
and training 
Scale: Why not have these as a number and they just rank putting no 
in? 
We are testing each and every statement not ranking them in order of 
preference. Therefore I would NOT change 
 
Section Validator 2 
A. 
Demographics 
"Age category in years": change to Your Age category in years (please 
circle/tick etc): 
I am not sure about this. I prefer 'age category in years' 
"Are you, yourself, currently on any regular medication?": I am not sure 
the relevance of asking this question to the health profession students. 
We can correlate the difference between responses of students who take 
medication versus ones who do not. However, not sure myself 
Agree with you 
Would this change an answer – perhaps could be seen in a pilot but not 
sure that important 
B. Awareness  
C. Perception  
D. Current 
practice, views 
and 
experiences 
 
E. Education 
and training 
 
 
Section Validator 3 
A. 
Demographics 
Check re spelling mistakes 
Spelling mistakes corrected 
B. Awareness  
C. Perception  
D. Current 
practice, views 
and 
experiences 
 
E. Education 
and training 
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Section Validator 4 
A. 
Demographics 
"health professional students": Is this the 'correct' term? It doesn't ring 
well. Check journals etc and see what terms they use 
I need to check 
B. Awareness  
C. Perception  
D. Current 
practice, views 
and 
experiences 
 
E. Education 
and training 
Maybe you ask them whether their curriculum contains any coverage of 
your subject 
I agree 
 
Section Validator 5 
A. 
Demographics 
These questionnaires have been well thought out but they look 
intimidatingly long as they are, and when properly formatted, will 
probably span close to ten pages ... People may just not bother. 
I agree. Will decide after formatting of questionnaires and possibly 
piloting 
B. Awareness  
C. Perception  
D. Current 
practice, views 
and 
experiences 
 
E. Education 
and training 
 
 
Section Validator 6 
A. 
Demographics 
I find the questionnaire comprehensive and in essence excellent. I made 
some minor corrections 
Spelling mistakes corrected 
B. Awareness  
C. Perception  
D. Current 
practice, views 
and 
experiences 
 
E. Education 
and training 
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Appendix 5.3: Maltese Public Questionnaire 
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Dear Sir/Madam 
 
We would like to invite you to take part in a research study. It is important that you understand why the research 
is being done and what it will involve. Thank you for taking the time to read this information carefully. Ask us if 
there is anything that is not clear or if you would like further information. Take time to decide whether or not you 
wish to participate.  
 
What is the purpose of the study? 
Medication wastage is a major problem amongst many countries. The purpose is to investigate awareness, 
perceptions, attitudes and behaviours amongst the Maltese population, healthcare professionals and students about 
medication which is wasted. 
 
Why have I been chosen? 
You have been chosen at random from all the members of public in Malta as per the electoral list 2013.   
 
Do I have to take part? 
No. Participation in the study is voluntary. 
 
What will happen to me if I take part? 
To take part in the study, we ask that you complete the enclosed questionnaire which should take no more than 
about 15 minutes. 
 
What are the possible benefits of taking part? 
There is no direct benefit to you from taking part. However, completion of the questionnaire will help to identify 
possible causes of medication wastage in our country. 
 
Will my taking part in this study be kept confidential? 
Yes. This study is not anonymous but information will be kept completely confidential.  
 
What will happen to the results of the research study? 
The main findings of the study will be published in a healthcare journal and on the University website. You may 
request a copy of the publication or report.  
 
Who is organizing and funding the research? 
This project is organized by Robert Gordon University in Scotland and partially funded by the Malta Government 
Scholarship Scheme. 
 
Who has reviewed the study? 
This study has been approved by the Ethical Review Panel of the School of Pharmacy & Life Sciences at Robert 
Gordon University and the Maltese University Research Ethics Committee.   
 
To participate in this study, please complete the questionnaire within 2 weeks and send it back to us 
using the enclosed paid self-addressed envelope. The information in Part 2 at the end of the 
questionnaire is about focus groups that will take place later on this year. It is OK to return the 
questionnaire even if you are not interested in taking part in the focus groups. 
 
Yours sincerely 
Lorna Marie West 
Contact number 99893001   
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Section A, Demographics 
Questions in this section are about you. Please tick only one answer. 
 
1. You are 
 
 □Female  □Male 
 
 
2. Your age is 
 
 □18-24 years  □25-34 years  □35-44 years  □45-54 years 
 
 □55-64 years  □65-74 years  □75-84 years  □85 and over 
 
 
3. Your level of education is 
 
 □No schooling     □Primary (Year 1 till Year 6)  
 
□Secondary (Form 1 till Form 5)  □Post secondary (Sixth form/College/ MCAST) 
 
□Tertiary (University)    □Post-graduate education 
 
  
4. Your locality of residence is __________________________ 
 
 
5. Your occupation is 
 
 □Employed, please specify the type of employment __________________________ 
 
 □Unemployed  
 
□Pensioner 
 
□Student 
 
□Other, please specify__________________________ 
 
 
6. Are you, or one of your close family members, any of the following?  
□Dentist  □Doctor  □Nurse  □Pharmacist  □No   
 
7. Are you taking or using any regular medications (medications that you have to take or use every day)? 
 □Yes (go to question 8)  □No (go to question 9) 
 
  
8. If yes, how do you obtain these medications? You may tick more than one answer. 
 
 □Free on yellow or pink card   □I or a family member pays for them 
  
 □The doctor gives me free samples  □Other, please specify__________________________ 
 
 
9. In the last 6 months, have you had a medication prescribed or have you bought any medications? 
□Yes I had a medication prescribed   
 
□Yes I bought medications over-the-counter  
 
 □No 
If you replied 'No' to question 9 please complete only Section B of the questionnaire and then return the 
questionnaire. If you replied 'Yes' to question 9 please complete the whole questionnaire.
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Section B, Awareness of Medication Wastage  
Please rate your level of agreement or disagreement with each of the following statements 
 
Statements Strongly 
disagree 
Disagree Unsure Agree Strongly 
agree 
I am fully aware of the issue of medication wastage 
in Malta 
□ □ □ □ □ 
I have no interest in the issue of medication wastage 
in Malta 
□ □ □ □ □ 
I feel that I contribute to the issue  of medication 
wastage in Malta 
□ □ □ □ □ 
I feel that other people are contributing to the issue 
of medication wastage in Malta 
□ □ □ □ □ 
I feel that the free health system is contributing to 
the issue of medication wastage in Malta 
□ □ □ □ □ 
I feel that dentists are responsible for the issue of 
medication wastage in Malta 
□ □ □ □ □ 
I feel that doctors are responsible for the issue of 
medication wastage in Malta 
□ □ □ □ □ 
I feel that nurses are responsible for the issue of 
medication wastage in Malta 
□ □ □ □ □ 
I feel that phamacists are responsible for the issue of 
medication wastage in Malta 
□ □ □ □ □ 
I am fully aware of the impact of medication wastage 
in Malta on patients 
□ □ □ □ □ 
I am fully aware of the impact of medication wastage 
in Malta on healthcare professionals 
□ □ □ □ □ 
I am fully aware of the impact of medication wastage 
in Malta on society 
□ □ □ □ □ 
I am fully aware of the impact of medication wastage 
in Malta on the economy 
□ □ □ □ □ 
I am fully aware of the impact of medication wastage 
in Malta on the environment 
□ □ □ □ □ 
I am fully aware of the impact of medication wastage 
in Malta on other, please specify_________ 
□ □ □ □ □ 
I have no interest in the impact of medication 
wastage in Malta on patients 
□ □ □ □ □ 
I have no interest in the impact of medication 
wastage in Malta on healthcare professionals 
□ □ □ □ □ 
I have no interest in the impact of medication 
wastage in Malta on society 
□ □ □ □ □ 
I have no interest in the impact of medication 
wastage in Malta on the economy 
□ □ □ □ □ 
I have no interest in the impact of medication 
wastage in Malta on the environment 
□ □ □ □ □ 
I have no interest in the impact of medication 
wastage in Malta on other, please specify_________ 
□ □ □ □ □ 
I feel that I could do more to reduce medication 
wastage in Malta 
□ □ □ □ □ 
I feel confident in my ability to reduce medication 
wastage in Malta 
□ □ □ □ □ 
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Please rate your level of agreement or disagreement with each of the following statements 
 
Statements Strongly 
disagree 
Disagree Unsure Agree Strongly 
agree 
Dentists could do more to reduce medication 
wastage in Malta 
□ □ □ □ □ 
Please provide any comments you would like to make 
 
 
 
 
Doctors could do more to reduce medication wastage 
in Malta 
□ □ □ □ □ 
Please provide any comments you would like to make 
 
 
 
 
Nurses could do more to reduce medication wastage 
in Malta 
□ □ □ □ □ 
Please provide any comments you would like to make 
 
 
 
 
Pharmacists could do more to reduce medication 
wastage in Malta 
□ □ □ □ □ 
Please provide any comments you would like to make 
 
 
 
 
The state could do more to reduce medication 
wastage in Malta 
□ □ □ □ □ 
Please provide any comments you would like to make 
 
 
 
 
Medications supplied to patients and returned, within 
their expiry dates, to healthcare professionals should 
be reused 
□ □ □ □ □ 
What, in your opinion, are the causes or reasons that could be leading to medication wastage in Malta? 
 
 
 
 
What, in your opinion, are the consequences (if any) of medication wastage? 
 
 
 
 
How, in your opinion, can medication wastage be reduced? 
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Section C, Current practice involving medications that you buy 
Questions in this section are ONLY about medications that you buy. This includes buying over-the-counter (e.g. 
paracetamol) or prescription medications from a pharmacy, health shops or the internet. 
 
If you do not buy any medications tick the box Not Applicable □ 
 
For each statement listed below, tick the option which you feel mostly relates to you. 
 
Statements Strongly 
disagree 
Disagree Unsure Agree Strongly 
agree 
I buy all my medications regularly whether 
or not I have run out of them 
□ □ □ □ □ 
I buy all my medications only when I run 
out of them 
□ □ □ □ □ 
I buy more medication than I need  □ □ □ □ □ 
I buy medications without checking if I 
already have a supply at home 
□ □ □ □ □ 
I pass medications that I buy for myself to 
other persons, such as relatives, 
neighbours and friends 
□ □ □ □ □ 
I buy different medications for the same 
condition as I follow the advice of different 
people 
□ □ □ □ □ 
When I visit the dentist, doctor, 
pharmacist, nurse, I put them under 
pressure to supply me medications 
□ □ □ □ □ 
I buy medications depending on what I 
read in books, magazines, internet 
□ □ □ □ □ 
I get medications from other people  □ □ □ □ □ 
I am aware of the approximate costs of 
the medications that I buy 
□ □ □ □ □ 
 
Section D, Current practice involving medications that you get for free 
Questions in this section are ONLY about medications that you get for free through the National Health System.  
 
If you do not get any free medications tick the box Not Applicable □ 
 
For each statement listed below, tick the option which you feel mostly relates to you. 
 
Statements Strongly 
disagree 
Disagree Unsure Agree Strongly 
agree 
I get all my free medications regularly 
whether or not I have run out of them 
□ □ □ □ □ 
I get all my free medications only when I 
run out of them 
□ □ □ □ □ 
I get more free medication than I need □ □ □ □ □ 
I get free medications from the 
pharmacy without checking if I already 
have a supply at home 
□ □ □ □ □ 
I pass medications that I get for free to 
other persons, such as relatives, 
neighbours and friends 
□ □ □ □ □ 
I am aware of the approximate costs of 
the medications that I get for free from 
the National Health Service 
□ □ □ □ □ 
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Section E, Experiences with medications  
Questions in the section are about your experiences with medications which you either buy or get for free 
 
Are you aware that all medications have an expiry date (the "use-by" date)? 
 
    □Yes                                  □No              □I am not sure 
 
Please tell me where on a medication package you find the expiry date 
 
Do you have problems with reading the expiry date?  
 
    □Yes                                   □No              □I am not sure 
 
Where do you currently store any medications that you have? Tick as many responses as you feel necessary. 
 
    □Medication cabinets in the kitchen  
    □Medication cabinets in the bedroom    
    □Medication cabinets in the bathroom 
    □Medication cabinets in the garage 
    □Cupboard in the kitchen  
    □Cupboard in the bedroom    
    □Cupboard in the bathroom 
    □Cupboard in the garage 
    □Office 
    □Car 
    □Fridge 
    □Carried around by individual 
    □Other, please specify_________________________ 
 
Do you recall who gave you the information on where to store the medications? Tick as many responses as you feel 
necessary. 
 
    □No one                                          □Dentist             □Doctor 
    □Nurse                                          □Pharmacist  □Television/ Radio 
    □Internet                                          □Friend             □Magazines/ Newspapers 
    □Information leaflet supplied with medication 
    □Other, please specify_________________________ 
 
In the last 6 months, do you recall if there were any unused medications in your household? 
 
    □Yes                                         □No      □I am not sure 
If yes, do you remember the reason why these unused medications remained unused? Tick as many responses as 
you feel necessary. 
 
    □Medication changed    
    □Condition got better 
    □Medication expired 
    □There was extra stock  
    □Patient passed away    
    □Stopped by patient 
    □I cannot remember 
    □Other, please specify_________________________ 
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If you end up with unused medications which are not expired yet, what would you do with them? Tick as many 
responses as you feel necessary. 
 
    □Throw them away with the household rubbish 
    □Throw them down the toilet or sink 
    □Give them to a pharmacy to give them to someone else 
    □Give them to another person or friend 
    □Take them to a medication disposal bring-in-site 
    □Give them to a pharmacy to dispose of them 
    □Keep them for possible future use 
    □Sell these medications 
    □Give to charity 
    □I do not know 
    □Other, please specify_________________________ 
If you end up with unused medications which are expired, what would you do with them? Tick as many responses 
as you feel necessary. 
 
    □Throw them away with the household rubbish 
    □Throw them down the toilet or sink 
    □Give them to a pharmacy to give them to someone else 
    □Give them to another person or friend 
    □Take them to a medication disposal bring-in-site 
    □Give them to a pharmacy to dispose of them 
    □Keep them for possible future use 
    □Sell these medications 
    □Give to charity 
    □I do not know 
    □Other, please specify_________________________ 
Do you remember who gave you the information on how to dispose (get rid) of unused or expired medications? 
Tick as many responses as you feel necessary. 
 
    □No one                                          □Dentist             □Doctor 
    □Nurse                                          □Pharmacist  □Television/ Radio 
    □Internet                                          □Friend             □Magazines/ Newspapers 
    □Information leaflet supplied with medication                               □Other, please specify_______________ 
Do you feel you have enough information on how to take all of your medications to get the most benefit from them 
(including medications which are used only occasionally)? 
 
    □Yes                                         □No   □I am not sure 
Do you feel you have enough information on how to take all of your medications to get the least side-effects from 
them (including medications which are used only occasionally)? 
 
    □Yes                                         □No   □I am not sure 
If yes to either of the last two questions, where did you get the information from? Tick as many responses as you 
feel necessary. 
 
    □I do not know                                    □Dentist             □Doctor 
    □Nurse                                          □Pharmacist  □Television/ Radio 
    □Internet                                          □Friend             □Magazines/ Newspapers 
    □Information leaflet supplied with medication                               □Other, please specify________________ 
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Section F, Taking your medications  
Questions in this section are about how you take your medications. Please complete this section if you take regular 
medications (medications that you have to take or use every day) or if you had a medication prescribed during the 
past two weeks.  
 
You indicated that you are taking medication for your health. Individuals have identified several issues regarding 
their medication-taking behaviour and we are interested in your experiences. There is no right or wrong answer. 
Please answer each question based on your personal experience with your medication. 
 
Tick the correct answer from "Yes" or "No". 
 
Do you sometimes forget to take your pills? 
    □Yes 
    □No    
People sometimes miss taking their medications for reasons other than forgetting. Thinking over the past two 
weeks, were there any days when you did not take your medicine? 
    □Yes 
    □No    
Have you ever cut back or stopped taking your medication without telling your doctor, because you felt worse 
when you took it? 
    □Yes 
    □No    
When you travel or leave home, do you sometimes forget to bring along your medication? 
    □Yes 
    □No    
Did you take your medicine yesterday? 
    □Yes 
    □No    
When you feel like your health is under control, do you sometimes stop taking your medicine? 
    □Yes 
    □No    
Taking medication everyday is a real inconvenience for some people. Do you ever feel hassled about sticking to 
your treatment plan? 
    □Yes 
    □No    
How often do you have difficulty remembering to 
take all your medications?                                                                            
Never/ 
Rarely 
□ 
Once in a 
while 
□ 
Sometimes 
 
□ 
Usually 
 
□ 
All the 
time 
□ 
 
 
Section G, Your overall health  
This question is about your overall health. Choose a point between 1 and 5 
 
      1 = As bad as it could be  5 = As good as it could be 
 
Statements 1 2 3 4 5 
How would you rate your health in the past 6 
months? 
□ □ □ □ □ 
 
 
Please give any other comments you have on medication wastage in Malta 
 
 
 
I would like to thank you for completing this questionnaire. Your contribution is of valuable importance 
to this research. Please return in the reply paid envelope.
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Dear Sir/Madam 
 
We would like to invite you to take part in a research study. It is important that you understand 
why the research is being done and what it will involve. Thank you for taking the time to read 
the following letter carefully. Ask us if there is anything that is not clear or if you would like 
further information. Take time to decide whether or not you wish to participate.  
 
What is the purpose of the study? 
The purpose of this part of the research is to allow for more discussion on experiences and views 
on medication wastage, and possible ways to reduce this in Malta.  
 
Do I have to take part? 
No. You do not have to take part and it is okay if you change your mind after sending back the 
questionnaire.  
 
What will happen to me if I take part? 
We ask that you complete the attached short form. We will then contact you to check that you 
are still interested in taking part and give you a date, time and venue for the focus group 
meeting. The group discussion will not last longer than 90 minutes. Refreshments will be served 
during the discussions.   
 
What are the possible benefits of taking part? 
There is no direct benefit to you from taking part. However, participation in this study will help 
to identify possible causes of medication wastage in our country. 
 
Will my taking part in this study be kept confidential? 
Yes. We will audio-record the discussions. These will then be written out in full. The recording 
will be deleted when the study is finished. All people taking part in the discussions will be asked 
not to divulge the information to others.  
 
What will happen to the results of the research study? 
The main findings of the study will be published in a healthcare journal and on the University 
website. You may request a copy of the publication or report.  
 
Who is organizing and funding the research? 
This project is organized by Robert Gordon University and partially funded by the Malta 
Government Scholarship Scheme. 
 
Who has reviewed the study? 
This study has been approved by the Ethical Review Panel of the School of Pharmacy & Life 
Sciences at Robert Gordon University and the Maltese University Research Ethics Committee.   
 
To take part in this part of the study, please complete the attached form and send it 
back to us together with the questionnaire using the enclosed paid self-addressed 
envelope.  
 
Yours sincerely 
Lorna Marie West 
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First Name & Surname  
 
 
 
How old are you?  
 
 
 
What is your profession? 
Dentist  Doctor  Nurse   Pharmacist   
Student  Other 
 
If you responded 'other', what is your current job? 
 
 
 
If you responded 'other', in the last 6 months, have you been taking or using any 
regular medications or had a medicine prescribed or have you bought any medicines? 
Yes   No 
 
If you are a student, what course are you undertaking? 
 
 
 
Telephone Number: 
 
 
 
Mobile Number: 
 
 
 
Preferred time of day when to attend the focus group: 
Morning   Afternoon   Evening  Any time 
 
 
Thank you in advance 
 
 
Yours sincerely 
Lorna Marie West 
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Appendix 5.4: HCP Questionnaire 
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Dear Healthcare Professional 
We would like to invite you to take part in a PhD research study. It is important that you understand why the 
research is being done and what it will involve. Thank you for taking the time to read this information carefully. Ask 
us if there is anything that is not clear or if you would like further information. Take time to decide whether or not 
you wish to participate.  
 
What is the purpose of the study? 
Medication wastage is a major problem amongst many countries. The purpose is to investigate awareness, 
perceptions, attitudes and behaviours amongst the Maltese population, healthcare professionals and students about 
medication which is wasted. 
 
Why have I been chosen? 
We have selected healthcare professionals (dentists, doctors, nurses and pharmacists) through random sampling 
from lists of healthcare professionals.  
 
Do I have to take part? 
No. Participation in the study is voluntary. 
 
What will happen to me if I take part? 
To take part in the study, we ask that you complete the enclosed questionnaire which should take no more than 
about 15 minutes. 
 
What are the possible benefits of taking part? 
There is no direct benefit to you from taking part. However, completion of the questionnaire will help to identify 
your views which will be valuable in studying medication wastage in our country. 
 
Will my taking part in this study be kept confidential? 
Yes. This study is not anonymous but information will be kept completely confidential. 
 
What will happen to the results of the research study? 
The main findings of the study will be published in a healthcare journal and on the University website. You may 
request a copy of the publication or report.  
 
Who is organizing and funding the research? 
This project is organized by Robert Gordon University in Scotland and partially funded by the Malta Government 
Scholarship Scheme. 
 
Who has reviewed the study? 
This study has been approved by the Ethical Review Panel of the School of Pharmacy & Life Sciences at Robert 
Gordon University and the Maltese University Research Ethics Committee.   
 
To participate in this study, please complete the questionnaire within 2 weeks and send it back to us 
using the enclosed paid self-addressed envelope. The information in Part 2 at the end of the 
questionnaire is about focus groups that will take place later on this year. It is OK to return the 
questionnaire even if you are not interested in taking part in the focus groups. 
 
Yours sincerely 
Lorna Marie West  
B.Pharm (Hons) MSc Clinical Pharmacy (Aberdeen) PgCert (Research Methods) 
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Section A, Demographics 
 
1. You are 
 
 □Female  □Male 
 
 
2. Your age is 
 
 □20-29 years □30-39 years □40-49 years □50-59 years □>59 years 
 
 
3. Your profession is 
 
□Dentist  □Doctor  □Nurse  □Pharmacist   
 
 
4. Your main place of work is 
 
 □Government services/ Public sector □Private Sector 
  
□Self-employed    □Other, please specify__________________________ 
      
 
5. You have been practising in your profession 
 
 □5 years or less □6-10 years  □11-15 years  □16-20 years  
  
□21-25 years □26-30 years □31-35 years  □>35 years 
 
 
6. You completed your undergraduate training in  
 
 □Malta   □Other, please specify__________________________ 
 
 
7. You have completed a postgraduate course 
 
 □No  □Yes, please specify the country__________________________ 
  
 
8. You have also practised as a health professional in countries other than Malta 
 
□No  □Yes, please specify the country__________________________  
 
 
9. In relation to changes to your professional practice, you would describe yourself as (tick one only) 
 
□I resist new ways of working 
 
□I am cautious in relation to new ways of working; I tend to change once most peers have done 
so 
 
□I deliberate for some time before adopting new ways of working 
 
□I serve as a role model for others in relation to new ways of working 
 
□I am venturesome and willing to be innovative with new ways of working  
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Section B, Awareness of Medication Wastage  
Please rate your level of agreement or disagreement with each of the following statements 
Statements Strongly 
disagree 
Disagree Unsure Agree 
Strongly 
agree 
Medication wastage encompasses any medication 
which expires or remains unused throughout the 
medication supply chain (manufacturing, storage, 
transport and handling of medications until these 
reach the consumer) and during use by the patient 
□ □ □ □ □ 
Medication wastage encompasses unnecessary or 
inappropriate consumption of medication by patients 
□ □ □ □ □ 
Medication wastage encompasses the unjustified 
non-adherence to treatment guidelines by healthcare 
professionals 
□ □ □ □ □ 
Medication wastage poses a financial burden on 
patients themselves, the state's economy and 
requires adequate education of all people concerned 
□ □ □ □ □ 
Please describe anything else you think should be encompassed within medication wastage 
I am fully aware of the extent of medication wastage 
in Malta 
□ □ □ □ □ 
I have no interest in the extent of medication 
wastage in Malta 
□ □ □ □ □ 
I am fully aware of the consequences of medication 
wastage in Malta on patients 
□ □ □ □ □ 
I am fully aware of the consequences of medication 
wastage in Malta on healthcare professionals 
□ □ □ □ □ 
I am fully aware of the consequences of medication 
wastage in Malta on society 
□ □ □ □ □ 
I am fully aware of the consequences of medication 
wastage in Malta on the economy 
□ □ □ □ □ 
I am fully aware of the consequences of medication 
wastage in Malta on the environment 
□ □ □ □ □ 
I am fully aware of the consequences of medication 
wastage in Malta on other, please specify_________ 
□ □ □ □ □ 
I have no interest in the consequences of medication 
wastage in Malta on patients 
□ □ □ □ □ 
I have no interest in the consequences of medication 
wastage in Malta on healthcare professionals 
□ □ □ □ □ 
I have no interest in the consequences of medication 
wastage in Malta on society 
□ □ □ □ □ 
I have no interest in the consequences of medication 
wastage in Malta on the economy 
□ □ □ □ □ 
I have no interest in the consequences of medication 
wastage in Malta on the environment 
□ □ □ □ □ 
I am no interest of the consequences of medication 
wastage in Malta on other, please specify_________ 
□ □ □ □ □ 
I am fully aware of factors potentially leading to 
medication wastage in Malta 
□ □ □ □ □ 
I have no interest in the factors potentially leading to 
medication wastage in Malta 
□ □ □ □ □ 
I am fully aware of laws, procedures and policies 
relating to medication wastage in Malta 
□ □ □ □ □ 
I have no interest in laws, procedures and policies 
relating to medication wastage in Malta 
□ □ □ □ □ 
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Section C, Your opinions of factors potentially leading to medication wastage 
For each statement listed below, rate the contribution of each as potentially leading to medication wastage 
 
1= No contribution at all   5=Major contribution  
 
Statements 1 2 3 4 5 
Short medication expiry dates  □ □ □ □ □ 
Large pack sizes when patients need smaller 
quantities of medications, particularly when starting 
new medications  
□ □ □ □ □ 
Inadequate audit of medication prescribing  □ □ □ □ □ 
Medications that remain unused within their expiry 
dates are not accepted for reuse by healthcare 
professionals 
□ □ □ □ □ 
Inappropriate storage of medications □ □ □ □ □ 
Patients' expectations to receive a prescription for 
medications 
 
□ □ □ □ □ 
Lack of patient education/ knowledge about 
medications in general 
□ □ □ □ □ 
Lack of patient education/ knowledge about 
monetary cost of medications 
□ □ □ □ □ 
Overstocking of medications by patients due to 
previous or potential out of stock situation 
□ □ □ □ □ 
Overstocking of medications by patients due to 
dependency on others to collect medication supply
  
□ □ □ □ □ 
Overstocking of medications by patients due to fear 
of refusal of medication supply due to entitlement 
problems 
□ □ □ □ □ 
Other family members or carers obtaining 
medications on behalf of patient unaware of stock at 
home 
□ □ □ □ □ 
Patients getting advice form more than one 
healthcare professional, family and friends regarding 
use of medications 
□ □ □ □ □ 
Non-adherence to medication regimens by patients □ □ □ □ □ 
Medications stopped by patient due to perceived 
ineffectiveness 
□ □ □ □ □ 
Medications stopped by patient due to perceived 
adverse events 
□ □ □ □ □ 
Medications stopped by patient due to perceived 
resolution of their symptoms/ medical condition 
□ □ □ □ □ 
Patient's death  □ □ □ □ □ 
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1= No contribution at all   5=Major contribution  
 
Statements 1 2 3 4 5 
Lack of education and training of healthcare 
professional students about medication wastage  
□ □ □ □ □ 
Lack of education and training of healthcare 
professional students about monetary cost of 
medications 
□ □ □ □ □ 
Lack of continuing professional development of 
healthcare professionals about medication wastage 
□ □ □ □ □ 
Lack of continuing professional development of 
healthcare professionals about monetary cost of 
medications 
□ □ □ □ □ 
Healthcare professionals’ lack of awareness of 
monetary cost of medications 
□ □ □ □ □ 
Lack of communication about medications between 
primary and secondary healthcare 
□ □ □ □ □ 
Lack of communication about medications between 
healthcare providers and patients 
 
□ □ □ □ □ 
Medications stopped by healthcare professional due 
to ineffectiveness of the medication 
 
□ □ □ □ □ 
Medications stopped by healthcare professional due 
to adverse events of the medication 
 
□ □ □ □ □ 
Medications stopped by healthcare professionals due 
to resolution of patients’ symptoms/ conditions  
 
□ □ □ □ □ 
Over-prescribing by healthcare professional 
 
□ □ □ □ □ 
Extra medication supply dispensed to patients □ □ □ □ □ 
Medication prescribed for no indication 
 
□ □ □ □ □ 
Healthcare professional's perceptions that patients 
expect to receive a medication 
 
□ □ □ □ □ 
Inadequate medication reviews by healthcare 
professionals  
 
□ □ □ □ □ 
Free healthcare system 
 
□ □ □ □ □ 
Medications which are obtained free through the 
National Health System are regularly out of stock in 
the pharmacy 
□ □ □ □ □ 
Medications that legally require a prescription are 
easily purchased from pharmacies without the need 
for a valid prescription 
□ □ □ □ □ 
Other, please specify_________________________ 
 
□ □ □ □ □ 
Other, please specify_________________________ □ □ □ □ □ 
Other, please specify_________________________ □ □ □ □ □ 
Other, please specify_________________________ □ □ □ □ □ 
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Section D, Current practice, views, experiences 
Please rate your level of agreement or disagreement with each of the following statements 
 
Statements Strongly 
disagree 
Disagree Unsure Agree Strongly 
agree 
I currently play an important part in reducing 
medication wastage in Malta 
□ □ □ □ □ 
I could be more active in reducing medication 
wastage in Malta 
□ □ □ □ □ 
There is little scope for me to further reduce 
medication wastage in Malta  
□ □ □ □ □ 
I feel confident in my ability to reduce medication 
wastage in Malta  
□ □ □ □ □ 
Healthcare professionals other than me have more 
responsibility in advising patients on use of their 
medications 
□ □ □ □ □ 
Healthcare professionals other than me have more 
responsibility in advising patients on storage of their 
medications 
□ □ □ □ □ 
Health professionals other than me have more 
responsibility in advising patients on disposal of 
unused medications 
□ □ □ □ □ 
Patient information leaflets, available in the 
medication package, are a good source of 
information for patients on use of their medications 
□ □ □ □ □ 
Patient information leaflets are a good source of 
information for patients on storage of their 
medications 
□ □ □ □ □ 
Patient information leaflets are a good source of 
information for patients on disposal of unused 
medications 
□ □ □ □ □ 
Patients put me under pressure to supply 
medications which I consider to be unnecessary 
□ □ □ □ □ 
Family members of patients put me under pressure 
to supply medications which I consider to be 
unnecessary 
□ □ □ □ □ 
Other health professionals put me under pressure to 
supply medications which I consider to be 
unnecessary 
□ □ □ □ □ 
I am fully aware of the costs of medications I supply  □ □ □ □ □ 
I review medications for the management of chronic 
conditions to ensure their continued indication 
 
□ □ □ □ □ 
Patients often bring me unwanted or unused 
medications 
□ □ □ □ □ 
Medications supplied to patients and returned to me 
within their expiry dates should be reused 
□ □ □ □ □ 
I have insufficient time in my daily practise to reduce 
the extent of medication wastage in Malta 
□ □ □ □ □ 
There is little incentive for me to reduce the extent of 
medication wastage in Malta 
 
□ □ □ □ □ 
Provision of medications to patients free of charge 
can lead to medication wastage in Malta 
□ □ □ □ □ 
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For each statement listed below, tick the option which you feel mostly relates to you. 
 
Statements Never Infrequently Around 
half the 
time 
Usually Always Unsure 
I advise patients on use of their 
medications 
□ □ □ □ □ □ 
I advise patients on storage of their 
medications 
 
□ □ □ □ □ □ 
I advise patients on disposal of 
unused medications 
 
□ □ □ □ □ □ 
 
In your opinion, which medications, therapeutic areas or patient groups should be considered as priority for 
targeting strategies to reduce medication wastage in Malta? 
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Section E, Education and Training 
Please rate your level of agreement or disagreement with each of the following statements 
 
Statements Strongly 
disagree 
Disagree Unsure Agree Strongly 
agree 
I have never thought about undertaking further 
education and training relating to medication 
wastage 
□ □ □ □ □ 
My undergraduate education and training had 
sufficient emphasis on medication wastage 
 
□ □ □ □ □ 
Current healthcare professional undergraduate 
education and training in Malta has sufficient 
emphasis on medication wastage 
 
□ □ □ □ □ 
Current healthcare professional postgraduate 
education and training in Malta has sufficient 
emphasis on medication wastage 
 
□ □ □ □ □ 
I require more education and training to further 
reduce medication wastage in Malta 
 
□ □ □ □ □ 
If you ticked strongly agree or agree to the last statement, what form of education and training are you most 
interested in (tick all that apply) 
 
    □lectures  
    □seminars    
    □conferences 
    □distance learning material  
    □provision of national guidelines  
    □online updates    
    □reading journal articles 
    □other, please specify_________________________ 
 
 
 
 
 
  
 
Please give any other comments you have on medication wastage in Malta 
 
 
 
 
 
 
 
 
 
 
 
I would like to thank you for completing this questionnaire. Your contribution is of valuable importance 
to this research.  
 
 
 
 
 
 
  
 
Appendix: Chapter 5  491 
 
 
 
Dear Healthcare Professional 
 
We would like to invite you to take part in a research study. It is important that you understand 
why the research is being done and what it will involve. Thank you for taking the time to read 
the following letter carefully. Ask us if there is anything that is not clear or if you would like 
further information. Take time to decide whether or not you wish to participate.  
 
What is the purpose of the study? 
The purpose of this part of the research is to allow for more discussion on experiences and views 
on medication wastage, and possible ways to reduce this in Malta.  
 
Do I have to take part? 
No. You do not have to take part and it is okay if you change your mind after sending back the 
questionnaire.  
 
What will happen to me if I take part? 
We ask that you complete the attached short form. We will then contact you to check that you 
are still interested in taking part and give you a date, time and venue for the meeting. The 
discussion  will not last longer than 90 minutes.  Refreshments will be served during the 
discussions.   
 
What are the possible benefits of taking part? 
There is no direct benefit to you from taking part. However, completion of the questionnaire will 
help to identify possible causes of medication wastage in our country. 
 
Will my taking part in this study be kept confidential? 
Yes. We will audio-record the discussions. These will then be written out in full. The recording 
will be deleted when the study is finished. All people taking part in the discussions will be asked 
not to divulge the information to others.  
 
What will happen to the results of the research study? 
The main findings of the study will be published in a healthcare journal and on the University 
website. You may request a copy of the publication or report.  
 
Who is organizing and funding the research? 
This project is organized by Robert Gordon University and partially funded by the Malta 
Government Scholarship Scheme. 
 
Who has reviewed the study? 
This study has been approved by the Ethical Review Panel of the School of Pharmacy & Life 
Sciences at Robert Gordon University and the Maltese University Research Ethics Committee.   
 
To take part in this part of the study, please complete the attached form and send it 
back to us together with the questionnaire using the enclosed paid self-addressed 
envelope.  
 
 
Yours sincerely 
Lorna Marie West 
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First Name & Surname  
 
 
 
How old are you?  
 
 
 
What is your profession? 
Dentist  Doctor  Nurse   Pharmacist   
Student  Other 
 
If you responded 'other', what is your current job? 
 
 
 
If you responded 'other', in the last 6 months, have you been taking or using any 
regular medications or had a medicine prescribed or have you bought any medicines? 
Yes   No 
 
If you are a student, what course are you undertaking? 
 
 
 
Telephone Number: 
 
 
 
Mobile Number: 
 
 
 
Preferred time of day when to attend the focus groups: 
Morning   Afternoon   Evening  Any time 
  
 
 
Thank you in advance 
 
 
Yours sincerely 
Lorna Marie West
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Appendix 5.5: HCP Student Questionnaire 
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Dear Healthcare Professional Student 
 
We would like to invite you to take part in a PhD research study. It is important that you understand why the 
research is being done and what it will involve. Thank you for taking the time to read this information carefully. Ask 
us if there is anything that is not clear or if you would like further information. Take time to decide whether or not 
you wish to participate.  
 
What is the purpose of the study? 
Medication wastage is a major problem amongst many countries. The purpose is to investigate awareness, 
perceptions, attitudes and behaviours amongst the Maltese population, healthcare professionals and students about 
medication wastage. 
 
Why have I been chosen? 
We have selected all students who are pursuing a first degree undergraduate healthcare professional course with the 
University of Malta and are in their final or pre-final year. 
 
Do I have to take part? 
No. Participation in the study is voluntary. 
 
What will happen to me if I take part? 
To take part in the study, we ask that you complete the enclosed questionnaire which should take no more than 
about 15 minutes. 
 
What are the possible benefits of taking part? 
There is no direct benefit to you from taking part. However, completion of the questionnaire will help to identify 
possible causes of medication wastage in our country. 
 
Will my taking part in this study be kept confidential? 
Yes. This study is not anonymous but information will be kept completely confidential. 
 
What will happen to the results of the research study? 
The main findings of the study will be published in a healthcare journal and on the University website. You may 
request a copy of the publication or report.  
 
Who is organizing and funding the research? 
This project is organized by Robert Gordon University in Scotland and partially funded by the Malta Government 
Scholarship Scheme. 
 
Who has reviewed the study? 
This study has been approved by the Ethical Review Panel of the School of Pharmacy & Life Sciences at Robert 
Gordon University and the Maltese University Research Ethics Committee.   
 
To participate in this study, please complete the questionnaire within 2 weeks and submit. The 
information in Part 2 at the end of the questionnaire is about focus groups that will take place later on 
this year. It is OK to submit the questionnaire even if you are not interested in taking part in the focus 
groups. 
 
Yours sincerely 
Lorna Marie West  
B.Pharm (Hons) MSc Clinical Pharmacy (Aberdeen) PgCert (Research Methods) 
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Section A, Demographics 
 
1. You are 
 
 □Female  □Male 
 
 
2. Your age is 
 
 □18-21 years  □22-25 years  □26-29 years  □30-33 years  □>33 years 
 
 
3. Your course of study is 
 
□Dentistry  □Medicine  □Nursing  □Pharmacy   
 
 
4. Your year of study is 
 
 □Second year     □Third year 
  
□Fourth year     □Fifth year 
      
 
5. Your nationality is 
 
 □Maltese     □Other, please specify__________________________ 
 
 
6. Your email address is: ___________________________________ 
 
 
7. Are you currently on any regular medications? 
 
 □Yes (go to question 8)  □No (go to question 9) 
 
  
8. If yes, how do you obtain these medications? You may tick more than one answer. 
 
 □Free on yellow or pink card   □I or a family member pays for them 
  
 □The doctor gives me free samples  □Other, please specify__________________________ 
      
 
9. In the last 6 months, have you had a medication prescribed or have you bought any medications over-the-counter? 
 
□Yes I had a medication prescribed   
 
□Yes I bought medications over-the-counter  
 
 □No 
 
 
10. Please tick one of the following which best describes you in relation to how you react/adjust to change, for example 
ways of working or studying: 
 
□I resist any change 
 
□I am cautious in relation to change; I tend to change once most peers have done so 
 
□I deliberate for some time before adopting change 
 
□I serve as a role model for others in relation to change 
 
□I am venturesome and willing to be innovative with change 
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Section B, Awareness of Medication Wastage  
Please rate your level of agreement or disagreement with each of the following statements 
Statements Strongly 
disagree 
Disagree Unsure Agree 
Strongly 
agree 
Medication wastage encompasses any medication 
which expires or remains unused throughout the 
medication supply chain (manufacturing, storage, 
transport and handling of medications until these 
reach the consumer) and during use by the patient 
□ □ □ □ □ 
Medication wastage encompasses unnecessary or 
inappropriate consumption of medications by 
patients 
□ □ □ □ □ 
Medication wastage encompasses the unjustified 
non-adherence to treatment guidelines by healthcare 
professionals 
□ □ □ □ □ 
Medication wastage poses a financial burden on 
patients themselves, the state's economy and 
requires adequate education of all people concerned 
□ □ □ □ □ 
Please describe anything else you think should be encompassed within medication wastage 
I am fully aware of the extent of medication wastage 
in Malta 
□ □ □ □ □ 
I have no interest in the extent of medication 
wastage in Malta 
□ □ □ □ □ 
I am fully aware of the consequences of medication 
wastage in Malta on patients 
□ □ □ □ □ 
I am fully aware of the consequences of medication 
wastage in Malta on healthcare professionals 
□ □ □ □ □ 
I am fully aware of the consequences of medication 
wastage in Malta on society 
□ □ □ □ □ 
I am fully aware of the consequences of medication 
wastage in Malta on the economy 
□ □ □ □ □ 
I am fully aware of the consequences of medication 
wastage in Malta on the environment 
□ □ □ □ □ 
I am fully aware of the consequences of medication 
wastage in Malta on other, please specify_________ 
□ □ □ □ □ 
I have no interest in the consequences of medication 
wastage in Malta on patients 
□ □ □ □ □ 
I have no interest in the consequences of medication 
wastage in Malta on healthcare professionals 
□ □ □ □ □ 
I have no interest in the consequences of medication 
wastage in Malta on society 
□ □ □ □ □ 
I have no interest in the consequences of medication 
wastage in Malta on the economy 
□ □ □ □ □ 
I have no interest in the consequences of medication 
wastage in Malta on the environment 
□ □ □ □ □ 
I have no interest in the consequences of medication 
wastage in Malta on other, please specify_________ 
□ □ □ □ □ 
I am fully aware of factors potentially leading to 
medication wastage in Malta 
□ □ □ □ □ 
I have no interest in the factors potentially leading to 
medication wastage in Malta 
□ □ □ □ □ 
I am fully aware of laws, procedures and policies 
relating to medication wastage in Malta 
□ □ □ □ □ 
I have no interest in laws, procedures and policies 
relating to medication wastage in Malta 
□ □ □ □ □ 
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Section C, Your opinions of factors potentially leading to medication wastage 
For each statement listed below, rate the contribution of each as potentially leading to medication wastage 
 
1 = No contribution at all   5 = Major contribution  
 
Statements 1 2 3 4 5 
Short medication expiry dates  □ □ □ □ □ 
Large pack sizes when patients need smaller 
quantities of medications, particularly when starting 
new medications  
□ □ □ □ □ 
Inadequate audit of medication prescribing  □ □ □ □ □ 
Medications that remain unused within their expiry 
dates are not accepted for reuse by healthcare 
professionals 
□ □ □ □ □ 
Inappropriate storage of medications □ □ □ □ □ 
Patients' expectations to receive a prescription for 
medications 
 
□ □ □ □ □ 
Lack of patient education/ knowledge about 
medications in general 
□ □ □ □ □ 
Lack of patient education/ knowledge about 
monetary cost of medications 
□ □ □ □ □ 
Overstocking of medications by patients due to 
previous or potential out of stock situation 
□ □ □ □ □ 
Overstocking of medications by patients due to 
dependency on others to collect medication supply
  
□ □ □ □ □ 
Overstocking of medications by patients due to fear 
of refusal of medication supply due to entitlement 
problems 
□ □ □ □ □ 
Other family members or carers obtaining 
medications on behalf of patient unaware of stock at 
home 
□ □ □ □ □ 
Patients getting advice form more than one 
healthcare professional, family and friends regarding 
use of medications 
□ □ □ □ □ 
Non-adherence to medication regimens by patients □ □ □ □ □ 
Medications stopped by patient due to perceived 
ineffectiveness 
□ □ □ □ □ 
Medications stopped by patient due to perceived 
adverse events 
□ □ □ □ □ 
Medications stopped by patient due to perceived 
resolution of their symptoms/ medical condition 
□ □ □ □ □ 
Patient's death  □ □ □ □ □ 
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1 = No contribution at all   5 = Major contribution  
 
Statements 1 2 3 4 5 
Lack of education and training of healthcare 
professional students about medication wastage  
□ □ □ □ □ 
Lack of education and training of healthcare 
professional students about monetary cost of 
medications 
□ □ □ □ □ 
Lack of continuing professional development of 
healthcare professionals about medication wastage 
□ □ □ □ □ 
Lack of continuing professional development of 
healthcare professionals about monetary cost of 
medications 
□ □ □ □ □ 
Healthcare professionals’ lack of awareness of 
monetary cost of medications 
□ □ □ □ □ 
Lack of communication about medications between 
primary and secondary healthcare 
□ □ □ □ □ 
Lack of communication about medications between 
healthcare providers and patients 
 
□ □ □ □ □ 
Medications stopped by healthcare professional due 
to ineffectiveness of the medication 
 
□ □ □ □ □ 
Medications stopped by healthcare professional due 
to adverse events of the medication 
 
□ □ □ □ □ 
Medications stopped by healthcare professionals due 
to resolution of patients’ symptoms/ conditions  
 
□ □ □ □ □ 
Over-prescribing by healthcare professional 
 
□ □ □ □ □ 
Extra medication supply dispensed to patients □ □ □ □ □ 
Medication prescribed for no indication 
 
□ □ □ □ □ 
Healthcare professional's perceptions that patients 
expect to receive a medication 
 
□ □ □ □ □ 
Inadequate medication reviews by healthcare 
professionals  
 
□ □ □ □ □ 
Free healthcare system 
 
□ □ □ □ □ 
Medications which are obtained free through the 
National Health System are regularly out of stock in 
the pharmacy 
□ □ □ □ □ 
Medications that legally require a prescription are 
easily purchased from pharmacies without the need 
for a valid prescription 
□ □ □ □ □ 
Other, please specify_________________________ 
 
□ □ □ □ □ 
Other, please specify_________________________ □ □ □ □ □ 
Other, please specify_________________________ □ □ □ □ □ 
Other, please specify_________________________ □ □ □ □ □ 
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Section D, Current practice, views, experiences 
Please rate your level of agreement or disagreement with each of the following statements 
 
Statements Strongly 
disagree 
Disagree Unsure Agree Strongly 
agree 
Dentists play an important part in reducing 
medication wastage in Malta 
□ □ □ □ □ 
Doctors play an important part in reducing 
medication wastage in Malta 
□ □ □ □ □ 
Nurses play an important part in reducing medication 
wastage in Malta 
□ □ □ □ □ 
Pharmacists play an important part in reducing 
medication wastage in Malta 
□ □ □ □ □ 
Dentists could play a more active role in reducing 
medication wastage in Malta 
□ □ □ □ □ 
Please provide any comments you would like to make 
 
 
 
Doctors could play a more active role in reducing 
medication wastage in Malta 
□ □ □ □ □ 
Please provide any comments you would like to make 
 
 
 
Nurses could play a more active role in reducing 
medication wastage in Malta 
□ □ □ □ □ 
Please provide any comments you would like to make 
 
 
 
Pharmacists could play a more active role in reducing 
medication wastage in Malta 
□ □ □ □ □ 
Please provide any comments you would like to make 
 
 
 
There is little scope for dentists to further reduce 
medication wastage in Malta 
□ □ □ □ □ 
There is little scope for doctors to further reduce 
medication wastage in Malta 
□ □ □ □ □ 
There is little scope for nurses to further reduce 
medication wastage in Malta  
□ □ □ □ □ 
There is little scope for pharmacists to further reduce 
medication wastage in Malta 
□ □ □ □ □ 
I feel confident in my ability to reduce medication 
wastage in Malta  
□ □ □ □ □ 
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Please rate your level of agreement or disagreement with each of the following statements 
 
Statements Strongly 
disagree 
Disagree Unsure Agree 
Strongly 
agree 
To my knowledge, dentists routinely advise patients 
on use of their medications 
□ □ □ □ □ 
To my knowledge, dentists routinely advise patients 
on storage of their medications 
□ □ □ □ □ 
To my knowledge, dentists routinely advise patients 
on disposal of unused medications 
□ □ □ □ □ 
To my knowledge, doctors routinely advise patients 
on use of their medications 
□ □ □ □ □ 
To my knowledge, doctors routinely advise patients 
on storage of their medications 
□ □ □ □ □ 
To my knowledge, doctors routinely advise patients 
on disposal of unused medications 
□ □ □ □ □ 
To my knowledge, nurses routinely advise patients 
on use of their medications 
□ □ □ □ □ 
To my knowledge, nurses routinely advise patients 
on storage of their medications 
□ □ □ □ □ 
To my knowledge, nurses routinely advise patients 
on disposal of unused medications 
□ □ □ □ □ 
To my knowledge, pharmacists routinely advise 
patients on use of their medications 
□ □ □ □ □ 
To my knowledge, pharmacists routinely advise 
patients on storage of their medications 
□ □ □ □ □ 
To my knowledge, pharmacists routinely advise 
patients disposal of unused medications 
□ □ □ □ □ 
To my knowledge, other healthcare professionals 
have more responsibility than doctors to advise 
patients on use of their medications 
□ □ □ □ □ 
To my knowledge, other healthcare professionals 
have more responsibility than doctors to advise 
patients on storage of their medications 
□ □ □ □ □ 
To my knowledge, other healthcare professionals 
have more responsibility than doctors to advise 
patients on disposal of unused medications 
□ □ □ □ □ 
Patient information leaflets, available in the 
medication package, are a good source of 
information for patients on use of their medications 
□ □ □ □ □ 
Patient information leaflets are a good source of 
information for patients on storage of their 
medications 
□ □ □ □ □ 
Patient information leaflets are a good source of 
information for patients on disposal of unused 
medications 
□ □ □ □ □ 
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Please rate your level of agreement or disagreement with each of the following statements 
Statements Strongly 
disagree Disagree Unsure Agree 
Strongly 
agree 
When I graduate, I intend considering medication 
wastage when supplying medication 
□ □ □ □ □ 
When I graduate, I intend to regularly educate 
patients about medication wastage 
□ □ □ □ □ 
Dentists can make little difference to reduce the 
extent of medication wastage in Malta 
□ □ □ □ □ 
Doctors can make little difference to reduce the 
extent of medication wastage in Malta 
□ □ □ □ □ 
Nurses can make little difference to reduce the 
extent of medication wastage in Malta 
□ □ □ □ □ 
Pharmacists can make little difference to reduce the 
extent of medication wastage in Malta 
□ □ □ □ □ 
I am concerned that when I graduate patients will 
put me under pressure to supply medications which I 
consider unnecessary 
□ □ □ □ □ 
I am concerned that when I graduate family 
members of patients will put me under pressure to 
supply medications which I consider unnecessary 
□ □ □ □ □ 
I am concerned that when I graduate other 
healthcare professionals will put me under pressure 
to supply medications which I consider unnecessary  
□ □ □ □ □ 
I am fully aware of the costs of medications 
commonly used in Malta 
□ □ □ □ □ 
Medications supplied to patients and returned to me 
within their expiry dates should be reused  
□ □ □ □ □ 
Dentists have insufficient time in their daily practise 
to reduce the extent of medication wastage in Malta 
□ □ □ □ □ 
Doctors have insufficient time in their daily practise 
to reduce the extent of medication wastage in Malta 
□ □ □ □ □ 
Nurses have insufficient time in their daily practise to 
reduce the extent of medication wastage in Malta 
□ □ □ □ □ 
Pharmacists have insufficient time in their daily 
practise to reduce the extent of medication wastage 
□ □ □ □ □ 
Provision of medications to patients free of charge 
can lead to medication wastage in Malta  
□ □ □ □ □ 
As a consumer of healthcare, I contribute to 
medication wastage in Malta 
□ □ □ □ □ 
My undergraduate training has sufficient emphasis 
on medication wastage 
□ □ □ □ □ 
I require more education and training on how to 
reduce medication wastage in Malta  
□ □ □ □ □ 
In your opinion, which medications, therapeutic areas or patient groups should be considered as priority for 
targeting strategies to reduce medication waste in Malta? 
 
 
Please give any other comments you have on medication wastage in Malta 
 
 
 
I would like to thank you for completing this questionnaire. Your contribution is of valuable importance to 
this research. 
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Dear Healthcare Professional Student 
 
We would like to invite you to take part in a research study. It is important that you understand 
why the research is being done and what it will involve. Thank you for taking the time to read 
the following letter carefully. Ask us if there is anything that is not clear or if you would like 
further information. Take time to decide whether or not you wish to participate.  
 
What is the purpose of the study? 
The purpose of this part of the research is to allow for more discussion on experiences and views 
on medication wastage, and possible ways to reduce this in Malta.  
 
Do I have to take part? 
No. You do not have to take part and it is okay if you change your mind after sending back the 
questionnaire.  
 
What will happen to me if I take part? 
We ask that you complete the attached short form. We will then contact you to check that you 
are still interested in taking part and give you a date, time and venue for the meeting. The 
discussion  will not last longer than 90 minutes.  Refreshments will be served during the 
discussions.   
 
What are the possible benefits of taking part? 
There is no direct benefit to you from taking part. However, completion of the questionnaire will 
help to identify possible causes of medication wastage in our country. 
 
Will my taking part in this study be kept confidential? 
Yes. We will audio-record the discussions. These will then be written out in full. The recording 
will be deleted when the study is finished. All people taking part in the discussions will be asked 
not to divulge the information to others.  
 
What will happen to the results of the research study? 
The main findings of the study will be published in a healthcare journal and on the University 
website. You may request a copy of the publication or report.  
 
Who is organizing and funding the research? 
This project is organized by Robert Gordon University and partially funded by the Malta 
Government Scholarship Scheme. 
 
Who has reviewed the study? 
This study has been approved by the Ethical Review Panel of the School of Pharmacy & Life 
Sciences at Robert Gordon University and the Maltese University Research Ethics Committee.   
 
To take part in this part of the study, please complete the attached form and submit it 
together with the questionnaire. 
 
 
Yours sincerely 
Lorna Marie West 
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First Name & Surname  
 
 
 
How old are you?  
 
 
 
What is your profession? 
Dentist  Doctor  Nurse   Pharmacist   
Student  Other 
 
If you responded 'other', what is your current job? 
 
 
 
If you responded 'other', in the last 6 months, have you been taking or using any 
regular medications or had a medicine prescribed or have you bought any medicines? 
Yes   No 
 
If you are a student, what course are you undertaking? 
 
 
 
Telephone Number: 
 
 
 
Mobile Number: 
 
 
 
Preferred time of day when to attend the focus groups: 
Morning   Afternoon   Evening  Any time 
 
 
 
Thank you in advance 
 
Yours sincerely 
Lorna Marie West 
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Appendix 5.6: Robert Gordon University Ethics Approval 
 
 
School of Pharmacy and Life Sciences 
Research Ethics Committee 
 
COMPLETED       24 April 2013 
 
 
Research Student 
Name 
Lorna Marie West 
Study Coordinator Professor Derek Stewart 
Research Project Title 
Awareness, perceptions, attitudes and behaviours regarding medication 
wastage amongst the Maltese population, healthcare professionals and 
healthcare professional students 
 
Dear Lorna 
 
We have reviewed your ethics applications (title above) and it has been approved 
with no changes. The panel recommends that it is of sufficient standard for you to 
proceed.  
 
If there are any questions on our response to the ethics submission please do not 
hesitate to get in touch. 
 
Regards 
 
Dr Lesley Diack* 
Chair of the School Ethics Review Panel 
 
*In view of potential conflict of interest Prof Diack did not participate in discussions 
for the approval of this research but acted only as endorser and signatory as Chair 
of the School Ethics Review Panel 
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Appendix 5.7: University of Malta Research Ethics 
Committee Approval 
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Appendix 6.1: Focus group guide: HCPs 
 
 
[5 minutes] Opening question: Asking participants to introduce themselves: 
their name/ profession/ place of work 
 
[5 minutes] Introductory question: Less than half of healthcare professionals 
responding to the questionnaire (42.1%) stated that they were fully aware of the 
extent of medication wastage in Malta. Before completing the questionnaire, had 
you really considered medication wastage as an issue in your practice? 
[Knowledge] 
 
[30 minutes] Key questions: Initial unstructured discussion 
1. Do you feel that there is a real need to reduce medication wastage? 
[Intentions] 
(Probe: Only 7% stated that there is little scope for them to further reduce 
medication wastage in Malta. Do you feel there is a scope to reduce 
medication wastage) 
2. Less than 50% of healthcare professionals stated that they felt confident in 
their ability to reduce medication wastage in Malta. How confident do you feel 
in your ability as professionals to further reduce medication wastage? [Beliefs 
about capabilities and social/professional role and identity]  
3. What is the reason for your confidence or lack of? [Beliefs about capabilities 
and social/professional role and identity] 
4. Almost three fourths of respondents stated that medication wastage 
encompasses the unjustified non-adherence to treatment guidelines by 
healthcare professionals. Are there any particular issues in professionals 
prescribing/recommending medications according to evidence based 
guidelines which might contribute to wastage? [Skills] 
5. Are there situations when professionals have prescribed/recommended 
inappropriate medication or more medication than is required? What could 
contribute to this? [Beliefs about consequences] 
(Probe: There may be a relationship between inappropriate prescribing (such 
as prescribing more medication than is required) and the pressure by 
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patients/relatives to supply medications which they consider to be 
unnecessary. Some of the respondents to the public questionnaire 
commented on healthcare professionals’ contributions towards wastage. One 
third of the public (35.0%) stated that doctors are responsible for the issue of 
medication wastage. One respondent from the public questionnaire claimed 
that doctors “do whatever the patient tells them to do” and another 
respondent stated that “doctors should not succumb to patients' pressures, 
who take medicines that they do not need any longer”. To what extent do 
you feel patients/family members of patients/ healthcare professionals/ the 
healthcare system influence prescribing? What are the reasons?) [Social 
influences] 
 
[40 minutes] Transitioned into a more structured discussion 
6. Which, in your opinion, are the factors or interventions that would help to 
reduce medication wastage? [Behavioural regulation] 
(Probe: Would you give me an example of how healthcare professionals can 
reduce medication wastage? (eg 66.3% of healthcare professionals stated 
that they review medications for the management of chronic conditions to 
ensure their continued indication)  
(Probe: 79.3% of healthcare professionals felt that they require more 
education and training to further reduce medication wastage in Malta. Do you 
feel this would help?) 
(Probe: Would you give me an example of how patients can reduce 
medication wastage?) 
(Probe: Half of the healthcare professionals responding to the questionnaire 
felt that there is little incentive for them to reduce the extent of medication 
wastage in Malta. What do you consider as an incentive for healthcare 
professionals to further reduce medication wastage in Malta? 
[Reinforcement]) 
7. Which, in your opinion, are the factors that would challenge prevention of 
medication wastage? [Environmental context and resources]  
(Probe: Potential out of stock situation was considered to be a major factor 
contributing to medication wastage. To what extent, in your opinion, does the 
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fear of out stock situation affect healthcare professionals’ prescribing or 
recommendation to give out medications? [Emotion]) 
(Probe: Almost half of public (42.4%) blame the free healthcare system as a 
contributor towards medication wastage. In what way is the free healthcare 
system linked to medication wastage?) 
(Probes: What is the relationship between competing tasks, time constraints 
and medication wastage?) 
8. What would help to overcome these factors? [Optimism] 
9. The following patient groups and areas were considered as high priority to 
target medication wastage: Patients having free medications, elderly patients 
and patients on chronic medications, high cost medications and healthcare 
professionals. What steps could be taken to help reduce medication wastage 
in these patient categories and areas? [Behavioural regulation] Do you feel 
there are other more important priorities? 
10. What are the potential strategies for moving forward and for maintaining 
long term change? [Goals] How can these best be implemented? 
 
[10 minutes] Ending question: Of all the issues that were discussed, 
which one is most important to you? 
The moderator will undertake to summarise the key questions and ideas that 
emerged from the discussion. 
Ending question: Is this an adequate summary? 
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Appendix 6.2: Focus group guide: Public 
 
 
[5 minutes] Opening question: Asking participants to introduce themselves: 
their name/ locality 
 
[5 minutes] Introductory question: The majority of public respondents 
(70.6%) stated that they were fully aware of the extent of medication wastage 
in Malta. Before completing the questionnaire, had you really considered 
medication wastage as an issue in your every day lives? [Knowledge] 
 
[30 minutes] Key questions: Initial unstructured discussion 
1. Do you feel that there is a real need to reduce medication wastage? 
[Intentions] 
(Probe: Only 7% stated that there is little scope for them to further reduce 
medication wastage in Malta. Do you feel there is a scope to reduce 
medication wastage?) 
2. Only a third of the public (35.6%) stated that they felt confident in their 
ability to reduce medication wastage in Malta. How confident do you feel in 
your ability as a Maltese citizen to further reduce medication wastage? 
[Beliefs about capabilities and social/professional role and identity]  
3. What is the reason for your confidence or lack of? [Beliefs about capabilities 
and social/professional role and identity] 
4. Three quarters of respondents (75.1% n=202) self-reported not being fully 
adherent to their medications. Are there any particular issues which might 
cause patients not to take their medications as they are supposed to? [Skills] 
5. Are there situations when professionals have prescribed/recommended 
inappropriate medication or more medication than is required? What could 
contribute to this? [Beliefs about consequences] 
(Probe: There may be a relationship between inappropriate prescribing (such 
as prescribing more medication than is required) and the pressure by 
patients/relatives to supply medications which they consider to be 
unnecessary. Some of the respondents to the public questionnaire 
commented on healthcare professionals’ contributions towards wastage. One 
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third of the public (35.0%) stated that doctors are responsible for the issue of 
medication wastage. One respondent from the public questionnaire claimed 
that doctors “do whatever the patient tells them to do” and another 
respondent stated that “doctors should not succumb to patients' pressures, 
who take medicines that they do not need any longer”. To what extent do 
you feel patients/family members of patients/ healthcare professionals/ the 
healthcare system influence prescribing? What are the reasons?) [Social 
influences] 
 
[40 minutes] Transitioned into a more structured discussion 
6. Which, in your opinion, are the factors or interventions that would help to 
reduce medication wastage? [Behavioural regulation] 
(Probe: Would you give me an example of how healthcare professionals can 
reduce medication wastage? (eg 66.3% of healthcare professionals stated 
that they review medications for the management of chronic conditions to 
ensure their continued indication)  
(Probe: 79.3% of healthcare professionals felt that they require more 
education and training to further reduce medication wastage in Malta. Do you 
feel this would help?) 
(Probe: Would you give me an example of how patients can reduce 
medication wastage?) 
(Probe: Half of the healthcare professionals responding to the questionnaire 
felt that there is little incentive for them to reduce the extent of medication 
wastage in Malta. What do you consider as an incentive for healthcare 
professionals to further reduce medication wastage in Malta? 
[Reinforcement]) 
7. Which, in your opinion, are the factors that would challenge prevention of 
medication wastage? [Environmental context and resources]  
(Probe: Potential out of stock situation was considered to be a major factor 
contributing to medication wastage. To what extent, in your opinion, does the 
fear of out stock situation affect the public to hoard medications? [Emotion]) 
(Probe: Almost half of public (42.4%) blame the free healthcare system as a 
contributor towards medication wastage. In what way is the free healthcare 
system linked to medication wastage?) 
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8. What would help to overcome these factors? [Optimism] 
9. The following patient groups and areas were considered as high priority to 
target medication wastage: Patients having free medications, elderly patients 
and patients on chronic medications, high cost medications and healthcare 
professionals. What steps could be taken to help reduce medication wastage 
in these patient categories and areas? [Behavioural regulation] Do you feel 
there are other more important priorities? 
10. What are the potential strategies for moving forward and for maintaining 
long term change? [Goals] How can these best be implemented? 
 
[10 minutes] Ending question: Of all the issues that were discussed, 
which one is most important to you? 
The moderator will undertake to summarise the key questions and ideas that 
emerged from the discussion. 
Ending question: Is this an adequate summary? 
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Appendix 6.3: Invitation to participate information letter 
for focus groups 
 
 
Part 2: Information letter ONLY if you are interested in 
participating in ONE focus group 
 
We would like to invite you to take part in a research study. It is important that you understand 
why the research is being done and what it will involve. Thank you for taking the time to read 
the following letter carefully. Ask us if there is anything that is not clear or if you would like 
further information. Take time to decide whether or not you wish to participate.  
 
What is the purpose of the study? 
The purpose of this part of the research is to allow for more discussion on experiences and views 
on medication wastage, and possible ways to reduce this in Malta.  
 
Do I have to take part? 
No. You do not have to take part and it is okay if you change your mind after sending back the 
questionnaire.  
 
What will happen to me if I take part? 
We ask that you complete the attached short form. We will then contact you to check that you 
are still interested in taking part and give you a date, time and venue for the meeting. The 
discussion will not last longer than 90 minutes.  Refreshments will be served during the 
discussions.   
 
What are the possible benefits of taking part? 
There is no direct benefit to you from taking part. However, completion of the questionnaire will 
help to identify possible causes of medication wastage in our country. 
 
Will my taking part in this study be kept confidential? 
Yes. We will audio-record the discussions. These will then be written out in full. The recording 
will be deleted when the study is finished. All people taking part in the discussions will be asked 
not to divulge the information to others.  
 
What will happen to the results of the research study? 
The main findings of the study will be published in a healthcare journal and on the University 
website. You may request a copy of the publication or report.  
 
Who is organizing and funding the research? 
This project is organized by Robert Gordon University and partially funded by the Malta 
Government Scholarship Scheme. 
 
Who has reviewed the study? 
This study has been approved by the Ethical Review Panel of the School of Pharmacy & Life 
Sciences at Robert Gordon University and the Maltese University Research Ethics Committee.   
 
To take part in this part of the study, please complete the attached form and send it 
back to us together with the questionnaire using the enclosed paid self-addressed 
envelope. Once we receive it, the questionnaire and this leaflet will be immediately 
stored separately. Therefore, the questionnaire will remain completely anonymous. 
 
Yours sincerely 
Lorna Marie West 
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Appendix 6.4: Expression of interest form to participate 
in focus groups  
 
 
Expression of interest form to participate in focus groups regarding medication 
wastage in Malta 
 
First Name & Surname  
 
 
 
How old are you?  
 
 
 
What is your profession? 
Dentist  Doctor  Nurse   Pharmacist   
Student  Other 
 
If you responded 'other', what is your current job? 
 
 
 
If you responded 'other', in the last 6 months, have you been taking or using 
any regular medications or had a medicine prescribed or have you bought any 
medicines? 
Yes   No 
 
If you are a student, what course are you undertaking? 
 
 
 
Telephone Number: 
 
 
 
Mobile Number: 
 
 
 
Preferred time of day when to attend the focus groups: 
Morning   Afternoon   Evening  Any time 
 
Thank you in advance 
 
Yours sincerely 
Lorna Marie West
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Appendix 6.5: Consent form focus groups  
 
 
Consent form focus groups: Attitudes and experiences regarding medication 
wastage and its reduction in Malta 
 
Please initial the circle beside each of the following statements to confirm your consent 
to participate in the study. All seven parts are required. 
 
I confirm that I have read and understood the information provided  
I confirm that I have had a chance to have my questions answered 
I agree to participate in the discussions regarding medication wastage 
I am aware that my participation is voluntary and that I can withdraw from the study 
whenever I would like to 
I understand that the findings will be utilized for research purposes  
I agree not to share any information divulged during the discussions 
I hereby assign the copyright for my research contribution to Robert Gordon 
University 
 
First Name & Surname  
 
 
Date 
 
 
Participant's Signature 
 
 
Principal Researcher's Signature 
 
 
 
Principal Researcher's Contact Details 
Email:  l.m.west@rgu.ac.uk 
Contact Number: 99893001 
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Appendix 6.6: Robert Gordon University Ethics Approval 
 
 
School of Pharmacy and Life Sciences 
Research Ethics Committee 
 
COMPLETED       24 April 2013 
 
Research Student 
Name 
Lorna Marie West 
Study Coordinator Professor Derek Stewart 
Research Project Title 
Awareness, perceptions, attitudes and behaviours regarding medication 
wastage amongst the Maltese population, healthcare professionals and 
healthcare professional students 
 
Dear Lorna 
 
We have reviewed your ethics applications (title above) and it has been 
approved with no changes. The panel recommends that it is of sufficient 
standard for you to proceed.  
 
If there are any questions on our response to the ethics submission please do 
not hesitate to get in touch. 
 
 
Regards 
 
 
Dr Lesley Diack* 
Chair of the School Ethics Review Panel 
 
*In view of potential conflict of interest Prof Diack did not participate in 
discussions for the approval of this research but acted only as endorser and 
signatory as Chair of the School Ethics Review Panel
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Appendix 6.7: University of Malta Research Ethics 
Committee Approval 
 
 
